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Abstract 
 
The persistent increase of bovine tuberculosis (bTB) over the past twenty years has put a 
substantial strain on both the British economy and the welfare of livestock.  However, the 
development of an effective bTB vaccine has been continually hindered by the lack of 
knowledge on the immune response following Mycobacterium bovis (M. bovis) infection.  In 
collaboration with the TB Research Group at the Veterinary Laboratories Agency (VLA, 
Surrey), this thesis is part of a much wider strategy managed by the Department of 
Environment, Food and Rural Agency (DEFRA) aimed at elucidating the immunopathogenesis 
of M. bovis and to develop more effective infection control measures.  The specific focus of this 
thesis was to enable a stronger understanding of the bovine immune response over different 
periods of M. bovis infection and to apply this new knowledge in evaluating the efficacy of a 
novel BCG vaccination. 
 
Time Course Study: Knowledge of time dependent cytokine expression following M. bovis 
infection would aid vaccine development by revealing potential correlates of protection.  
Interferon gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), interleukin (IL) 4 and 10 
expression were analysed using quantitative (q) PCR in formalin fixed bovine lymph nodes 
following five, twelve and nineteen weeks of M. bovis infection.  A strong pro-inflammatory/ T 
helper 1 (TH1) lymphocyte response was evident at five weeks post M. bovis infection, 
represented by IFN-γ and TNF-α expression (log2 copies of 6.5 and 2.15, respectively) in the 
absence of IL4.  Between five and twelve weeks of infection, a significant increase was 
observed in IL10 (log2 copies from 5.97 to 8.27, p<0.01, Mann Whitney test), accompanied by 
an increase in both IFN-γ (log2 7.53) and TNF-α (log2 3.94).  This data conformed to a recently 
described aspect of TH1 lymphocytes, a ‘self-limiting’ nature in which cells produced both IFN-γ 
and IL10 with the aim of controlling the heightened pro-inflammatory response.  The role of 
IL10 as an immunosuppressive became evident when comparing cytokine expression between 
four different types of thoracic lymph node; the left bronchial (LB), cranial mediastinal (CRM), 
caudal mediastinal (CM) and cranial tracheobronchial (CRT) nodes.  The LB and CRM lymph 
nodes produced significantly higher levels of IFN-γ expression (log2 copies between 8.2 and 
10) as compared to the CM and CRT (log2 copies between 2.6 and 5.5, p<0.001, Mann 
Whitney test).  Further analysis of the data as a profile of cytokine expression for each lymph 
node type revealed that IFN-γ was dominantly expressed within the LB and CRM nodes, 
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whereas within the CM and CRT nodes, IL10 was the dominant cytokine.  The former nodes 
also displayed a higher level of pathological damage (represented by mean percentage area 
coverage of granuloma, 33.6 and 20%, respectively) as compared to the CM (13%) and the 
CRT lymph node types (10.8 %).  This suggests conflicting roles for IFN-γ and IL10 in the 
development of immune-associated pathology.  Following nineteen weeks of infection, the 
expression levels of IFN-γ, TNF-α and IL10 reduced (log2 6.22, 3.02 and 7.03, respectively) 
implying a loss of the cellular response.  The later stages of bovine tuberculosis have been 
shown within the literature to display characteristics of a humoral rather than cell mediated 
response.  However, within this study at nineteen weeks post infection IL4 (an important 
cytokine in the development of the humoral response) remained undetectable.        
The results from this study therefore confirm the importance of the cell mediated immune 
profile in response to M. bovis infection as well as the integral role of IFN-γ in both protection 
and pathology.  It also further demonstrates the involvement of IL10 in controlling the IFN-γ 
response and highlights this cytokine as being potentially important in future immunology-
based vaccination studies.   
 
BCG Vaccination Study: The current vaccine used against human tuberculosis, BCG, has 
provided variable results on protection against infection in experimental bovine studies.  The 
BCG bacterium has lost a comparatively large quantity of genomic DNA through attenuation 
since its primary production in 1921, of which the majority represented genes encoding 
antigenic proteins.  MPB70 and MPB83 are differentially expressed between BCG sub-strains 
due to a single nucleotide polymorphism in the alternative sigma factor K (SigK).  BCG Pasteur 
has been shown to produce low levels of these antigenic proteins; however complementation of 
BCG Pasteur with a copy of sigK from BCG Russia resulted in up-regulating expression.  It was 
therefore hypothesised that the recombinant BCG (sigK) Pasteur would prove more efficient in 
controlling M. bovis infection by inducing a stronger protective immune response post 
vaccination.   
 
IFN-γ, TNF-α, IL 4 and 10 expression were analysed using qPCR within the freshly dissected 
lymph nodes of five experimental cattle groups; BCG Pasteur vaccinated M. bovis challenged, 
BCG (sigK) Pasteur vaccinated challenged, non-vaccinated infected, non-vaccinated non-
infected and BCG Pasteur vaccinated non-infected.  Five weeks following infection, a strong 
IFN-γ mRNA response was detected in both the non-vaccinated and vaccinated cattle (mean 
log2 copies between 9.6 and 10.5 as compared to between 7.84 and 8.58 in the non-infected 
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cattle).  M. bovis infection also induced a significant reduction in IL10 mRNA levels in both 
vaccinated and non-vaccinated cattle (mean log2 14.4 in the infected groups compared to 15.5 
in the non-infected cattle, p<0.005, Mann Whitney test) although there was little difference in 
TNF-α expression (mean log2 copies between 11.06 and 11.8 in all five groups).  Interestingly, 
IL4 mRNA was detectable only within the two non-infected control groups (mean log2 12.4), 
further supporting the concept of a strong cell mediated response after five weeks of infection.     
Vaccination prior to challenge had an effect on IFN-γ mRNA levels only, as both the BCG 
Pasteur and BCG (sigK) Pasteur vaccinated groups displayed a smaller increase in IFN-γ 
mRNA following challenge (mean log2 10.3 and 9.6, respectively) as compared to the non-
vaccinated group (mean log2 10.5).  This reflected the role of vaccination in priming the immune 
response to enable more rapid elimination of the bacteria and subsequently inducing a lesser 
pro-inflammatory response.  Interestingly, the BCG Pasteur vaccinated group appeared to 
control the immune response to a greater extent, as IFN-γ mRNA was significantly similar to 
that observed in the non-vaccinated non-infected group (mean log2 8.58, p>0.05, Mann 
Whitney test).   
In addition to the qPCR data, levels of IFN-γ and TNF-α protein (represented by the number of 
cells producing these proteins) were also analysed by immunohistochemistry.  IFN-γ protein in 
the five experimental groups displayed the same pattern as that observed for IFN-γ mRNA 
expression (p<0.001, Spearmans correlation coefficient).  However, analysis of TNF-α protein 
revealed significant differences between the five groups (p<0.005, Kruskal Wallis test) in 
contrast to that observed for the mRNA levels (p>0.05, Spearmans correlation coefficient) 
suggesting that posttranscriptional controls may play an important role in TNF-α translation. 
The difference in IFN-γ mRNA and protein expression between the two vaccination groups was 
also reflected within the pathological data.  Although both BCGs reduced levels to below that of 
the non-vaccinated group (represented by mean percentage area coverage of granuloma, 
59%), the BCG Pasteur group displayed less pathology (mean 6%) compared to the BCG 
(sigK) Pasteur cattle (mean 35%).  It was suggested that the increased antigenic repertoire of 
the recombinant BCG (sigK) Pasteur did result in a stronger stimulation of the immune 
response post vaccination but that, as a consequence the bacterial threat was eliminated more 
rapidly.  This resulted in shortening the duration of antigenic stimulation thereby effecting the 
development of the memory T cell response.  These results imply that enhancing the antigen 
repertoire of the current BCG alone is not sufficient in improving upon protection against M. 
bovis infection.   They further support the benefits of a prime/boost vaccination protocol, in 
which primary antigenic stimulation of the bovine immune response is boosted at a later stage. 
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Supplementary studies: To complement the above studies, supplementary work was also 
performed to investigate the effect of tissue fixation on the quality of extracted RNA and the 
impact of M. bovis dosage on the bovine immunological response post infection.  Archived 
tissues provide an extensive source of experimental material on which to perform molecular 
techniques many years after the initial investigations.  Formalin is a popular choice of fixative 
however its ability to conserve the molecular composition of tissue sections has been 
questioned.  This has led to the development of new alternatives such as the Hepes glutamic 
acid buffer-mediated organic solvent protection effect (HOPE) fixative.  In order to analyse the 
efficacy of formalin and HOPE fixation in preserving RNA integrity, total RNA was extracted 
from fixed bovine lymph node samples and the mRNA expression of housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) measured using qPCR.  Using two 
different extraction procedures (a commercial kit from Ambion (UK) and an in-house trizol 
method), the HOPE-fixed lymph node tissue provided total RNA of a high integrity, shown by 
producing two strong rRNA bands following gel electrophoresis.  The total RNA extracted from 
the formalin-fixed tissues using the Optimum Ambion kit appeared to be of a slightly lesser 
quality, as only one of the two rRNA bands was visualised on the agarose gel following 
electrophoresis.  The use of the trizol method on formalin fixed tissues failed to provide total 
RNA, confirmed by both the absence of rRNA bands and a negative spectrophotometry 
reading.  QRT-PCR for GAPDH expression using total RNA extracted from HOPE-fixed tissues 
displayed higher levels of messenger RNA (4.05 x10-2 pg/100ng total RNA using the 
commercial Ambion kit and 6.45 x10-2 pg/100ng total RNA using the trizol method) as 
compared to that extracted from formalin-fixed tissues (5.69 x10-4 pg/100ng total RNA using the 
Ambion kit).  These results suggest that the RNA did experience a certain degree of 
degradation whilst exposed to formalin-fixation and that HOPE fixative did provide a total RNA 
template of better quality.  This was reflected in the gene expression study, as the RNA of 
higher integrity extracted from the HOPE-fixed tissues displayed a higher concentration of 
GAPDH mRNA.  The consequences of this study are extensive, particularly when considering 
the results of the time course study, as it suggests that the expression levels observed were 
probably lower than what might have been observed if HOPE-fixed tissues were available.  It 
also supports the use of HOPE rather than formalin fixative in future molecular expression 
studies. 
The second supplementary study focused on the possible effects of different M. bovis 
inoculation concentrations on bovine cytokine expression levels.  Experimental infection of 
cattle has traditionally involved the use of extremely high concentrations of M. bovis inoculum 
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(between 104 and 106 cfu’s) so as to ensure that the animal successfully display disease.  
However, recent field studies have shown that cattle need only inhale one to two bacterial cells 
to become infected and therefore experimental models using high dosage levels may not be 
representative of natural disease.  A study performed at the VLA confirmed that there was no 
pathological difference between cattle infected with 1, 10, 100 or 1,000 cfu’s of M. bovis, 
suggesting that dosage concentration had little effect on disease progression.  This study 
aimed to further this comparison by measuring the genetic expression of IFN-γ, TNF-α, IL10 
and IL4 within the same lymph node samples (this work was performed entirely by an MSc 
student using the RNA extraction and qRT-PCR methods developed for this thesis).  The 
results showed that expression of these four cytokines increased as the infecting dose of M. 
bovis increased.  Between 1 and 1,000 cfu’s of M. bovis, there was a significant increase in 
IFN-γ (2.1 x105 and 9.0 x105 copies, respectively), IL10 (9.3 x104 and 5.1 x105, respectively) 
and IL4 (2.0 x105 and 6.3 x105, respectively, p<0.05, Mann Whitney test).  Although there was 
a simultaneous increase in TNF-α, the difference was not significant (2.5 x105 and 7.1 x105, 
respectively, p>0.05, Mann Whitney test).  The increasing expression of these cytokines may 
be a direct effect of the increased level of antigenic stimulation from a higher concentration of 
bacterial cells.  Expression of IFN-γ and IL10 experienced the largest increase between 1 and 
1,000 cfu’s (fold increase of 4.23 and 5.5, respectively) as both are produced by CD4+ T cells, 
an important part of the immune response against M. bovis infection.  In contrast, TNF-α 
expression showed little difference over the four M. bovis concentrations and this may be due 
to the role of posttranscriptional regulation in controlling protein production.   
In conclusion, although there were no obvious differences in lymph node pathology, there were 
significant differences in the expression of these four cytokines.  This would suggest that the 
levels of expression observed at higher concentrations of M. bovis would be greatly increased 
in comparison to those observed at lower concentrations (i.e. natural infection).  However, it is 
important to note that, as all of the cytokines increased in expression relative to each other, the 
patterns observed at high M. bovis concentrations may still be relevant to lower M. bovis 
concentrations.  
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Introduction  
 
Mycobacterium bovis and bovine tuberculosis 
 
Mycobacterium bovis (M. bovis) was first described as the causative agent of bovine 
tuberculosis (bTB) in 1896 by the American bacteriologist Theobald Smith (Sakula, 1982).  
Predominantly a pathogen of animals and in particular cattle (Francis, 1947 and 1958), M. 
bovis has the ability to cross the species barrier from animal to human. 
 
In 1934, the first government applied statistical survey was performed to quantify the spread of 
bTB within Britain (Reynolds 2006).  This concluded that approximately 40% of cattle within 
each individual dairy herd were infected with bTB and an estimated 0.5% of these animals 
were releasing tubercle bacilli within their milk (DEFRA 2005a).  M. bovis infection was held 
accountable for over 2,500 human deaths and more than 50,000 new cases of human TB each 
year (DEFRA 2005a).   
Systematic testing, compulsory slaughter of infected animals and the restricted movement of 
potentially infected herds resulted in the dramatic reduction of British bTB cases, from 40% in 
1934 to 0.41% in 1996 (Krebs et al, 1997).  Similar control programs applied across the world 
also led to complete eradication of bTB from Australia (Radunz, 2006), Canada and some 
American states (Essey and Koller, 1994).  However the last twenty years have seen a 
dramatic resurgence in British bTB levels (Jalava et al 2007), with a reported annual increase 
of approximately 18% (Reynolds 2006).  BTB has had extensive economical and welfare 
consequences, as it dramatically reduces farm productivity, impedes export to the EU and 
results in the premature death of animals.  In 2006/2007, bTB cost the British tax payer an 
average of £79.8 million of which £24.5 million was paid to farmers as compensation for the 
slaughter of infected cattle and £37.8 million towards cattle bTB testing (DEFRA, 2008).  In 
response to the increase in bTB, research into developing an effective bovine vaccination and 
more sensitive testing regimes are now regaining their significance as both veterinary and 
economical priorities.   
 
Mycobacterium complex 
 
The Mycobacterium genus (belonging to the phylum Actinobacteria) currently consists of 
approximately 139 different species (including subspecies) of mycobacteria (Klenk, 2008, 
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Pitulle et al, 1992).  The majority of these species are environmental saprophytes (able to 
absorb dead organic matter) and have been found to exist around the world in a variety of 
habitats including drinking water (McSwiggan and Collins, 1974, Goslee and Wolinsky, 1976) 
soil (Jones and Jenkins, 1965) and dust (Dawson, 1971).  These non-tuberculous 
mycobacteria (NTM) have generally been considered harmless, although a large number have 
been known for their opportunistic pathogenic properties in humans (Grange, 1987), commonly 
producing M. tuberculosis-like pulmonary symptoms. The remainder of the Mycobacterium 
genus consists of the highly pathogenic species M. leprae, M. lepraemurium, M. avium 
subspecies paratuberculosis and the Mycobacterium complex 
The Mycobacterium complex includes the major causative agents of TB in humans (M. 
tuberculosis, M. africanum, M. canetti), in animals (M. bovis) and in rodents (M. microti).  
Commonly known as tubercle bacilli, the evolutionary development of these five species has 
long been a topic of debate (Frothingham et al, 1994, Aranaz et al, 1999, van Embden et al, 
2000, Huard et al, 2006).  Using molecular techniques such as the polymerase chain reaction 
(PCR), genetic sequencing and restriction fragment length polymorphisms (RFLP), the species 
of the Mycobacterium complex have been found to possess highly conserved genetic 
sequences with approximately 99.9% similarity (Brosch et al, 2002).  However, there are clear 
differences in the pathogenicity and structural properties of each species (Garnier et al, 2003).  
M. bovis is known to have an extremely wide host spectrum with the ability to produce disease 
within a variety of animal species as well as humans, whereas the other members of the 
complex appear to be more restricted in their host tropisms.   
A major advancement in the area of genetic evolution was the complete mapping of the 
bacterial genome sequences for M. tuberculosis strain H37Rv (Cole et al, 1998) and M. bovis 
strain AF2122/97 (Garnier et al, 2003).  It has been hypothesised that M. bovis evolved at a 
much later point than M. tuberculosis, from the same common ancestor (Brosch et al, 2002).  
The genomes of M. africanum, M. canetti and M. microti are also currently being sequenced 
(Wellcome Trust Sanger Institute) and the information gained will add much to our knowledge 
on the Mycobacterium complex. 
 
Mycobacterium bovis phenotype 
 
M. bovis is a rod shaped bacilli approximately 1-10 μm in length and 0.2-0.6 μm in width 
(Kaneda et al, 1988).  The bacilli are microaerophilic, as they require oxygen at a preferentially 
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reduced level to grow and are unable to survive in oxygen-depleted environments (Wayne and 
Diaz, 1967).  However, research has shown that both M. tuberculosis (Wayne and Sohaskey, 
2001) and M. smegmatis (a fast growing NTM species closely related to the Mycobacterium 
complex, Dick et al, 1998) are able to survive within anaerobic environments that have been 
slowly depleted of oxygen, thus allowing the bacilli to adapt accordingly to anaerobiosis.  This 
has also been described for the attenuated form M. bovis Bacillus Calmette-Guerin or BCG 
(Lim et al, 1999) and has been suggested as the means by which tubercle bacilli are able to 
persist within anaerobic phagocytic cells in a non-replicating state, followed by latent 
reactivation of the disease many years later (Wayne and Sohaskey, 2001). 
The durability and pathogenesis of the tubercle bacilli is in part aided by its unique cell wall 
(Takayama et al, 2005).  Approximately 60% of the cell wall is composed of wall-associated 
lipids and mycolic acids (long-chained, branched fatty acids) subsequently providing a strongly 
hydrophobic structure (Asselineau and Lederer, 1950, Minnikin and Goodfellow, 1980, Ducati 
et al, 2006).  The mycolic acids are covalently bonded to arabinogalactan, a polysaccharide 
that is linked in turn to peptidoglycan to produce an immensely thick cross linked matrix (Petit 
et al, 1975).  The mycobacterial cell wall consists of an unusually high number of cross-links 
(approximately 70-80% in M. tuberculosis compared to 20-30% in E. coli) providing immense 
mechanical support to the bacterial cell (Palomino et al, 2007).  The presence of mycolic acids 
within the cell wall has also provided a means of identification for the mycobacterial species as 
they have the ability to retain arylmethane dyes (such as red carbol fuchsin) after 
decolourisation with acidic-alcohol solutions (Wade, 1952, Sakula, 1982).  Acid fast staining of 
pathological specimens is now a universal diagnostic test for mycobacterial infection, although 
there are some reports on the failure of acid fast staining due to alterations in the bacterial cell 
wall (Palomino et al, 2007).   
As mentioned previously, there is a 99.95% genetic homology between M. tuberculosis and M. 
bovis, despite their vast differences in host tropisms (Brosch et al, 2002).  It has been reported 
that the majority of the 0.05% genetic variation between the two species is located within the 
genes encoding for secreted and cell wall proteins (Garnier et al, 2003).  An example of 
differential protein expression between M. bovis and M. tuberculosis is the ESAT-6 family of 
secreted proteins (including culture filtrate proteins (CFP) 10 and 7).  These proteins are known 
for their antigenic properties in stimulating the host immune response and have been used 
widely in experimental infection models (Meher et al, 2007, Maue et al, 2007, Meher et al, 
2006).  They are actively secreted by M. tuberculosis but studies on M. bovis have shown that 
six of these proteins are either missing or altered (Garnier et al, 2003).  Little is known of the 
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consequences to M. bovis in losing these proteins.  It has been suggested that certain genes 
may prove unfavourable in specific host-bacterial interactions and so are selectively deleted 
(Brosch et al, 2001).  Interestingly, murine studies have shown M. bovis strains to have a 
considerably higher level of virulence as compared to M. tuberculosis strains (in relation to their 
ability to cause progressive pathology and premature mortality of the host, Dunn and North, 
1995).  This suggests that the specific deletion of the ∆RD4 region may have had extensive 
beneficial effects on the pathogenicity of M. bovis.   
 
Immunology of bovine tuberculosis 
 
M. bovis is believed to be spread predominantly between cattle via aerosols of bacterial cells 
exhaled by an infectious host (Palmer, 2002, Goodchild and Clifton-Hadley, 2001, Wells et al, 
1948, Gannon et al, 2007); however transmission is possible via other means such as ingestion 
of milk during the nursing of calves.  An infectious host releases airborne particles containing 
the bacilli (termed respiratory droplets) of various sizes upon coughing or sneezing (Louden 
and Roberts, 1968, Louden and Spohn, 1969).  The smaller respiratory droplets or droplet 
nuclei (1-5 μm in diameter) evaporate immediately after exhalation and can be carried on 
normal air currents for long periods of time (Gannon et al, 2007).  Droplet nuclei need only to 
contain a small number of bacilli (two or more cells) to initiate TB within a potential host 
(Schafer et al, 1999).  This theory has been supported by recent experimental models of bovine 
infection, reporting that levels of pathological disease were indistinguishable between animals 
infected with 1 colony forming unit (cfu) and those infected with 1000 cfu (Dean et al, 2005).  
As previously mentioned, pro-longed periods within the vicinity of an infected host may also 
increase the probability of becoming infected due to the high numbers of bacilli exhaled into the 
surrounding environment (Goodchild and Clifton-Hadley, 2001).   
 
Innate immune response to M. bovis infection 
Upon inhalation of the bacterial cells, the innate immune response is the first line of defence 
against progressive disease (Metchnikoff, 1905).  The innate immune response can be divided 
into four categories, anatomic, phagocytic, inflammatory and physiologic (Goldsby et al, 2003).  
The anatomic innate response includes the respiratory cilia that prevent bacteria from travelling 
down the trachea by using mucus to coat the bacilli and propel them away from the hosts’ 
lungs (Ganz, 2002, Fleming, 1922, Metchnikoff, 1905).  If bacilli are able to evade these 
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mechanisms they encounter firstly alveolar macrophages and dendritic cells within the 
bronchial airways and then neutrophils and monocytes, initiating the phagocytic innate immune 
response (Chan et al, 1994).  Within the infiltrating phagocytic cells, neutrophils are the more 
abundant cell type (Cassidy, et al, 1998), ingesting bacterial cells quickly in response to the 
infection and surviving only a few hours.  Monocytes are less abundant and upon ingesting the 
bacilli within the tissue can differentiate into either macrophages or dendritic cells which are 
able to survive for longer time periods (Goldsby et al, 2003).  These phagocytic cells recognise 
pathogens via pathogen recognition receptors (PRRs) including Toll-like receptors (Medzhitov 
and Janeway, 2000), mannose receptors and complement receptors (Schlesinger et al, 1990).  
Mannose receptors complimentary to the terminal mannose residue on bacterial glycoproteins 
facilitate binding of the bacterial cell to the phagocytic cells (Schlesinger et al, 1994) 
subsequently aiding endocytosis of the invading bacilli.    Toll-like receptors (TLRs) are 
transmembrane proteins on the surfaces of phagocytic cells that recognise conserved bacterial 
structures termed pathogen-associated molecular patterns (PAMPs) (Underhill and Ozinsky, 
2002, Kopp and Medzhitov, 2003).  The two major TLRs involved in mycobacterial infection are 
TLR2 and TLR4 (Means et al, 1999, Gilleron et al, 2006, Nicolle et al, 2004).  Recognition of 
PAMPs by TLRs induces the phagocytic cell to produce specific cytokines, for example the M. 
tuberculosis 19-kD lipoprotein has been shown to induce monocyte-produced interleukin 12 
(IL12) through recognition by TLR2 (Brightbill et al, 1999).   
 
In response to bacterial cell endocytosis and TLR2 activation, macrophages release cytokines 
tumour necrosis factor alpha (TNF-α) and interleukin 1 (IL1) which act on the neighbouring 
endothelial cells to increase expression of adhesion molecules E (Sung et al, 1994) and P – 
selectin.  Dendritic cells (DCs) circulating within the peripheral blood have been shown to bind 
to E and P- selectins via a glycosylated form of P-selectin glycoprotein ligand (PSGL) –1 
expressed upon their cell surface (Robert et al, 1999).  Activated macrophages and 
neighbouring endothelial cells simultaneously produce chemokines (chemoattractant cytokines) 
to stimulate an increase in the affinity of phagocyte integrins to the associated ligands upon the 
endothelium surface (Algood et al, 2003).  The integrin-ligand interaction strengthens the bonds 
between the phagocytes and the endothelium surface and with associated re-arranging of the 
phagocyte cytoskeleton, allows the cells to spread out over the alveolar wall (Lasunskaia et al, 
2006).  The phagocytic cells are then able to move via chemotaxis along a concentration 
gradient supplied by the chemokines to the site of infection (Goldsby et al, 2003).   This is 
termed inflammatory recruitment and directs the accumulation of phagocytes, lymphocytes and 
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effector cells to the site of inflammation by the recognition of various chemokine-specific 
receptors on the cell surface (Peters and Ernst, 2003).  TNF-α has been shown to be essential 
within this process, as mice lacking TNF-α displayed significantly reduced chemokine 
expression and reduced T cell infiltration to the lungs (Roach et al, 2002).   
The inflammatory part of the innate response involves accumulation of leukocytes to the 
infected area accompanied by vasodilation (an increase in blood vessel diameter producing 
tissue redness and high temperatures) and increased vascular permeability (producing tissue 
swelling or edema).  Lastly, the physiologic innate response includes soluble and cell 
associated molecules such as lysozymes (capable of breaking down bacilli cell membranes) 
and the complement system.  The complement system involves a large number of membrane-
bound and freely circulating proteins which act as chemoattractants to leukocytes initiating 
localised inflammation.  They also form polymeric proteins that disrupt the permeability of 
bacterial cell membranes leading to either osmotic lysis or apoptotic death and they are able to 
coat bacilli (termed opsinisation) to enhance phagocytosis (Goldsby et al, 2003).   
Phagocytes, primarily macrophages and dendritic cells have the ability to internalise bacterial 
cells (phagocytosis) by extending pseudopods around the bacilli and containing them within a 
phagosome (Maxwell and Marcus, 1968).  Proton ATP-ase pumps located along the 
membrane of the phagosome are activated following bacterial ingestion (Lukacs et al, 1990) 
and create an acidic environment of approximately pH 5.3-5.4 that is detrimental to the bacilli.  
The phagosome then fuses with lysosomes to form a phagolysosome inducing the release of 
proteolytic enzymes into the compartment to digest the bacterial cell (Armstrong and Hart, 
1971).  In addition to these mechanisms, a metabolic process known as the respiratory burst, 
involving the activation of oxidase embedded within the phagolysosome membrane catalyzes 
the reduction of oxygen into superoxide anions and creates an extremely toxic environment 
alongside hypochlorite and nitric oxide radicals (Goldsby et al, 2003).  By effectively breaking 
down the bacterial cell wall, the phagocytic cell is able to process bacterial antigens and 
present them upon their cell surface to activate specific T lymphocyte cells for a cell mediated 
immune response. 
  
Cytokines have been shown to be heavily involved within the development of the innate 
immune response.  As previously mentioned, activation of TLR2 via the M. tuberculosis 19-kDa 
lipoprotein induces TNF-α and IL12 (Brightbill et al, 1999) expression within macrophages.  
TNF is initially produced as a transmembrane (26-kD TmTNF) precursor before it is cleaved by 
a membrane-bound metalloprotease-disintegrin termed the TNF-α-converting enzyme (Black et 
  Introduction 
 
7  
al, 1997).  This generates a soluble TNF molecule (17-kD sTNF).  A study involving knockout 
mouse models expressing TmTNF in the absence of sTNF and lymphotoxin-α revealed a role 
for both TmTNF and sTNF in the control of mycobacterial growth (Olleros et al, 2005).  TmTNF 
in particular is able to reduce the bacterial population by inducing apoptosis of M. tuberculosis-
infected alveolar macrophages (Keane et al, 1997).  However, virulent M. tuberculosis strain 
H37Rv has also shown the ability to block TNF-α-dependent macrophage apoptosis by 
producing soluble TNF-R2 (Balcewicz-Sablinska et al, 1998).  This allows proliferation of the 
bacterial cells within macrophages and is favourable for progressive infection. 
IL12 is a covalently linked heterodimer (Podlaski et al, 1992) consisting of a 35 kDa light chain 
(p35 or IL12α) and a 40 kDa heavy chain (p40 or IL12β).  Activation of the TLRs of phagocytic 
cells induces very low concentrations of IL12 p40 (monomer or homodimer) and TNF-α has 
been shown to be essential in up-regulating IL12 p40 expression within M. tuberculosis infected 
guinea pig macrophages (Cho et al, 2005).       
The receptor for IL12 consists of two chains, IL-12Rβ1 and IL-12Rβ2 which are expressed 
predominantly by natural killer (NK) lymphocytes and activated T lymphocyte cells, although 
they have also been found on dendritic cells (Grohmann et al, 1998).  The constitutive 
expression of low levels of the IL12 receptor on NK cells (unlike resting T cells where it is 
undetectable), enables them to respond quickly to activation by IL12 secreted from phagocytic 
cells (Trinchieri 2003).  NK cells are extremely important constituents of the innate immune 
response (Denis et al, 2007) as they are able to recognise infected host cells independent of 
direct antigenic stimulation and destroy them to suppress bacterial spread (Hamerman et al, 
2005).  IL12 induces NK cells to secrete IFN-γ in the presence of low levels of TNF and IL1 
(Gazzinelli et al, 1994), producing a positive feedback effect on the macrophage by increasing 
phagocytosis efficiency.  Un-stimulated bovine NK cells have also been reported to reduce M. 
bovis growth within macrophages even in the absence of IFN-γ, suggesting that IFN-γ may act 
as a contributing mediator but is not solely responsible for macrophage activation (Denis et al, 
2007).  IL12 is potent in inducing IFN-γ expression within T lymphocytes (this will be discussed 
later in this chapter) and in turn, IFN-γ acts synergistically with TNF-α to produce reactive 
nitrogen intermediates during phagocytosis (Chan et al, 1992b).  The ability to control M. 
tuberculosis infection in mice has been shown to positively correlate with the ability of the 
mouse to produce the nitrogen intermediate inducible nitric oxide (iNOS, Olleros et al, 2005) 
due to its importance in the phagocytic pathway.  
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In addition to phagocytic cells, γ/δ T cells accumulate early within the site of infection (Cassidy 
et al, 2001).  Bovine γ/δ T cells are characterised based on the presence of the workshop 
cluster 1 (WC1) molecule (Clevers et al, 1990).  Both WC1+ and WC1-   γ/δ T cells are 
differentially distributed throughout bovine tissues, however WC1+ are found mainly within the 
peripheral blood and skin (MacHugh et al, 1997) allowing a faster response to bacterial 
infection (Hein and Mackay, 1991).  WC1+ γ/δ T cells play a supportive role in the delayed-type 
hypersensitivity (DTH) reaction which is characteristically produced by the detection of 
tuberculosis infection via the intradermal skin test (Doherty et al, 1996).   An injection with 
purified protein derivative (PPD) is typically followed 6-24 hours later by a perivascular 
aggregation of WC1+ γ/δ T cells and neutrophils.  By 72 hours post injection, WC1+ cells play 
only a minor role in the reaction (Doherty et al, 1996) and so it is believed that the kinetics of 
WC1+ cells are associated primarily with the earlier stages of M. bovis infection (Pollock et al, 
1996).  As the γ/δ T cells are not major histocompatibility complex (MHC) molecule restricted 
and rarely express CD4 or CD8 membrane proteins, they are able to have a broader range of 
action.  They also produce IFN-γ to activate macrophages and lyse infected phagocytic cells 
(Rhodes et al, 2001).  
 
The innate immune response is extremely effective in removing the disease threat and is 
essential in the development of an effective adaptive immune response which dictates 
subsequent progression of the disease (Pollock and Neill, 2002).  It has been speculated that 
bacterial transmission within whole cattle herds may only produce disease within one or two 
cattle, while the other cattle appear to have successfully dealt with the infection at the innate 
immune stage (Morrison et al, 2000).   There have been a number of suggestions as to the 
reasons behind increased cattle susceptibility to M. bovis infection, including nutrition 
deficiencies (Doherty et al, 1995) and concurrent infections of immunosuppressive viruses 
(such as bovine viral diarrhoea virus or BVD) (Menzies and Neill, 2000).  However, bacterial 
cells have also developed a number of mechanisms to evade the innate immune response.  
Virulent mycobacteria species have the ability to reside within the hosts phagocytes and 
produce persistent infection, essentially hidden from the hosts’ immune response.  Early 
studies showed that M. tuberculosis infected macrophage vacuoles did not fuse with the 
lysosomal compartment (Armstrong and Hart, 1971 and 1975) and therefore led to the 
arrestment of phagosomal maturation.  Modern molecular studies have added to this 
hypothesis by illustrating that different cell markers are expressed upon the phagosomal 
membrane surface specific to early and late stages of phagosomal maturation (Hestvik et al, 
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2005).  Typically, the phagosomes of cells infected with virulent, live mycobacteria bacilli 
express cell markers associated with early phagosomal development.  The proton ATP-ase 
pump proteins are a feature of late phagosomal development and appear to be absent form 
bacilli infected cells (Sturgill-Koszycki et al, 1994).  This may explain why mycobacterial 
infected phagosomes generally display a pH of around 6.2-6.3, less acidic than during the 
normal phagocytic process (Sturgill-Koszycki et al, 1994).  This therefore suggests that the 
bacteria are able to arrest phagosomal maturation and survive within immature phagosomes 
which contain a less harmful environment (Flynn and Chan, 2005).   
 
Adaptive immune response to M. bovis infection 
Macrophages and dendritic cells are termed antigen presenting cells (APCs) as they both have 
the ability to process bacterial antigens during the phagocytic process and display these to the 
naïve T lymphocytes (Bodnar et al, 2001, Gonzalez-Juarrero and Orme, 2001, Hickman et al, 
2002).  The presence of the metabolically active bacterial cell within the phagosome allows 
direct access of mycobacterial antigens to the major histocompatibility complex (MHC) class II 
molecules (Barnes et al, 1994), to which they bind and are transported to the cell surface.  
MHC class II molecules displaying antigen are specific to activating T lymphocytes expressing 
the membrane glycoprotein CD4 (Orme et al, 1993).  Mycobacterial cells that are effectively 
destroyed within the phagocytic cell give rise to somatic proteins which are broken down into 
peptide fragments within the cytoplasm.  These antigens are displayed via MHC class I 
molecules and are specific to activating T lymphocytes expressing the dimeric membrane 
glycoprotein CD8 (Barnes et al, 1994).   
There is ample evidence to suggest that the priming of naïve T lymphocytes occurs primarily 
within the lung draining lymph nodes (Flynn and Chan, 2001, Bhatt et al, 2004, Thacker et al, 
2007, Widdison et al, 2006).  The lymph nodes are bean-like structures located at the junctions 
of the lymphatic system and can be separated into the cortex, paracortex and medulla regions 
containing α/β lymphocytes (B and T cells) integrated with large numbers of dendritic cells 
(Steinman et al, 1997).  It is believed that the infected phagocytic cells move within the 
lymphatic fluid to the local lymph nodes via the lymphatic system (Fu et al, 1999).  They are 
then able to filter through the lymph nodes thus giving a high level of contact with the T 
lymphocytes and increasing the chance of activating the specific adaptive immune response.  
Within the lungs of M. tuberculosis infected mice, macrophages have been shown to be the 
main population of cells containing the invading bacteria (Humphreys et al, 2006).  However, 
the same study using Green Fluorescent Protein (GFP)-labelled M. tuberculosis to track the 
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movement of infection from the lungs to the mediastinal lymph nodes of murine models 
implicated dendritic cells as the main cell type responsible for mycobacterial dissemination 
(Humphreys et al, 2006).         
Pre-infection, immature dendritic cells display the ability for efficient phagocytosis (Romani et 
al, 1989) and respond particularly to chemokines MIP-3α, RANTES and MIP-1α (Sozzani et al, 
1995, Xu et al, 1996).  Following mycobacterial infection and TLR activation, dendritic cells 
undergo a maturation process characterised by up-regulation of co-stimulatory molecules 
CD40 (Rescigno, 2002), B7.1 and B7.2 (Larsen et al, 1994), increased expression of adhesion 
molecules and up-regulation of chemokine receptor CCR7 (Dieu et al, 1998).  Chemokines are 
believed to aid in the migration of the dendritic cells to the lymph nodes along a concentration 
gradient (Bhatt et al, 2004).  Macrophages however do not express CCR7 before infection and 
express only minimal levels post infection, thus reducing their ability to detect chemokines and 
severely hampering their ability to migrate to the draining lymph nodes (Bhatt et al, 2004).  The 
immature dendritic cells express low levels of MHC class II and I molecules and therefore are 
unable to act as antigen presenting cells until after maturation, during which the MHC 
molecules are significantly up-regulated (Cella et al, 1997, Mellman and Steinman, 2001).  
Conversely, the cells ability to capture and process bacterial antigens is reduced post 
maturation (Romani et al, 1989, Streilein et al, 1989, Larsen et al, 1992).   
 
Following CD4+ T cell (also known as T helper (TH) cells) activation via the MHC class II-
antigen complex, the cells divide to produce effector cell clones specific also for the same 
antigen-MHC class II complex.  There are two main types of TH class response, TH1 which is 
predominately pro inflammatory and cell mediated and TH2 which is associated with B cells and 
the humoral immune response (Mosmann et al, 1986).  The type of response that is activated 
is based primarily on the associated cytokine environment that the naïve TH cells experience 
early on in the infection (Trinchieri 2003).  M. tuberculosis infection of bone marrow-derived 
murine macrophages and dendritic cells illustrate the different abilities of the two cells to induce 
naïve T cell development towards a TH1 phenotype (Hickman et al, 2002).  Upon infection, 
dendritic cells have been shown to secrete both IL12 and IL10 (Hickman et al, 2002).  IL-12 is a 
potent TH1 type inducer and previous reports of IL10 suggest the ability to suppress cell 
mediated immunity (Akbari et al, 2001).  Despite this, the dendritic cells still displayed the ability 
to induce naïve T cell differentiation into TH1 effector cells (Hickman et al, 2002).  The authors 
suggested that the rapid production of IL12 meant that the later presence of IL10 did not effect 
the polarisation of the T cells.  In contrast, macrophages have been shown to secrete IL10 but 
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be unable to produce IL12 following infection unless co-stimulated by IFN-γ (the primary 
macrophage-activating factor, MAF) first (Schultz et al, 1983).  This is believed to be due to the 
role of IL10 in inhibiting IL12 expression, supported by the ability of macrophages to secrete 
IL12 in IL10 knock-out mouse models (Hickman et al, 2002).  The dendritic cells are therefore 
extremely important in priming the initial differentiation of the T cells to a TH1 cell mediated 
immune response and mark the progression from innate to adaptive immunity. 
Upon antigenic stimulation, it has been shown that activated human and murine T lymphocytes 
experience an up-regulation in the transcription and expression of the receptor for IL12.  The 
increased expression of the IL12 receptor and in particular the IL12 Rβ2 chain is enhanced by 
IL12, IFN-γ and TNF, thus expression of the IL12 Rβ2 chain is limited to the TH1 cell profile 
(Szabo et al, 1997).  IL12 is then able to bind to its associated receptor and irreversibly activate 
NK cells and T cells to produce IFN-γ (a TH1 type associated cytokine) by targeting both 
transcriptional (Chan et al, 1992a) and post transcriptional control mechanisms (Hodge et al, 
2002).  
Activation of the CD8+ T cells (also known as T cytotoxic (TC) cells) via the MHC class I-
antigen complex leads to subsequent cell differentiation into cytotoxic T lymphocytes (CTLs).  
CTLs have been shown to have the capacity to specifically lyse M. bovis infected macrophages 
in vivo (Skinner et al, 2003b) and to destroy mycobacteria directly in vitro (Stenger et al, 1997).  
Destruction of infected macrophages may occur by two methods.  It has been theorised that 
the CTLs use extracellular ATP to induce apoptosis of infected macrophages and destroy the 
bacterial cell (Stober et al, 2001).  Secondly, CTLs are able to release granulysin into the 
infected phagocyte to destroy both the host and bacterial cell (Stenger et al, 1997).      
IL12 has a positive effect on the generation of CTLs and their cytotoxic functions by up-
regulating the transcription of genes encoding for cytotoxic granule-associated and adhesion 
molecules (Trinchieri 1998).  Apart from their main function of recognising and destroying 
infected host cells, CTLs are also able to secrete a limited range of cytokines, including IFN-γ 
(Schluger et al, 1998).  It is believed that CTLs may play a part in increasing the efficiency of 
antigen presentation by lysing infected hosts cells and allowing more proficient APCs to ingest 
the released bacterial cells (Skinner et al, 2003b).   
 
Granuloma formation 
In addition to attacking the infection in the lymph nodes, activated CD4+ and CD8+ T 
lymphocytes and macrophages also migrate to the sites of initial infection (generally the lungs) 
through the vascular system (Flynn et al, 2005) via a concentration gradient supplied by 
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chemokines (as in innate immune response inflammatory recruitment).  TNF-α and 
lymphotoxin-α secreted by macrophages has a controlling effect on the level of cellular influx 
by inducing chemokine secretion and enhancing expression of cell surface adhesion molecules 
(Munro et al, 1989).  This in turn has a major effect on the size of developing granuloma (Scott 
Algood et al, 2003).  Granulomas are characteristic of the cell mediated response and are 
formed by the influx of monocytes, CD4+ T cells, CD8+ T cells and macrophages around the 
infected phagocytic cell both in the lymph nodes and the lungs (Saunders and Cooper, 2000, 
Figure 1).   
 
 
 
Figure 1: The structure of a mature granuloma, consisting of centralised M. bovis infected macrophages that have 
fused together to form either multi-nucleated giant cells or large epithelioid cells.  The periphery of the granuloma 
consists of activated lymphocytes and macrophages (modification of Zahrt, 2003).      
 
The development of granuloma have been characterised into four stages (Wangoo et al, 2005).  
• Stage I: Un-encapsulated clusters of epithelioid macrophages with interspersed 
lymphocytes and a few neutrophils.  Small numbers of multi-nucleated giant cells may 
also be present. 
• Stage II: Majority of the cell types are epithelioid macrophages, with many distributed 
lymphocytes, neutrophils and multi-nucleated giant cells.  The granuloma starts to take 
shape with partial or complete coverage within a thin capsule. 
• Stage III: The centre of the granuloma contains necrotic areas which are caseous and 
mineralised, interspersed with epithelioid cells and giant cells.  The periphery of the 
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granuloma is composed of macrophages with clusters of lymphocytes and scattered 
neutrophils, completely encapsulated. 
• Stage IV:  The granulomas are thickly encapsulated with multiple centres displaying 
advanced caseous necrosis and vast islands of mineralization.  Epithelioid 
macrophages and giant cells surround the necrotic areas and lymphocytes are densely 
clustered around the periphery.  
Essentially the granuloma is beneficial in providing an enclosed environment in which T cells 
and phagocytic cells can concentrate their bactericidal efforts and enhance cell to cell 
communication to remove the bacilli (Widdison et al, 2008).  It also provides a mechanism of 
containing the bacteria locally and reducing the chances of disseminated infection.  However, 
as the granuloma develops it inevitably becomes the pathognomic lesion characteristic of 
tuberculosis infection due primarily to host and bacterial cell interactions (Mustafa et al, 2008). 
Prior to granuloma formation, M. bovis infected macrophages are differentiated into epithelioid 
cells and/or fuse together to form multi-nucleated giant cells (also known as Langhans giant 
cells, Wangoo et al, 2005, Figure 2).  Little is known on this phenomenon in bovine cells; 
however, a human in vitro model of macrophage differentiation has shown this process to occur 
in response to endocytosis of virulent tubercle bacilli (Lay et al, 2007).   
 
 
 
 
 
 
 
 
                                        
 
                                                                                       
                                                                                                                                         
Figure 2: Immunohistochemical staining of an M. bovis infected bovine lymph node section.  The brown stain is 
specific to immune cells expressing TNF-α and the blue staining (Mayers haematoxylin) allows visualisation of all 
cells.  The section shows two large multi-nucleated giant cells, one of which is positive for TNF-α expression 
(photograph taken from sections used within the BCG vaccination study for this thesis). 
 
M. tuberculosis infected human epithelioid cells express higher levels of TNF-α as compared to 
IFN-γ, IL10 and Transforming Growth Factor (TGF)-β and are believed to possess strong 
 
Multi-nucleated giant 
cell expressing TNF-α 
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bactericidal properties (Mustafa et al, 2008).  These cells therefore have a small antigenic load 
and may act as weak APCs to T lymphocytes (Lay et al, 2007).  In comparison, multi-nucleated 
giant cells (Figure 2) express increased levels of TGF-β, a strong anti-inflammatory cytokine 
associated with the TH2 lymphocyte response that down-regulates expression of IFN-γ, TNF-α 
and IL12 (Barnes et al, 1994).  As a consequence, the giant cells possess a much lower 
bactericidal ability and a larger antigenic load as compared to the epithelioid cells, therefore 
acting as stronger APCs (Mustafa et al, 2008).      
Interestingly, studies on the effect of M. tuberculosis infection in human differentiated 
macrophages has shown a selective ability of infected epithelioid cells to evade apoptosis 
allowing subsequent fusion into giant cells (Mustafa et al, 2008).  Mycobacteria are known to 
be able to inhibit apoptosis of host cells to ensure their own survival and growth within 
phagocytic cells (Keane et al, 2000).  By inhibiting apoptosis of infected epithelioid cells, the 
bacteria ensure epithelioid differentiation into giant cells which have a much stronger APC role 
(Mustafa et al, 2008).  This therefore maintains cellular recruitment and proliferation and allows 
the granuloma to grow substantially in size (Wangoo et al, 2005).   
The size of the granuloma has been positively related to its’ advancement through the four 
stages of development, as granulomas can approximately double in size between each stage 
(Wangoo et al, 2005).  As the granuloma enlarges, the centre inevitably becomes necrotic due 
to un-infected cell apoptosis (as seen in stage III) causing subsequent loss of cell to cell 
interaction.  Smaller granulomas are less likely to become necrotic and this could be due to 
cytokines such as IFN-γ, IL12 and TNF-α being able to reach the inner macrophages and 
maintain their activity (Orme et al, 1998).  In response to giant cell antigen presentation and 
cellular recruitment, high levels of advancing cytolytic T cells may lead to uncontrolled cell 
destruction and granuloma liquefaction (Pratt et al, 2005).  Protein digesting enzymes secreted 
by activated macrophages can weaken the granuloma wall and liquefy the necrotic tissue to 
produce eroding of the bronchi and extreme tissue damage.  This process can expose any 
viable, persister bacteria to the lungs and lead to a highly infectious host (Pratt et al, 2005). 
 
T lymphocyte profiles 
A cell mediated response is characteristic of early tuberculosis infection.  However, it has been 
reported that there is a shift of the immune response from a primarily TH1 pro-inflammatory type 
to an anti-inflammatory, TH2 type humoral response (Welsh et al, 2005) in advanced disease 
states.  It is now understood that there is a degree of cross-regulation between cell mediated 
and humoral immune responses, when one is high the other is generally low.  A reason for this 
  Introduction 
 
15  
is the inhibitory effects of the cytokines.  Interleukin 4 (IL4) is a major cytokine in the anti-
inflammatory response that is essential in TH2 type development (Seder et al, 1994, Abbas et 
al, 1996).  It induces production of IgE antibodies, decreases expression of toll like receptors 
(particularly TLR2), suppresses nitric oxide synthase (Rook et al, 2004) and induces the 
generation of regulatory T cells (Pace et al, 2005).  IL4 has also been found to exist in two 
splice variant forms (Waldvogel et al, 2004).  IL4δ2 (deletion of exon 2) is able to bind to IL4 
receptors and is therefore a natural antagonist of IL4 activity by inhibiting IL4 mediated T cell 
proliferation (Atamas et al, 1996).  However, it also has a positive effect on collagen synthesis 
by fibroblasts (Atamas et al, 1999).  In human TB studies, an increase in IL4δ2 has been 
described in latent infection states (Demissie et al, 2004) however its significance in cattle 
immune responses is still under debate (Widdison et al, 2006).    
More recently the splice variant IL4δ3 (deletion of exon 3) was reported in cattle infected with 
Fasciola hepatica parasite (Waldvogel et al, 2004).  In bTB studies, IL4δ3 appears to be 
expressed dominantly over IL4δ2 (Rhodes et al, 2007) and levels were found to increase upon 
both BCG vaccination and M. bovis challenge but were virtually non-detectable in the non-
infected controls (Rhodes et al, 2007).      
IFN-γ (TH1) and IL4 (TH2) are able to render TH cells less susceptible to cytokines of the 
opposite TH type (Goldsby et al, 2003).  This is done by either down regulating or up-regulating 
two transcriptional factors within the TH cells, T-Bet (required for TH1 associated cytokine 
receptors) and GATA-3 (required for TH2 associated cytokine receptors). 
 IL10 has been shown to be secreted by a number of cells including various T cell subsets, 
CD4+, CD8+ (Bendelac et al, 1991), TH2 (Del Prete et al, 1993), TH0 (Katsikis et al, 1995), 
CD4+ regulatory T cells type one (Tr1, Cools et al, 2007) and specifically for human IL10, in 
TH1 (Del Prete et al, 1993, Rutz et al, 2007) as well as B lymphocytes and macrophages.  It 
has the ability to control the expression of various cytokines, chemokines and cell surface 
molecules of monocytes, macrophages, dendritic and T lymphocyte cells (Moore et al, 2001). 
As a ‘suppressor’ cytokine, IL10 is able to dampen the TH1 response (Welsh et al, 2005) by 
targeting phagocytic cells.  This is believed to occur via competitive IL10- and IFN-γ-induced 
intracellular mechanisms of the stat1 activation pathways (Ito et al, 1999).  As the concentration 
of IL10 increases relative to IFN-γ, inhibition of IFN-γ induced gene expression is enhanced.  
IFN-γ acts to up-regulate expression of MHC class II molecules thereby increasing CD4+ TH 
cell activation (Goldsby et al, 2003), In contrast, IL10 is able to down-regulate MHC class II 
molecule expression via posttranscriptional inhibition of their transport to the plasma membrane 
(Koppelman et al, 1997) subsequently reducing CD4+ TH cell activation.   IL10 is also able to 
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suppress the formation of nitric oxide during phagocytosis resulting in reduced expression 
levels of inflammatory cytokines IL1 and TNF-α as well as blocking transcription of both the p40 
and p38 encoding genes of IL12.   
Although IL10 may have extensive suppressor functions it has also been shown to enhance 
survival of human B cells by increasing expression of the anti-apoptotic protein bcl-2 (Levy and 
Brouet, 1994).  Proliferation of B cells is also enhanced by IL10, IL2 and IL4 activity (Rousset et 
al, 1992).   
Overall this has the effect of reducing the cell mediated response and increasing the antibody 
response (Pollock and Neill, 2002).  It is not fully understood why this shift in the immune 
response occurs however it could be a mechanism of the host to reduce the harmful effects of 
the pro-inflammatory effect.   
In recent years, it has been recognised that a third subset of TH associated cells exists, termed 
the TH0 type immune response (Widdison et al, 2006).  This is characterised by the presence of 
both TH1 (IFN-γ) and TH2 (IL4 and IL5) cell types together.  This type of response may be an 
intermediate between the pro-inflammatory and anti-inflammatory immune responses.  The TH0 
type response has been reported to correlate with an increase in pathogenesis of the disease 
(Welsh et al, 2005).  This could be due to the combined TH1/TH2 cytokine profile.  TNF-α is 
essential for bacilli containment however in high concentrations or when the surrounding 
cytokines represent a TH2 type response, typically IL4 (Rook et al, 2004), TNF-α can lead to 
extensive levels of necrosis.  It therefore becomes apparent that the host immune response to 
M. bovis infection is a highly dynamic process and that there is an extremely intimate 
relationship between protecting the host and causing pathological tissue damage.  
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Epidemiology of bovine tuberculosis within Great Britain 
 
Across Great Britain, the distributions of TB incidents within cattle herds show areas of strong 
clustering.  These areas are located particularly to the south west and west midlands of 
England and to the southern and western regions of Wales (Figure 3, Reynolds, 2006).  A 
possible reason for the concentration of bTB herd breakdowns in the south west of the country 
is due to its geographical location (White and Benhin, 2004).  The topography and climate of 
the south west of England and Wales has had a substantial impact on its commercial use in 
agriculture and animal farming (White and Benhin, 2004).  Approximately three quarters of the 
southwest region is utilised in farming, supporting over half a million dairy cows and 174,000 
beef cows, accounting for almost a third of the country’s current total cattle population 
(statistics from the National Farmers Union).  Although the number of individual cattle herds in 
Great Britain have decreased since 1975 (VetNet, unpublished), there has been an increase in 
the average number of cattle within each herd (Goodchild and Clifton-Hadley, 2001).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The geographical distribution of confirmed bTB herd breakdowns within Great Britain in 1998 and 2004.  
There has been a definite increase in bTB breakdowns, particularly to the west and south west of the country and 
the occurrence of breakdowns within previously non-infected areas (1998) such as the midlands and north east of 
Scotland (Veterinary Laboratory Agency, 2006).    
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The high density cattle farming performed within the southwest of England may therefore have 
an impact on the probability of cattle to cattle transmission of M. bovis infection (Shirima et al, 
2003, Goodchild and Clifton-Hadley, 2001).  In addition, M. bovis from environmental sources 
may contribute to bTB in cattle herds as mycobacterium bacilli have been reported to be able to 
survive for long periods of time within damp and warm (approximately 37oC) soils (Young et al 
2005).  However, since 1993 bTB has spread into areas across the United Kingdom that 
previously had not shown herd incidences for many years beforehand (Figure 3).  This spread 
in bTB has occurred in a northwardly direction from the southwest and has increased 
significantly in frequency since 1997 (Green and Cornell, 2005, VLA, 2006, Figure 3). 
 
Bovine tuberculosis control within Great Britain 
 
In response to the increasing number of bTB cases, the government developed a programme 
aimed at regular testing of infected animals, slaughter of those tested positive and restricted 
cattle movements (Reynolds 2006).  This programme became compulsory in 1950 and by the 
mid-1960s bTB was limited to only a few isolated cases in the southwest of England.  
Pasteurisation of milk is now a common procedure (although it is not compulsory in the UK, 
Howie, 1985) and meat is regularly checked for disease at the slaughterhouses to protect 
against animal to human transmission (Edwards et al, 1997).  Regardless of these beneficial 
control programmes, bTB cases have been increasing significantly over the last twenty years 
(Delahay et al, 2002) and the reasons behind this increase remain largely elusive.  In 1997 an 
independent scientific review (ISR) group chaired by Professor Sir John Krebs was formed to 
provide a strategy for investigating the main concerns of bTB infection (Krebs et al, 1997).  
Based on the prioritised recommendations of the Krebs report, the government initiated the 
bTB ‘Five Point Plan’ aimed at:        
  
- Protection of public health 
Currently, M. bovis infection in humans occurs at a much lower incidence as compared to that 
seen at the start of the twentieth century, with approximately less than 1% of microbiologically 
confirmed human TB cases within the UK caused by M. bovis (Evans et al, 2007).  There has, 
however, been some recent evidence of person to person transmission between young 
individuals through social contact at a local bar (Evans et al, 2007).  This has strong 
implications on the control of Mycobacterium bovis infection in humans.  
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- Research into the spread of TB 
Studies into the dynamics of bovine nasal shedding have revealed a dose response pattern 
associated with the concentration of the initial M. bovis inoculum.  More importantly, it was 
found that skin test negative animals displaying no visible lesions still had the potential to 
secrete M. bovis (VLA, IAH and QUB, 2005).  This highlights the value of the diagnostic test in 
detecting M. bovis during the earlier stages of infection before transmission is possible.  
However it also confirms the inadequacy of the current skin test method.  
 
-Testing and control 
The current bTB test is based on the intradermal injection of a purified protein derivative (PPD) 
produced from heat-treated M. bovis (termed tuberculin or PPD-B, Dickson, 1965, Lesslie et al, 
1976).  A positive response to the test is portrayed by a characteristic swelling under the skin 
around the injection site due to the accumulation of M. bovis sensitised T cells and phagocytes, 
termed the cell mediated delayed-type hypersensitivity (DTH) reaction (Dannenberg, 1991, Ng 
et al, 1995, Doherty et al, 1996).  Within Britain and Europe, the test has been evolved to 
account for environmental infection by Mycobacterium avium (M. avium) and involves injection 
of both bovine and avian tuberculin (PPD-B and PPD-A), termed the single intradermal 
comparative tuberculin test (SICTT, Lesslie and Herbert, 1975).  However, a problem 
associated with the skin test is its low level of sensitivity resulting in a number of infected 
animals being falsely labelled as negative (Monaghan et al, 1994).  To increase sensitivity of 
bTB testing, an enzyme-linked immunosorbent assay (ELISA) has been developed to measure 
the level of IFN-γ produced in response to tuberculin stimulation of isolated bovine peripheral 
blood mononuclear cells (PBMCs, Rothel et al, 1990, Wood et al, 1991). 
However, the use of tuberculin within the assay has limited its flexibility as a diagnostic tool, as 
it is unable to distinguish between cattle that have become infected and those that have been 
vaccinated with BCG (Doherty et al, 1996, Buddle et al, 1999, Vordermeier et al, 1999).  This 
has meant that worldwide, countries including the United Kingdom are not implementing cattle 
BCG vaccination as part of their control policy.  It is therefore an important consideration that a 
newly developed vaccine does not interfere with the intradermal skin test or that, alongside the 
new vaccine, a new diagnostic test for cattle is adopted.  Studies investigating the specificity 
and sensitivity of antigens present within M. bovis but deleted from the BCG bacilli have 
highlighted two potential targets for developing a new bTB test.  The early secretory antigenic 
target (ESAT)-6 kDa protein and culture filtrate protein (CFP)-10 (Van Pinxteren et al, 2000) 
are both encoded for within the RD1 region of M. bovis and have shown immunological activity 
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(Vordermeier et al, 2001).  In addition to these, comparative genomics focused on the three 
genomic regions RD1, 2 and 14 (present in M. bovis but absent from BCG Pasteur) uncovered 
twenty-eight antigens that potentially could distinguish BCG vaccinated cattle from infected 
cattle (Cockle et al, 2002).  Further analysis revealed three of the twenty-eight antigens 
(orthologues of the M. tuberculosis genes Rv1986, Rv3872 and Rv3878) induced immune 
responses within infected but not vaccinated non-infected cattle, thus may be important for 
future bTB detection assays (Cockle et al, 2006).  
 
- Badger control 
Since the mid 1970s, the Eurasian badger (Meles meles) has been recognised as the true 
maintenance host and principle reservoir of M. bovis infection (Muirhead et al, 1974).  M. bovis 
can be transmitted between the two animal species via indirect aerosol inhalation from animal 
faeces and ingestion of grassland that had become contaminated by faeces and urine 
(Sweeney et al, 2007, Scantlebury et al, 2004).  The Randomised Badger Culling Trial was 
designed to determine the effects of badger culling on the level of bTB across designated cattle 
herds within Britain (McDonald et al, 2008, Reynolds 2006).  Over 10 years, three culling 
treatment regimes including proactive, reactive and a control (no culling) were applied within 
designated areas across the west and south west of England (Reynolds, 2006).  The reactive 
regime was suspended after 5 years due to a 20% increase in bTB cases (Le Fevre et al, 
2005).  However the proactive culling produced conflicting results, as bTB cases were reported 
to decrease by 23% within the designated areas but increase by 24.5% in the farmlands 
adjacent to the trial zones (Donnelly et al, 2006).  It has been suggested that the detrimental 
effect of badger culling observed in both the proactive and reactive test sites could be attributed 
to the social organisation of the badger population (Pope et al, 2007).  The trial resulted in 
disruption of the delicate badger community by reducing the population density and removing 
the social limitations observed in undisturbed populations (McDonald et al, 2008).  This allowed 
individual social groups to increase their movements outside of the trial areas therefore 
increasing the probability of M. bovis transmission (Pope et al, 2007) and placing doubt on the 
efficacy of wide-scale badger culling as a disease control method. 
 
- Development of an effective cattle vaccine 
The current human TB vaccine Bacillus Calmette- Guérin (BCG) was attenuated from a strain 
of M. bovis between 1908 and 1921 within the Pasteur Institute (King et al, 1929).  Primary 
studies in experimental vaccination of animals reported the beneficial inhibition of the tubercle 
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bacilli post BCG vaccination (Smith et al, 1966).  However, it became apparent that the use of 
BCG vaccination interfered with the intradermal tuberculin skin test (Hart et al, 1967) and was 
therefore abandoned for animals in favour of the diagnostic test.  The vaccine has, however, 
been distributed worldwide to humans, traditionally via oral administration and then 
intradermally to over three billion people (Gagliardi et al, 2004).  Its advantages include its safe 
use for children and its relatively cheap production, however an increasing number of trials over 
the last 70 years have shown variable results on its efficacy against TB, in particular adult 
pulmonary TB (Orme et al, 2001).  Due to the extensive similarities between human and cattle 
TB, developmental work on TB vaccines for bovine infection has followed closely behind on an 
almost identical path to that of human studies (Hewinson et al, 2003).  BCG vaccination studies 
in cattle have shown potential in reducing TB severity and pathological damage (Buddle et al, 
1995, Skinner et al, 2003a, Wedlock et al, 2000, Widdison et al, 2006).  However, the degree of 
protection is extremely variable and full protection was rarely seen (Francis 1947, Francis 
1958, Widdison et al, 2006).  In response to these studies, extensive research has been 
centred on the development of an improved TB vaccine that could be applied cattle.   
 
Bovine tuberculosis control worldwide 
 
M. bovis infection of cattle is a worldwide veterinary problem and is of particular importance in 
developing countries where M. bovis still remains a significant cause of human TB.  The control 
of bTB infection in developing countries faces an extensive list of problems including the costs 
associated with sustainable ‘test and slaughter’ programs, the continuous displacement of huge 
numbers of humans and their animals due to wars and political instabilities as well as the lack 
of a suitable veterinary infrastructure (Ayele et al, 2004).  
The main method of controlling disease spread in most developed countries such as America 
(Olmstead and Rhode, 2004), Australia (Radunz, 2006) and those under the European Union 
(Caffrey, 1994) has included a procedure of rigorous testing and subsequent slaughter of 
infected animals.  In some cases this has been extremely successful.  Following the formation 
of governmental strategic committees, both Austalia and the majority of American states have 
been awarded a ‘free from bovine TB’ status (Olmstead and Rhode, 2004 and Radunz, 2006).  
Due to this, both countries have now stopped regular testing of cattle herds and have adopted 
nationwide surveillance of slaughter houses as a means of disease control (Lehane, 1996).  In 
the event that a particular animal at slaughter is found to be infected, it is possible for the 
  Introduction 
 
22  
authorities to trace the livestock back to the original herd and isolate the farm for subsequent 
tests.  This method has proved economically more viable to both the livestock keepers and the 
government.   
Interestingly, the same ‘test and slaughter’ procedures applied in other areas such as Britain, 
New Zealand (Porphyre et al, 2008) or the American state of Michigan (O’Brien et al, 2006) 
have been proven unsuccessful in providing complete eradication of bTB.  An important aspect 
of this failure is the existence of natural reservoir hosts, as described previously for the 
European badger in Britain (Muirhead et al, 1974).  The bTB-free status of Australia may be in 
part attributed to the fact that the native Brushtail possum (Trichosurus vulpecula), although 
susceptible to M. bovis infection, does not appear to become naturally infected (Radunz, 2005).  
This is in contrast to New Zealand, where the native Brushtail possum has been of huge 
detriment to the national TB eradication programme (Ekdahl et al, 1970).  This difference in 
disease kinetics is probably due to the extremely high possum densities inhabiting New 
Zealand compared to the relatively low levels in Austalia, the abundance of food and the lack of 
any natural predators.  A similar problem has occurred in Michigan due to the endemic state of 
M. bovis infection in white-tailed deer (Odocoileus virginianus, Schmitt et al, 1997), in Canada 
with the Bison (Bison bison, Choquette et al, 1961) and in Spain with the European wild boar 
(Sus scrofa, Gortazar et al, 2003).  This has meant that these countries have had to extend the 
traditional ‘test and slaughter’ methods to include the reservoir hosts, such as in Spain where 
serological ELISA tests are now being applied to wild boar (Aurtenetxe et al, 2008).       
 
Vaccine development 
 
It is clear from the situation within the United Kingdom and across the world that, although test 
and slaughter procedures remain central in the fight against M. bovis infection, they are an 
extremely expensive (both for the government as well as the farmer) and transient method of 
disease control.  Faced with the presence of a natural reservoir host, the system is unable to 
cope with the continuous source of infection and acts only to maintain the threat rather than 
eradicate the disease altogether.  Vaccination provides a low cost and extremely effective 
method against infection transmission.  Its benefits would be extensive, as farmers would be 
able to retain their herd whilst ensuring productivity and trade status.  Vaccination may also 
provide a more viable alternative in developing countries, as it would be easier to vaccinate 
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each animal once (or in the case of a booster, twice) rather than setting up a system in which 
animals would need to be tested every year.   
There are a number of possible methods to improve upon the BCG vaccination procedure 
(Figure 4).  One method is subunit vaccines involving the isolation of a small part of the M. 
bovis or M. tuberculosis bacterium, such as its DNA or selective proteins and utilising it with a 
suitable adjuvant to induce an immune response (Vordermeier et al, 2006).  Culture filtrate 
proteins (CFP) from M. tuberculosis with the adjuvant dimethyldeoctadecyl ammonium chloride 
(DDA) have been shown to induce a significant level of protection in mice and guinea pigs 
(Hewinson et al, 2003).  The same subunit vaccine used in cattle studies however induced an 
adequate antibody response but failed to produce the cellular immune response necessary to 
protect against bTB (Wedlock et al, 2002).  This represents a common problem seen in protein 
subunit vaccines and illustrates the importance of applying experimental conditions to the host 
in question, as adjuvants that may work in smaller animal models will not necessarily have the 
same effect in cattle (Wedlock et al, 2000 and 2002).   
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Strategies currently being explored to develop new bovine TB vaccines (from Vordermeier et al, 2006).  
There are three main methods of choice, improving the current BCG by genetic modification, attenuating a new M. 
bovis mutant to replace the current BCG or to selectively isolate subunits (either DNA sequences or proteins) from 
M. bovis and applying these via an adjuvant (such as attenuated recombinant viral vectors).      
 
Another possible avenue of research is live recombinant vaccines such as Modified Vaccinia 
Ankara (MVA) or adenoviruses (Figure 4) which express mycobacterial antigens, for example 
M. tuberculosis Ag85A.  The advantage of recombinant viral vaccines is their ability to induce a 
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strong cellular immune response and a long lasting T cell memory, effectively lengthening the 
time period of vaccine protection (Vordermeier et al, 2006).  These have proved particularly 
successful in murine M. tuberculosis infection models, for example a recombinant adenovector-
based vaccine expressing Mtb antigens Ag85A, Ag85B and TB10.4 in a single fusion protein 
(Radosevic et al, 2007) displayed strong T-cell responses, reduced bacterial lung loads and 
suppressed bacterial dissemination.  
Other vaccines that are currently being developed include new attenuated M. bovis strains in 
which genes encoding virulent factors or proteins for metabolic pathways are specifically 
targeted for deletion (Figure 4).   Protection against M. bovis in cattle was induced by an 
auxotrophic M. bovis strain, as a significantly lower number of animals developed lesions in 
comparison to the BCG control group (Buddle et al, 2002).  There is also the potential of 
improving the BCG vaccine directly by recombination with additional antigens not expressed 
within the strains or to increase the expression of some of the existing antigenic proteins 
(Hewinson et al, 2003). 
With extensive research being performed on vaccine development, it is becoming apparent that 
the most successful course of providing both M. bovis and M. tuberculosis protection in many 
host species has involved priming the immune system with BCG and following with a boost 
from one of the subunit vaccines described in figure 4 (Vordermeier et al, 2006).  A number of 
combinations of heterologous prime-boost strategies have been used involving the subunit 
vaccines already mentioned.  The vaccine combination that has shown very promising results 
in protection of cattle against bTB used BCG followed by modified vaccinia virus (MVA) 
expressing the mycobacterial antigen 85A (Vordermeier et al, 2004).  This prime-boost strategy 
is currently undergoing phase I clinical trials as a vaccine in humans against M. tuberculosis 
(McShane et al, 2005) and so further supports the links between the human and bovine TB 
vaccine research developmental pathways.  More recently, cattle vaccinated with an ESAT-
6:CFP10 DNA vaccine alongside plasmid-encoded co-stimulatory molecules (granulocyte 
macrophage-colony stimulating factor (GM-CSF) and CD80/86) followed by a homologous 
booster dose twenty days later displayed enhanced recall responses to antigens as compared 
to controls (Maue et al, 2007).  The addition of co-stimulatory molecules resulted in an 
increased cell-mediated response, possibly via activation of DCs whilst leaving the humoral 
response un-affected and lowering the degree of pathology within each animal (Maue at al, 
2007).       
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Aims and Objectives 
 
The aims of this study, in collaboration with the Veterinary Laboratories Agency (Surrey) and 
under the guidance of the Department of Environment, Food and Rural Agency (DEFRA, UK) 
are to: 
 
• Provide a greater understanding of the bovine immune response (specifically IFN-γ, 
TNF-α, IL10 and IL4 expression) following M. bovis infection at the site of pathological 
disease (the thoracic lymph nodes).  This was done by observing the cytokine 
expression within bovine bronchial lymph nodes after five, twelve and nineteen weeks 
of M. bovis infection.  The ability of vaccinations to protect a host against disease is 
based purely on eliciting the correct immune response.  The information gained from 
this study will therefore provide an immunological basis on which to develop novel 
vaccination compounds by revealing the dynamics of a successful immune response 
against infection.     
 
• Apply this new immunological knowledge in assessing the protective ability of a novel 
BCG vaccine complement.  Cattle were vaccinated with both the current BCG Pasteur 
and a genetically engineered alternative, followed by infection with M. bovis for five 
weeks.  The comparison between the immunological profiles of cattle from the two 
vaccination groups provides an understanding on the most effective method of 
manipulating the BCG to increase its protective ability.  This will contribute to the 
numerous vaccination developmental studies occurring across the globe with the 
united aim of complete M. bovis eradication.     
 
 
 
 
   
 
 
 
 
 
 
 
 
Chapter 2 
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Methods and Materials 
 
The infection, vaccination and post mortems of cattle were carried out by trained personnel at 
the Veterinary Laboratories Agency (VLA, Surrey, UK).  They were approved by the local 
ethical review board in accordance to national U.K guidelines and undertaken with a home 
office licence, under the “Animals (Scientific Procedures) Act of 1986”.  RNA extraction and 
quantitative Polymerase Chain Reaction experiments were performed at the University of 
Hertfordshire.  Immunohistochemistry was performed at the Department of Histopathology, 
VLA (Surrey).    
 
Bacterial culture 
Mycobacterium bovis  
The Mycobacterium bovis (M. bovis) inoculum used to infect the cattle was prepared from a 
mid-log phase frozen seed stock of a reference strain AF2122/97 (VLA, Surrey).  Seed stocks 
were thawed and diluted to a known titre using Middlebrook 7H9 medium (Difco Laboratories, 
Detroit, US) containing 0.05% Tween 80 (to prevent bacterial cell clumping).  To confirm the 
infective dose retrospectively, the inoculum was plated in triplicate on a modified formulation of 
Middlebrook 7H11 agar and incubated for four weeks (37oC), followed by colony counting. 
 
Bacillus Calmette Guerin Pasteur 
The BCG Pasteur strain used to vaccinate the cattle was grown in Middlebrook 7H9 medium 
(Difco Laboratories, Detroit, US) containing 0.05% Tween 80 (Sigma-Aldrich, US), 10% 
albumin-dextrose-catalase supplement (Becton Dickinson and Co, US) and 25 μg/ml 
Kanamycin, upon a rotating platform (37oC).  Bacterial BCG cultures were stored frozen (-80oC) 
and thawed in fresh 7H9 medium when required.         
 
Cattle experiments 
 
Due to the extensive costs of biosecure containment facilities and the associated ethical issues 
surrounding M. bovis infection of previously healthy animals, cattle numbers in the published 
literature are generally low (between three and six animals in each experimental group, 
Thacker et al, 2007, Dean et al, 2005, Widdison et al, 2006).  Therefore the animal numbers 
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employed within these studies are of a similar size (between three and five cattle within each 
group) and this is described in more detail within each chapter.  The use of smaller animal 
numbers, however, has considerable implications on the statistical analysis of the data as the 
natural variation of the immune response is amplified.  This therefore needs to be taken into 
consideration when interpreting the results of each study.     
 
BCG vaccination 
Friesian Holstein heifers and bullocks of approximately six months of age and with no history of 
tuberculosis infection were vaccinated by a subcutaneous injection of BCG Pasteur (between 5 
and 6.3x105 colony forming units) to the neck.   
 
Mycobacterium bovis infection 
The animals were infected intratracheally with M. bovis strain AF2122/97 (between 6x103 and 
1.0x104 colony forming units).  This was performed by passing an endotracheal tube (80 cm) 
holding a fine cannula through the trachea of the anesthetised animal into the top of the left 
lung lobe.  The infecting M. bovis dose was then injected through the cannula and flushed out 
with saline (2 ml).         
 
Cattle post mortem 
 
The animals were euthanized by intravenous injection of sodium pentobarbitonic at specific 
time points post M. bovis infection (the duration of infection has been outlined in the methods 
section of each individual study).  The cattle post mortems were performed within category 
three containment facilities at the VLA (Surrey) and all personnel present were required to wear 
specialist protective clothing with fitted respirators.  During the post mortems, the thoracic 
lymph nodes (specifically the cranial mediastinal, caudal mediastinal, cranial tracheobranochial 
(time course study only) and left bronchial nodes) were removed from each animal.  The 
studies focused specifically on the thoracic lymph nodes as these have been shown to be the 
primary draining nodes involved in M. bovis infection (Liebana et al, 2007).  It also avoids any 
inconsistencies that would be introduced by measuring cytokine expression in both respiratory 
and lymphatic systems.    
Tissue samples (approximately 1 cm3) were then taken consistently from the middle regions of 
visible lesions where possible for each lymph node.  The samples were submerged in 10 ml of 
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formalin fixative for subsequent pathology analysis, total RNA extraction (time course study 
only) and immunohistochemistry (BCG vaccination study only).  Specific for the BCG 
vaccination study, fresh tissue sections (approximately 0.5 cm3) were also submerged in 5 ml 
of Trizol reagent (Invitrogen, Paisley, Renfrewshire, Scotland) for subsequent total RNA 
extraction.       
 
Formalin fixed, paraffin embedded tissue preparation 
M. bovis infected cattle lymph node tissue sections (approximately 1 cm3) from each animal 
were fixed in neutral-buffered formalin (10% formaldehyde) for seven days followed by 
embedding within paraffin wax.  For pathology analysis, the paraffin embedded samples were 
cut into 4 μm sections and mounted onto glass slides.  For RNA extraction (time course study 
only), samples were cut into 10 μm sections and placed into microcentrifuge tubes. 
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Pathology analysis of infected lymph nodes 
The slide preparation and pathology analysis was performed at the Pathology Department, VLA 
(Surrey) as a routine procedure.  The paraffin embedded formalin fixed tissues from each 
lymph node sample were sectioned (4 μm) using a microtome and placed upon the surface of 
pre-heated water (37oC) in order to stop the sections from rolling up.  Microscope slides pre-
treated with Vectabond (Vector Laboratories, UK) were placed underneath the tissue sections 
and lifted above the water surface to allow the sections to bind to the slide.  The slides were 
dried overnight (37oC) and incubated for thirty minutes (60oC) before de-paraffinising the 
sections in xylene for five minutes, followed by incubation within absolute alcohol (five minutes) 
and then 70% alcohol (five minutes).  The sections were stained using haematoxylin counter 
stain and each slide was then observed by a Veterinary Pathologist (100 x magnification).  The 
pathology of the lymph node samples were measured using two methods; by observing the 
percentage area coverage of granulomatous lesions and also the developmental stage of each 
granuloma within the tissue sections.   
• To determine percentage area coverage of granulomas within the samples, the lymph 
node section was first measured by counting the number of fields of view that each 
section covered.  The granuloma lesions were also measured using the same method.  
It was then possible to calculate the percentage area coverage of each individual 
granuloma in relation to the total number of fields covered by the lymph node section.   
• A scoring method developed at the VLA (Wangoo et al, 2005) was used to determine 
the developmental stage of each granuloma within the sections.  Granuloma were 
categorised into four types based on their physiological properties. Type I granulomas 
were characterised as irregular, unencapsulated granulomatous inflammations 
composed of clustered epithelioid macrophages and peripheral lymphocytes.  Type II 
were organised, partially or completely encapsulated and composed of primarily 
epithelioid macrophages with minimal necrosis.  Type III was encapsulated granuloma 
displaying central necrosis and focal mineralization.  Type IV was multilobular to 
irregular, large, well-encapsulated granuloma displaying prominent central necrosis 
with extensive mineralization.  The numbers of granuloma within each stage were 
counted for each individual lymph node section (left bronchial, cranial mediastinal, 
caudal mediastinal and cranial tracheobronchial) and the results combined for each 
animal.  The total counts for each granuloma stage were then weighted according to a 
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log2 scale to account for the increased size of granuloma as they advanced through the 
four stages.     
 
Total RNA extraction from formalin fixed, paraffin embedded tissues (time 
course study only)  
 
The published protocol for total RNA extraction from M. bovis infected, formalin fixed paraffin 
embedded lymph node tissue has been previously described (Witchell et al, 2008). 
 
Diethyl pyrocarbonate (DEPC) treatment: 
All glass wear, plastic and pipette tips were treated with 0.1% (v/v) DEPC solution over twenty 
four hours followed by autoclaving at 121oC for thirty minutes to remove RNase contamination. 
 
Table 1: Reagents and suppliers for total RNA extraction from formalin fixed, paraffin embedded lymph node 
tissues of cattle infected with M. bovis for five, twelve and nineteen weeks. 
 
Reagent Supplier 
Ethanol (absolute) 
Optimum FFPE RNA Isolation kit 
Xylene 
Sigma-Alderich (Poole, Dorset, UK) 
Ambion (Applied Biosystems, Warrington, Cheshire, UK) 
BDH (Poole, Dorset, UK) 
 
 
Deparaffinisation: 
Xylene (1 ml) was added to each microcentrifuge tube containing three times 10 μm sections of 
formalin fixed paraffin-embedded tissue.  The tubes were kept at room temperature for five 
minutes followed by centrifugation (16,500 x g) at room temperature for ten minutes.  The 
supernatant was discarded and the tissue sections dehydrated in three changes of alcohol 
(100%, 90% and 70%) for three minutes each.  Each time the sections were centrifuged for one 
minute (16,500 x g) and the supernatant was discarded.  The tissue sections were then left to 
air dry for ten minutes at room temperature. 
 
Total RNA extraction: 
Total RNA was extracted from the formalin fixed, paraffin embedded tissue sections according 
to the manufacturer’s instructions for the Optimum FFPE isolation kit (Ambion, UK).  Prior to 
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total RNA extraction, a solution of 10 μl Proteinase K (60 units/μl, Ambion, UK) and 100 μl 
Digestion buffer (Ambion, UK) was incubated at 37oC for ten minutes (to dissolve any 
precipitate).  This was added to the deparaffinised tissue sections and incubated at 37oC for six 
hours.  The samples were centrifuged for one minute (16,500 x g) to pellet un-dissolved tissue 
residue and the supernatant transferred to a new microcentrifuge tube.  RNA extraction buffer 
(Ambion, UK) was added to the supernatant and vortexed vigorously for ten seconds.  The 
sample was passed through a micro filter cartridge by centrifugation for one minute (16,500 x 
g) and the flow through was discarded via the micro waste collection tube.  The filter cartridge 
was washed through by a series of centrifugation steps with the appropriate wash solutions 
(Ambion, UK) followed by a final centrifugation step for two minutes to remove any excess 
ethanol.  The filter cartridge was transferred to a micro elution tube and two times 10 μl 
volumes of pre-heated (70oC) RNA elution solution (Ambion, UK) were added directly to the 
filter.  This was then left at room temperature for one minute before centrifuging (16,500 x g) for 
one minute to elute the total RNA.  Total RNA samples were stored at -70oC.  
 
Total RNA isolation from freshly dissected tissues (BCG vaccination study only) 
 
Table 2: Reagents and suppliers for total RNA extraction from M. bovis experimentally challenged fresh cattle 
lymph nodes. 
 
Reagent Supplier 
β-Mercaptoethanol 
Chloroform >99% 
Ethanol (absolute) 
Isopropanol 
RNeasy Mini RNA Extraction kit 
Trizol 
Turbo DNA-free 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Qiagen (Crawley, Sussex, UK) 
Invitrogen (Paisley, Scotland) 
Ambion (Applied Biosystems, Cheshire, UK) 
 
 
Isolation was based on the single-step RNA isolation method developed by Chomczynski and 
Sacchi (1987) and followed per the manufacturer’s instructions (Invitrogen, Scotland).  All 
tissue manipulations were carried out in a class III cabinet (homogenisation) or a class I cabinet 
(RNA isolation) before washing with 70% ethanol, in which the sample was deemed safe to 
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remove.  The tissue sections were homogenised while submerged in the Trizol reagent 
followed by the addition of chloroform (0.4 volumes) and vortexed vigorously.  The sections 
were left at room temperature for five minutes before centrifugation for five minutes (5,000 x g) 
and the upper aqueous layer containing the total RNA was transferred to a new centrifuge tube.  
This step was repeated using chloroform (1 volume).  Precipitation of the total RNA was 
performed using isopropanol (0.8 volumes) and sodium acetate (0.1 volumes, 3 M, pH 4.8).  
The sample was divided into several microcentifuge tubes and centrifuged for fifteen seconds 
(16,500 x g) to pellet the total RNA and the supernatant discarded.  An equal volume of ethanol 
(70%) was added to the sample and the pellet gently re-suspended and washed.  This was 
centrifuged for fifteen seconds (16,500 x g) and the pellet left to dry for ten minutes at room 
temperature.  The latter part of RNA isolation was performed per the manufacturers’ 
instructions for the RNeasy® Mini kit (Qiagen, UK) RNA cleanup protocol.  The pellet was re-
suspended in RNase-free water and mixed thoroughly with lysis Buffer RLT (Buffer RLT 
containing β-mercaptoethanol, Qiagen, UK).  Absolute ethanol was added and the solution 
mixed gently by pipetting.  This was passed through an RNeasy mini column (Qiagen, UK) by 
centrifugation for fifteen seconds (16,500 x g) and the flow through discarded.  Buffer RPE 
(Qiagen, UK) was added to the RNeasy column and centrifuged for fifteen seconds (16,500 x 
g) to wash the column.  The buffer RPE wash was repeated and the total RNA eluted in 
RNase-free water (50 μl total volume) by centrifugation for one minute (16,500 x g). 
 
DNA digestion of total RNA samples 
The total RNA sample was diluted to 200 μg/ml in a total volume of 50 μl RNase-free water.  1 
μl DNase I (2 U/μl) and 1/10 the sample volume of 10x DNase buffer (Ambion, UK) were added 
to the eluted RNA and mixed thoroughly by pipetting.  This was incubated at 37oC for thirty 
minutes.  The DNase was inactivated using DNase Inactivation Reagent (Ambion, UK) and 
vortexing.  The reaction mixture was kept at room temperature for two minutes before 
centrifugation (16,500 x g).  The treated total RNA could then be transferred to a new 
microcentrifuge tube and stored at -70oC. 
 
Total RNA Quantification 
Individual lymph node total RNA samples were quantified using a BioPhotometer (Eppendorf, 
Hamburg, Germany).  200 μl of a 10-2 dilution of the total RNA sample (diluted using sterile 
distilled water) was placed within an UVette (Eppendorf, Germany) and the absorbance read at 
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260 nm.  The BioPhotometer (Eppendorf, Germany) automatically calculated the RNA 
concentration in the original sample using the following equation: 
 
(Absorbance at 260 nm x RNA coefficient) dilution factor = μg/ml of RNA 
• RNA coefficient: 40 ng/μl equivalent to an absorbance reading of 1 
• Dilution factor: 102 
 
The BioPhotometer (Eppendorf, Germany) also gave an indication of the purity of the RNA 
sample by calculating the ratio between the absorbance at 260 nm (specific for nucleic acids) 
and 280 nm (specific for protein).  A pure total RNA sample should give a ratio of between 1.7 
and 2.1. 
 
Gel electrophoresis of total RNA 
 
Table 3: Reagents and suppliers for agarose gel electrophoresis of total RNA from M. bovis infected (five, twelve 
and nineteen weeks) formalin fixed cattle lymph node tissues. 
 
 
 
Total RNA samples were analysed by agarose gel electrophoresis.  A 1% agarose gel solution 
was prepared using sterile 1x Tris Acetate EDTA (TAE) buffer and poured into the gel cassette.  
The comb was inserted to form the sample wells and the gel left to solidify.  The gel was 
transferred to the electrophoresis tank and submerged with sterile 1x TAE buffer.  The total 
Reagent Supplier 
Acetic Acid 
Agarose 
Bromophenol blue 
EDTA 
Ethidium Bromide 
RNA Ladder (0.5-10 Kb) 
Sucrose 
Tris base 
Xylene cyanol FF 
Sigma (Poole, Dorset, UK) 
BDH (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK 
Invitrogen (Paisley, Renfrewshire, Scotland) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Invitrogen (Paisley, Renfrewshire, Scotland) 
Sigma (Poole, Dorset, UK) 
Fisher (Loughborough, Leicestershire, UK) 
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RNA samples were loaded with loading buffer (TAE buffer, bromophenol blue, sucrose and 
xylene cyanol FF) alongside a 0.5-10 Kb RNA ladder (Sigma, Poole, Dorset, UK).  The gel was 
run at a constant voltage (100 volts) for thirty minutes.  It was then stained in ethidium bromide 
(1 μg/ml) for twenty minutes followed by de-staining in 1x TAE buffer for ten minutes.  The total 
RNA samples were visualised using a UV light box (Gene Genius Bio imaging System, 
Syngene, Cambridge, UK) and documented with the Gene Snap program (Syngene, UK). 
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Quantitative Polymerase Chain Reaction 
 
Primer and probe oligonucleotide sequences: 
 
Table 4: Primer and dual labelled fluorescent probe oligonucleotide sequences for quantitative PCR. 
Primer and probe sequences were designed at the VLA (Surrey) and received from Dr Shelley Rhodes.  Primer 
and probe properties (including GC content and melting temperatures) are displayed in Appendix 1. 
 
Table 5: Reagents and suppliers for dual labelled probe quantitative PCR.  
 
Reagent Supplier 
Clear Seal Diamond
QuantitectTM Probe RT-PCR kit  
THERMO-FAST® 96 PCR Plate 
Primer and Probe oligonucleotides 
ABgene (Epsom, Surrey, UK) 
Qiagen (Crawley, Sussex, UK) 
ABgene (Epsom, Surrey, UK) 
Biomers.net (Ulm, Germany) 
 
Real time qRT-PCR using dual labelled probes was carried out according to the manufacturers’ 
guidelines for the QuantitectTM Probe RT-PCR kit (Qiagen, Crawley, West Sussex, UK).  A 
standard reaction mixture (Table 6) was produced and then aliquoted (25μl) into a ninety six 
well plate followed by the template.  All reactions were set up on ice. 
Target gene Forward primer 
5’-3’ 
Reverse Primer 
5’-3’ 
Fluorescent Probe 
GAPDH TGCACCACCAACTGCTT
GG 
GGCGTGGACAGTGGTC
ATCCA 
HEX: 
ATGACCACTTTGGCATCGTGGAGG
GA : BHQ-1 
TNF-α 
 
CGGTGGTGGGACTCGT
ATG 
GCTGGTTGTCTTCCAGC
TTCA 
FAM: 
CAATGCCCTCGTGGCCAACGG: 
BHQ-1 
IFN-γ 
 
CAGAAAGCGGAAGAGA
AGTCAGA 
CAGGCAGGAGGACCAT
TACG 
FAM: 
TCTCTTTCGAGGCCGGAGAGCATC
A: BHQ-1 
IL10 GGTGATGCCACAGGCT
GAG 
AGCTTCTCCCCCAGTGA
GTTC 
FAM: 
CACGGGCCTGACATCAAGGAGCA: 
BHQ-1 
IL4 GCCACACGTGCTTGAA
CAAA 
TCTTGCTTGCCAAGCTG
TTG 
FAM: 
TCCTGGGCGGACTTGACAGG: 
BHQ-1 
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Table 6: Standard Reaction mixture components for dual labelled probe quantitative RT-PCR. 
 
Reaction mixture components Final Concentration 
2x QuantiTect Probe RT-PCR Master Mix 
Total RNA template 
Forward Primer 
Reverse Primer 
Probe 
RNase-free water 
1x 
100 ng 
700 nmoles 
700 nmoles 
200 nmoles 
Up to 25 μl 
 
Concentrations of primers, probes and template were optimised in previous experiments (Appendix 2). 
 
Each lymph node sample was analysed for the expression of all four cytokines; IFN-γ, TNF-α, 
IL10 and IL4.  The mRNA expression of the housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was also measured within each sample to ensure the quality of the 
starting template.   
 
Standard templates: 
Standard templates for each cytokine were produced to enable absolute quantification of 
mRNA levels within the experimental samples.  The standard templates were designed based 
on the primer and probe sequences of each specific mRNA target with an extra ten bases on 
each end to provide space for oligonucleotide binding (Table 7).  It was necessary to design 
both complimentary strands of the target sequence to ensure efficient binding of the forward 
and reverse primers during PCR (Table 7).  Each standard template strand (Biomers.net, Ulm, 
Germany) was dissolved in sodium tris EDTA (STE) buffer and the complimentary strands 
mixed in equal molar amounts.  The mixed complimentary strands were heated to 94oC and 
then cooled gradually over three hours by ‘unplugging’ the heated block.  This allowed the two 
strands to bind together. The stable double stranded product was then diluted to 5 μmoles 
working solution and stored at -20oC. 
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Table 7: Standard template sequences for qPCR (produced by Biomers.net, Germany).  The standards were 
designed to be complimentary to the relevant forward primer (blue), probe (green) and reverse primer (red) with 10 
bases either end to allow space for oligonucleotide binding.  Both complimentary strands of the genetic sequence 
were synthesised (strand 1 and 2) and then annealed together to ensure efficient binding of both the reverse and 
forward primer during PCR. 
 
 
Target 
gene 
Genetic sequence 5’to 3’ Total no. of 
base pairs 
after 
annealing 
 
IFN-γ 
Strand 1 
 
Strand 2 
 
 
AATCTAACCTCAGAAAGCGGAAGAGAAGTCAGAATCTCTTTCGAGGCCGGAGAGCAT 
CAACGTAATGGTCCTCCTGCCTGCAATATTTGA 
 
TCAAATATTGCAGGCAGGAGGACCATTACGTTGATGCTCTCCGGCCTCGAAAGAGAT 
TCTGACTTCTCTTCCGCTTTCTGAGGTTAGATT 
 
 
90 
 
TNF-α 
Strand 1 
 
Strand 2 
 
 
GGGGCAGCTCCGGTGGTGGGACTCGTATGCCAATGCCCTCGTGGCCAACGGTGTGAA 
GCTGGAAGACAACCAGCTGGTGGTGCC 
 
GGCACCACCAGCTGGTTGTCTTCCAGCTTCACACCGTTGGCCACGAGGGCATTGGCA 
TACGAGTCCCACCACCGGAGCTGCCCC 
 
 
84 
 
IL10 
Strand 1 
 
Strand 2 
 
 
ACCTGGAAGAGGTGATGCCACAGGCTGAGAACCACGGGCCTGACATCAAGGAGCACGTGAACTCACT
GGGGGAGAAGCTGAAGACCCT 
 
CAGGGTCTTCAGCTTCTCCCCCAGTGAGTTCACGTGCTCCTTGATGTCAGGCCCGTGGTT 
CTCAGCCTGTGGCATCACCTCTTCCAGGT 
 
 
89 
 
IL4 
Strand 1 
 
Strand 2 
 
 
ATCTACAGGAGCCACACGTGCTTGAACAAATTCCTGGGCGGACTTGACAGGAATCTC 
AACAGCTTGGCAAGCAAGACCTGTTCTGT 
 
ACAGAACAGGTCTTGCTTGCCAAGCTGTTGAGATTCCTGTCAAGTCCGCCCAGGAAT 
TTGTTCAAGCACGTGTGGCTCCTGTAGAT 
 
 
86 
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Standard template concentrations: 
From the 5 μmole working solution, a volume corresponding to 500 ng standard template was 
calculated and used as the starting concentration for serial dilutions.  To allow for the results to 
be quoted in the form of copy number, the concentration (converted into g/μl) was transformed 
into copy number using the following calculation: 
 
 
                                                          g/μl    
Copy number  =                                  x 6.022x1023 
                            (number of bases x 340 daltons/base) 
 
 
The starting concentration was then serially diluted and the dilutions 10-4, 10-8, 10-10 and 10-12 
were used to produce the standard curves in PCR.  The corresponding copy number for each 
dilution was imputed into the PCR program prior to running the experimental plates (Table 8).  
Standard curves specific to the target cytokine gene were run on every PCR plate. 
 
 
Table 8: Copy numbers of each standard template corresponding to the serial dilution of the templates.  The 
concentrations were used to produce the standard curves and were run in every experimental plate to allow 
quantification of the unknown samples. 
 
Template dilution IFN-γ  
copy number 
TNF-α 
copy number 
IL10 
copy number 
IL4 
copy number 
 
10-4 
10-8 
10-10 
10-12 
 
361826050 
36182.6 
362 
3.6 
 
349276000 
34927.6 
349.3 
3.5 
 
343254000 
34325.4 
343.25 
3.4 
 
348673800 
34867.4 
348.7 
3.5 
 
 
Experimental reactions: 
Each reaction was performed in either duplicate or triplicate.  Control reactions were performed 
with the standard reaction mixture (Table 6) excluding the template for the no template control 
(to detect possible PCR product contamination).   The reactions were carried out within a 
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Quantica Real Time Nucleic Acid Detection System (Techne, Fradley, Staffordshire, UK) to a 
specific program (Table 9). 
 
Table 9: Amplification program (incubation temperatures and time periods) for dual labelled probe qRT-PCR. 
 
qPCR Step No. of cycles Incubation temperature 
(oC) 
Incubation time 
Reverse Transcription  1 cycle 50oC 30 minutes 
 
Initial Activation step 
 
 
1 cycle 
 
95oC 
 
15 minutes 
 
Denaturation, 
annealing/extension 
 
50 cycles 
 
94oC 
60oC 
 
15 seconds 
1 minute 
 
 
The real time fluorescent dye reading was taken at the annealing/extension stage (Table 9).  
The crossing point (CP) value was calculated for each reaction by the Quansoft program 
(Techne, UK) using the point at which the fluorescence of the reaction reached a set threshold 
level relative to the corresponding PCR cycle number.  The CP values of the standard template 
were plotted against its known concentrations (log copy number) to produce a standard curve.  
This was then used to convert the CP values of the unknown samples into copy number.  The 
CP values of the housekeeping gene were used to ensure the quality of the starting template.  
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Immunohistochemistry (BCG vaccination study only) 
 
Table 10: Reagents and suppliers for immunohistochemistry (IFN-γ and TNF-α protein) of both M. bovis 
experimentally challenged and non-infected formalin fixed cattle lymph nodes. 
 
Reagent 
 
Supplier 
Vectorbond-treatment for slides 
Hydrogen peroxide 
Methanol 
Citric acid 
Trypsin 
α-chymotrypsin 
Calcium chloride 
Tris 
Sodium Chloride 
Tween 20 
Normal serum block- goat 
Primary antibodies (IFN-γ and TNF-α) 
Secondary antibodies (goat vs. mouse) 
Vector Elite Conjugate (ABC) 
Diaminobenzidine chromogen 
Mayers Haemalum stain 
Vector Laboratories (Peterborough, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
Vector Laboratories (Peterborough, UK) 
Serotech (Oxford, Oxfordshire, UK) 
Vector Laboratories (Peterborough, UK) 
Vector Laboratories (Peterborough, UK) 
Sigma (Poole, Dorset, UK) 
Sigma (Poole, Dorset, UK) 
 
 
During the cattle post mortems, lymph node tissue samples were collected from each animal 
from the five experimental groups and submerged within formalin fixative for subsequent 
immunohistochemistry (IHC).  IHC was performed on each section primarily once for each 
cytokine with the addition of one negative control slide per animal.  A random selection of ten 
slides (equating to approximately a quarter of the total number of sections) were then used to 
repeat IHC for each cytokine to indicate the reproducibility of the protocol.  A selection of ten 
slides with known immunostaining profiles (VLA, Surrey) were run in parallel to the 
experimental sections to provide positive controls.    
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The formalin fixed sections were mounted upon vectorbond-treated slides (Vector Laboratories, 
Peterborough, UK) and the sections de-paraffinised as previously.  The slides were then 
incubated within a solution of hydrogen peroxide (3%) and methanol (97%) for fifteen minutes 
to block endogenous peroxidase activity, followed by washing in tap water (3x two minutes).   
 
Epitope de-masking: 
The sections were pre-treated with antigen retrieval reagents to ensure that any protein cross-
links formed by formalin fixation (obstructing antigenic sites) were broken.  The IHC method for 
IFN-γ protein involved a heat induced epitope retrieval (HIER) system.  The slides were 
submerged within citric buffer (0.01 M, pH 6) and heated within a microwave (100oC) for six 
minutes (repeated three times).  The sections were then cooled at room temperature for ten 
minutes and washed under running tap water for a further ten minutes.    
The IHC method for TNF-α protein involved a proteolytic induced epitope retrieval (PIER) 
system.  The slides were incubated within a pre-heated purified water trough (37oC) for a 
minimum of ten minutes.  A solution of trypsin (0.02 M), α-chymotrypsin (0.02 M), calcium 
chloride (9 mM) and purified water (pH adjusted to 7.8) was pre-heated for fifteen minutes 
(37oC) and the slides submerged in the proteolytic solution for ten minutes (37oC).  This was 
then followed by washing under running tap water for ten minutes.  
 
IHC staining: 
After epitope retrieval, the slides were incubated for five minutes (room temperature) in TBS 
buffer (working concentration of x1, Table 11) for the IFN-γ protein IHC method and in TBST 
buffer (working concentration of x1, Table 11) for the TNF-α protein IHC method.  The slides 
were then incubated in normal serum block from the same species used to raise the secondary 
link antibody (goat serum diluted 1/66 using TBS/TBST buffer) for twenty minutes at room 
temperature.  This solution was then replaced by the primary antibody (conditions in Table 12) 
followed by a buffer wash (2x five minutes at room temperature).  To provide negative controls, 
an additional lymph node section from each animal was incubated in mouse IgG antibody in 
place of the primary antibody to check for any non-specific binding.     
The slides were incubated within the biotinylated secondary link antibody specifically targeted 
to the same species that was used to raise the primary antibody (goat vs. mouse, diluted 1/200 
using TBS/TBST buffer) for thirty minutes (room temperature).  This was followed by a buffer 
wash (2x five minutes).  
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The sections were then incubated within the Vector Elite Conjugate (ABC) solution (diluted 1/25 
using TBS/TBST buffer, Vector Laboratories, UK) for thirty minutes (room temperature) 
followed by a buffer wash (2x five minutes).   
 
Table 11: Reagents used to produce the immunohistochemical buffers TBS (used in the IFN-γ protocol) and TBST 
(used in the TNF-α protocol).  The stock solution of each buffer was at a concentration of x10 and this was diluted 
to a working concentration of x1 for the IHC protocol. 
 
Buffer (x10 concentration) Reagent Final conc. 
TBST (0.85% NACL) pH 7.6 
 
 
 
TBS (0.85% NACL) pH 7.6 
Sodium chloride 
TRIS 
Distilled water 
Tween 20 
Sodium chloride 
TRIS 
Distilled water 
1.36 M 
0.04 M 
Up to 1 litre 
0.05% 
1.36 M 
0.04 M 
Up to 1 litre 
 
 
Table 12: The primary antibody (IFN-γ and TNF-α) incubation conditions for immunohistochemistry. 
  
Target 
cytokine 
Antibody/ clone Dilution Incubation time Incubation 
temperature 
IFN-γ 
 
TNF-α 
Mouse anti-bovine 
IFN-γ / CC330 
Mouse anti-bovine 
TNF-α / CC327 
1/100 in TBS 
buffer 
1/2000 in TBST 
buffer 
One hour 
 
One hour 
Room 
temperature 
Room 
temperature 
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Preparation of the Diaminobenzidine (DAB) chromogen solution: 
The sections were incubated in diaminobenzidine (DAB) chromogen to develop the peroxidase 
in the ABC kit (Vector Laboratories, UK) and produce the end coloured product.  The DAB 
solution was prepared as per the manufacturer’s instructions (Sigma, Poole, Dorset, UK).   
 
Table 13: Components and final concentrations of reagents for the two solutions (A and B) used to produce the 
phosphate citrate buffer needed in the preparation of the Diaminobenzidine (DAB) chromogen.  
 
Solution Reagent Final concentration 
Solution A  
 
 
Solution B 
Disodium Hydrogen Orthophosphate (NA2HPO4) 
Tween 20 
Distilled water 
Citric Acid 
Tween 20 
Distilled water 
0.16 M 
0.05 % 
Up to 1 litre 
0.03 M 
0.05 % 
Up to 0.5 litre 
 
 
Briefly, two solutions (A and B, Table 13) were prepared and stored at room temperature.  A 
phosphate citrate buffer (McIlvanes) was prepared by mixing solution A (70 ml) and solution B 
(30 ml) using a magnetic stirrer.  The pH was measured and adjusted to pH 6.4 using either 
solution A or B as required.  The phosphate citrate buffer was then transferred (20 ml) into a 
plastic universal container and a DAB tablet (10 mg, Sigma, UK) added to the solution.  The 
tablet was broken down using a magnetic stirrer and the solution mixed for five minutes.  The 
solution was extracted from the universal container using a syringe (20 ml) and filtered through 
a Millipore filter (0.45 μ) into a clean plastic universal container.  Hydrogen peroxide (10 μl) was 
added to the phosphate citrate/ DAB solution (20 ml) and mixed thoroughly using a vortex.  It 
was then possible to check the quality of the citrate buffered DAB solution by applying a small 
amount to excess Vector Elite ABC conjugate solution (\Vector Laboratories, UK) therefore 
producing a dark brown colour change.  The slides were incubated in citrate buffered DAB 
solution for ten minutes (room temperature).   This was followed by a purified water wash for 
five minutes and the sections then placed under running tap water for ten minutes. 
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Mayers Haemalum counterstain: 
The sections were counterstained with Mayers Haemalum to allow accurate visualisation of the 
positively stained brown cells against a blue coloured background.  The protocol was followed 
as per the manufacturer’s instructions (Sigma, UK).  Briefly, sections were stained in Mayers 
Haemalum for fifteen minutes, followed by a wash under running tap water for fifteen minutes.  
The sections were placed in distilled water for thirty seconds and counter stained in Eosin Y 
solution for one minute.  The sections were then incubated in two changes of 95% ethanol, 
absolute ethanol and xylene (two minutes each) before being covered in DPX mounting 
reagent and a cover slip placed over the slide. 
 
Analysis of immunostained sections: 
The sections were analysed semi-quantitatively based on a scoring method.  Upon examination 
under the microscope (x100 and x400), the sections contained few granuloma which were 
difficult to pin-point visually.  The scoring method was therefore based on the percentage of 
lymph node area covered by positively stained cells (the lymph node stained up as blue and 
the positively stained cells as brown, Figures 5 and 6).   The sections were scored on a five 
point scale (0 to ++++) with an absence of staining represented by a 0 and maximum staining 
represented by ++++.  The IFN-γ stained sections were scored as + = <5 %, ++ = 5-20%, +++ 
= 21-40 % and ++++ = >40 % area coverage of positively stained cells (Figure 5).  The TNF-α 
stained sections were scored as + = <1%, ++ = 1- 10 %, +++ = 11-20% and ++++ = >20 % 
area coverage of positively stained cells (Figure 6). 
 
Each slide contained approximately three-five sections of the same lymph node from the same 
animal and so each individual section was scored for percentage area coverage (100x 
magnification for IFN-γ and 400x for TNF-α).  The results were then averaged to give overall 
percentage area coverage for that one lymph node.  All of the IHC analysis was performed 
blindly to the experimental group that the animal came from and repeated twice. 
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• Score 0: no positive cells 
 
• Score +  
Percentage area coverage of positively stained cells:  
<5 % 
Sparse staining across the section 
 
 
 
• Score ++ 
Percentage area coverage of positively stained cells:  
5-20 % 
 
 
 
• Score +++ 
Percentage area coverage of positively stained cells:  
21-40 % 
 
 
 
• Score ++++ 
Percentage area coverage of positively stained cells: 
>40 % 
 
 
 
 
Figure 5: Immunohistochemistry scoring method of cells stained positive for IFN-γ production in the lymph node 
sections of cattle from five experimental groups; BCG (sigK) Pasteur vaccinated M. bovis challenged, BCG 
Pasteur vaccinated challenged, non-vaccinated infected, non-vaccinated non-infected and BCG Pasteur 
vaccinated non-infected.  The positive cells were stained brown by diaminobenzidine chromogen and the 
background counterstained blue by Mayers haemalum.  The sections were scored under a microscope 
magnification of 100x and analysis was performed in duplicate. 
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• Score 0: no positive cells 
 
• Score + 
Percentage area coverage of positively stained cells: 
<1 % 
Very sparse staining (indicated by the arrow) 
 
 
 
• Score ++ 
Percentage area coverage of positively stained cells: 
1-10 % 
 
 
 
• Score +++ 
Percentage area coverage of positively stained cells: 
11-20% 
 
 
 
• Score ++++ 
Percentage area coverage of positively stained cells: 
>20% 
 Some staining present in Langhans’ giant cells   
 (indicated by arrow) 
 
 
Figure 6: Immunohistochemistry scoring method of cells stained positive for TNF-α production in the lymph node 
sections of cattle from five experimental groups; BCG (sigK) Pasteur vaccinated M. bovis challenged, BCG 
Pasteur vaccinated challenged, non-vaccinated infected, non-vaccinated non-infected and BCG Pasteur 
vaccinated non-infected.  The positive cells were stained brown by diaminobenzidine chromogen and the 
background counterstained blue by Mayers haemalum.  The sections were scored under a microscope 
magnification of 400x and analysis was performed in duplicate. 
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Whole blood IFN-γ cultures 
 
Whole blood cultures were collected from each animal prior to euthanisation by scientists at the 
VLA (Surrey).  The concentration of IFN-γ protein within whole blood cultures from each animal 
were measured using the BOVIGAM® test (Prionics, Schlieren, Switzerland).  The samples 
were incubated overnight (100 μl per well in a 96-well flat-bottom microtiter plates) in the 
presence of three different antigens (final concentration 10 μg/ml), tuberculin purified protein 
derivative (PPD) B, early secretory antigenic target 6-kDa (ESAT-6) and culture filtrate protein 
10 (CFP-10) in 100 μl culture medium (RPMI 1640 with Glutamax (Gibco) supplemented with 
5% control serum protein replacement (CSPR3, Gibco), nonessential amino acids (Gibco), 100 
U/ml penicillin, 100 μg/ml streptomycin and 5x10-5 M 2-mercaptoethanol (Gibco)).  The 
antigens stimulated lymphocytes within the blood cultures to produce IFN-γ which was then 
measured using a commercially available enzyme-linked immunosorbent assay kit 
(BOVIGAM®) according to the manufacturer’s instructions.  The antigen stimulated samples 
were transferred to microplates coated with an antibody to IFN-γ which upon incubation, bound 
to the IFN-γ within the blood sample.  A second conjugate antibody (horseradish peroxidase 
labelled anti-bovine IFN-γ) was added to the reaction and bound to the primary antibody/IFN-γ 
complex.  The conjugate antibody was labelled with an enzyme that generated a coloured 
signal upon IFN-γ binding.  Therefore the degree of colour within the blood sample was directly 
proportional to the amount of IFN-γ within the sample.  The colour change was measured using 
a spectrophotometer (450 nm) and the results given as mean optical density (OD) readings.  
When comparing the OD reading of a sample in the presence of antigen to the OD reading of 
the medium, a difference in readings of more than 0.1 was considered a positive response. 
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Statistical analysis  
 
All statistical analysis was performed using a Statistical Package for the Social Sciences 
(SPSS, edition 15 and 16).  The differences of the variances of each experimental group within 
the Time course and BCG vaccination studies were explored using the ANOVA one-way test 
(selecting Levenes F-test for homogeneity of variances).  The results showed a significant 
difference between the variances of each experimental group.  As a consequence of this and 
due to the relatively small number of data points with a skewed nature (descriptive statistics), it 
was decided to employ non-parametric tests to analyse the data.    
To enable the data to be portrayed graphically, it was necessary to convert copy number into a 
logarithmic scale (log 2) however all statistical analysis was performed on the original data set.  
The means calculated from the logarithmic data are therefore geometric means whilst those 
calculated from the copy number data are arithmetic means.    
The non-parametric Kruskal Wallis test was used to determine whether there were any 
statistically significant differences between more than two groups of data.  Following a result of 
‘significant difference’ with a 5% confidence interval (p<0.05), each experimental group was 
then assessed individually using the Mann Whitney test.  The Bonferroni correction was applied 
to each Mann Whitney p value (dividing the p value by the number of comparisons made) to 
reduce the likelihood of identifying differences between the experimental groups by chance.  
Pearsons correlation coefficient was used to determine whether there were any significant 
correlations between two groups of continuous data, such as copy number or percentage.  
Spearmans correlation coefficient was used to determine whether there were any significant 
correlations between two groups that contained categorical data, such as protein score. 
   
 
 
 
 
 
 
 
Chapter 3 
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Introduction 
 
Cytokine expression studies 
 
Mycobacterium bovis experimental studies aimed at elucidating the immunological progression 
of the disease have focused significantly on cytokines.  As previously mentioned, cytokines are 
extremely important in the response to M. bovis infection due to the associated activation of 
both cell-mediated and humoral immunity.  They have an extremely broad range of biological 
targets and processes distributed throughout the entire immunological response that can be 
studied at both the transcription and translational levels.  Cytokine responses, in particular IFN-
γ, have been used to provide a method of diagnosing M. bovis infection via the cell-mediated 
delayed-type hypersensitivity (DTH) reaction (Dickson, 1965). 
 
Cytokine expression levels from antigen stimulated peripheral blood samples are believed to be 
a reliable method of determining the immunological state of M. bovis challenged animals 
throughout the infection process (Hope et al, 2005, Rhodes et al, 2000).  Testing for IFN-γ 
levels in blood samples has therefore become a common measurement of bTB infection due to 
the extremely high levels of IFN-γ expression observed in response to M. bovis challenge 
(Welsh et al, 2005, Thacker et al, 2007).  Thacker et al (2007) measured cytokine expression 
levels in isolated PPD stimulated bovine peripheral blood mononuclear cells (PBMCs) over a 
period of eighty-five days post M. bovis experimental infection.  Levels of IFN-γ mRNA were 
detectable as early as fifteen days post infection and peaked at thirty days, accompanied by a 
peak in TNF-α and iNOS expression (Thacker et al, 2007).  Throughout the infection period, 
IFN-γ, TNF-α and iNOS expression was higher within the infected as compared to the non-
infected cattle.  However, IL10 displayed a decrease in infected as compared to non-infected 
animals, with an evident trough in expression at thirty days post infection (Thacker et al, 2007).  
The authors suggest that this cytokine profile reflects a cell mediated TH1 type response to 
early M. bovis infection with the accompanied suppression of TH2 associated cytokine IL10.  
This hypothesis was supported by another similar study performed by Joardar et al (2002), that 
reported an increase in CD4+ T cells accompanied by an increase in IFN-γ expression within 
bovine PBMCs between four and nine weeks post M. bovis infection.  The increase in CD4+ T 
cells was preceded by a dominant population of γδ+ T cells (for the first four weeks of infection) 
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which would support the theory of these cells being the ‘first line of defence’ appearing early in 
the infection process (Doherty et al, 1996, Pollock et al, 1996).   
As the infection progresses, cytokine levels present a dynamic shift in immune profile.  Welsh 
et al (2005) showed that cell mediated immunity was prominent in PPD-B stimulated bovine 
PBMCs through to twenty weeks post infection although the levels of IFN-γ expression showed 
reduced levels post twenty weeks.  Similar patterns in IFN-γ expression have been reported 
elsewhere (Dean et al, 2005, Thacker et al, 2006) with marked reduction in levels 
approximately fifteen weeks following infection.  Conversely, expression of IL10 was greater at 
twenty-six weeks as compared to the levels observed in the earlier stages of infection (Welsh 
et al, 2005).  The high levels of IL10 corresponded with strong IgG1 antibody responses due to 
its role in the differentiation of B-cell immunoglobulin into IgG1 (Garraud and Nutman, 1996).  
The authors suggest that this change in profile from TH1 to TH2/humoral response may be a 
result of either the host actively suppressing the cell mediated immune response to reduce 
further tissue damage (Stenger and Modlin, 2002) or immunosuppressive cytokine stimulation 
via bacterial antigens (Dahl et al, 1996).  
 
Another site for cytokine expression studies in bTB are the lymph nodes.  The majority of 
pathological lesions in M. bovis naturally infected cattle are confined to the cranial and 
bronchial lymph nodes (Cassidy, 2006) as the primary source of infection is via aerosol delivery 
to the lungs (Palmer et al, 2002).  The infection can become disseminated (travel to other 
bodily organs), however the ‘test and slaughter’ programs used in developed countries rarely 
allow the infection to reach this stage (Cassidy, 2006).  Therefore the bronchial and cranial 
lymph nodes provide the most accurate visualisation of the active site of bTB infection (Liebana 
et al, 2007).  Due to the logistical problems of isolating the lymph nodes and the costs of 
housing large numbers of cattle, the majority of studies analysing cytokine levels in bovine 
lymph nodes have been focused on one time point following infection (Widdison et al, 2006, 
Thacker et al, 2007, Liebana et al, 2007, Johnson et al, 2006).  Widdison et al (2006) reported 
cytokine expression changes in the head lymph nodes of cattle infected with M. bovis for 
sixteen weeks.  The levels of TNF-α, IL4 and IL10 were shown to significantly decrease post 
infection while there was no difference in IFN-γ or IL12 expression (Widdison et al, 2006).  This 
suggests that cytokines are expressed in healthy tissue (Tanaka et al, 2005) and that some 
cytokines are preferentially suppressed in response to M. bovis infection.  The authors 
conclude that the suppression of anti-inflammatory cytokines IL10 and IL4 was of a 
consequence of the maintaining pro-inflammatory population (Widdison et al, 2006).  IL4 has 
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been shown to be suppressed following mycobacterial infection in previous studies (Rhodes et 
al, 2007, Thacker et al, 2007) and has also proved undetectable in some experimental models 
(Welsh et al, 2005, Aung et al, 2000).   
 
Table 14: Summary of cytokine protein levels measured over different time points post M. bovis infection in cattle.  
Due to the ease with which blood samples can be taken, the time courses have all been performed on either 
peripheral blood mononuclear cells or whole blood cultures. 
 
Reference Experimental design Cytokine Pattern of expression 
    
Thacker et 
al, 2007 
 
 
 
 
 
 
 
PBMCs collected at 
five, fifteen, thirty, 
sixty and eighty-five 
days following 
infection. 
 
IFN-γ 
 
 
TNF-α 
 
IL4 
 
IL10 
 
Detected at fifteen days post infection and peaked at thirty 
days, followed by a slight drop in expression at fifty days which 
was maintained until day eighty-five. 
Detected from day zero and peaked at thirty days post infection.  
Expression maintained fairly consistent thereafter. 
Detected at thirty days post infection and remained consistent 
thereafter. 
Detected from day zero and reduced dramatically at day thirty 
to below the level observed in the non-infected controls.  The 
level increased after sixty days of infection but dropped again at 
eighty-five days. 
    
    
Joardar et 
al, 2002 
 
PBMCs collected over 
forty-five days of 
infection 
IFN-γ 
 
An increase in expression between four and nine weeks 
(twenty-eight and sixty-three days) post infection. 
 
    
    
Welsh et al, 
2005 
 
PBMCs, collected at 
four, twelve, twenty, 
twenty-four and 
twenty-six weeks 
following infection. 
 
IFN-γ 
 
 
IL4 
IL10 
 
Expression peaked at four weeks (twenty-eight days) and 
declined at twelve weeks (eighty-four days) where it remained 
stable for the remainder of the experiment. 
Expression was undetectable for the entire experiment. 
A decrease in expression was noted in the first four weeks of 
infection.  Levels remained consistent until twenty-six weeks, 
where expression increased dramatically. 
    
    
Dean et al, 
2005 
Whole blood cultures 
collected over twenty-
three weeks of 
infection. 
 
IFN-γ Protein levels increased significantly between five and fifteen 
weeks of infection, followed by a reduction post fifteen weeks 
until the end of the experiment. 
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Shifts in cytokine profiles are believed to affect the development of granulomatous lesions 
within the lymph nodes (Widdison et al, 2006, Thacker et al, 2007) and therefore pathology can 
also be used as an indicator of disease progression.  Microscopic lesions were detected as 
early as fifteen days (two weeks) post M. bovis challenge in bovine retropharyngeal lymph 
nodes (Palmer et al, 2007).  This time frame coincides exactly with the first detectable levels of 
IFN-γ expression (Thacker et al, 2007) and illustrates both the importance of the cell mediated 
response in producing granuloma as well as the efficient speed of lesion development.  The 
microscopic granuloma grew in size and became gross lesion by approximately twenty-eight 
days (four weeks) following infection.  After forty-two days (six weeks), the lesions reached a 
plateau in size and remained consistent thereafter (Palmer et al, 2007).  The production of 
iNOS was detectable from fifteen days through to ninety days (twelve and a half weeks) of 
infection with a significant peak at forty-two days (Palmer et al, 2007).  Human studies have 
shown a positive association between iNOS and TH1 cytokines such as IFN-γ due to their role 
in inducing macrophages to produce iNOS (Munder et al, 1998).  The production of iNOS 
during the early stages of infection therefore further support the theory of a strong cell mediated 
response.  
 
Knowledge on the dynamics of the immune response following M. bovis infection is extremely 
important to vaccination developmental studies, as: 
a) The ability of the vaccination to protect the host is dependent entirely on the immune 
response that it elicits.  Vaccinations are therefore designed specifically to stimulate 
the key immune-associated cells that aid in infection control.  Time course studies can 
be used to select those key targets.      
b) A common method of assessing the efficacy of a vaccination is to measure cytokine 
levels (particularly IFN-γ).  It is therefore important to know which cytokines are 
expressed at which time points before they can be used to indicate disease 
progression. 
   
Within this present study, archival tissue was sourced from three separate investigations 
involving the infection of cattle with M. bovis for five, twelve and nineteen weeks.  The tissue 
samples consisted of thoracic lymph nodes; the cranial mediastinal, caudal mediastinal, left 
bronchial and cranial tracheobronchial nodes.  As previously mentioned, time course 
experiments are traditionally performed using whole blood cultures due to the ease with which 
they can be extracted whilst keeping the animal viable.  However, the site of M. bovis disease 
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is focused specifically within the lymph nodes (Liebana et al, 2007) and therefore a study 
based on the nodes would provide more accurate information on the time-dependent 
expression of cytokines.   
The three time points (five, twelve and nineteen weeks) were selected as they pertain to a 
previously un-studied area.  The majority of published experiments focusing on cytokine 
expression within lymph nodes have been taken at later stages of infection post sixteen weeks 
(Widdison et al, 2006, Thacker et al, 2007, Johnson et al, 2006).  However, cytokine 
expression within PBMCs has been detected as early as two to three weeks post infection 
(Thacker et al, 2007, Hanna et al, 1989).  It was therefore decided to start the time course 
experiment as early as possible to provide a comparison in the lymph nodes.  The shortest 
investigations performed on M. bovis infected cattle by the VLA are five weeks (as it is neither 
ethically or economically beneficial to infect cattle for a lesser period of time).  The final time 
point of nineteen weeks was selected as it complemented those experiments published in the 
literature (Widdison et al, 2006, Thacker et al, 2007, Johnson et al, 2006) and thus the twelve 
week point provided a mid-way comparison.      
 
RNA extraction and quantitative polymerase chain reaction 
The conventional method of studying cytokine transcription levels within infected tissues 
samples involves tissue liquefaction and total RNA isolation, however, as technology develops 
this step is becoming less important (Hosokawa et al, 2006).  There are a number of methods 
used to isolate total RNA although the gold standard remains to be the Chomczynski and 
Sacchi single step method (Chomczynski and Sacchi, 1987).  RNA degradation is a major 
concern during isolation as it can lead to a distorted cytokine profile and it is recommended that 
the tissue be processed immediately after dissection (Bhudevi et al, 2003).  Modern methods to 
reduce RNA degradation during tissue storage include aqueous storage compounds such as 
Trizol (Witchell et al, 2008).  The standard method of storing tissue sections is to have them 
fixed immediately after collection in traditionally formalin (Bhudevi et al, 2003) but more recently 
zinc (Mikaelian et al, 2004) and Hepes glutamic acid buffer mediated organic solvent protection 
effect (also known as HOPE) (Olert et al, 2001, Witchell et al, 2008) prior to embedding within 
paraffin wax. 
Post total RNA isolation, the specific cytokine mRNA population can be identified and amplified 
using Fluorescent Quantifiable Reverse Transcriptase Polymerase Chain Reaction or qRT-
PCR (Bustin, 2002).  The advantage of qRT-PCR compared to standard RT-PCR is that it has 
allowed complete automation of the PCR amplification and analysis stages therefore providing 
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a higher consistency in data reproducibility (Fleige and Pfaffl, 2006).  The methodology of qRT-
PCR is based on the same principle as standard RT-PCR using complimentary 
oligonucleotides that bind to the target sequence allowing repeated temperature dependent 
‘copying’ of the sequence.  However, qRT-PCR also involves the use of fluorescence 
technology to enable a computer to track target sequence amplification/fluorescence build-up in 
real time.  The computer program sets a fluorescence threshold level and as the fluorescence 
within each reaction exceeds the level set, the computer calculates the number of cycles it 
takes for this to occur and subsequently produces numerical data.  By applying a standard 
curve of known target sequence quantity, the computer is able to accurately quantify the target 
sequence within each reaction.   
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Aim and Objectives  
It was proposed to study the immunological responses of cattle infected with M. bovis for three 
specific periods of time.  The study was focused on the lymph nodes draining the bronchial 
region of the animals allowing a response profile to be created for the actual site of infection.   
 
Aim: To produce a time course study of immunological responses in cattle infected with M. 
bovis for five (three animals), twelve (three animals) and nineteen weeks (four animals). 
 
The immune response was measured using quantitative polymerase chain reaction targeting 
the cytokines interferon gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), interleukin 10 
(IL10) and interleukin 4 (IL4). 
 
Objectives: 
 
1. Isolation and dissection of the left bronchial, caudal mediastinal, cranial mediastinal 
and cranial tracheobronchial lymph nodes of each animal from the three experimental 
groups.  The tissue samples were fixed in buffered formalin and embedded within a 
paraffin wax block to allow storage.  
2. Pathological damage within each lymph node was measured by observing the 
percentage of granuloma coverage and the stage of granuloma development within 
mounted sections. 
3. Total RNA was extracted from the formalin fixed, paraffin embedded, M. bovis infected 
lymph node tissues followed by quality checks of the extracted nucleic acid using 
spectrophotometry and agarose gel electrophoresis. 
4. QRT-PCR was performed on the extracted total RNA from each lymph node tissue 
sample by firstly converting total RNA to complimentary DNA (cDNA) followed with 
target cytokine amplification.  The housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was also targeted to ensure the quality of the starting 
template.  The target mRNA sequences within each lymph node tissue sample was 
quantified using specifically designed standard curves and expressed in copy 
numbers. 
5. Comparisons were made between the three experimental groups with combined data 
from all four types of lymph nodes to show the cytokine expression profile over time 
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post infection.  The data was also expressed as individual lymph node types to 
determine differences in cytokine levels due to lymph node location.  
6. To compliment the cytokine expression data within the lymph nodes, levels of IFN-γ 
protein were measured in cultured peripheral blood samples from each animal using 
enzyme linked immunosorbant assays (ELISA). 
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Materials and methods 
 
Source of experimental samples 
Experimental infection of large animals such as cattle involves extensive ethical consideration.  
Archival tissue therefore provides a source on which further experimental procedures can be 
performed without having to infect more animals.  The scientists at the VLA (Surrey) keep an 
archive of all experimental tissue from each investigation performed, fixed in buffered formalin.  
It is therefore possible to use the archived tissue samples in numerous molecular and 
histological techniques many years after the initial experiments took place.  To enable study of 
cytokine expression over different periods of M. bovis infection, archived lymph node tissue 
samples were sourced from three separate experiments in which the parameters met the aims 
of this study.  Each of the studies involved the use of non-vaccinated Friesian Holstein heifers 
and bullocks of approximately six months of age (with no prior history of tuberculosis infection) 
which were infected intratracheally with M. bovis (a dose of between 0.8 and 1.0 x104 cfu’s).  In 
one study the cattle were euthanized at five weeks of infection (three animals), in another they 
were euthanized at twelve weeks of infection (three animals) and finally, in the last study the 
cattle were euthanized at nineteen weeks of infection (four animals).  The cattle from all three 
studies were euthanized by an intravenous injection of pertobarbitonic and the bronchial lymph 
nodes processed according to the methods described in Chapter 2 (including pathological 
analysis and tissue fixation). 
 
Archived tissues are an extremely precious source of experimental material and thus are 
conserved to the highest possible degree.  Due to the relatively large amounts of formalin-fixed 
tissue needed to perform total RNA extraction and quantitative PCR, it was decided to focus 
this study on four specific lymph node types, the left bronchial, cranial mediastinal, caudal 
mediastinal and tracheobronchial nodes.  Bronchial lymph nodes have been shown to display 
high levels of pathological development in both natural and experimental M. bovis infection 
(Cassidy et al, 2006, Liebana et al, 2007) and were therefore specifically selected for analysing 
immunological activity for the purpose of this study. 
 
Total RNA extraction 
Total RNA was extracted from the formalin-fixed lymph node tissues as described in Chapter 2. 
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Quantitative Polymerase Chain Reaction 
 
Complimentary DNA (cDNA) synthesis: 
 
Table 15: cDNA synthesis reaction mixture for total RNA isolated from M. bovis infected (five, twelve and nineteen 
weeks) formalin fixed lymph node tissues. 
 
Reaction mixture components Final concentration 
ImProm-IT Reaction Buffer 
MgCl2 
dNTP mix 
ImProm-RT 
1x 
4mM 
0.5mM 
1x 
 
 
The protocol was carried out as per the manufacturers’ guidelines for the ImProm RT kit 
(Promega, Southampton, Hampshire, UK).  A concentration of 1 ug total RNA was added to a 
oligo(dT) solution (0.5 μg) and incubated at 70oC for five minutes followed by immediate chilling 
on ice for five minutes.  This was then added to the reaction mixture (Table 15) and vortexed 
gently.  A negative no reverse transcriptase reaction per total RNA sample was also included to 
ensure that there was no contaminating DNA.  The reaction mixture was then incubated at 
25oC for five minutes followed then by 42oC for sixty minutes.  The resulting cDNA product was 
quantified using a BioPhotometer (Eppendorf, Germany) and stored at -20oC for subsequent 
quantitative PCR. 
 
Quantitative PCR was performed using the QuantitectTM Probe PCR kit (Qiagen, Crawley, West 
Sussex) as described in Chapter 2.  The qPCR experiments were designed to allow direct 
comparison between the three experimental groups of five, twelve and nineteen weeks M. 
bovis infection (Figure 7).  Therefore each sample from the three groups had to be included in 
the same ninety six well PCR plate to avoid the complication of plate to plate variation.  Within 
each PCR plate, all samples of one lymph node over the three experimental groups were 
analysed for one target cytokine. Each lymph node sample was analysed for the expression of 
all four cytokines; IFN-γ, TNF-α, IL10 and IL4.  The mRNA expression of the housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was also measured within each 
sample to ensure the quality of the cDNA transcript.  Lastly, each PCR plate included the 
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bovis infection 
groups 
Plate 13 IFN-γ 
Plate 14 TNF-α 
Plate 15 IL10 
Plate 16 IL4 
diluted standard templates specific to the target cytokine to allow construction of the standard 
curve (as described in Chapter 2).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Quantitative PCR experimental designs for the time course study.  Each 96 well plate contained 
reactions analysing one cytokine from all samples of one lymph node from the three experimental groups (five, 
twelve and nineteen weeks of infection).   This allowed the direct ‘in- plate’ comparison of cytokine levels between 
the three experimental groups and reduced the potential problem of plate to plate variability.  The specific standard 
curve for the cytokine and GAPDH were also run on each plate.  Each reaction was performed either in duplicate 
or triplicate.   
 
Whole blood IFN-γ cultures 
Samples of heparinized whole blood were collected from each of the animals prior to 
euthanization by a trained scientist at the VLA (Surrey), as described in Chapter 2.  The data 
from the BOVIGAM® tests were used to compare against the lymph node cytokine data. 
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Results 
 
Total RNA extraction  
 
The first step in the study of cytokine gene expression was to isolate total RNA from the four 
thoracic lymph nodes of each M. bovis infected cow in the three experimental groups (five, 
twelve and nineteen weeks post infection).  The formalin fixed, paraffin embedded samples 
required a modified method of RNA extraction that involved deparaffinisation of the sample with 
xylene followed by tissue liquefaction and RNA isolation.  Total RNA was quantified (Table 16) 
using a BioPhotometer (Eppendorf, Germany) and run on a 1% agarose electrophoresis gel 
(TAE buffer) to determine integrity (visualisation of the ribosomal RNA bands, Figure 8). 
  
Table 16: Quantification (μg/ml) and purity determined by spectrophotometry of total RNA isolated from M. bovis 
infected formalin-fixed, paraffin embedded cattle lymph node tissues.  The results represent averaged lymph node 
results of over 500 extractions in total. 
 
Tissue type 
(n=500) 
Total RNA (20 μl) 
quantification μg/ml 
(mean ± SD) 
260/280 nm ratio 
(mean ± SD) 
 
Formalin fixed paraffin 
embedded lymph node tissue 
 
170.28 ± 80.3 
 
1.8 ± 0.11 
 
 
Total RNA was successfully isolated from all of the lymph node samples of cattle infected with 
M. bovis for five, twelve and nineteen weeks.  The mean concentration of total RNA extracted 
from approximately 500 formalin fixed tissue sections was 170.28 μg/ml (or 3.4 μg/20 μl, Table 
16).  The large standard deviation from the mean associated with this data (80.3, Table 16) 
suggests that the concentration of total RNA extracted from the different lymph node samples 
was extremely varied (range from 44.5 to 388 μg/ml).  The ratio of total RNA (OD at 260 nm) to 
protein (OD at 280 nm) was within the recommended range of between 1.7 and 2 (mean ratio 
of 1.8, Table 16) (Fleige and Pfaffl, 2006).  
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Figure 8: Agarose gel electrophoresis (1% agarose within TAE buffer and ethidium bromide staining) of total RNA 
samples (300 ng/ well) isolated from M. bovis infected formalin-fixed, paraffin embedded cattle lymph node tissues 
(lanes 3 and 4).  Both total RNA samples displayed a 28S ribosomal RNA band of approximately 4 Kb in length.  
Lane 1 is a 0.5-10 Kb RNA ladder with highlighted standard RNA base pair lengths of 6 and 1.5 Kb.   Lane 2 was 
not used.  The electrophoresis experiment was repeated with different total RNA samples 10 times and displayed 
consistent results. 
 
 
Each total RNA sample displayed a band of approximately 4 Kb in length (Figure 8).  This 
nucleotide length corresponds to the expected length of 28S ribosomal RNA (Bradford et al, 
2005) and gives an indication to the high level of integrity of the total RNA samples.  There was 
little evidence of DNA contamination, which would be represented by clear bright bands nearer 
to the wells.  
 1   2    3 Lanes: 
← 28S rRNA band 
6.0 Kb 
1.5 Kb 
4 
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Quantitative Polymerase Chain Reaction 
 
Standard curves 
 
Standard templates for the cytokines IFN-γ, TNF-α, IL10 and IL4 were designed and serially 
diluted to produce a standard curve (Table 7 and 8).  This allowed conversion of the calculated 
crossing point values of the unknown samples into quantitative copy number.  
 
As can be seen from figure 9, each standard template produced a standard curve to enable 
quantification of the unknown samples.  The line equation of each graph fulfilled the 
requirements of a reliable standard curve, as the slope of each line was around the ideal value 
of -3.32 (signifying a doubling of PCR product during each cycle), the R2 of each graph was 
between 0.98-0.99 (Figure 9) suggesting an extremely tight fit/correlation of the data points and 
the amplification efficiency ‘E’ was between 2-2.1 (Figure 9) indicating 100% efficiency of each 
reaction. 
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Figure 9: Quantitative PCR standard curves for IFN-γ, TNF-α, IL10 and IL4.  Each standard template was 
designed to mimic the specific mRNA target cytokine sequence to allow sequence specific annealing of the 
complimentary primer and probe set during qPCR.  A known concentration of the standard template was serially 
diluted and four of these dilutions (corresponding to 3x108, 3x104, 3x102 and 3 copies) were run on each PCR 
plate.  The computer program (Quantica, Techne) calculated the crossing point value for each standard template 
and produced a standard curve to enable quantification of the unknown samples.  The equation of each graph is 
also displayed.      
IFN-γ 
TNF-α
IL10
IL4 
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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
 
The housekeeping gene GAPDH was analysed by PCR for each sample alongside each target 
cytokine to ensure the quality of the starting cDNA template.  In the absence of a cytokine PCR 
product, the presence of a GAPDH PCR product ensured that the sample template was of a 
high quality.  The mean crossing point values of GAPDH expression for each lymph node from 
all of the cattle within the three experimental groups was plotted within a bar chart (Figure 10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The crossing point (CP) values of GAPDH expression from cattle infected with M. bovis for five (n=3), 
twelve (n=3) and nineteen (n=4) weeks.  The data represents the mean values from the lymph node samples of all 
cattle within each experimental group.  The error bars represent the standard deviation (±) of the data. 
 
There was no difference between the three experimental groups (five weeks post infection 
mean of 35.3, twelve weeks post infection mean of 34 and nineteen weeks post infection mean 
of 34.7, Figure 10) for GAPDH expression.  This suggested that any potential differences in 
cytokine expression between the three groups were unlikely to be due to the physical condition 
of the template.  
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Cytokine mRNA expression in the combined lymph nodes 
 
Cattle infected with M. bovis over three different time periods (five, twelve and nineteen weeks) 
were used within this study to explore the changes in cytokine mRNA expression as the 
infection progressed.  IFN-γ, TNF-α, IL10 and IL4 mRNA levels were quantitatively measured 
in four different lymph nodes from each animal (left bronchial, cranial mediastinal, caudal 
mediastinal and cranial tracheobronchial lymph nodes).  The individual lymph node results 
were then combined to give an overall view of cytokine expression over time.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Quantitative PCR of IFN-γ mRNA in the lymph nodes of cattle infected with M. bovis for five, twelve and 
nineteen weeks.  The data are presented in log2 copy number and each individual point represents the mean 
triplicate data of an individual lymph node from one animal.  Four lymph node types were used from each animal 
(the left bronchial, cranial mediastinal, caudal mediastinal and cranial tracheobronchial) and within each group 
there were either three (five and twelve weeks post infection) or four (nineteen weeks post infection) animals.  
Error bars represent standard deviation (±) of each point and the mean of each group is shown by — symbol.  
There was no significant difference between the three experimental groups (p>0.05, Kruskal Wallis test). 
 
At five weeks post infection, the expression levels of IFN-γ mRNA (Figure 11) were 
comparatively lower (mean log2 copy number of 6.50) than at twelve weeks post infection 
(mean log2 copy number 7.53).  The IFN-γ mRNA levels then decreased between twelve and 
nineteen weeks post infection (mean log2 copy number 6.22, Figure 11).  The expression level 
at nineteen weeks was slightly lower than at five weeks post infection.  The differences in IFN-γ 
levels over time were not significant (p> 0.05, Kruskal Wallis test). 
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Figure 12: Quantitative PCR of TNF-α mRNA in the lymph nodes of cattle infected with M. bovis for five, twelve 
and nineteen weeks.  The data are presented in log2 copy number and each individual point represents the mean 
triplicate data from an individual lymph node from one animal.  Four lymph node types were used from each 
animal (the left bronchial, cranial mediastinal, caudal mediastinal and cranial tracheobronchial) and within each 
group there were either three (five and twelve weeks post infection) or four (nineteen weeks post infection) 
animals.  Error bars represent standard deviation (±) of each point and the mean of each group is shown by — 
symbol.  There were no significant differences between the three experimental groups (p>0.05, Kruskal Wallis 
test).  
 
The mRNA expression level of TNF-α (Figure 12) was comparatively lower at five weeks post 
infection (mean log2 copy number of 2.15) as compared to twelve weeks post infection (mean 
log2 copy number of 3.94).  Similar to the IFN-γ profile, there was a decrease in TNF-α mRNA 
expression (Figure 12) between twelve and nineteen weeks post infection (mean log2 copy 
number 3.02).  However the level of mRNA at nineteen weeks stayed above the level 
measured at five weeks post infection.  The changes in TNF-α mRNA expression over time 
were not significant (p>0.05, Kruskal Wallis test) 
Interestingly there appeared to be a slight segregation of data points, particularly in Figure 11 
but also at twelve weeks post infection in Figure 12, with a group of points positioned above the 
mean and a group positioned below.  This suggests that the lymph node samples could be 
separated into two groups, those expressing considerably higher cytokine IFN-γ and those 
expressing lower levels.  This difference is not reflected in the mean of each time point post 
infection and will be described in more detail at a later point. 
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Figure 13: Quantitative PCR of IL10 mRNA in the lymph nodes of cattle infected with M. bovis for five, twelve and 
nineteen weeks.  The data are presented in log2 copy number and each individual point represents the mean 
triplicate data from an individual lymph node from one animal.  Four lymph node types were used from each 
animal (the left bronchial, cranial mediastinal, caudal mediastinal and cranial tracheobronchial) and within each 
group there were either three (five and twelve weeks post infection) or four (nineteen weeks post infection) 
animals.  Error bars represent standard deviation (±) of each point and the mean of each group is shown by — 
symbol.  A significant difference between the three experimental groups is represented by * (p<0.01, Mann 
Whitney test). 
 
IL10 mRNA expression levels (Figure 13) were significantly lower at five weeks post infection 
(mean log2 copy number 5.97) compared to the expression at twelve weeks post infection 
(mean log2 copy number 8.27, p<0.01, Mann-Whitney test and Bonferroni corrected).  Between 
twelve and nineteen weeks post infection, there was a slight reduction in expression for IL10 
(mean log2 copy number 7.03) however this was not significant (p>0.05, Mann Whitney test).  
Though the IL10 mRNA level at nineteen weeks stayed above the level measured at five weeks 
post infection there was no statistical difference between the two time periods (p>0.05, Mann 
Whitney test).   
 
Quantitative PCR of IL4 mRNA expression produced a PCR product with the same crossing 
point values as the negative controls consistently in all of the animal samples.  It was therefore 
not possible to include the data as a reliable indication of IL4 mRNA within the cattle samples. 
 
 
*
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Cytokine mRNA expression in the individual lymph nodes 
 
The cytokine mRNA expression levels of IFN-γ, TNF-α and IL10 over the three time periods 
were analysed within the individual lymph node types (left bronchial, caudal mediastinal, cranial 
mediastinal and cranial tracheobronchial).  The copy numbers of IFN-γ, TNF-α and IL10 from 
every animal over the three different time periods (five, twelve and nineteen weeks) were 
grouped and divided into four categories based on the lymph node type.  The four groups were 
then compared using the Kruskal Wallis test to determine whether there were any statistical 
differences in cytokine expression between the lymph node types.  There was a significant 
difference in the cytokine levels of IFN-γ (p<0.001) and TNF-α (p<0.01) however there was no 
significant difference in IL10 mRNA levels (p>0.05, Kruskal Wallis test).  The same data was 
then applied to the Mann Whitney test (using Bonferroni correction, Table 17) to determine 
specifically which lymph node types displayed a significant difference in IFN-γ and TNF-α 
mRNA expression.  
 
Table 17: Statistical differences (p values determined by Mann Whitney test) of IFN-γ (top right corner) and TNF-α 
(bottom left corner) mRNA expression levels between the four lymph node types over the three experimental time 
periods (five, twelve and nineteen weeks post infection).  
 
 
 
 
 
 
 
 
 
 
 
Significant differences in cytokine mRNA expression levels between the four lymph node types were first ensured 
using the Kruskal Wallis test (IFN-γ; p<0.001, TNF-α; p=0.009 and IL10; p=0.832).  The data for IFN-γ and TNF-α 
expression was then applied to the Mann-Whitney test and the p-values displayed within the table (values are 
deemed significant if lower than 0.008 (Bonferroni corrected) and are in bold type and underlined).  LB: left 
bronchial; CM: caudal mediastinal; CRM: cranial mediastinal; CRT: cranial tracheobronchial lymph nodes. 
 
 
 LB CM CRM CRT 
         
LB   <0.001 0.684 <0.001 
          
CM 0.529   <0.001 0.529 
          
CRM 0.353 0.481   <0.001 
          
CRT 0.029 0.043 <0.001   
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Figure 14: Quantitative PCR of IFN-γ, TNF-α and IL10 mRNA expression within the left bronchial, caudal 
mediastinal, cranial mediastinal and cranial tracheobronchial lymph nodes of cattle infected with M. bovis for five, 
twelve and nineteen weeks.  The data are presented as log2 copy number and each data point represents the 
mean triplicate mRNA expression of each lymph node (at each time point) from either three (five and twelve weeks 
infection) or four animals (nineteen weeks infection).  
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The left bronchial lymph node had between 8.4 and 10 mean log2 copies of IFN-γ mRNA over 
five, twelve and nineteen weeks post M. bovis infection (Figure 14).  This was significantly 
higher than the IFN-γ mRNA expression levels in both the caudal mediastinal (mean log2 copy 
numbers between 2.6 and 5.5, Figure 14) and the cranial tracheobronchial lymph nodes (mean 
log2 copy numbers between 3.2 and 5.5, Figure 12, p<0.001, Mann Whitney test and 
Bonferroni correction, Table 17). 
The cranial mediastinal lymph node had between 9.4 and 9.5 mean log2 copy numbers of IFN-γ 
mRNA over five, twelve and nineteen weeks post M. bovis infection (Figure 14).  This was 
significantly higher than the IFN-γ mRNA expression levels in both the caudal mediastinal and 
the cranial tracheobronchial lymph nodes (p<0.001, Mann Whitney test and Bonferroni 
correction, Table 17).  
There was no significant difference in the level of IFN-γ mRNA expression between the left 
bronchial and cranial mediastinal lymph nodes (p>0.05, Mann Whitney test, Table 17) or 
between the caudal mediastinal and cranial tracheobronchial lymph nodes (p>0.05, Mann 
Whitney test, Table 17).     
 
The cranial tracheobronchial lymph node had between -1.3 and 1.4 mean log2 copies of TNF-α 
mRNA over the five, twelve and nineteen weeks post M. bovis infection (Figure 14). This 
appeared to be significantly lower than the TNF-α mRNA expression levels in the left bronchial 
(mean log2 copy numbers between 2.7 and 4, Figure 14), the caudal mediastinal (mean log2 
copy numbers between 1.4 and 4, Figure 14) and the cranial mediastinal lymph nodes (mean 
log2 copy number between 3.3 and 6, Figure 14, p<0.05, Mann Whitney test, Table 17).  
However, applying Bonferroni correction, the only significant difference in TNF-α expression 
was between the cranial tracheobronchial and cranial mediastinal lymph nodes (p>0.001, Mann 
Whitney test, Table 17).   
There was no significant difference in the level of TNF-α mRNA expression between the left 
bronchial, cranial mediastinal and caudal mediastinal lymph nodes (p>0.05, Mann Whitney test, 
Table 17). 
 
As previously mentioned, there was no significant difference in IL10 mRNA expression 
between the four lymph node types (p>0.05, Kruskal Wallis test).  The expression of IL10 
mRNA ranged between 5.5 and 10 mean log2 copies over the five, twelve and nineteen weeks 
post infection for all four lymph nodes (Figure 14).   
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Cytokine profile of the left bronchial lymph node 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Quantitative PCR of IFN-γ, IL10 and TNF-α mRNA expression within the left bronchial lymph node of 
cattle infected with M. bovis for five, twelve and nineteen weeks.  The data are presented as log2 copy number and 
each point represents the combined mean triplicate data of each left bronchial lymph node from either three 
animals (five and twelve weeks post infection) or four animals (nineteen weeks post infection).  Differences 
between time periods were not significant (p>0.016, Mann Whitney and Bonferroni correction). 
 
Within the left bronchial lymph node, the mRNA expression levels of IFN-γ, TNF-α and IL10 
over the three time periods paralleled the results seen in combining all of the lymph nodes 
(Figures 11, 12 and 13).   
Between five and twelve weeks post infection there was a slight increase in IFN-γ mRNA 
expression (mean log2 copy number 9.81 and 10, respectively, Figure 15) and then a decrease 
between twelve and nineteen weeks (mean log2 copy number 8.39).  The level of IFN-γ at 
nineteen weeks post infection was lower than at five and twelve weeks post infection, however 
this was not significant (p>0.016, Mann Whitney test and Bonferroni correction).   
IL10 mRNA levels displayed an increase between five and twelve weeks post infection (mean 
log2 copy number 5.87 and 9.65, respectively, Figure 15) and a decrease between twelve and 
nineteen weeks (mean log2 copy number 5.46) to that below the expression level at five weeks.   
The mRNA level of TNF-α also increased between five and twelve weeks post infection (mean 
log2 copy number 2.95 and 3.92, respectively) and then decreased between twelve and 
nineteen weeks (mean log2 copy number 2.73). 
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Within the left bronchial lymph node, IFN-γ mRNA was the dominant cytokine expressed at a 
significantly higher level when compared to IL10 and TNF-α mRNA over the three time periods 
(p=0.01 and <0.001, respectively, Mann Whitney test and Bonferroni correction).  IL10 was the 
second highest expressed cytokine mRNA and was higher than TNF-α mRNA expression, 
however this was not significant after application of the Bonferroni correction (p=0.022, Mann 
Whitney test).  TNF-α was the least expressed cytokine mRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Percentage profile of cytokines IFN-γ, TNF-α and IL10 mRNA within the left bronchial lymph node over 
five (a), twelve (b) and nineteen (c) weeks post infection.  The cytokine copy number data from the mean triplicate 
results of each left bronchial lymph node from either three (five and twelve weeks) or four (nineteen weeks) cattle 
were combined and each individual cytokine value calculated as a percentage of the overall expression profile. 
 
The data in Figure 15 was used to build a profile of the percentage of each expressed cytokine 
within the left bronchial lymph node at each time point (Figure 16).   As previously mentioned, 
IFN-γ mRNA was expressed at a significantly higher level (in copy number) as compared to 
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TNF-α and IL10 mRNA within the left bronchial lymph node (Figure 15).  Similarly, when the 
copy number data was converted into a percentage profile, IFN-γ was the largest component 
over the entire nineteen week infection period (Figure 16).  Between five and twelve weeks of 
infection, the percentage of IFN-γ as a component of the left bronchial lymph node profile 
decreased (from 53% to 42%) accompanied by an increase in both TNF-α (from 16% to 18%) 
and IL10 (from 31% to 40%, Figure 16).  At nineteen weeks post infection, IFN-γ mRNA 
expression as a percentage of the profile increased (50%) whereas levels of TNF-α and IL10 
decreased (17% and 33%, respectively, Figure 16).   
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Cytokine profile of the cranial mediastinal lymph node 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Quantitative PCR of IFN-γ, IL10 and TNF-α mRNA expression within the cranial mediastinal lymph 
node of cattle infected with M. bovis for five, twelve and nineteen weeks.  The data are presented as log2 copy 
number and each point represents the combined mean triplicate data of each cranial mediastinal lymph node from 
either three animals (five and twelve weeks post infection) or four animals (nineteen weeks post infection).  
Differences between time periods were not significant (p>0.05, Kruskal Wallis test). 
 
Within the cranial mediastinal lymph node, the cytokine expression levels of IL10 and TNF-α 
mRNA showed a similar pattern to the combined lymph node data (Figures 11, 12 and 13).  
Between five and twelve weeks post infection, there was an increase in IL10 mRNA levels 
(mean log2 copy number 6 and 10.22, respectively, Figure 17) and a decrease between twelve 
and nineteen weeks post infection (mean log2 copy number 7.35).   
The expression levels of TNF-α mRNA increased between five and twelve weeks post infection 
(mean log2 copy number 3.35 and 5.91, respectively, Figure 17) and decreased between 
twelve and nineteen weeks post infection (mean log2 copy number 4.95). 
The expression levels of IFN-γ showed a slightly different pattern over time (Figure 17).  The 
mRNA level remained stable between five and twelve weeks post infection (mean log2 copy 
number 9.53, Figure 17) with a very slight decrease at nineteen weeks infection (mean log2 
copy number 9.40).  The changes in cytokine mRNA copy number seen within the cranial 
mediastinal were not significant (p>0.05, Kruskal Wallis test). 
The cytokine mRNA copy numbers of the cranial mediastinal lymph node showed a joint 
dominance of IFN-γ and IL10 mRNA expression (p>0.05, Mann Whitney test).  IFN-γ was 
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expressed at a significantly higher level when compared to TNF-α (p<0.001, Mann Whitney 
test).  However, upon application of the Bonferroni correction, there was no significant 
difference between IL10 and TNF-α expression (p>0.016, Mann Whitney test) despite IL10 
being expressed at a higher level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Percentage profile of cytokines IFN-γ, TNF-α and IL10 mRNA within the cranial mediastinal lymph node 
over five (a), twelve (b) and nineteen (c) weeks post infection.  The cytokine copy number data from the mean 
triplicate results of each cranial mediastinal lymph node from either three (five and twelve weeks) or four (nineteen 
weeks) cattle were combined and each individual cytokine value calculated as a percentage of the overall 
expression profile. 
 
The data in Figure 17 was used to build a profile of the percentage of each cytokine within the 
cranial mediastinal at each time point (Figure 18).   As previously mentioned, IFN-γ and IL10 
mRNA were both expressed at a higher level (in copy number) as compared to TNF-α mRNA 
within the cranial mediastinal lymph node (Figure 17).  Following conversion into a percentage 
profile, IFN-γ mRNA is the largest expressed component in the cranial mediastinal lymph node 
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at five weeks post infection (IFN-γ at 50%, TNF-α at 18% and IL10 at 32%, Figure 18).  At 
twelve weeks post infection, although IFN-γ mRNA copy number levels remained constant 
(Figure 17), the percentage of IFN-γ mRNA as a component of the lymph node cytokine profile 
decreased (37%, Figure 18).  Between five and twelve weeks, the percentages of both IL10 
and TNF-α mRNA increased (40% and 23%, respectively, Figure 18).  As a consequence, IL10 
expression replaced IFN-γ as the largest component of the cytokine profile at twelve weeks of 
infection.  Following nineteen weeks of M. bovis infection, the percentage of IFN-γ mRNA 
within the lymph node increased (43%) however this was still lower than at five weeks post 
infection.  The percentage of IL10 mRNA within the cranial mediastinal lymph node decreased 
at nineteen weeks post infection (34%) whereas levels of TNF-α mRNA remained stable (23%, 
Figure 18). 
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Cytokine profile of the cranial tracheobronchial lymph node 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Quantitative PCR of IFN-γ, IL10 and TNF-α mRNA expression within the cranial tracheobronchial lymph 
node of cattle infected with M. bovis for five, twelve and nineteen weeks.  The data are presented as log2 copy 
number and each point represents the combined mean triplicate data of each cranial tracheobronchial lymph node 
from either three animals (five and twelve weeks post infection) or four animals (nineteen weeks post infection).  
Differences between time periods were not significant (p>0.05, Kruskal Wallis test) 
 
The expression patterns of IFN-γ and TNF-α were very similar within the cranial 
tracheobronchial lymph node (Figure 19).  IFN-γ mRNA increased between five and twelve 
weeks post infection (mean log2 copy number 4.07 and 5.07, respectively, Figure 19) and 
decreased between twelve and nineteen weeks (mean log2 copy number 3.19). 
The level of TNF-α mRNA expression increased between five and twelve weeks post infection 
(mean log2 copy number 0.85 and 1.4, respectively, Figure 19) and decreased between twelve 
and nineteen weeks infection (mean log2 copy number -0.32). 
The expression level of IL10 mRNA showed a slightly different pattern (Figure 19), by 
increasing steadily between five (mean log2 copy number 6.68) twelve (mean log (2) copy 
number 7.32) and nineteen weeks post infection (mean log2 copy number 7.78).  The 
differences in cytokine expression between the time periods were not significant (p>0.05, 
Kruskal Wallis test). 
Within the cranial tracheobronchial lymph node, IL10 mRNA was dominantly expressed above 
both IFN-γ and TNF-α (p<0.001, Mann Whitney test and Bonferroni correction).  IFN-γ mRNA 
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was expressed at a significantly higher level as compared to TNF-α (p<0.001, Mann Whitney 
test and Bonferroni correction). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Percentage profile of cytokines IFN-γ, TNF-α and IL10 mRNA within the cranial tracheobronchial lymph 
node over five (a), twelve (b) and nineteen (c) weeks post infection.  The cytokine copy number data from the 
mean triplicate results of each cranial tracheobronchial lymph node from either three (five and twelve weeks) or 
four (nineteen weeks) cattle were combined and each individual cytokine value calculated as a percentage of the 
overall expression profile. 
 
The data in Figure 19 was used to build a profile of the percentage of each cytokine within the 
cranial tracheobronchial lymph node at each time point (Figure 20).   As previously mentioned, 
IL10 mRNA was expressed at a significantly higher level (in copy number) as compared to IFN-
γ and TNF-α mRNA within the cranial tracheobronchial lymph node (Figure 19).  Similarly, 
when the copy number data was converted into a percentage profile, IL10 was the largest 
component over the entire nineteen week infection period (Figure 20).  Between five and twelve 
weeks of infection, the percentage of IL10 as a component of the cranial tracheobronchial 
lymph node profile decreased (from 58% to 53%), accompanied by an increase in both IFN-γ 
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(from 35% to 37%) and TNF-α (from 7% to 10%, Figure 20).  Nineteen weeks post infection, 
the percentage of IL10 mRNA expression within the profile increased to a level above that 
observed at five weeks of infection (69%) whereas percentage levels of both IFN-γ and TNF-α 
mRNA expression decreased (28% and 3%, respectively, Figure 20). 
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Cytokine profile of the caudal mediastinal lymph node 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Quantitative PCR of IFN-γ, IL10 and TNF-α mRNA expression within the caudal mediastinal lymph 
node of cattle infected with M. bovis for five, twelve and nineteen weeks.  The data are presented as log2 copy 
number and each point represents the combined mean triplicate data of each caudal mediastinal lymph node from 
either three animals (five and twelve weeks post infection) or four animals (nineteen weeks post infection).  
Differences between time periods were not significant (p>0.05, Kruskal-Wallis test). 
 
The expression of IFN-γ mRNA increased between five and twelve weeks (mean log2 copy 
number 2.57 and 5.51, respectively, Figure 21) and decreased between twelve and nineteen 
weeks post infection (mean log2 copy number 3.89). 
Between five and twelve weeks post infection, TNF-α mRNA expression increased (mean log2 
copy number 1.5 and 3.9, respectively) and then increased further between twelve and 
nineteen weeks (mean log2 copy number 4.5, Figure 21). 
The level of IL10 mRNA expression increased steadily over five (mean log2 copy number 5.31), 
twelve (mean log2 copy number 6.99) and nineteen weeks post infection (mean log2 copy 
number 7.51, Figure 21).  
The cytokine profile within the caudal mediastinal lymph node showed a dominant expression 
of IL10 mRNA significantly higher than IFN-γ expression (p<0.016, Mann Whitney test and 
Bonferroni correction) and higher than TNF-α mRNA expression (p<0.05, Mann Whitney test 
and Bonferroni correction).  IFN-γ and TNF-α were expressed at a similar level (p>0.05, Mann 
Whitney test). 
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Figure 22: Percentage profile of cytokines IFN-γ, TNF-α and IL10 mRNA within the caudal mediastinal lymph node 
over five (a), twelve (b) and nineteen (c) weeks post infection.  The cytokine copy number data from the mean 
triplicate results of each caudal mediastinal lymph node from either three (five and twelve weeks) or four (nineteen 
weeks) cattle were combined and each individual cytokine value calculated as a percentage of the overall 
expression profile. 
 
The data in Figure 21 was used to build a profile of the percentage of each cytokine within the 
caudal mediastinal lymph node at each time point (Figure 22).   As previously mentioned, IL10 
mRNA was expressed at a significantly higher level (in copy number) as compared to both IFN-
γ and TNF-α mRNA within the caudal mediastinal lymph node (Figure 21).  Similarly, when the 
copy number data was converted into a percentage profile, IL10 was the largest component 
over the entire nineteen week infection period (Figure 22).  Between five and twelve weeks of 
infection, the percentage of IL10 as a component of the caudal mediastinal lymph node profile 
decreased (from 57% to 43%), accompanied by an increase in both IFN-γ (from 27% to 33%) 
and TNF-α (from 16% to 24%, Figure 22).  Between twelve and nineteen weeks post infection, 
IL10 mRNA percentage expression levels increased (48%) however the levels did not reach 
(c) 
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those seen at five weeks post infection.  At the same time, the percentage levels of IFN-γ 
mRNA within the profile decreased (24%).  The levels of TNF-α mRNA as percentage of the 
profile increased slightly at nineteen weeks post infection (28%) to become the second largest 
component of the cytokine lymph node profile.  This is in contrast to the other three lymph 
nodes at nineteen weeks post infection, where IFN-γ and IL10 mRNA were the two largest 
components of the lymph node profile (Figures 16, 18 and 20).  
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Correlations between cytokine mRNA expressions  
 
The previous results shown in Figures 15, 17, 19 and 21 suggest that there may be a 
relationship between the expression patterns of IFN-γ, TNF-α and IL10 mRNA.  This was 
further explored using Pearsons correlation co-efficient analysis. 
 
 
 
 
 
 
 
 
(a) 
 
 
 
 
 
 
 
 
(b) 
 
 
Figure 23: Correlations between (a) IL10 and TNF-α mRNA expression levels and (b) IFN-γ and TNF-α mRNA 
expression levels.  The data are presented in log2 copy number and each individual point represents the mean 
triplicate data from an individual lymph node from one animal.  Each graph displays the equation of the line of best 
fit and the R2 value to indicate the fit of the data points. 
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A significant correlation was found between IL10 and TNF-α mRNA copy number expression 
levels (p<0.001, Pearsons correlation coefficient, Figure 23a) within the lymph nodes of cattle 
infected with M. bovis for five, twelve and nineteen weeks.  The data presented a positive 
correlation (Pearsons correlation coefficient R value of 0.7) and therefore indicates that as one 
cytokine expression level increased, the other cytokine also experienced an increase.  There 
was also a significant correlation between IFN-γ and TNF-α mRNA copy number expression 
levels (p≤0.001, Pearsons correlation coefficient, Figure 23b) within the lymph nodes of cattle 
infected with M. bovis for five, twelve and nineteen weeks.  The data presented a positive 
correlation (Pearsons correlation coefficient R value of 0.5) however this relationship was 
slightly weaker than the relationship between IL10 and TNF-α.  This was further represented by 
the coefficient of determination (R2 displayed on Figure 23) as the correlation of IL10 and TNF-
α mRNA had an R2 value of 0.45 (Figure 23a) indicating that 45% of the variance in one 
cytokine expression level was due to the other cytokine.  The coefficient of determination for 
the correlation of IFN-γ and TNF-α mRNA (R2 of 0.26, Figure 23b) suggested that 26% of the 
variance in one cytokine expression level was due to the other cytokine. 
 
There was no significant correlation between IFN-γ and IL10 mRNA expression levels over the 
five, twelve and nineteen weeks post M. bovis infection (p>0.05, Pearsons correlation 
coefficient).  
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Lymph node pathology of cattle infected with M. bovis for five, twelve and 
nineteen weeks.   
 
Percentage area coverage of granuloma  
Granulomatous lesions within lymph nodes are a characteristic feature of M. bovis infection.  
The percentage area coverage of granulomas within individual lymph nodes can be used as an 
indication of the pathology caused by infection.  Microscope slides of lymph node tissue were 
prepared for each animal infected for five, twelve and nineteen weeks.  The lymph node section 
was first measured by counting the total fields of view that the section covered (100 x 
magnifications).  Each individual granuloma within the section was then measured by counting 
the number of fields of view that the granulomas covered and the percentage area coverage 
calculated in respect to the entire lymph node section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Percentage area coverage of granulomas (representing pathology) within cattle infected with M. bovis 
for five, twelve and nineteen weeks.  The data represents the mean percentage of the combined individual lymph 
node results from either three cattle (five and twelve week groups) or four cattle (nineteen week group).  Error bars 
represent standard deviation (±) of data from the mean.  There was no statistically significant difference between 
the three groups (p>0.05, Kruskal Wallis test). 
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Figure 25: Percentage area coverage of granulomas (representing pathology) plotted against IFN-γ mRNA 
expression levels in the lymph nodes of cattle infected with M. bovis for five, twelve and nineteen weeks.  The data 
represents the mean values (either percentage or copy number) for each lymph node type from a total of ten cattle 
(three infected for five weeks, three infected for twelve weeks and four infected for nineteen weeks).  Error bars 
represent standard deviation (±) of data from the mean.  There was no statistical significance between the four 
groups (p>0.05, Kruskal Wallis test).  
 
The percentage area coverage of granulomas within lymph node tissues varied considerably 
over the nineteen week infection time period (Figure 24).  The cattle infected for five weeks 
displayed the highest level of granuloma percentage coverage (mean 32%, Figure 24) followed 
by the twelve week group (mean 19.2%) and finally the nineteen week group (mean 14%).  
However, due to the very large variations in data within each group, these differences were not 
significant (p>0.05, Kruskal Wallis test).   
 
There was a strong positive relationship between the level of pathology and the level of IFN-γ 
mRNA expression within the individual lymph nodes (Pearsons correlation coefficient R value 
of 0.9, Figure 25) although this was not significant (p>0.05, Pearsons correlation co-efficient).  
There was also a marked difference in the level of pathology and the level of IFN-γ expression 
between the different lymph nodes.  The left bronchial lymph node displayed the highest level 
of pathology (mean of 33.6% granulomatous coverage, Figure 25) and the highest level of IFN-
γ mRNA expression (mean 962.3 copies, Figure 25).  The cranial mediastinal lymph node 
displayed the second highest level of pathology (mean of 20% granulomatous coverage, Figure 
25) and the second highest level of IFN-γ mRNA expression (mean 732.44 copies).  The third 
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highest level of pathology was found in the cranial tracheobronchial lymph node (mean of 13% 
granulomatous coverage) and the lowest pathology was displayed by the caudal mediastinal 
lymph node (mean of 10.8% granulomatous coverage, Figure 25).  Both the cranial 
tracheobronchial and caudal mediastinal lymph nodes had similar levels of IFN-γ mRNA (mean 
24.7 and 25.6 copies, respectively, Figure 25). 
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Granuloma developmental stage 
Granulomas have been shown to progress through specific stages of development, 
independent of neighbouring lesions.  It is therefore possible to categorise each granuloma 
depending on its physiological state (Wangoo et al, 2005) into: 
• Stage I: Un-encapsulated clusters of epithelioid macrophages with interspersed 
lymphocytes and few neutrophils. 
• Stage II: Partial or complete coverage of granuloma by a thin capsule, containing 
mainly epithelioid macrophages and distributed lymphocytes, 
• Stage III: Completely encapsulated granuloma displaying necrotic centres and 
peripheral clusters of macrophages, lymphocytes and neutrophils. 
• Stage IV: Thickly encapsulated with multiple centres displaying advanced caseous 
necrosis and vast islands of mineralisation.  Epithelioid macrophages and giant cells 
surround the necrotic areas and lymphocytes are densely clustered around the 
periphery.   
It was therefore possible to group the granulomas observed within the slide mounted sections 
of bovine lymph node into the above stages. 
 
Table 18: Categorisation of granulomas within the lymph node sections of cattle infected with M. bovis for five, 
twelve and nineteen weeks.  Granuloma specific for each of the four stages of development (I-IV) were counted 
within slide mounted lymph node sections.  The counts were then weighted using a log2 scale to account for the 
larger sizes of the more advanced granuloma.  
 
Granuloma score (weighted score) 
Animal  M. bovis infection 
(weeks) 
Stage I Stage II Stage III Stage IV Total Mean (SEM) 
8452 
8454 
8453 
8199 
8197 
8198 
4238 
4240 
4241 
4242 
Five 
Five  
Five 
Twelve 
Twelve 
Twelve 
Nineteen 
Nineteen 
Nineteen 
Nineteen 
2 (2) 
0 (0) 
3 (3) 
13 (13) 
10 (10) 
2 (2) 
9 (9) 
1 (1) 
4 (4) 
3 (3) 
4 (8) 
0 (0) 
3 (6) 
0 (0) 
13 (26) 
1 (2) 
3 (6) 
0 (0) 
0 (0) 
1 (2) 
0 (0) 
0 (0) 
3 (12) 
0 (0) 
3 (12) 
0 (0) 
7 (28) 
0 (0) 
3 (12) 
1 (4) 
1 (8) 
1 (8) 
4 (32) 
2 (16) 
4 (32) 
0 (0) 
9 (72) 
0 (0) 
5 (40) 
0 (0) 
18 
8 
53 
29 
80 
4 
115 
1 
56 
9 
 
 
26.3 (13.64) 
 
 
37.6 (22.36) 
 
 
 
45.2 (26.22) 
Weighting was applied accordingly: Stage I (x1), Stage II (x2), Stage III (x4), Stage IV (x8). Data represents the 
combined results from each of the four lymph nodes within each animal.  
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The data for the percentage area coverage of granulomatous lesions for each individual animal 
displayed a positive relationship with the categorised granuloma stage results (p<0.05, 
Spearmans correlation co-efficient, Table 18).  Therefore as the percentage area coverage of 
granulomas within the lymph nodes increased, there was also an increase in the weighted total 
of granuloma development. 
 
There was also a marked difference between the three experimental groups in granuloma 
development (Table 18) however, due to the large variations in the data sets these differences 
were not significant (p>0.05, Kruskal Wallis test).  The cattle infected for five weeks showed the 
lowest score for granuloma development (mean 26.3, Table 18).  This score increased within 
the lymph nodes of cattle infected for twelve weeks (mean 37.6).  Finally, the nineteen week 
infection group displayed the highest level of granuloma development (mean 45.2, Table 18).   
 
Focusing on the individual granuloma stage results, the five and twelve week groups had 
exactly the same scores for stage III (total of all three animals within each group was 12, Table 
18) and stage IV (total 48) granuloma.  However, the five week group had lower scores for 
granuloma within stages I (total 5) and II (total 14) as compared to the twelve week group (total 
25 and 28, respectively). 
Between twelve and nineteen weeks post infection, the number of granuloma within stages I 
and II decreased (total of all four animals within the nineteen week group was 17 and 8, 
respectively, Table 18).  Alternatively, the number of granuloma within stages III and IV 
increased (total 44 and 112, respectively).  Due to the small number of data points, these 
differences were not significant (p>0.05, Kruskal Wallis test). 
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Whole blood IFN-γ culture 
 
To complement the cytokine expression studies within the lymph nodes, heparinized whole 
blood samples were taken from each animal prior to the cattle being euthanized for subsequent 
IFN-γ analysis.  Three individual antigens were used to stimulate the blood culture lymphocytes 
to produce IFN-γ; PPD-B, ESAT-6 and CFP-10.  PPD-A was also measured to ascertain 
previous exposure of cattle to environmental mycobacterial species (data not shown).  The 
levels of IFN-γ were measured using a commercially available enzyme-linked immunosorbent 
assay kit (BOVIGAM®) and the results were expressed as mean optical density (OD at 450 
nm).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Expression of IFN-γ mRNA in lymph nodes and IFN-γ protein in whole blood of cattle infected with M. 
bovis for five, twelve and nineteen weeks.  PBMCs were stimulated by PPD-B and the results expressed as mean 
optical density (OD) of the combined animal results within each group (three cattle in the five and twelve week 
groups and four cattle in the nineteen week group).  The lymph node mRNA data represents the mean of the 
combined results for every animal (including all four lymph nodes examined for each animal) within each group.  
Error bars represent standard deviation (±) from the mean.  There was no significant difference between the three 
groups (p>0.05, Kruskal Wallis test). 
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Figure 27: Expression of IFN-γ mRNA in lymph nodes and IFN-γ protein in whole blood of cattle infected with M. 
bovis for five, twelve and nineteen weeks.  PBMCs were stimulated by ESAT-6 and the results expressed as mean 
optical density (OD) of the combined animal results within each group (three cattle in the five and twelve week 
groups and four cattle in the nineteen week group).  The lymph node mRNA data represents the mean of the 
combined results for every animal (including all four lymph nodes examined for each animal) within each group.  
Error bars represent standard deviation (±) from the mean.  There was no significant difference between the three 
groups (p>0.05, Kruskal Wallis test). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Expression of IFN-γ mRNA in lymph nodes and IFN-γ protein in whole blood of cattle infected with M. 
bovis for five, twelve and nineteen weeks.  PBMCs were stimulated by CFP-10 and the results expressed as mean 
optical density (OD) of the combined animal results within each group (three cattle in the five and twelve week 
groups and four cattle in the nineteen week group).  The lymph node mRNA data represents the mean of the 
combined results for every animal (including all four lymph nodes examined for each animal) within each group.  
Error bars represent standard deviation (±) from the mean.  There was no significant difference between the three 
groups (p>0.05, Kruskal Wallis test). 
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Antigenic stimulation of whole blood samples isolated from cattle experimentally infected with 
M. bovis for five, twelve and nineteen weeks showed differing patterns in IFN-γ protein 
expression dependent on the antigen used (Figures 26, 27 and 28).  Stimulation with PPD-B 
displayed little difference in IFN-γ protein expression over the nineteen week period (mean OD 
of 2.49 at five weeks, 2.45 at twelve weeks and 2.5 at nineteen weeks, Figure 26).  ESAT-6 
antigenic stimulation of isolated PBMCs displayed a higher level of IFN-γ protein at five weeks 
(mean OD of 0.99), followed by a decrease at twelve weeks (mean OD of 0.11) and a final 
increase at nineteen weeks (mean OD of 1.2, Figure 27) post infection.  In contradiction, 
antigenic stimulation by CFP produced an increase in IFN-γ protein expression between five 
and twelve weeks (mean OD of 2 and 2.19, respectively) followed by a decrease between 
twelve and nineteen weeks (mean OD of 1.2, Figure 28) post infection.  These differences were 
statistically not significant (p>0.05, Kruskal Wallis test). 
 
The IFN-γ protein expression patterns of antigenic stimulated whole blood did not show a 
positive relationship with the IFN-γ mRNA expression patterns of the lymph nodes over the 
nineteen week period (Figures 26, 27 and 28).  The ESAT-6 stimulated PBMCs actually 
displayed a negative correlation with the lymph node data (p<0.05, Pearsons correlation co-
efficient, Figure 27).  This signified that as the level of IFN-γ protein expression within the 
ESAT-6 stimulated blood sample increased, the IFN-γ mRNA expression levels within the 
lymph nodes decreased accordingly.  
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Discussion 
 
Mycobacterium bovis infection of cattle is a major threat to both the global economy and 
healthcare state.  Despite nearly sixty years of extensive control and preventative schemes, the 
incidence of M. bovis infection has been increasing significantly within Great Britain over the 
last twenty years (Delahay et al, 2002).  Following the Krebs report in 1997, governmental 
emphasis has focused on scientific research into both the transmission of M. bovis and its 
pathogenic capabilities, with the aim of developing a more effective vaccination protocol (Krebs 
et al, 1997).  A major part of this work has included detailed exploration of the bovine immune 
response post M. bovis infection to provide a greater understanding of the fine line between 
protection and immunopathology (Reynolds 2006).  There is currently ample evidence to 
suggest that the cell mediated immune response is an essential component of the hosts fight 
against the disease (Widdison et al, 2006, Thacker et al, 2007).  The study of cytokines has 
therefore become a useful representative of the bovine immune response to M. bovis infection.     
      
The common route of M. bovis infection is through inhalation of the bacilli leading to 
pathological damage primarily within the lungs (Palmer et al, 2002).  Murine Mycobacterium 
tuberculosis studies have revealed that transport of the bacilli from the lungs to the draining 
lymph nodes is essential in activating a cell mediated immune response (Chackerian et al, 
2002).  Therefore the primary site of infection and adaptive immunity occurs within the hosts’ 
lung draining lymph nodes, thus providing the optimal site for investigation.  To enable study of 
cytokine expression at the site of infection (lymph nodes) in vivo places huge limitations on the 
flexibility of the research study.  The majority of studies focusing on immune responses within 
the lymph nodes, in particular within larger animals such as cattle have been restricted to one 
time period post infection only (Widdison et al, 2006, Thacker et al, 2007, Liebana et al, 2007).  
Alternatively, it has been suggested that the cytokine levels within the hosts peripheral blood 
mononuclear cells (PBMCs) could be used to provide a measure of the cell mediated response 
occurring within the lymph nodes (Guerkov et al, 2003).  The ease with which PBMCs can be 
collected from experimentally infected animals has meant that many time course experiments 
based on cytokine expression have been performed on PBMCs (Thacker et al, 2007, Joardar 
et al, 2002).  The disadvantage of this method is the reliability of the PBMCs to represent a true 
profile of the activated cell mediated immune response within the lymph nodes, a concept that 
is still under debate (Coussens et al, 2004, Rhodes et al, 2000).  This study was aimed at 
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analysing the expression of four cytokines; interferon gamma (IFN-γ), tumour necrosis factor 
alpha (TNF-α), interleukin 10 and interleukin 4 directly within the lymph nodes of the bovine 
thorax over a nineteen week time period (five, twelve and nineteen weeks post infection).  The 
lymph nodes of the thorax including the cranial mediastinal, caudal mediastinal, left bronchial 
and cranial tracheobronchial nodes have been previously shown to display pathological lesions 
within naturally infected cattle (Liebana et al, 2007) due to their direct contact via drainage from 
the lungs.  The study of these particular four cytokines within the lymph nodes therefore 
allowed a greater understanding of the dynamics of the immune response, including both 
innate and adaptive immunity dependent on time post infection.          
    
Total RNA extraction from formalin-fixed, paraffin embedded M. bovis 
infected bovine lymph nodes 
 
To enable the quantification of target cytokine expression levels, total RNA was extracted from 
the formalin-fixed, paraffin embedded lymph node tissue samples using a previously published 
methodology (Witchell et al, 2008).  The total RNA was then analysed by agarose gel 
electrophoresis and spectrophotometry to determine the overall integrity of the extracted 
samples. 
Extensive debate has been focussed on the use of formalin-fixed tissues as a source of total 
RNA (Bustin, 2006, Castiglione et al, 2007, Witchell et al, 2008, Gilbert et al, 2007).  Variable 
results have been obtained on the efficacy of RNA extraction from formalin-fixed tissues due to 
the formation of amino acid methylene bridges during the fixation process (Srinivasan et al, 
2002).  The cross-linked matrix formed by these bridges traps the RNA molecules thereby 
impeding the extraction process.  However, the methodology employed to extract the RNA can 
have a great effect on the quality of the isolated nucleic acid (Gilbert et al, 2007).  Extraction 
methods involving a proteinase K tissue digestion step have shown an enhanced ability to 
isolate total RNA from formalin-fixed tissues as compared to methods independent of 
proteinase K (Witchell et al, 2008).  This is believed to be due to proteinase K being able to 
separate the RNA from its cross-linked matrix (Lewis et al, 2001).  Also, the development of the 
real time polymerase chain reaction (PCR) from the conventional agarose gel PCR has 
established the use of comparatively shorter target amplicon sequences, thus allowing 
successful amplification of partially degraded RNA templates (Huggett et al, 2005, Castiglione 
et al, 2007). 
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Within this study, total RNA was extracted from formalin-fixed lymph node samples and 
displayed the appropriate 28S ribosomal band on the agarose gel (Figure 8).  The 
spectrophotometry results confirmed the purity of the total RNA samples (Table 16), as the 
260/280 nm ratio of 1.8 was between the expected range (Fleige and Pfaffl, 2006), thus 
indicating a lack of protein contamination (Bustin, 2004).  As the lymph node samples produced 
variable quantities of total RNA (with a range of 44.5 to 388μg/ml, Table 16) it was decided to 
perform a two-step quantitative RT-PCR protocol to provide a cDNA pool, allowing a greater 
efficiency in the use of the template.              
 
Cytokine mRNA expression in the combined lymph nodes 
 
The total RNA extracted from the formalin-fixed, M. bovis experimentally infected bovine lymph 
nodes was reverse transcribed and applied to qPCR targeting the cytokines IFN-γ, TNF-α, IL10 
and IL4, in addition to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH).  As GAPDH is a constitutively expressed gene, it was possible to use the amplified 
GAPDH PCR product to determine the overall integrity of the cDNA template.  The crossing 
point values for each GAPDH reaction displayed a consistency in mRNA expression across the 
three experimental groups (average of 35.3 for the five week group, 34 for the twelve week 
group and 34.7 for the nineteen week group, Figure 10).  This suggested that any potential 
differences in cytokine expression between the three experimental groups were unlikely to be 
due to the physical condition of the template.  The mRNA expression levels of IFN-γ, TNF-α, 
IL10 and IL4 were then measured quantitatively in four different lymph nodes from each animal; 
the left bronchial, cranial mediastinal, caudal mediastinal and cranial tracheobronchial lymph 
nodes within the three experimental groups.  The crossing point values of each PCR reaction 
were converted to a quantitative value using the standard curve specific to each cytokine 
(Figure 9).  The standard curves show that as the concentration of the target transcript 
increased, there was a related increase in the level of fluorescence observed.  The resulting 
standard curve was therefore a straight line between the two extreme concentrations (Figure 9) 
and provided a means to quantify the unknown samples.  The qPCR data from the individual 
lymph nodes was combined to produce a complete view of cytokine expression over the entire 
nineteen week time period (Figures 11, 12 and 13).   
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Five weeks post M. bovis infection 
Upon M. bovis infection, the invading bacterial cells within the lungs are believed to be taken up 
by phagocytic cells (Fu et al, 1999) and disseminated to the local lymph nodes via dendritic cell 
movement through the draining lymphatic system (Humphreys et al, 2006, Bhatt et al, 2004) in 
an innate immune dependent manner.  This has been shown to occur at approximately twelve 
to thirteen days (two weeks) post M. tuberculosis infection within murine models (Chackerian et 
al, 2002) and fifteen days following M. bovis infection within bovine models (Thacker et al, 
2007).  Murine studies have also revealed that an adaptive immune response could be initially 
detected (via IFN-γ expression) three to four days after the first appearance of the bacilli within 
the lymph node (Chackerian et al, 2002).  This is due to the infected dendritic cells activating 
naïve T lymphocytes (Cella et al, 1997, Mellman and Steinman, 2001) and inducing a cell 
mediated immune response.   Published bovine infection models have reported the detection of 
an adaptive immune response via the analysis of PBMCs (Thacker et al, 2007, Hanna et al, 
1989) and directly within the draining lymph nodes (Palmer et al, 2007) approximately two to 
three weeks post M. bovis experimental infection.  Delayed activation of the cell mediated 
immune response within the lymph nodes is therefore believed to be a common feature in both 
animal models.   
Within this study, mRNA expression of IFN-γ, TNF-α and IL10 within the bovine lung draining 
lymph nodes was detected at the first time point analysed, five weeks after M. bovis infection 
(Figures 11, 12 and 13).  This time point has been reported to coincide with a peak in the ratio 
of CD4+ and CD8+ T cells circulating within PBMCs of M. bovis infected cattle (Pollock et al, 
1996, Joardar et al, 2002) created due to a significantly larger increase in CD4+ T cells in 
response to infection compared to CD8+ T cells (Villarreal-Ramos et al, 2003, Kennedy et al, 
2002).  CD4+ T cells are preferentially activated due to antigen presentation by dendritic cells 
occurring via the major histocompatibility complex II molecules (Barnes et al, 1994).  In an 
IL12-rich environment, CD4+ T cells express high levels of IFN-γ and infected bovine PBMCs 
have been shown to produce a peak in IFN-γ expression at around thirty days (four weeks) 
post inoculation (Thacker et al, 2007).  This was accompanied by a peak in TNF-α (due to the 
role of IFN-γ in phagocytic cell activation) and a decrease in IL10 expression (Thacker et al, 
2007).  This data, combined with that presented within this study supports the hypothesis that 
at five weeks post infection the immune response is largely cell mediated, characterised by the 
presence of pro-inflammatory cytokines and associated down-regulation of anti-inflammatory 
IL10.  
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Five to twelve weeks post M. bovis infection 
Studies on cytokine expression post mycobacterial infection have shown noticeable fluctuations 
in mRNA expression levels over time (Thacker et al, 2006 and 2007, Dean et al 2005, Welsh et 
al, 2005).  This suggests that the expression patterns of cytokines are not continuous events 
and are subject to numerous control mechanisms as time of infection progresses.  As a result 
of the dynamic characteristics of the immune response, there are conflicting reports of cytokine 
expression in the early stages of M. bovis infection.  PBMCs from infected bovine (Dean et al, 
2005, Joardar et al, 2002) and deer (Thacker et al, 2006) models have been shown to produce 
increasing levels of IFN-γ expression between four and twelve weeks.  However, infected 
bovine PBMC have also been shown to display decreasing levels of both IFN-γ and TNF-α 
expression between five and twelve weeks post inoculation, accompanied by a slight increase 
in IL10 expression (Thacker et al, 2007).  Time dependent changes in cytokine expression are 
also evident in other animal models.  A study on guinea pig lung granulomas displayed a 
decrease in IFN-γ expression between three and six weeks following M. tuberculosis infection, 
with little difference in TNF-α and IL10 expression levels (Ly et al, 2007).  In comparison, a 
cytokine expression study within the lung granuloma of mice revealed an increase in IFN-γ and 
IL10 mRNA levels between three and six weeks of M. tuberculosis infection (Zhu et al, 2003).  
Both studies employed laser microdissection and real time PCR to analyse cytokine expression 
levels and therefore differences in cytokine profiles may be attributed to the different host 
species.  Variations in cytokine expression profiles between the bovine studies may be due to 
the extreme difference in initial inoculation concentration, as the Thacker et al (2007) study 
utilised 103 CFU of M. bovis in comparison to the Dean et al (2005) study that used 1 CFU of 
M. bovis.  The extreme heterogeneity of the immune response between studies and even 
between individual animals within the same study is therefore evident, thus making 
comparisons problematic.  Within this study, there was an increase in mRNA expression of 
both IFN-γ (from a mean log2 copy number of 6.50 to 7.53, Figure 11) and TNF-α (from a mean 
log2 copy number of 2.15 to 3.94, Figure 12) between five and twelve weeks of M. bovis 
infection.  There was also a significant increase in expression of IL10 (from a mean log2 copy 
number of 5.97 to 8.27, p<0.01, Mann Whitney test, Figure 13).       
 
It was originally hypothesised that IL10 was produced primarily by TH2 T cells (Fiorentino et al, 
1989) however more recent evidence has shown IL10 to be produced by a variety of cell types, 
including macrophages (Katakura et al, 2004), dendritic cells (Corinti et al, 2001) and various 
subsets of CD4+ and CD8+ T cells (Vieira et al, 2004, Barrat et al, 2002).  It is typically a 
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cytokine associated with immunoregulation, due to its various roles including suppression of T 
cell differentiation into the effector TH1 subset by down-regulation of macrophage MHC class II 
molecule expression (Sendide et al, 2005) and direct inhibition of IL2, IL4 and IL5 production by 
CD4+ T cells (Joss et al, 2000, Schandene et al, 1994).  IL10 also has an effect on the 
bactericidal properties of phagocytic cells by manipulating the phagocytic pathway and 
inhibiting production of toxic nitric oxide (Gazzinelli et al, 1992, Bogdan et al, 1991).  An 
intermediate of the phagocytic process termed inducible nitric oxide synthase (iNOS) has been 
shown to peak in activity at forty-two days (six weeks) within cattle post M. bovis infection, 
followed by a significant reduction at sixty days (eight and a half weeks, Palmer et al, 2007).  
The reduction in iNOS observed by Palmer et al (2007) therefore occurred around the same 
time (post infection) as the significant increase in IL10 within this study. 
 
Despite its immunosuppressive role on IFN-γ expression, levels of IL10 mRNA have been 
shown to increase relative to mRNA levels of IFN-γ within the lymph nodes of TB-infected 
patients (Lin et al, 1996).  Further analysis of cytokine production by T cell clones derived from 
the bronchoalveolar lavages of Mycobacterium tuberculosis infected humans revealed the 
presence of CD4+ T cell clones producing both IFN-γ and IL10 (Gerosa et al, 1999).  It was 
suggested by Gerosa et al (1999) that the CD4+ IFN-γ+ IL10+ cell phenotype acted as a ‘self-
limiting’ mechanism, with IL10 regulating levels of both TH1 and TH2 cytokines thereby reducing 
the severity of pathology associated with heightened immunological activity.  This hypothesis 
has been supported by recent studies into the T cell response towards Leishmania major 
infection in mice (Anderson et al, 2007).  Protection against the parasite Leishmania is 
dependent upon an efficient and fast-responding TH1 pro-inflammatory response (Locksley et 
al, 1987, Scott et al, 1988) comparable to infection by M. bovis.  Analysis of chronic, localised 
lesions caused by the parasite revealed high levels of pro-inflammatory cytokines as well as 
IL10 but either low or undetectable levels of anti-inflammatory TH2 cytokines (Melby et al, 
1994).  It was found that the antigen-specific IFN-γ+ TH1 cells were responsible for the main 
production of IL10 involved in restricting pathological damage during Leishmania infection 
(Anderson et al, 2007).  This theory may also be applied to tuberculosis infection, as the 
excessive amounts of pro-inflammatory cytokine IFN-γ implicated in extensive pathological 
damage may be controlled by simultaneous expression of IL10.  Therefore the increase in 
expression levels of IFN-γ and TNF-α between five and twelve weeks of infection may 
represent the expanding population of activated T cells and phagocytic cells in response to the 
bacterial threat.  The corresponding significant increase in IL10 expression signifies the hosts’ 
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efforts in controlling this strong cell mediated phenotype which was activated in the earlier 
stages of the infection.     
 
Conversely, as a direct consequence of down-regulating the pro-inflammatory response, IL10 
expression has also been correlated with the decreased ability of the immune system to 
contain the mycobacterial threat (Jamil et al, 2007, Turner et al, 2002).  There is evidence to 
suggest that mycobacteria preferentially induce IL10 expression to suppress the cell mediated 
immune response and therefore prolong bacterial survival (Roque et al, 2007).  M. tuberculosis 
is able to induce dendritic cell production of IL10 via TLR-2 signalling (Jang et al, 2004) and 
IL10 production by macrophages suppresses apoptosis of M. avium infected cells thereby 
preserving bacterial proliferation (Balcewicz-Sablinska et al, 1999).  Co-culture of human 
monocyte-derived dendritic cells with M. bovis Bacillus Calmette Guerin (BCG) has been 
shown to display increased levels of IL10 in a dose-dependent manner as compared to cells 
co-cultured with LPS (Larsen et al, 2007).  The BCG-exposed dendritic cells were also able to 
induce differentiation of naïve T cells into IL10-producing populations (Larsen et al, 2007).  This 
introduces a conflicting concept of the beneficial role of IL10, as it is difficult to differentiate 
between whether the high levels of IL10 produced during infection are the cause of or are in 
response to high bacterial loads (Couper et al, 2008).  For example, early production of IL10 
within M. tuberculosis murine models results in the inability of the host to contain the bacterial 
threat, leading to increased propagation of the bacilli (Roque et al, 2007).  However in 
Leishmania infection, the delayed onset of CD4+ IL10+ T cells is believed to occur in response 
to excessive TH1 levels produced by high bacterial burdens (Anderson et al, 2005, Belkaid et 
al, 2001).  This results in suppression of the cell mediated response and persistence of the 
infection.  The timing of IL10 production may have a considerable effect on its role in the 
development of the infection.  The significant increase in IL10 expression observed within this 
study at twelve weeks post M. bovis infection may therefore have also been induced by the 
invading bacilli and could aid the development of pro-longed disease.   
 
Twelve to nineteen weeks post M. bovis infection 
Between twelve and nineteen weeks post M. bovis infection there was a decrease in mRNA 
expression of IFN-γ (mean log2 copy number of 6.22, Figure 11), TNF-α (mean log2 copy 
number of 3.02, Figure 12) and IL10 (mean log2 copy number of 7.03, Figure 13).  The 
reduction in cell mediated associated cytokine activity at advanced stages of infection has been 
previously reported, with IFN-γ expression showing dramatic decreases between twelve and 
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twenty weeks post infection in bovine PBMCs (Joardar et al, 2002, Dean et al, 2005, Welsh et 
al, 2005) and sixteen weeks post infection in deer PBMCs (Thacker et al, 2006).  Although the 
reductions in cytokine expression at nineteen weeks reported in this study were not significant, 
they do fit the general consensus that advanced stages of disease are associated with a 
dynamic shift from cell mediated to humoral immune responses (Welsh et al, 2005, Pollock et 
al, 2001, Palmer et al, 2000).  Welsh et al (2005) commented on the level of cytokine 
expression diverging from the observed cellular activity twenty weeks after M. bovis infection.  
It was suggested that this may be due to a significant shift in the immune profile from cell 
mediated to humoral, as antibody levels (IgG) were shown to plateau from as early as fifteen 
weeks in the same animals (Welsh et al, 2005).  Thacker et al (2007) also observed that 
cytokine gene expression diminished as the infection progressed.  In support of this, bovine 
antibody responses measured by capture ELISA in response to MPB83 antigen have also been 
shown to peak between one hundred and one hundred and seventy days (fourteen and twenty-
four weeks, McNair et al, 2001), suggesting a heightened humoral response during these time 
periods.    
Possible mechanisms involved in the shift of cell mediated to humoral immunity are still largely 
unknown although there does appear to be an inverse relationship between the two profiles 
(Ritacco et al, 1991).  This may be due to the inhibitory abilities of the different cytokines driving 
either the cell mediated (TH1) or humoral (TH2) responses, as both IFN-γ (cell mediated) and 
IL4 (humoral) have been shown to affect transcriptional factors required for TH receptors within 
T lymphocytes (Goldsby et al, 2003).  However, the results from this study do not support the 
development of a TH2 immune profile, as the expression of TH2 cytokine IL4 remained elusive 
throughout the nineteen weeks of infection (this will be discussed at a later point).  The same 
lack of TH2 development was also reported by Thacker et al (2007) in a bovine cytokine 
expression study performed during the first three months of M. bovis infection.  However, 
although a TH2 specific phenotype was not observed during this time period, the authors 
suggest that the conversion from pro-inflammatory to anti-inflammatory cytokine environment 
may occur after this time. 
Interestingly, within this study although all three cytokines (IFN-γ, TNF-α and IL10) were seen 
to decrease between twelve and nineteen weeks post infection, only IFN-γ expression was 
seen to reduce to levels below that observed at five weeks (Figure 11).  This may be indicative 
of the regulatory role of IL10 described earlier. 
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Absence of IL4 expression over the nineteen week infection period 
Results on the expression of IL4 mRNA within the three experimental groups were deemed 
unreliable due to the comparative levels of expression noted within the associated negative 
controls.  IL4 mRNA has a very short half-life (one hour or less, Ulmland et al, 1998) and has 
been shown to be exceedingly difficult to target during assays (Welsh et al, 2005) due to being 
active at very low copy numbers.  The expression of IL4 has also been reported to decrease 
significantly following mycobacterium infection (Rhodes et al, 2007, Welsh et al, 2005, Thacker 
et al, 2007, Widdison et al, 2006) thus making detection even more difficult.               
 
Cytokine mRNA expression in the individual lymph nodes  
 
The design of the time course study allowed cytokine expression to be studied specific to four 
different types of lung draining lymph node; the left bronchial, cranial mediastinal, caudal 
mediastinal and cranial tracheobronchial.  It was therefore decided to analyse the lymph node 
qPCR data individually to ascertain whether there were any potential differences in cytokine 
expression levels dependent on lymph node location.  Statistical analysis revealed a striking 
difference in IFN-γ (p<0.001, Kruskal Wallis test) and TNF-α (p=0.009, Kruskal Wallis test) 
mRNA expression between the four types of lymph node (Table 17).  Further tests confirmed 
that the four lymph node types could be grouped into two categories dependent on IFN-γ 
mRNA expression.  The left bronchial and cranial mediastinal lymph nodes displayed 
comparatively similar levels of IFN-γ mRNA expression (mean log2 copies between 8.4 and 10 
over the nineteen week period, Figure 14) and were significantly higher (p<0.001, Mann 
Whitney test, Table 17) as compared to the caudal mediastinal and cranial tracheobronchial 
lymph nodes (mean log2 copies between 2.6 and 5.5 over the nineteen week period, Figure 
14).  The expression of TNF-α mRNA did not differ as widely between the four lymph node 
types and only the cranial tracheobronchial lymph node showed some variation, with a 
significantly lower level of expression as compared to the cranial mediastinal node (p<0.016, 
Mann Whitney test and Bonferroni correction, Table 17).  Statistically, IL10 mRNA expression 
levels showed no significant difference between the four lymph node types (p>0.05, Kruskal 
Wallis test, Figure 14).  These results suggest that there was a location dependent effect on the 
immune response exhibited by each of these lymph nodes and that mRNA expression of IFN-γ 
was associated with this variation.   
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Heterogeneity of cytokine expression profiles has also been described for the lung lobes of M. 
tuberculosis infected guinea pigs (Ly et al, 2007).  Comparisons between the peripheries of 
granulomas located in the upper left and lower left lung lobes at six weeks post infection 
revealed a large variation in the percentage of each cytokine in relation to the overall immune 
profile.  The lower left lobes contained granulomas expressing 99.9% TNF-α, 0.1% IFN-γ and 
less than 0.01% IL10 (Ly et al, 2007) whereas the upper left lobe contained granulomas 
expressing 17.73 % TNF-α, 38.45% IFN-γ and 4.99% IL10, equating to a 384.5 fold difference 
in IFN-γ mRNA expression between the two sites.  The authors suggest that haematogenous 
reseeding (bacterial cells returning to the lung via the vascular system, Ho et al, 1978) may 
have led to the upper left lobe containing mainly secondary (blood borne) granulomas (Ly et al, 
2007).  Murine infection models have been used to show that dissemination of bacterial cells 
from the infected lung lobe to the lung draining lymph nodes occurs before extrapulmonary 
dissemination to the contra lateral lung (Mischenka et al, 2002) and may produce vast 
differences in immune responses between the two lung cavities.  Differences in bacterial 
burden have been shown to affect the cytokine profile, observed in the previous supplementary 
study (Boddu-Jasmine et al, 2008), as a lower level of bacilli results in fewer activated T cells 
and a less forceful IFN-γ response.  A study performed on the intratonsilar M. bovis infection of 
cattle revealed a predominance of bacilli within the left medial retropharyngeal lymph node at 
twenty weeks post infection (Griffin et al, 2006b).  This was due to the left medial 
retropharyngeal lymph node being the first lymphatic junction to drain the tonsils.  The high 
number of bacilli correlated with a higher level of pathology as compared to adjacent head 
lymph nodes (Griffin et al, 2006b).  From the data within this study, it is not possible to 
ascertain the reasons behind such a difference in IFN-γ mRNA expression between the four 
lymph node types.  However, it may represent a possible ‘route of dissemination’ in which 
some lymph nodes are infected prior to others and therefore display a more advanced immune 
response.          
 
Cytokine expression profiles within the left bronchial and cranial mediastinal lymph 
nodes 
The individual lymph node types (Figures 15, 17, 19 and 21) displayed a similar cytokine 
expression pattern over the nineteen weeks of infection to that of the combined cytokine data 
(Figures 11, 12 and 13).  Within each lymph node type, the cytokine expression levels of IFN-γ, 
TNF-α and IL10 displayed an increase between five and twelve weeks post infection, followed 
by a decrease between twelve and nineteen weeks post infection, with some exceptions 
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(Figures 19 and 21).  However, by converting the individual cytokine expressions into a 
percentage of the overall profile of the three cytokines, the data reveals differences in the 
dynamic pattern of the response (Figures 16, 18, 20 and 22).  Within the left bronchial and 
cranial mediastinal lymph nodes (both showing overall significantly high levels of IFN-γ mRNA, 
Figure 14), the level of IFN-γ mRNA expression remained consistent between five and twelve 
weeks post infection (mean log2 copies of 9.81 to 10 within the left bronchial and 9.53 within 
the cranial mediastinal lymph node, Figures 15 and 17).  However as a percentage of the 
overall cytokine profile, IFN-γ mRNA expression within both the left bronchial and cranial 
mediastinal lymph nodes decreased between five and twelve weeks (from 53% to 42% and 
50% to 37%, respectively, Figures 16 and 18).  This decrease was accompanied by an 
increase in IL10 (from 31% to 40% within the left bronchial and 32% to 40% within the cranial 
mediastinal lymph node, Figures 16 and 18) and a very slight increase in TNF-α (from 16% to 
18% in the left bronchial and 18% to 23% in the cranial mediastinal).  Between twelve and 
nineteen weeks post infection, both the left bronchial and cranial mediastinal lymph nodes 
showed a decrease in IFN-γ mRNA expression (mean log2 copy of 8.39 and 9.4, respectively, 
Figures 15 and 17).  However, the percentage of IFN-γ mRNA in the overall cytokine profile 
increased between twelve and nineteen weeks (from 42% to 50% within the left bronchial and 
37% to 43% within the cranial mediastinal, Figures 16 and 18).  This increase was 
accompanied by a decrease in the percentage of IL10 mRNA (from 40% to 33% in the left 
bronchial and 40% to 34% in the cranial mediastinal) and little change in the percentage of 
TNF-α mRNA (from 18% to 17% within the left bronchial and a stable 23% in the cranial 
mediastinal, Figures 16 and 18).  These results imply that although the expression levels of 
IFN-γ mRNA were relatively consistent in both lymph node types over the nineteen week 
period, the percentage population of IFN-γ mRNA as a part of the overall immune profile did 
experience changes.  As the percentage population of TNF-α mRNA was also fairly consistent; 
this suggests that a difference in IL10 mRNA expression was the main contributor to the 
changes seen in the immune profile.  Between five and twelve weeks post infection, IL10 
mRNA expression increased to such an extent that it became equal to or larger a percentage of 
the immune profile than IFN-γ mRNA (Figures 16 and 18).  This supports the hypothesis 
mentioned previously, that at twelve weeks post infection the cattle exhibited a significantly 
increased expression of IL10 to regulate over-expression of TH1 cytokines.  However, this 
increase in IL10 appeared to have little impact on IFN-γ and TNF-γ mRNA expression as both 
either remained stable or increased (Figures 15 and 17).  IL10 has been shown to have the 
ability to down-regulate expression of MHC class II associated molecules thereby dampening 
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CD4+ TH1 cell activation (Goldsby et al, 2003) as well as blocking IL12 transcription and 
suppressing nitric oxide formation.  However, murine M. tuberculosis models have shown that 
neutralising IL10 production in CD4+ populations has a negligible effect on IFN-γ production 
(Mason et al, 2007).  Also, studies on IL10 in human models have suggested that the cytokine 
may have both inhibitory and stimulatory roles on CD8+ cells in a time dependent manner 
(Groux et al, 1998) and this may therefore compensate for any loss of IFN-γ production by 
CD4+ cells.     
Between twelve and nineteen weeks of infection, the decrease in IL10 mRNA expression 
resulted in an increase in the percentage contribution of IFN-γ, despite evidence of a decrease 
(Figure 15) or consistent (Figure 17) expression of IFN-γ mRNA.   
The comparatively large decrease in IL10 mRNA expression at nineteen weeks is surprising 
due to its beneficial role in controlling the cell meditated immune response and its reported up-
regulation by mycobacterial antigenic/TLR-2 interaction (Jang et al, 2004).  Interestingly, 
although there was an increase in the percentage of IFN-γ mRNA at nineteen weeks post 
infection, the level was still comparatively lower than the level at five weeks post infection and 
IL10 comparatively higher (Figures 16 and 18).  This may support the hypothesis mentioned 
previously of the down-regulation of pro-inflammatory cytokines as the disease progresses. 
 
Cytokine expression profiles within the cranial tracheobronchial and caudal mediastinal 
lymph nodes 
The cranial tracheobronchial and caudal mediastinal lymph nodes (both showing significantly 
lower levels of IFN-γ expression, Figure 14) displayed a different pattern in the cytokine profile 
compared to the left bronchial and cranial mediastinal lymph nodes.  Between five and twelve 
weeks post infection, there was an increase in all three cytokine mRNA levels within the cranial 
tracheobronchial (mean log2 copies of 4.07 to 5.07 for IFN-γ, 6.68 to 7.32 of IL10 and 0.85 to 
1.4 of TNF-α, Figure 19) and caudal mediastinal lymph nodes (mean log2 copies of 2.57 to 5.51 
for IFN-γ, 5.31 to 6.99 for IL10 and 1.5 to 3.9 for TNF-α, Figure 21).  The same data 
transformed into percentages of the cytokine profile revealed an increase in the percentage of 
IFN-γ (from 35% to 37% for the cranial tracheobronchial and from 27% to 33% for the caudal 
mediastinal lymph node, Figures 20 and 22).  This was accompanied by an increase in TNF-α 
expression (from 7% to 10% and 16% to 24%, respectively) and a decrease in IL10 expression 
(from 58% to 53% and 57% to 43%, respectively).  However, at five and twelve weeks post 
infection, the percentage expression of IL10 was still comparably higher than IFN-γ.      
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Between twelve and nineteen weeks post infection within the cranial tracheobronchial lymph 
node, both IFN-γ and TNF-α mRNA expression decreased (mean log2 copies of 3.19 and 0.32, 
respectively, Figure 19) while IL10 expression increased (mean log2 copies of 7.78, Figure 19).  
The same data transformed into percentages of the cytokine profile revealed an increase in the 
percentage of IL10 to that above what was seen at five weeks of infection (from 53% to 69%, 
Figure 20).  This was accompanied by a decrease in both IFN-γ and TNF-α expression (from 
37% to 28% and 10% to 3%, respectively).  The caudal mediastinal lymph node displayed a 
slightly different pattern between twelve and nineteen weeks, as the expression level of TNF-α 
and IL10 both increased (mean log2 copies of 4.54 and 7.51, respectively, Figure 21) while IFN-
γ decreased (mean log2 copies of 3.89).  This pattern was reflected in the percentage profile, 
as both TNF-α and IL10 increased (from 24% to 28% and 43% to 48%, respectively, Figure 22) 
and IFN-γ decreased in percentage (from 33% to 24%).  The strong presence of IL10 
expression within these two lymph nodes is therefore evident from the very beginning and 
throughout the entire nineteen week period of infection.  This may have had a substantial 
impact on the development of pathological disease, as will be discussed later. 
 
Correlations between cytokine mRNA expressions 
 
The mRNA expression data from the three experimental groups (five, twelve and nineteen 
weeks post infection) displayed a positive relationship between TNF-α and both IL10 (p<0.001, 
Pearsons correlation coefficient, Figure 23a) and IFN-γ (p=0.001, Pearsons correlation 
coefficient, Figure 23b).  Relationships between IFN-γ and TNF-α mRNA expression have been 
previously reported within the lymph nodes (Widdison et al, 2006) and PBMCs (Thacker et al, 
2007) of cattle infected with M. bovis.  IFN-γ has been found to be released by activated T 
lymphocytes directly into the immunological synapse formed at the interface between the T cell 
and APC (Huse et al, 2006).  This allows direct communication between the two cells and 
induces the macrophage to produce TNF-α (Decker et al, 1987), thus creating a positive 
relationship between the two cytokines.   
A relationship between TNF-α and IL10 mRNA expression has also been described previously 
(Widdison et al, 2006). However, this is slightly more difficult to explain as IL10 is known to 
actively down regulate TNF-α expression by inducing macrophage production of soluble TNF-α 
receptor type 2 (TNFR2) to form inactive TNF-α-TNFR2 complexes (Fratazzi et al, 1999).  
However, as previously mentioned TH1 cells have the ability to produce both IFN-γ (which 
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stimulates macrophages to produce TNF-α) and IL10 (Gerosa et al, 1999), therefore providing 
a possible positive relationship between the expression of IL10 and TNF-α.  Alternatively, IL10 
is known to be heavily regulated post-transcription.  Studies into the production of IL10 have 
revealed the importance of transcriptional regulatory factors Sp1 and Sp3 (Brightbill et al, 2000, 
Tone et al, 2000) in IL10 expression, which bind to the IL10 promoter within LPS-stimulated 
macrophages.  Sp1 and Sp3 are both constitutively and ubiquitously expressed (Tone et al, 
2000), however, it has been found that constitutively expressed IL10 mRNA is extremely 
unstable in non-stimulated cells and therefore is unlikely to be translated successfully (Powell 
et al, 2000), thus implying posttranscriptional regulatory controls are involved.  LPS stimulation 
of murine macrophages has been shown to increase IL10 mRNA levels by ~2000 fold while 
secreted IL10 protein levels were increased by only ~10 fold (Nemeth et al, 2007).  Thus, a 
positive relationship between IL10 and TNF-α mRNA expression may not reflect a positive 
association in protein levels.  The knowledge of posttranscriptional regulation of IL10 is 
extremely important for this study as it would suggest that dynamic changes in IL10 mRNA 
expression levels may not directly represent changes in protein levels.  This must therefore be 
taken into consideration when translating mRNA expression in terms of overall cellular 
responses.    
 
Lymph node pathology of cattle infected with M. bovis for five, twelve and 
nineteen weeks 
 
Within this study two comparable factors were used to represent the levels of pathology within 
the M. bovis infected lymph nodes; percentage area coverage of granulomas (Figure 24 and 
25) and granuloma stage (Table 18).  Granulomas are formed by the accumulation of T 
lymphocytes and antigen presenting cells around a central focus to contain bacterial spread 
(Saunders and Cooper, 2000).  Initially a structure to protect the host, as the granuloma grows 
in size as a response of cellular activity it becomes associated with immunopathological harm 
(Mustafa et al, 2008).  Therefore, the percentage area coverage of the granulomas within the 
lymph node sections can give an indication to the progression of the immune response.  A 
study aimed at describing temporal changes in granuloma development within M. bovis 
infected cattle lymph nodes revealed that microscopic lesions could be detected within all 
animals as early as twenty-eight days (four weeks, Palmer et al, 2007) post infection.  Gross 
lesions within the mediastinal and tracheobronchial lymph nodes were later identified at forty-
  Time Course Study 
 
107  
two days (six weeks) post infection (Palmer et al, 2007).  Within this study, granulomas were 
observed within the bovine lymph nodes by microscopy within all three experimental groups 
(five, twelve and nineteen weeks post infection, Figure 24).  Interestingly, the cattle at five 
weeks post infection showed the highest level of pathology (mean 32% granuloma coverage), 
followed by the twelve week (mean 19.2% granuloma coverage) and nineteen week groups 
(mean 14% granuloma coverage, Figure 24).  These differences were not significant due to the 
large variation in data within each experimental group and exclusion of one particular animal 
from the analysis dramatically reduced the mean percentage of the five week group (mean 
17% granuloma coverage, data not shown).  This data would suggest therefore that differences 
in granuloma coverage of the lymph nodes between the three time periods (five, twelve and 
nineteen weeks) were negligible.  Similarly, in the study performed by Palmer et al (2007), 
scoring of the granuloma within the medial retropharyngeal lymph node based on lesion size 
revealed little change in scores between forty-two (six weeks) and three hundred and seventy 
days (fifty-three weeks) post infection.              
Due to the difference in cytokine expression profiles between the four types of lymph node over 
the nineteen week infection period, the percentage granuloma coverage for each lymph node 
was also examined individually (Figure 25).  The mean percentage granuloma spread 
measured within each animal from the three experimental groups was highest within the left 
bronchial lymph node (33%, Figure 25).  This was followed by the cranial mediastinal (20%), 
cranial tracheobronchial (13%) and the caudal mediastinal (10.8%, Figure 25) lymph nodes.  
Therefore, both of the lymph node types displaying high levels of IFN-γ expression (left 
bronchial 962.3 and cranial mediastinal 732.44 mean copies, Figure 25) also displayed the 
highest level of granuloma coverage, revealing a positive relationship between the two 
variables (Figure 25).  A common hypothesis among many published articles on bovine 
tuberculosis infection is the involvement of IFN-γ in high levels of pathological damage 
(Villarreal-Ramos et al, 2003, Thacker et al, 2007, Dean et al, 2005).  IFN-γ is a major 
contributor to the formation of granuloma due to its role in macrophage activation (Orme, 1998) 
and therefore increased levels of IFN-γ expression leads to enhanced granuloma formation.  
Within this study, those lymph node types that displayed stronger cellular activity and IFN-γ 
expression in response to bacterial infection also showed subsequent increased levels of 
pathological damage. 
Immunological studies have also shown a negative relationship between IL10 mRNA 
expression and lesion score (based on increasing severity, Widdison et al, 2006).  IL10 acts to 
down-regulate pro-inflammatory cytokines TNF-α and IFN-γ, and subsequently reduces the 
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formation of granulomas resulting in less pathological damage.  As mentioned previously, 
evidence from murine Leishmania infection models have shown the ability of TH1 cells to 
produce both IFN-γ and IL10 simultaneously with the aim of providing a ‘self-regulative’ 
mechanism (Anderson et al, 2007). Within this study, there were no significant differences in 
IL10 mRNA expression levels between the high pathology and low pathology lymph node types 
(Figure 14).  The same consistency in IL10 expression between cattle displaying high 
pathological levels and those displaying lower levels was also seen within a similar study 
(Thacker et al, 2006).  However, the lymph node types displaying the lower levels of IFN-γ 
expression (caudal mediastinal and cranial tracheobronchial) subsequently showed dominant 
IL10 expression (Figures 20 and 22) and the lowest level of pathology (Figure 25), therefore 
reinforcing the significance of IFN-γ on pathological damage.  Similarly to the Leishmania 
infection model, Thacker et al (2006) suggested that anti-inflammatory cytokine IL10 may act to 
moderate IFN-γ levels to reduce pathological damage.  Interestingly, only the level of IFN-γ and 
not that of IL10 changed in accordance with the level of pathological damage observed within 
this study.  This implies that in environments of high IFN-γ expression, the level of IL10 
produced by the TH1 cells may be insufficient to control pathological development (Jankovic et 
al, 2007).  However, as the level of IFN-γ decreases in response to other stimuli (such as 
decreasing bacterial load), the previously insufficient levels of IL10 may become able to control 
the pro-inflammatory response and subsequently the level of pathological damage.  
Alternatively, it has been suggested by Jankovic et al (2007) that high levels of IFN-γ may lead 
to active blocking of the activity of TH1-produced IL10, therefore allowing an uncontrolled pro-
inflammatory response.  Both of these theories would explain why IL10 levels remain 
consistent between low pathological and high pathological groups, although it would be 
important to also consider the role of post-transcriptional regulation (creating differing levels of 
IL10 protein as compared to IL10 mRNA).        
 
A second method of measuring pathological development within this study was based on the 
stage of granuloma development (Table 18).  Granulomas can be categorised into four stages 
of development depending on their physiological and immunological status (Wangoo et al, 
2005).  The numbers of granuloma within each stage of development were counted for each 
lymph node sample and the data weighted to account for the larger size of the later staged 
granuloma (Table 18).  Comparing the granuloma stage data with the percentage area 
coverage of granuloma for each animal revealed a statistically positive relationship (p<0.05, 
Spearmans correlation co-efficient), due to the close association between granuloma 
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development and granuloma spread throughout the lymph node.  The cattle infected with M. 
bovis for five weeks showed the lowest score for granuloma stage (mean 26.3, Table 18), 
followed by the twelve week (mean 37.6) and the nineteen week groups (mean 45.2), although 
there was no statistical difference (p>0.05, Kruskal Wallis test). 
Research in granuloma development has shown that granulomas are ‘autonomous 
microenvironments’ (Fenhalls et al, 2000) that advance physically irrespective of the state of 
adjacent granuloma.  This therefore creates a vast heterogeneity between different granuloma 
within the same tissue, as different stages of lesion can exist together.  This was seen within 
the experimentally infected cattle of this study, as cattle from each group showed a spread of 
granuloma of each developmental stage (Table 18).  The main difference in granuloma 
development between five and twelve weeks post infection was the number of smaller stage I/II 
granuloma (Table 18).  This coincided with the reported increase in cytokine expression 
between five and twelve weeks (Figures 11, 12 and 13) leading to increased lesion formation.  
Between twelve and nineteen weeks post infection, there was an increase in the number of 
later stage III/VI granuloma (Table 18).  As previously mentioned, the expression levels of IFN-
γ, TNF-α and IL10 decreased between twelve and nineteen weeks, suggesting a loss of 
cellular activity.  However, as IFN-γ expression decreased to a level lower at nineteen weeks to 
that observed at five weeks of infection, the level of TNF-α and IL10 remained higher.  TNF-α is 
crucial in the maintenance of an effective innate response and controlling cellular influx, 
however under the influence of IL4 in a TH2 environment (Hernandez-Pando and Rook, 1994, 
Hernandez-Pando et al, 1997) or in excessively high levels (Bekker et al, 2000) TNF-α displays 
toxic characteristics.  The action of TNF-α under these circumstances leads to increased 
necrosis of susceptible lymphocytes (Seah and Rook, 2001).  This therefore leads to the further 
development of granulomas, from early stage I/II to advanced necrotic stage III/ IV, as 
observed within this study between twelve and nineteen weeks post infection.  This further 
illustrates the immense sophistication of the immune response and the fine line between 
protection and immunopathology.          
 
Whole blood IFN-γ cultures from cattle infected with M. bovis for five, 
twelve and nineteen weeks 
 
The aforementioned cytokine expression studies were performed at the site of infection within 
the lung draining lymph nodes.  However, many previous studies published by different 
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scientific groups have been based on cytokine expression within peripheral blood mononuclear 
cells (PBMC) due to the logistical problems of isolating lymph nodes.  Therefore, IFN-γ protein 
levels from PBMCs were also measured for each animal within the three experimental groups 
of this study using stimulatory antigens purified protein derivative bovis (PPD-B, Figure 26), 
early secretory antigenic target 6-kDa (ESAT-6, Figure 27) protein and culture filtrate protein 
(CFP, Figure 28).  Antigenic stimulation of PBMCs produces a delayed –type hypersensitivity 
(DTH) reaction during which activated T cells, macrophages and neutrophils converge and 
express high levels of IFN-γ (Pollock et al, 1997).  This allowed study into the comparison of 
IFN-γ production between the periphery and actual site of infection over time post infection.   
PPD-B stimulated peripheral IFN-γ expression displayed little change over the nineteen week 
period post infection (mean OD of 2.49 at five weeks, 2.45 at twelve weeks and 2.53 at 
nineteen weeks post infection, Figure 26).  ESAT-6 stimulated peripheral IFN-γ expression 
displayed a significantly negative relationship when compared to the IFN-γ mRNA expression 
within the lymph nodes (p<0.05, Pearsons rank correlation coefficient, Figure 27).  Thus the 
levels decreased between five and twelve weeks (mean OD 0.9 and 0.1, respectively) and 
increased between twelve and nineteen weeks (mean OD 1.29, Figure 27).  However, CFP 
stimulation of PBMC expressed IFN-γ produced a very similar pattern to that observed for the 
IFN-γ mRNA expression within the lymph nodes, with a slight increase between five and twelve 
weeks (mean OD 2 and 2.2, respectively) and a decrease between twelve and nineteen weeks 
(mean OD 1.2, Figure 28) post infection.  There were therefore clear differences in IFN-γ 
expression depending on the stimulatory antigen used.  This phenomenon has also been 
reported in previously published papers, such as a time course study performed on M. bovis 
infection in cattle (Thacker et al, 2007) in which PPD stimulation produced a very different 
pattern of IFN-γ expression as compared to stimulation by an ESAT6:CFP10 recombinant 
fusion antigen.  In contrast, bovine PBMCs infected with 1 cfu of M. bovis displayed very similar 
IFN-γ expression profiles over time post infection when stimulated by either PPD-B or ESAT-6 
(Dean et al, 2005) although the levels were lower after ESAT-6 stimulation, as seen in this and 
other studies (Pollock et al, 2003).  Interestingly, the pattern of IFN-γ expression produced 
within the study by Dean et al (2005) was very similar to the pattern seen in the lymph nodes of 
this study. 
The difference in IFN-γ expression between the three antigenic stimulants may be due to their 
composition affecting differential T cell activation.  A comparative study by Maue et al (2005) 
reported that in vitro stimulation of infected bovine PBMCs by PPD-B and a recombinant ESAT-
6: CFP-10 protein displayed similar responses irrespective of the antigen used, except for 
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CD4+ proliferation.  Antigenic stimulation using PPD-B produced four times the magnitude of 
CD4+ cell proliferation as compared to the recombinant ESAT-6: CFP-10 protein (Maue et al, 
2005).  As CD4+ T cells have been shown to be major producers of IFN-γ, this would therefore 
explain why PPD-B produced a comparatively higher level of IFN-γ in response to stimulation.  
The authors suggest that PPD-B may be more effective in producing a CD4+ response 
because of its composition as an extremely complex antigen (Maue et al, 2005).       
The use of peripheral IFN-γ levels as a representative of the immune response at the site of 
infection is still under debate and there have been numerous studies to support (Hope et al, 
2005, Rhodes et al, 2000 and Vordermeier et al, 2002) and refute (Barnes et al, 1993 and 
Coussens et al, 2004) the theory.  As no significant positive relationship was revealed in IFN-γ 
expression between the lymph nodes and antigenic stimulated PBMCs within this study, the 
data suggests that peripheral cytokine levels are not representative of the site of infection.  The 
results of the ESAT-6 stimulated PBMCs actually refute the theory, due to presenting a 
significantly negative relationship between the two variables (Figure 27).  However, as there 
were no significant differences in IFN-γ expression between the three experimental groups for 
either lymph node data or PBMC data, then the differences seen may be due to natural 
heterogeneity of the immune system.         
 
Conclusion 
 
The bovine immune response post M. bovis infection is an extremely dynamic system, 
displaying huge heterogeneity within the host as well as between different hosts.  The data 
from this study supports the general consensus that a strong cell mediated immune response is 
preferentially activated following M. bovis infection, leading to high levels of IFN-γ mRNA and 
associated TNF-α mRNA expression.  As the infection progressed, the cell mediated immune 
response displayed a ‘self-limiting’ phenotype, in which IL10 was expressed at significantly 
higher levels to compensate for the increased expression of IFN-γ.  This was followed by 
diminished cytokine expression levels at nineteen weeks of infection, suggesting a loss of 
cellular activity perhaps due to a developing humoral response.  This pattern complements 
cytokine and antibody data reported previously by other groups (Palmer et al, 2007, Joardar et 
al, 2002, Dean et al, 2005, Thacker et al, 2006, Thacker et al, 2007, McNair et al, 2001) and 
further adds to the currently insufficient knowledge of immune responses within the actual site 
of infection, the lymph nodes.   
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This study also allowed the comparison of cytokine expression profiles of different lymph node 
types from the bovine lung draining area.  The data showed a significant difference in IFN-γ 
expression between the lymph node types which may imply a specific ‘route of bacterial 
dissemination’ throughout the lymph system.  Interestingly, the lymph node types displaying 
high levels of IFN-γ expression (left bronchial and cranial mediastinal) also displayed the 
highest levels of granuloma coverage, suggesting a positive relationship between IFN-γ and 
pathological disease.  Subsequently, those lymph node types displaying lower levels of IFN-γ 
expression (caudal mediastinal and cranial tracheobronchial) had alternatively dominating IL10 
expression profiles and lower levels of granuloma coverage.  Previous reports had suggested 
that IL10 acted to down-regulate IFN-γ expression to control pathological disease (Thacker et 
al, 2007) and studies on Leishmania infection have shown the ability of TH1 cells to produce 
IFN-γ and IL10 simultaneously as a ‘self-limiting’ mechanism (Anderson et al, 2007).  However, 
there was no significant difference in IL10 expression between the four lymph node types within 
this study irrespective of the level of pathological damage displayed.  This may suggest that the 
control of IL10 on the development of immunopathology may be dependent on the level of IFN-
γ (Jankovic et al, 2007).  It is also important to take into consideration that this data has been 
based purely on mRNA expression of the target cytokines and as mentioned previously, the 
presence of posttranscriptional regulatory controls on IL10 may imply that IL10 mRNA is not a 
true representative of protein levels. 
Finally, the study of PBMC producing IFN-γ protein levels within the same cattle used to 
analyse lymph node IFN-γ mRNA expression levels has shown an ambiguous relationship 
between the two variables.  As there were no significant differences between the three 
experimental groups (five, twelve and nineteen weeks post infection) for either the PBMC or 
lymph node IFN-γ levels, the data remains inconclusive as to whether PBMC immune 
measurements truly represent lymph node profiles.  However, the significant negative 
correlation between ESAT-6 stimulated PBMC IFN-γ production and lymph node IFN-γ levels is 
an interesting result that may need further investigation.             
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RNA isolation and quantitative PCR from HOPE- and formalin-fixed bovine 
lymph node tissues  
 
Introduction 
 
Archived biological material is extremely versatile as it allows analysis of parameters such as 
the pathological and molecular composition many years after the initial experiments were 
performed (Lehmann and Kreipe, 2006, Lewis et al, 2001, Wacharapluesadee et al, 2006).  
Buffered formalin has been widely used as a fixative as it has the capacity to conserve the 
morphological state of the tissue to a high level (Bhudevi and Weinstock, 2003, Srinivasan et 
al, 2002).  Scientists at the VLA (Surrey) therefore routinely archive all experimental material in 
buffered formalin so as to keep a tissue catalogue of their research.  It was therefore possible 
to perform total RNA extraction and quantitative PCR on tissue samples that were collected 
many years previously (as was done in the time course study).   
 
There has, however, been some debate on the practical use of formalin as a fixative that 
conserves the integrity of nucleic acids within the tissue (Goldmann et al, 2006).  It is believed 
that methylene bridges form between the amino acids within the RNA molecules thereby 
rendering the nucleic acid impervious to extraction procedures (Lewis et al, 2001, Srinivasan et 
al, 2002).  A recent development in tissue fixatives has led to the production of Hepes glutamic 
acid buffer-mediated organic solvent protection effect (HOPE) fixative (Olert et al, 2001, 
Wiedorn et al, 2002) which has been shown to protect the integrity of RNA molecules within 
human tissues to a considerably higher level (Goldmann et al, 2006).  This therefore increases 
the reliability of subsequent quantitative PCR by allowing more efficient primer/probe binding 
during the amplification step of the procedure.  The use of HOPE fixative in the literature has so 
far been limited to human tissues; however it was believed that it could also prove beneficial in 
conserving the integrity of RNA within bovine tissue samples.   It was therefore decided to 
perform a supplementary study to assess the quality of total RNA extracted from HOPE as 
compared to formalin fixed bovine lymph node samples.  In addition, two different extraction 
methods were used, the commercial OptimumTM Formalin Fixed Paraffin Embedded (FFPE) kit 
and an in-house Trizol method to determine whether the type of method used provided 
variability in the quality of total RNA extracted.  The outcome of this study provides valuable 
information on the use of formalin and HOPE fixative in molecular studies and aid decisions on 
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the most appropriate RNA extraction methods for the fixative used.  It also has a considerable 
impact on the interpretation of the time course study results as formalin fixed tissues provided 
the primary source of total RNA.  This work has been published (Witchell et al, 2008 – paper 
included in the appendix).  
 
Methods 
 
Archived bovine Mycobacterium bovis infected lymph node tissue (VLA, Surrey) fixed in either 
buffered formalin (as described in Chapter 2) or HOPE (Goldmann and Olert, 2008) were 
subjected to total RNA extraction.  The two methods used for RNA extraction were the 
commercially available OptimumTM formalin-fixed, paraffin embedded (FFPE) kit (Ambion) and 
a Trizol method, both of which have been described in Chapter 2.  Spectrophotometry and 
agarose gel electrophoresis were then performed to determine the overall integrity of the total 
RNA samples. 
 
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was performed using 
the QuantitectTM Probe kit (Qiagen, Crawley, West Sussex) targeting the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as described in Chapter 2.  To enable 
quantification of the GAPDH transcript within the lymph node total RNA samples, a standard 
template was designed and manufactured (Biomers.net, Germany).  The standard 
oligonucleotide was identical to the GAPDH-specific amplicon produced following PCR and 
used to produce a standard curve (as described in Chapter 2).  The results were expressed as 
picograms of GAPDH mRNA in 100 ng of total RNA (pg/100 ng) in each tissue sample. 
 
Results 
 
Total RNA extracted from formalin- and HOPE-fixed, paraffin-embedded tissues using 
the OptimumTM FFPE kit (Ambion, UK) 
The total RNA extracted from both the formalin- and HOPE-fixed bovine lymph node tissues 
using the OptimumTM FFPE kit produced comparative spectrophotometer results (mean of 
108.1 and 96 μg/ml, respectively, p>0.05 Mann Whitney test, Table 19).  The purity of the total 
RNA from each tissue sample was also within the recommended range of between 1.7 and 1.9 
(Table 19).   
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Table 19: Quantification and purity (260/280nm ratio) of total RNA determined by spectrophotometry isolated from 
three formalin- and three HOPE-fixed, paraffin embedded cattle lymph node tissue sections using the OptimumTM 
FFPE kit (Ambion).   
 
 
 
 
 
 
 
 
 
 
The three tissue sections from each fixative are a representative group of the isolation procedure that was 
repeated more than 10 times.  
 
 
Following agarose gel electrophoresis, the total RNA isolated from formalin-fixed tissues using 
the OptimumTM kit (Ambion, UK) displayed a visible 28S rRNA band at the expected weight of 
approximately 4 kb (Figure 29).  In comparison, the total RNA extracted from the HOPE-fixed 
tissues displayed both the 18S and 28S rRNA bands (2 Kb and 4 Kb, respectively, Figure 30).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixation method and sample 
number 
Total RNA quantification 
(μg/ml) 
260/280 nm ratio 
(purity) 
HOPE 1 107.9 1.8 
HOPE 2 82.7 1.9 
HOPE 3 97.3 1.9 
Formalin 1 80.6 1.7 
Formalin 2 145.7 1.8 
Formalin 3 97.9 1.9 
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Figure 29: Agarose gel electrophoresis (ethidium bromide staining) of total RNA samples (1 μg) isolated using the 
OptimumTM FFPE kit (Ambion, UK) from formalin-fixed, M. bovis infected bovine lymph nodes (lanes 3 and 4).  
Lane 1 was a 0.5-10 Kb RNA ladder.  Lane 2 was not used.  Experiment was repeated three times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Agarose gel electrophoresis (ethidium bromide staining) of total RNA samples (1 μg) isolated using the 
OptimumTM FFPE kit (Ambion, UK) from HOPE-fixed, M. bovis infected bovine lymph nodes (lanes 2-4).  Lane 1 
was a 0.5-10 Kb RNA ladder.  Experiment was repeated three times. 
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Total RNA extracted from formalin- and HOPE-fixed, paraffin-embedded tissues using 
the Trizol method 
The extraction of total RNA from formalin-fixed bovine lymph node tissue using the Trizol 
method proved unsuccessful as confirmed by the spectrophotometry results (Table 20) and the 
absence of rRNA bands on the agarose gel following electrophoresis (Figure 31).   
 
The total RNA extracted from the HOPE-fixed bovine lymph nodes using the Trizol method 
(mean 131.6 μg/ml, Table 20) had purity within the recommended range (Table 20) and 
displayed strong 18S and 28S rRNA bands at the expected molecular weights (2 Kb and 4 Kb) 
following agarose gel electrophoresis (Figure 31).   
 
Table 20: Quantification and purity (as determined by 260/280nm ratio) of total RNA determined by 
spectrophotometry isolated from three formalin- and three HOPE-fixed, paraffin embedded cattle lymph node 
tissues using the Trizol method.   
 
 
 
 
 
 
 
 
The three tissue sections from each fixative are a representative group of the isolation procedure that was 
repeated more than 10 times. 
 
 
 
 
 
 
 
 
Fixation method and 
Sample number 
Total RNA quantification 
(μg/ml) 
260/280 nm ratio 
(purity) 
HOPE 1 146.7 1.8 
HOPE 2 87.0 1.8 
HOPE 3 161.1 1.9 
Formalin 1 Negative Negative 
Formalin 2 Negative Negative 
Formalin 3 Negative Negative 
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Figure 31: Agarose gel electrophoresis (ethidium bromide staining) of total RNA samples (1 μg) isolated using the 
Trizol method from formalin-fixed (lanes 2 and 4) and HOPE-fixed (lanes 3 and 5), M. bovis infected bovine lymph 
nodes.  Lane 1 was a 0.5-10 Kb RNA ladder.  Lane 6 was not used.  Experiment was repeated three times. 
 
Quantitative reverse-transcriptase polymerase chain reaction 
Quantitative RT-PCR targeting the expression of GAPDH mRNA was performed on the total 
RNA extracted from both the formalin and HOPE-fixed, M. bovis infected bovine lymph node 
tissues.  Each total RNA sample produced a quantifiable PCR product (Figure 32) with the 
exception of that extracted from the formalin-fixed tissues using the Trizol method.   
  
 
 
 
 
 
 
 
 
 
Figure 32: Quantitative RT-PCR of total RNA extracted from both the formalin- and HOPE-fixed, paraffin 
embedded bovine lymph node tissues using either the OptimumTM FFPE kit (brown and red lines, respectively) or 
the Trizol method (blue and green lines, respectively).  The target sequence was an 87 base pair fragment of the 
bovine glyceraldehyde-3-phosphate dehydrogenase mRNA and each reaction was performed in duplicate.   
←28S rRNA  
←18S rRNA  
         1          2          3          4        5         6 
6.0Kb
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A GAPDH standard template was included in each PCR plate at varying concentrations to 
allow the production of a standard curve.  It was then possible to compare the CP values of the 
unknown total RNA samples to the standard curve thereby determining the exact concentration 
of the GAPDH template (Table 21 and Figure 32).  Using the OptimumTM FFPE kit (Ambion, 
UK), the total RNA extracted from the formalin-fixed lymph node tissue using had a lower level 
of GAPDH expression (mean 5.69 x10-4 pg/100ng) as compared to that isolated from the 
HOPE-fixed tissue (4.05 x10-2 pg/100ng, Table 21).  Using the Trizol method, the extract from 
the formalin-fixed tissues failed to produce a quantifiable product, however, the total RNA 
extracted from the HOPE-fixed tissues contained a GAPDH mRNA concentration of 6.45 x10-2 
pg/100 ng of total RNA (Table 21).     
 
 
Table 21: QRT-PCR crossing point (CP) values for the expression of GAPDH mRNA in total RNA (100ng) 
extracted from formalin- and HOPE-fixed, paraffin embedded bovine lymph node samples using two methods, the 
OptimumTM Kit (Ambion) and a trizol method.  Each reaction was performed in duplicate and the mean displayed 
in the table.  The average CP values were then converted into quantitative values using the standard curve (data 
not shown) and expressed in picograms (pg) of GAPDH mRNA in 100ng total RNA. 
 
 
 
 
 
 
 
Total RNA extraction 
method 
Sample fixation method Mean CP value GAPDH mRNA 
concentration  (pg/100ng 
total RNA) 
Formalin 34.71 5.69 x10-4 
OptimumTM Kit (Ambion) 
HOPE 28.19 4.05 x10-2 
Formalin Negative Negative 
Trizol 
HOPE 27.39 6.45 x10-2 
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Discussion 
 
The quality of total RNA extracted from archived tissue samples has a considerable affect on 
the outcome of subsequent molecular techniques (Bustin, 2002, Bustin and Mueller, 2006).  It 
has been suggested in the literature that formalin fixation compromises the integrity of the 
nucleic acids within the tissue samples thus reducing the efficacy of extraction procedures 
(Bustin and Mueller, 2006, Srinivasan et al, 2002, Lewis et al, 2001).  This supplementary study 
aimed to determine the quality of total RNA extracted from formalin-fixed, bovine lymph node 
samples as compared to novel fixative HOPE.  This also included the use of two different 
extraction methods, a commercial kit from Ambion (UK) and a Trizol method developed in-
house.  The results showed that, although the total RNA extracted from both the formalin- and 
HOPE-fixed tissues using the OptimumTM kit was of a comparable concentration (Table 19), 
there was a difference in the level of GAPDH mRNA expression between the two fixative types 
(Figure 32 and Table 21).  The total RNA extracted from the formalin-fixed bovine lymph node 
tissues displayed a lower level of GAPDH expression following qRT-PCR as compared to that 
observed in the HOPE-fixed derived total RNA (a concentration of approximately 70x less 
mRNA, Table 21).  This suggests that HOPE fixative conserved the integrity of the bovine RNA 
to a much higher degree, as suggested by Wiedorn et al (2002) in human tissues.  This was 
further supported by the agarose gel electrophoresis results, as the total RNA extracted from 
the HOPE-fixed tissues displayed both rRNA bands compared to that extracted from the 
formalin-fixed tissue which displayed only the 28S rRNA band (Figures 29 and 30).  The ability 
of HOPE fixative to preserve both morphological and molecular composition may be due to the 
increased rate of tissue dehydration, enabled by the diffusion of a protective solution of amino 
acids into the tissue section (Srinivasan et al, 2002). 
 
The total RNA extracted from the HOPE-fixed tissues using the trizol method produced very 
similar spectrophotometry and qRT-PCR results to that extracted using the OptimumTM kit 
(Tables 20 and 21).  Interestingly, it was not possible to extract quantifiable total RNA from the 
formalin-fixed tissues using the trizol method (Table 20 and Figure 31).  The ability of the 
OptimumTM kit (Ambion) but not the trizol method to isolate the total RNA from the formalin-
fixed tissues may be attributed to the use of proteinase K.  Proteinase K is efficient at 
separating the RNA from the cross-linked matrix formed as a result of the reactive ability of 
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formaldehyde (Srinivasan et al, 2002).  Therefore, with the absence of a proteinase k step, the 
trizol method was not able to successfully isolate total RNA from the formalin-fixed tissues.    
 
In conclusion, this study supports a strong consensus that HOPE fixative is a more appropriate 
fixative for tissue sections that will be used in molecular methods.  This is because HOPE 
fixative is able to conserve the integrity of total RNA to a much higher level as compared to 
formalin fixative. This is the first study to explore HOPE fixation in M. bovis infected bovine 
lymph node tissues.  Since this study, the scientists at the VLA have started to routinely fix 
tissues in HOPE as well as formalin to allow more versatile use of the archived samples.  In 
addition, these results highlight the importance of selecting the appropriate extraction method 
dependent on the fixative used to enable the most efficient isolation of total RNA. 
It is also important to consider these findings when analysing the time course study described 
previously.  As the total RNA templates for the time course study were extracted from formalin 
fixed M. bovis infected lymph node tissues, it would be appropriate to assume that the cytokine 
expression levels observed were relatively low due to partial RNA degradation.  The 
conclusions drawn from the time course study still provide some valid theories on the role of 
cytokines in M. bovis infection, however, the exact quantification of the expression levels may 
be compromised as a result of using a template extracted from formalin fixed tissues.      
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Cytokine mRNA expression in cattle infected with different dosages of 
Mycobacterium bovis 
 
Introduction 
 
An important feature of experimental M. bovis models is their relevance and applicability to 
natural M. bovis bovine infection.  In previous years, cattle have been experimentally infected 
with relatively large doses of infectious M. bovis to ensure that the animals successfully 
presented disease (for example, 106 cfu’s in Johnson et al, 2006 and Joardar et al, 2002 or 104 
cfu’s in Widdison et al, 2006 and Villarreal-Ramos et al, 2003).  Studies have shown, however, 
that a host need only inhale one or two bacterial cells to become naturally infected (Schafer et 
al, 1999).  To determine the possible effects of different infecting dosages, Dean et al (2005) 
experimentally inoculated cattle with 1, 10, 100 and 1,000 cfu’s of M. bovis and described the 
pathological state of the lymph nodes as well as the profile of whole blood IFN-γ and IL4 
proteins after twenty-six weeks.  Surprisingly, there did not appear to be any difference in the 
pathology scores of the lymph nodes for the skin test-positive calves between the different 
groups.  This suggests that 1 cfu of bacteria created a level of pathological disease similar to 
that produced by 1,000 cfu (Dean et al, 2005).  The group also found that there were no 
significant differences in whole blood IFN-γ or IL4 protein between the animals infected with 
different dosages of M. bovis.    
 
The concentrations of M. bovis used within the time course (104 cfu’s) and BCG vaccination 
(103 cfu’s) studies were either at the higher end or supra-threshold to those concentrations 
used in Dean et al (2005).  Therefore to supplement the studies within this thesis and to 
determine their relevance to natural M. bovis infection, it was decided that the molecular 
methods developed and described in chapter 2 would be applied to the same experimental 
samples used by Dean et al (2005).  This new information provides an insight into the 
immunological state of the lymph nodes and determines whether the concentration of the 
starting inoculum provided any variation in cytokine response.  This work was carried out 
entirely by an MSc student using the RNA extraction and quantitative PCR methods that were 
developed for this thesis (Boddu-Jasmine et al, 2008 - paper included in the appendix). 
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Methods 
 
Sixteen six month old Friesian Holstein heifers were intratracheally infected with 1, 10, 100 or 
1,000 cfu’s of M. bovis (strain AF 2122/97, four cattle within each group) as described in Dean 
et al (2005).  The animals were then euthanized at twenty-six weeks post infection by an 
intravenous injection of sodium pentobarbitone and the lymph nodes (cranial mediastinal, 
caudal mediastinal and left bronchial) dissected.  Following on from Supplementary study 1, it 
was decided to fix the lymph node tissue samples in HOPE to provide optimum preservation of 
the nucleic acid (fixation method described in Boddu-Jasmine et al, 2008).  The trizol method 
(Witchell et al, 2008) was used to extract total RNA from each HOPE-fixed bovine sample.  
Quantitative PCR targeting the expression of IFN-γ, TNF-α, IL10 and IL4 were performed on 
each lymph node sample using the QuantitectTM Probe kit (Qiagen, UK) as described in 
Chapter  2. 
 
Results 
 
The expression of IFN-γ, TNF-α, IL10 and IL4 mRNA measured using quantitative RT-PCR 
displayed a significant difference in response to varying concentrations of M. bovis infecting 
inoculum (p<0.05, Kruskal Wallis test, Table 22).  As the starting dosage of M. bovis inoculum 
increased, there was a related increase in the level of cytokine gene expression (Table 22).   
IFN-γ expression increased over 1, 10, 100 and 1,000 cfu’s of infecting M. bovis (2.1 x105, 2.3 
x105, 4.2 x105 and 9.0 x105 copies, respectively, Table 22).  There was a significant difference 
in IFN-γ expression between 1 and 1,000 cfu’s (4.23 fold increase) and between 10 and 1,000 
cfu’s (3.88 fold increase, p<0.05, Mann Whitney test). 
TNF-α expression displayed a slight decrease between 1 and 10 cfu’s of M. bovis infecting 
dosage (2.5 x105 and 2.6 x105, respectively, Table 22) although this was not significant 
(p>0.05, Mann Whitney test).  Between 10, 100 and 1,000 cfu’s there was an increase in TNF-
α expression (2.6 x105, 5.6 x105 and 7.1 x105 copies, respectively) however these differences 
were not significant (p>0.05, Mann Whitney test).  
IL4 expression increased over 1, 10, 100 and 1,000 cfu’s of infecting M. bovis concentration 
(2.0 x105, 2.2 x105, 4.5 x105 and 6.3 x105 copies, respectively, Table 22).  There was a 
significant difference in IL4 expression between 1 and 1,000 cfu’s (3.15 fold increase) and also 
10 and 1,000 cfu’s (2.86 fold increase, p<0.05, Mann Whitney test).  
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The expression of IL10 increased significantly between 1 and 100 cfu’s of M. bovis (9.3 x104 
and 4.5 x105, respectively, Table 22).  There was also a significant increase in IL10 expression 
between 1 and 1,000 cfu’s of M. bovis (9.3 x104 and 5.1 x105, respectively, 5.5 fold increase, 
Table 22).  
 
Table 22: The mean copy numbers of cytokine (IFN-γ, TNF-α, IL10 and IL4) mRNA within the lymph nodes of 
cattle infected with either 1, 10, 100 or 1,000 cfu’s of M. bovis (measured using quantitative RT-PCR). 
 
 
 
Cytokine expression (molecules/μl) at different experimental M. bovis dosages 
Cytokines 1 cfu 10 cfu 100 cfu 1,000 cfu 
IFN-γ 213,500 234,665 425,825 904,750 
TNF-α 252,450 260,675 565,000 715,125 
IL10 200,875 221,125 449,250 633,000 
IL4 93,850 288,975 450,000 510,750 
 
 
Discussion 
 
In the study performed by Dean et al (2005), no significant difference in pathological score was 
noted in the lymph nodes of cattle infected with either 1, 10, 100 or 1,000 cfu’s of M. bovis.  In 
addition, there were no significant differences in whole blood IFN-γ or IL4 protein between the 
four experimental groups (Dean et al, 2005).  The same bovine lymph node samples were used 
to investigate the expression of IFN-γ, TNF-α, IL10 and IL4 within this study, and interestingly, 
significant differences between the four experimental groups were revealed (p<0.05, Mann 
Whitney test).  As the concentration of M. bovis inoculum increased, there was a simultaneous 
increase in the expression of the four target cytokines.  This is believed to be due to the 
increased antigenic stimulation associated with higher levels of bacterial infection thereby 
producing a stronger cytokine immune response.  The largest increases were in IFN-γ (fold 
increase of 4.23 between 1 and 1,000 cfu’s) and IL10 expression (fold increase of 5.5 between 
1 and 1,000 cfu’s, Table 22).  IFN-γ, as mentioned previously, is an extremely important part of 
the immune response following M. bovis infection and is strongly activated via the TH1 pro-
inflammatory profile.  It is therefore not surprising that IFN-γ expression experienced such a 
large increase with increased infective dose.  IFN-γ has also been shown to be heavily involved 
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in the pathological development of the disease.  However, the data from these animals show 
that increasing IFN-γ expression did not have any effect on the level of pathology and this may 
be as a consequence of the time point post infection the samples were taken.  In a bovine M. 
bovis infection study performed by Palmer et al (2007), little difference was seen in lesion 
coverage of lymph nodes between six and fifty three weeks following inoculation.  This 
suggests that for any difference in pathological state to be observed as a result of increasing M 
.bovis dose, it would be necessary to take lymph node samples at a much earlier time point 
pre-twenty-six weeks.  
A reoccurring theme in both the time course and BCG vaccination studies was the role of IL10 
in limiting the damage of pro-inflammatory cytokine IFN-γ.  As noted from the results of this 
study, IFN-γ and IL10 expression have been shown to increase relative to one another (Lin et 
al, 1996) as both are produced by CD4+ T cell clones (Gerosa et al, 1999).  Gerosa et al 
(1999) suggested that this may be a mechanism of ‘self-limiting’ to control the destructive 
properties of TH1 and TH2 associated cytokines.  This would explain why both IFN-γ and IL10 
displayed the largest increase in expression as response to increasing M. bovis dosage. 
 
Interestingly, expression of IL4 was evident in all of the lymph node samples from each of the 
four experimental groups (Table 22).  IL4 is associated with the TH2 anti-inflammatory response 
that develops late in bTB infection (Welsh et al, 2005).  It was not possible to detect IL4 mRNA 
expression in any of the M .bovis infected lymph nodes of the time course or BCG vaccination 
studies and again, this may be due to the time points post infection that were used.  IL4 was 
not detected at five, twelve or nineteen weeks following infection; however, in this specific study 
it was detectable at twenty-six weeks.  This represents the importance of IL4 in the later stages 
of bTB infection when the cell mediated response is actively dominated by the developing 
humoral response (Welsh et al, 2005). 
Lastly, TNF-α was the only cytokine to not show a significant increase in expression as the M. 
bovis inoculation concentration increased (Table 22).  These results reflect those seen in the 
time course and BCG vaccination studies, as expression of TNF-α shows little variation to 
differing conditions as compared to the other cytokines.  This may be due to the role of 
posttranscriptional regulation.  Therefore the lack of significant differences in TNF-α expression 
may not be representational of the pattern in TNF-α protein production. 
In conclusion, although there were no apparent differences in pathology of the bovine lymph 
nodes as a result of increasing the inoculation concentration of M. bovis, the expression levels 
of IFN-γ, IL10 and IL4 did show significant changes.  The increasing concentrations of M. bovis 
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led to enhanced antigenic stimulation and subsequently an enhanced rate of cytokine 
expression.  This therefore suggests that the cytokine expression levels observed in 
experimental bovine models that use relatively high concentrations of M. bovis may not 
necessarily represent those that would be observed in natural infection conditions.  However it 
is important to note that as all of the cytokines increased in expression relative to each other, 
the patterns observed at high M. bovis concentrations may still be relevant to lower M. bovis 
concentrations.  This supports the use of experimental bovine models in exploring bTB 
infection but also shows that it is possible to use smaller doses of infecting inoculums to 
produce immune profiles that more resemble natural infection.       
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Introduction 
 
Developing a new and improved BCG vaccine 
 
BCG bacterium evolution 
A critical step in the development of an improved BCG is the understanding of where and why 
the current BCG may be failing to induce sufficient and consistent protection against 
tuberculosis.  The BCG vaccine used today is extremely different genomically to the BCG that 
was first produced at the beginning of the twentieth century and this is partly due to the lack of 
production standardisation (Charlet et al, 2005).  Although the attenuated form of the BCG 
bacterium was produced in 1921, the technology used to store bacterial stocks (freezing or 
lyophilisation) was not developed until 1961.  This meant 53 years passed between the 
production of the vaccine and the ability to store it in a metabolically inactive state.  In this time 
the BCG bacterium underwent an estimated 1,173 passages under laboratory selective 
pressures, equating to around 15,000 generations (Mostowy et al, 2003).  Current legislation 
recommends that bacterial stocks for vaccine production undergo a maximum of 12 passages 
to ensure the consistency of each vaccine batch (Brosch et al, 2007).   
A pivotal step in understanding the evolutionary path of the BCG has been the complete 
mapping of the genome for M. bovis (Garnier et al, 2003), M. tuberculosis (Cole et al, 1998) 
and BCG Pasteur (Brosch et al, 2007).  This, in combination with advances in modern 
comparative tools such as genome microarrays, has made it possible to determine the genetic 
basis of the original attenuation of BCG and the sequence polymorphisms experienced post 
1921 (Charlet et al, 2005).  Amazingly, in the comparatively short time of 53 years (between 
BCG production and immortalisation), the average BCG bacterium lost more genomic DNA 
than isolated clinical strains of M. tuberculosis had over centuries (Kato-Maeda et al, 2001).  A 
large percentage of these deletions are due to the loss of the RD1 group, representing genes 
encoding mostly antigenic proteins (Behr, 2002).  A possible reason for these particular 
deletions could be due to the redundancy of antigenic proteins under laboratory growth 
conditions (Mostowy et al, 2003).  Bovine TB pathogenesis relies heavily on the action of 
antigenic proteins and the loss of the RD1 region including ESAT-6 during attenuation of BCG 
was one of the major factors in its development.  It has been suggested that further losses of 
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antigenic proteins between 1921 and 1961 could have rendered BCG less able to mimic the in 
vivo disease and reduced its immunising properties (Charlet et al, 2005).  
 
Antigenic proteins MPB70 and MPB83 
There are a number of antigenic proteins that are differentially expressed between M. 
tuberculosis, M. bovis and BCG.  Two of the more well-known are MPB70 and MPB83 (MPT in 
M. tuberculosis, Said-Salim et al, 2006).  Both of these proteins are antigenic, are believed to 
play a role in determining the host preference of the bacteria (Hewinson et al, 2006) and are 
well known for their ability to induce cellular and humoral immune responses (Lyashchenko et 
al, 2001).  The expression of these proteins is controlled by the extracytoplasmic alternative 
sigma factor K (SigK) which is in turn regulated post-translationally by the anti-sigma factor 
RskA (Said-Salim et al, 2006).  Within M. tuberculosis, RskA binds to SigK thus preventing the 
transcription of both mpt70 and mpt83 (Husson, 2006).  In response to the appropriate 
environmental stimuli and in particular during phagosomal containment (Schnappinger et al, 
2003), RskA releases SigK and allows it to bind to the promoter of mpt70 and mpt83, up-
regulating the expression of these antigenic proteins (Said-Salim et al, 2006).  Genetic studies 
based on the sequenced genomes of M. tuberculosis and M. bovis have shown that there is no 
variation in the sequences of mpt/mpb70, mpt/mbp83 or sigK between the two mycobacterial 
species (Charlet et al, 2005).  However within M. bovis, the gene sequence encoding for RskA 
(Rv0444c) displayed two single nucleotide polymorphisms (SNPs) and therefore a distorted 
ability to repress SigK resulting in over-production of the antigenic proteins.   MPB/MPT70 and 
MPB/MPT83 are therefore produced in an inducible manner by M. tuberculosis but are 
constitutively expressed by M. bovis species (Said-Salim et al, 2006).  In murine infection 
models M. bovis has been shown to produce increased levels of pathological disease and 
extensive dissemination as compared to M. tuberculosis (Medina et al, 2006), however the 
effect of the inactivated anti-sigma factor RskA on this enhanced level of virulence is as yet 
unknown.      
 
MPB70 and MPB83 are produced by the M. bovis derivative BCG in vitro although the 
expression levels vary dramatically between different sub-strains (Charlet et al, 2005).  Based 
on the production of MPB70, it is possible to separate BCG strains (Harboe and Nagai, 1984) 
into those derived from the parental BCG strain before 1929, termed high producers of MPB70 
and those derived after 1931, termed low producers of MPB70.  The MPB83 protein also 
seems to follow the same pattern although not as consistently as MPB70 (Wiker et al, 1996).  
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Extensive research has been performed on these two proteins to elucidate this difference in 
expression profiles.  There is a detectable difference in mpb70 transcription between the two 
BCG strains Tokyo (high producer) and Pasteur (low producer), however when complementing 
BCG Pasteur with mpb70 from BCG Tokyo there was no significant increase in the level of 
MPB70 (Matsuo et al, 1995, Matsumoto et al, 1995).  These results therefore indicate a 
possible difference in the control of mpb70 transcription by regulatory proteins in addition to the 
mutation described for the gene Rv0444c.  The gene responsible for encoding SigK (Rv0445c) 
has been shown to be down-regulated in the low producing BCG strains and subsequent 
sequence analysis of Rv0445c revealed a polymorphism in its associated start codon (Charlet 
et al, 2005).  The high producer strains of BCG (and all members of the mycobacterium family) 
contained an AUG start codon whereas the low producers contained an AUA start codon due 
to a G→A single nucleotide polymorphism in the third nucleotide (Table 23).  Both start codons 
are functional however the AUA codon (also detected in Escherichia coli and Salmonella spp.) 
results in significantly lower translational levels of SigK.  This in turn leads to a significantly 
lower level of MPB70 and MPB83.  
 
Table 23: Genetic comparison of different BCG strains on the level of MPB70 and MPB83 production and the 
sequence of the sigK start codon (adapted from Charlet et al, 2005).  The species highlighted in blue (including M. 
bovis) are termed high producers of MPB70 and MPB83 whereas those highlighted in red are low producers 
following a mutation in the sigK start codon. 
 
Strains High / low producers 
of MPB70 and MPB83 
Third nucleotide of 3 bp start codon 
M. bovis 
BCG Russia 
BCG Moreau 
BCG Japan 
BCG Sweden 
BCG Birkhaug 
BCG Prague 
BCG Glaxo 
BCG Denmark 
BCG Tice 
BCG Connaught 
BCG Frappier 
BCG Phipps 
BCG Pasteur 
High 
High 
High 
High 
High 
High 
Low 
Low 
Low 
Low 
Low 
Low 
Low 
Low 
G 
G 
G 
G 
G 
G 
A 
A 
A 
A 
A 
A 
A 
A 
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The protective properties of MPT83 have been explored in DNA and RNA vaccine trials and 
have been shown to induce protection against M. tuberculosis infection in mice (Xue et al, 
2004).  However in cattle, DNA vaccines expressing MPB70 and MPB83 when used 
individually or as a MPB70 DNA prime- protein boost strategy showed no evidence of 
significant protection against M. bovis infection (Wedlock et al, 2003).  Both DNA vaccines 
failed to induce a cell mediated immune response (characterised by IFN-γ and IL-12) and the 
DNA prime-protein boost preferentially activated a strong antibody response with minimal IFN-γ 
production.  Interestingly, the vaccines did not produce a DTH reaction in response to the PPD 
tuberculin test which is a huge advantage in the development of a vaccine/diagnostic testing 
strategy for infected cattle.  The authors suggest that these vaccines may provide a basis for 
future vaccine development and that improvements in inducing an appropriate cell mediated 
response may be possible by subunit modification (Wedlock et al, 2003). 
 
Although comparative genomics have provided a greater understanding of the genetic basis 
and evolution of MPB70 and MPB83 expression across the different BCG sub-strains (Mostowy 
et al, 2003, Brosch et al, 2007), an area that has received less attention is that of standardising 
the actual levels of MPB70 and MPB83 production.  A study involving the comparison of these 
protein expression profiles in high and low BCG producers would provide much more insight 
into their importance on the protective efficacy of the vaccine (Charlet et al, 2005).  Vaccination 
studies on human infants has suggested that BCG Japan (a high producer) provides a higher 
level of protection as compared to BCG Denmark (low producer) by inducing significantly 
higher levels of TH1 cytokines and T cells (both CD4 and CD8, Davids et al, 2006).  Although 
the contribution of MPB70 and MPB83 to this increased immunological ability is unknown, 
evidence of the immunogenic properties of these proteins in related studies (Liu et al, 2007, 
Vordermeier et al, 2000, Rhodes et al, 2000) provides a compelling idea on their importance in 
vaccine efficacy.    
 
Experiments based on the complementation of BCG Pasteur with wild-type sigK have 
significantly increased levels of mpb70 and mpb83 transcription and as a result levels of 
MPB70 and MPB83 protein were comparable to those of high producer BCG strains (Charlet et 
al, 2005).  However to date there has been a lack of studies aimed at investigating whether a 
genetically modified BCG Pasteur complemented with a wild-type sigK would improve its 
immunological ability and therefore its protective efficacy as a vaccine against tuberculosis. 
  BCG Vaccination Study 
 
131  
Aims and Objectives 
 
It was proposed to study the immunological responses of cattle vaccinated with either BCG 
Pasteur or a genetically modified BCG Pasteur and challenged with M. bovis.  The genetically 
modified BCG Pasteur was complemented with a wild-type copy of the sigK gene from BCG 
Russia in order to up-regulate expression of MPB83 and MPB70.  The study also included 
three control groups of cattle, non-vaccinated M. bovis infected, non-vaccinated non-infected 
and BCG Pasteur vaccinated non-infected.  This aided in determining the dynamics of the 
immune response to infection and vaccination. 
 
Aim 1: To compare the immunological responses of BCG Pasteur vaccinated challenged cattle 
to the three control groups. 
 
Aim 2: To compare the immunological responses of genetically modified sigK BCG Pasteur 
vaccinated challenged cattle to the three control groups. 
 
The study focused on the lymph nodes draining the bronchial region of the animals therefore 
allowing a response profile to be created for the actual site of infection.    The immune 
response was measured using quantitative polymerase chain reaction targeting the cytokines 
interferon gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), interleukin 10 (IL10) and 
interleukin 4 (IL4).  This was followed up by studying the protein expression of IFN-γ and TNF-
α within the same samples using immunohistochemistry. 
 
Objectives: 
 
1. The left bronchial, caudal mediastinal and cranial mediastinal lymph nodes of each 
animal from the five experimental groups were isolated and dissected.  The dissected 
tissue samples were then either incubated in Trizol and prepared for immediate 
extraction of total RNA or fixed in buffered formalin and embedded within a paraffin 
wax block for subsequent immunohistochemistry (IHC). 
2. Pathological damage within each lymph node was measured by observing the 
percentage of granuloma coverage and the developmental stage of each lesion within 
the mounted sections. 
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3. Total RNA was extracted from the freshly dissected lymph node tissues and quality 
checked using spectrophotometry and agarose gel electrophoresis. 
4. QRT-PCR was performed on the extracted total RNA from each lymph node tissue 
sample targeting the four cytokines as well as the housekeeping gene glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) to ensure the quality of the starting template.  
The target mRNA sequences from each of the lymph node tissue samples were 
quantified using specifically designed standard curves and expressed in copy 
numbers. 
5. The formalin fixed, paraffin embedded tissue samples were sectioned and mounted 
onto slides for IHC.  This was performed for both IFN-γ and TNF-α protein analysis on 
all of the lymph node tissues from each animal.  The results were expressed semi-
quantitatively by using a scoring method based on the percentage coverage of 
positively stained cells over the lymph node section.  
6. To compliment the cytokine expression data within the lymph nodes, levels of IFN-γ 
protein were measured in cultured peripheral blood samples from each animal using 
enzyme linked immunosorbant assays (ELISA). 
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Materials and Methods 
 
Experimental design 
Twenty Friesian Holstein heifers and bullocks of approximately six months of age and with no 
history of tuberculosis infection were divided into five experimental groups.  Cattle from group 
one (three animals) and group five (four animals) were vaccinated by subcutaneous injection of 
standard BCG Pasteur (6.3x105 colony forming units of BCG).  Cattle from group two (four 
animals) were vaccinated by subcutaneous injection of genetically modified sigK BCG Pasteur 
(5x105 colony forming units of BCG).  The BCG Pasteur::pRUSS (sigK complemented) 
construct was provided by Marcel Behr (University of McGill, Montreal, Canada).  The construct 
consisted of a BCG Pasteur strain containing a copy of the sigK gene from a BCG Russia 
strain (Charlet et al, 2005).  Cattle from group three (four animals) and group four (five animals) 
were left unvaccinated.  Each animal within groups one, two and three were challenged 
intratracheally with M. bovis (strain AF2122/97, 6x103 cfu) ten weeks following vaccination, as 
described in Chapter 2.  Groups four and five were non-infected controls. 
 
Table 24: Combinations of experimental vaccination (BCG Pasteur or BCG (sigK) Pasteur) and M. bovis challenge 
in the five cattle groups. 
 
Animal group Vaccination Challenge No. cattle 
1 
2 
3 
4 
5 
BCG Pasteur 
BCG (sigK) Pasteur 
None 
None 
BCG Pasteur 
M. bovis 
M. bovis 
M. bovis 
None 
None 
3 
4 
4 
5 
4 
 
 
Post mortems and lymph node tissue preparation 
The M. bovis challenged cattle (groups one, two and three) were euthanized at five weeks post 
infection (fifteen weeks after the start of the experiment).  Cattle within groups four and five (the 
non-infected animals) were euthanized at fourteen and sixteen weeks after the experimental 
start date due to logistical restraints (limited category three space and resources).  The cattle 
were euthanised as per the method described in Chapter 2.  Tissue sections were dissected 
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from the lymph nodes (left bronchial, cranial mediastinal and caudal mediastinal nodes) and 
submerged in both trizol for subsequent total RNA extraction and buffered formalin for 
immunohistochemistry (as described in Chapter 2). 
 
Quantitative reverse transcriptase polymerase chain reaction 
Quantitative PCR was performed using the QuantitectTM Probe RT-PCR kit (Qiagen, Crawley, 
West Sussex) as described in Chapter 2.  The qRT-PCR experiments were designed to allow 
direct comparison between the five experimental cattle groups (Figure 33).  Therefore each 
sample from the five groups had to be included in the same ninety six well PCR plate to avoid 
the complication of plate to plate variation.  Within each PCR plate, all samples of one lymph 
node over the five experimental groups were analysed for one target cytokine. Each lymph 
node sample was analysed for the expression of all four cytokines; IFN-γ, TNF-α, IL10 and IL4.  
The mRNA expression of the housekeeping gene GAPDH was also measured within each 
sample to ensure the quality of the total RNA transcript.  Lastly, each PCR plate included the 
diluted standard templates specific to the target cytokine to allow construction of the standard 
curve (as described in Chapter 2).   
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Figure 33: Quantitative RT-PCR experimental designs for the BCG vaccination study.  Each 96 well plate 
contained reactions analysing one cytokine from all samples of one lymph node from the five experimental groups 
(BCG Pasteur vaccinated challenged, BCG (sigK) Pasteur vaccinated challenged, non-vaccinated infected, non-
vaccinated non-infected and BCG Pasteur vaccinated non-infected).   This allowed the direct ‘in- plate’ comparison 
of cytokine levels between the five experimental groups and reduced the potential problem of plate to plate 
variability.  The specific standard curve for the cytokine and a GAPDH for each sample were also run on each 
plate.  Each reaction was performed either in duplicate or triplicate.   
 
Immunohistochemistry  
The formalin-fixed lymph node tissue samples were used for immunohistochemistry to detect 
cells positive for IFN-γ and TNF-α protein secretion, as described in Chapter 2. 
 
Whole blood IFN-γ cultures 
Samples of heparinized whole blood were collected from each of the animals prior to 
euthanization (Surrey), as described in Chapter 2.  The data from the BOVIGAM® tests were 
used to compare against the lymph node cytokine data. 
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Results 
 
Total RNA extraction  
 
The first step in the study of cytokine gene expression was to isolate total RNA from the three 
thoracic lymph nodes of each animal in the five experimental groups (BCG Pasteur vaccinated 
challenged, BCG (sigK) Pasteur vaccinated challenged, non-vaccinated infected, non-
vaccinated non-infected and BCG Pasteur vaccinated non-infected).  The freshly sectioned 
lymph node samples were homogenised while submerged in trizol and the total RNA was 
extracted using chloroform – isopropanol.  Total RNA was quantified (Table 25) using a 
BioPhotometer (Eppendorf, Germany) and run on a 1% agarose electrophoresis gel (TAE 
buffer) to determine sample integrity (visualisation of the ribosomal RNA bands, Figure 34). 
  
Table 25: Quantification (μg/ml) and purity determined by spectrophotometry of total RNA isolated from the lymph 
nodes of M. bovis infected and non-infected cattle.  The data represents averaged lymph node results of 
approximately 50 extractions in total. 
 
Tissue type 
(n=50) 
Total RNA (50 μl) 
quantification μg/ml 
(mean ± SD) 
260/280 nm ratio 
(mean ± SD) 
 
Freshly dissected lymph 
node tissue 
 
 781.92 ± 451.78  
 
1.9 ± 0.11 
 
 
Total RNA was successfully isolated from all of the lymph node samples of cattle from the five 
experimental groups.  The mean concentration of total RNA extracted from approximately 50 
freshly dissected tissue sections was 781.92 μg/ml (in a 50 μl total volume, Table 25).  The 
large standard deviation of the mean associated with this data (451.78, Table 25) suggests that 
the concentration of total RNA extracted from the different lymph node samples was extremely 
varied (range from 170 to 1,952 μg/ml).    The ratio of total RNA (OD at 260 nm) to protein (OD 
at 280 nm) was within the recommended range (mean 1.9, Table 25) (Fleige and Pfaffl, 2006). 
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Figure 34: Agarose gel electrophoresis (1% agarose within TAE buffer and ethidium bromide staining) of total RNA 
samples (300 ng/ well) isolated from M. bovis challenged and non-challenged cattle lymph node tissues (lanes 2 to 
5).  All total RNA samples displayed a 28S ribosomal RNA band of approximately 4 Kb in length and an 18S 
ribosomal band of approximately 2 Kb.  Lane 1 is a 0.5-10 Kb RNA ladder with highlighted standard RNA base 
pair lengths of 6 and 1.5 Kb.  The electrophoresis experiment was repeated with different total RNA samples 10 
times and displayed consistent results. 
 
 
Each total RNA sample displayed bands of approximately 4 Kb and 2 Kb in length (Figure 34).  
These nucleotide lengths correspond to the expected lengths of 28S and 18S ribosomal RNA 
(Bradford et al, 2005) and give an indication to the high level of integrity of the total RNA 
samples.  There was little evidence of DNA contamination, which would be represented by 
clear bright bands nearer to the wells (Figure 34).  The total RNA samples extracted from the 
freshly dissected cattle lymph nodes showed high levels of messenger RNA when run on the 
agarose gels, represented by the localised smearing seen on the gel (Bradford et al, 2005). 
←28S rRNA band 
←18S rRNA band 
4 5 3 2 1 Lanes: 
6Kb 
1.5Kb 
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Quantitative Reverse Transcriptase Polymerase Chain Reaction 
 
Standard curves 
Standard templates for the cytokines IFN-γ, TNF-α, IL10 and IL4 were designed and serially 
diluted to produce a standard curve.  This allowed conversion of the calculated crossing point 
values of the unknown samples into quantitative copy number.  The results of the standard 
curves were as previously described for the Time course study. 
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The housekeeping gene GAPDH was analysed by qRT-PCR for each sample alongside each 
target cytokine to ensure the quality of the starting total RNA template.  In the absence of a 
cytokine PCR product, the presence of a GAPDH PCR product ensured that the sample 
template was of a high quality.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: The crossing point (CP) values of GAPDH expression within the thoracic lymph nodes of cattle either 
vaccinated with BCG (sigK) Pasteur prior to M. bovis challenge (n=4), vaccinated with BCG Pasteur prior to 
challenge (n=3), non-vaccinated infected (n=4), non-vaccinated non-infected (n=5) or BCG Pasteur vaccinated 
non-infected (n=4).  The data represents the mean triplicate values from the lymph nodes (left bronchial, cranial 
mediastinal and caudal mediastinal) of all cattle within each experimental group.  Error bars represent the 
standard deviation (±) of the data. 
 
There was no difference in GAPDH crossing point (CP) values (Figure 35) between the cattle 
BCG vaccinated M. bovis challenged (average CP of 22.8), BCG (sigK) vaccinated M. bovis 
challenged (average CP of 23.3), non-vaccinated M. bovis infected (average CP of 22.8), non-
vaccinated non-infected (average CP of 22.4) and BCG vaccinated non-infected (average CP 
of 23).  This suggested that any potential differences in cytokine expression between the five 
groups were unlikely to be due to the physical condition of the template.  
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Cytokine mRNA expression in the combined lymph nodes 
 
Five experimental groups of cattle, each displaying a different combination of vaccination and 
M. bovis infection were analysed for cytokine mRNA expression levels.  IFN-γ, TNF-α, IL10 and 
IL4 mRNA levels were quantitatively measured in three lymph nodes from each animal (left 
bronchial, cranial mediastinal and caudal mediastinal lymph nodes).  The individual lymph node 
results were then combined for each animal to give an overall view of cytokine expression 
within each experimental group.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: Quantitative RT-PCR of IFN-γ mRNA in the lymph nodes of cattle from five experimental groups; BCG 
(sigK) vaccinated followed by M. bovis challenge (n=4), BCG vaccinated followed by M. bovis challenge (n=3), 
non-vaccinated M. bovis infected (n=4), non-vaccinated non-infected (n=5) and BCG vaccinated non-infected 
(n=4).  The data are presented in log2 copy number and each individual point represents the mean triplicate data 
from an individual lymph node from one animal.  Three lymph nodes were used from each animal (left bronchial, 
cranial mediastinal and caudal mediastinal).  Error bars represent standard deviation (±) of each point and the 
mean of each group is shown by — symbol.  Significant differences between groups are displayed as * (p<0.05) 
and ** (p<0.005, Mann Whitney test). 
 
*
*
*
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There were significant differences in IFN-γ mRNA expression between the five experimental 
groups (p<0.005, Kruskal Wallis test, Figure 36).  The non-vaccinated M. bovis infected cattle 
showed the highest level of IFN-γ mRNA expression (mean log2 copy number of 10.5, Figure 
36) and was significantly higher than both the non-vaccinated non-infected group (mean log2 
copy number 8.58, p<0.05, Mann Whitney Test and Bonferroni corrected) and the BCG 
vaccinated non-infected group (mean log2 copy number 7.84, p<0.01, Mann Whitney test and 
Bonferroni corrected).   
Prior vaccination with either BCG (sigK) Pasteur or BCG Pasteur caused a slight reduction in 
IFN-γ mRNA levels (mean log2 copy number of  10.3 and 9.6, respectively) as compared to the 
animals that were non-vaccinated prior to infection (Figure 36) however this was not significant.   
The BCG (sigK) Pasteur vaccinated challenged animals showed a significantly higher level of 
IFN-γ mRNA as compared to the non-vaccinated non-infected group (p<0.005, Mann Whitney 
test and Bonferroni corrected) and the BCG vaccinated non-infected group (p<0.005, Mann 
Whitney test and Bonferroni corrected).  Whereas the BCG Pasteur vaccinated challenged 
group showed a significantly higher level of IFN-γ mRNA expression only when compared to 
the BCG vaccinated non-infected group (p<0.05, Mann Whitney test and Bonferroni corrected).  
There was no significant difference between the non-vaccinated non-infected and BCG 
vaccinated non-infected groups (p>0.05, Mann Whitney test, Figure 36).  
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Figure 37: Quantitative RT-PCR of TNF-α mRNA in the lymph nodes of cattle from five experimental groups; BCG 
(sigK) vaccinated followed by M. bovis challenge (n=4), BCG vaccinated followed by M. bovis challenge (n=3), 
non-vaccinated M. bovis infected (n=4), non-vaccinated non-infected (n=5) and BCG vaccinated non-infected 
(n=4).  The data are presented in log2 copy number and each individual point represents the mean triplicate data 
from an individual lymph node from one animal.  Three lymph nodes were used from each animal (the left 
bronchial, cranial mediastinal and caudal mediastinal).  Error bars represent standard deviation (±) of each point 
and the mean of each group is shown by — symbol.  There was no significant difference between the five 
experimental groups (p>0.05, Kruskal Wallis test). 
 
There were no significant differences in TNF-α mRNA expression levels between the five 
experimental groups (p>0.05, Kruskal Wallis test, Figure 37).  The non-vaccinated non-infected 
group showed the highest level of TNF-α mRNA expression (mean log2 copy number 11.8, 
Figure 37).  The BCG vaccinated non-infected group showed the lowest level of TNF-α mRNA 
expression (mean log2 copy number 11.06, Figure 37).  The three M. bovis infected groups 
(BCG (sigK) Pasteur vaccinated, BCG Pasteur vaccinated and non-vaccinated) showed 
extremely similar TNF-α mRNA expression levels (mean log2 copy numbers of 11.53, 11.47 
and 11.55, respectively, Figure 37).      
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Figure 38: Quantitative RT-PCR of IL10 mRNA in the lymph nodes of cattle from five experimental groups; BCG 
(sigK) vaccinated followed by M. bovis challenge (n=4), BCG vaccinated followed by M. bovis challenge (n=3), 
non-vaccinated M. bovis infected (n=4), non-vaccinated non-infected (n=5) and BCG vaccinated non-infected 
(n=4).  The data are presented in log2 copy number and each individual point represents the mean triplicate data 
from an individual lymph node from one animal.  Three lymph nodes were used from each animal (the left 
bronchial, cranial mediastinal and caudal mediastinal).  Error bars represent standard deviation (±) of each point 
and the mean of each group is shown by — symbol.  Significant differences between groups are displayed as ** 
(p<0.005, Mann Whitney test). 
 
There were significant differences in IL10 mRNA expression levels between the five 
experimental groups (p=0.005, Kruskal Wallis test, Figure 38).  The non-vaccinated non-
infected group showed the highest level of IL10 mRNA expression (mean log2 copy number 
15.5, Figure 38) and was statistically higher (p<0.005, Mann Whitney test and Bonferroni 
corrected) than the three M. bovis infected groups; BCG (sigK) Pasteur vaccinated, BCG 
Pasteur vaccinated and non-vaccinated (mean log2 copy number of 14.4, 14.4 and 14.44, 
respectively, Figure 38).  There were no significant differences between the three M. bovis 
infected groups (p>0.05, Mann Whitney test) and no significant difference between the BCG 
vaccinated non-infected group (mean log (2) copy number 14.6, Figure 38) and the non-
vaccinated non-infected group (p>0.05, Mann Whitney test). 
**
**
**
 
BCG (sigK) vaccinated, challenged 
 
BCG vaccinated, challenged 
 
Non-vaccinated, infected 
 
Non-vaccinated, non-infected 
 
BCG vaccinated, non-infected 
  BCG Vaccination Study 
 
144  
7
8
9
10
11
12
13
14
15
16
Lo
g 
(2
) c
op
y 
no
. I
L4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: Quantitative RT-PCR of IL4 mRNA in the lymph nodes of cattle from two experimental groups; non-
vaccinated non-infected (n=5) and BCG vaccinated non-infected (n=4).  The data are presented in log2 copy 
number and each individual point represents the mean triplicate data from an individual lymph node from one 
animal.  Three lymph nodes were used from each animal (the left bronchial, cranial mediastinal and caudal 
mediastinal).  Error bars represent standard deviation (±) of each point and the mean of each group is shown by 
— symbol.  There was no significant difference between the two groups (p>0.05, Kruskal Wallis test). 
 
Expression of IL4 mRNA was found only within the two non-infected groups; non-vaccinated 
non-infected and BCG vaccinated non-infected (Figure 39).  The crossing point values obtained 
for IL4 mRNA within the three M. bovis infected groups (BCG (sigK) Pasteur vaccinated, BCG 
Pasteur vaccinated and the non-vaccinated) were extremely similar to those of the negative 
controls for each sample (reactions excluding the reverse transcriptase enzyme) and therefore 
were not considered reliable data. 
There was no significant difference in IL4 mRNA expression levels between the two 
experimental groups (p>0.05, Kruskal Wallis test).  The non-vaccinated non-infected group 
showed a slightly higher level of IL4 mRNA expression (mean log2 copy number of 12.6, Figure 
39) as compared to the BCG vaccinated non-infected group (mean log2 copy number of 12.2, 
Figure 39). 
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Correlations between cytokine mRNA expression levels 
 
Previous work on expression profiles over different time periods of M. bovis infection revealed 
relationships between different cytokines.  The expression levels of cytokines IFN-γ, TNF-α, 
IL10 and IL4 from the combined lymph node data of all five experimental groups (BCG (sigK) 
Pasteur vaccinated challenged, BCG Pasteur vaccinated challenged, non-vaccinated infected, 
non-vaccinated non-infected and BCG vaccinated non-infected) were analysed using Pearsons 
correlation coefficient (Table 26).   
 
 
Table 26: Statistically tested correlations (p values determined by Pearsons correlation coefficient) between IFN-γ, 
TNF-α, IL10 and IL4 mRNA expression levels.  Data represents the combined lymph node results of all five 
experimental groups; BCG (sigK) vaccinated M. bovis challenged, BCG vaccinated challenged, non-vaccinated 
infected, non-vaccinated non-infected and BCG vaccinated non-infected animals.  
 
 
 
 
 
 
 
 
 
 
Significant correlations (p<0.05, Pearsons correlation coefficient) highlighted in bold and underlined. 
 
 
 
 
 
 
 
 IFN-γ TNF-α IL10 IL4 
         
IFN-γ   0.111 0.518 0.006 
          
TNF-α 0.111   0.008 0.002 
          
IL10 0.518 0.008   0.002 
          
IL4 0.006 0.002 0.002   
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Figure 40: Correlation between IL10 and TNF-α mRNA expression levels in the lymph nodes of cattle either BCG 
(sigK) Pasteur vaccinated M. bovis challenged, BCG Pasteur vaccinated challenged, non-vaccinated infected, 
non-vaccinated non-infected or BCG Pasteur vaccinated non-infected.  The data are presented in log2 copy 
number and each individual point represents the mean triplicate data from an individual lymph node from one 
animal.  The graph displays the equation of the line of best fit and the R2 value to indicate the fit of the data points. 
 
There was a significant correlation between IL10 and TNF-α mRNA expression levels within 
cattle from the five experimental groups; BCG (sigK) Pasteur vaccinated M. bovis challenged, 
BCG Pasteur challenged, non-vaccinated infected, non-vaccinated non-infected and BCG 
Pasteur vaccinated non-infected (p=0.008, Pearsons correlation coefficient, Table 26).  The 
data showed a positive correlation (Pearsons correlation coefficient R value of 0.5) and 
therefore indicated that as one cytokine increased in expression, the other cytokine also 
increased in expression.  The coefficient of determination (R2 of 0.2697 (multiplied by 100 to 
give as a percentage), Figure 40) suggested that 26.9% of the variance in one cytokine 
expression level was due to the other cytokine.  This also gave an indication of the fit of the 
data points to the linear trend line, as the further R2 from the value of 1, the larger the variation 
in data around the trend line. 
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Figure 41: Correlation between IL4 and IFN-γ mRNA expression levels in the lymph nodes of cattle either non-
vaccinated non-infected or BCG Pasteur vaccinated non-infected.  The data are presented in log2 copy number 
and each individual point represents the mean triplicate data from an individual lymph node from one animal.  The 
graph displays the equation of the line of best fit and the R2 value to indicate the fit of the data points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42: Correlation between IL4 and TNF-α mRNA expression levels in the lymph nodes of cattle either non-
vaccinated non-infected or BCG Pasteur vaccinated non-infected. The data are presented in log2 copy number 
and each individual point represents the mean triplicate data from an individual lymph node from one animal.  The 
graph displays the equation of the line of best fit and the R2 value to indicate the fit of the data points. 
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Figure 43: Correlation between IL4 and IL10 mRNA expression levels in the lymph nodes of cattle either non-
vaccinated non-infected or BCG Pasteur vaccinated non-infected.  The data are presented in log2 copy number 
and each individual point represents the mean triplicate data from an individual lymph node from one animal.  The 
graph displays the equation of the line of best fit and the R2 value to indicate the fit of the data points. 
 
There was a significant correlation between IL4 mRNA expression levels and IFN-γ, TNF-α and 
IL10 mRNA levels within cattle from two of the five experimental groups; non-vaccinated non-
infected and BCG vaccinated non-infected (p=0.006, 0.002 and 0.002, respectively, Pearsons 
correlation coefficient, Table 26).  The data showed a positive correlation for all three 
relationships (Pearsons correlation coefficient R values of 0.76, 0.73 and 0.8, respectively, 
Figures 41, 42 and 43) therefore indicating that an increase in IL4 mRNA expression level was 
paralleled by an increase in IFN-γ, TNF-α and IL10 mRNA expression within these two 
experimental groups.  The correlations were relatively strong, shown by the coefficient of 
determination for each relationship (R2 multiplied by 100 to give a percentage, Figures 41, 42 
and 43).  The correlation between IL4 and IFN-γ mRNA expression showed a relationship of 
58% (Figure 41), between IL4 and TNF-α mRNA expression the relationship was 53% (Figure 
42) and between IL4 and IL10 mRNA expression the relationship was 65% (Figure 43).  This 
also indicated the fit of the data to the linear trend line, as the relationship between IL4 and 
IL10 showed a tighter fit of data (R2 closer to a value of 1). 
  BCG Vaccination Study 
 
149  
Immunohistochemistry  
 
Quantitative RT-PCR allowed the quantification of IFN-γ, TNF-α, IL10 and IL4 mRNA templates 
within the lymph node samples of cattle either BCG (modified sigK) Pasteur vaccinated M. 
bovis challenged, BCG Pasteur vaccinated M. bovis challenged, non-vaccinated M. bovis 
infected, non-vaccinated non-infected or BCG Pasteur vaccinated non-infected.  This gave an 
indication of the genetic expression profile of the animal’s immune response at five weeks post 
M. bovis challenge.   This work was followed by exploring the level of IFN-γ and TNF-α protein 
production within the same lymph node samples at the same time point using 
immunohistochemistry.  The results were expressed as a scoring method based on the 
percentage area coverage of positively identified cells expressing IFN-γ and TNF-α.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44: Protein and mRNA expression of IFN-γ within cattle either BCG (sigK) Pasteur vaccinated M. bovis 
challenged (n=4), BCG Pasteur vaccinated challenged (n=3), non-vaccinated infected (n=4), non-vaccinated non-
infected (n=5) and BCG Pasteur vaccinated non-infected (n=4).  Protein data are expressed as a score of 
percentage area coverage of cells expressing IFN-γ (IHC) based on the scale of 0 = no positive cells, 1 = <5% 
area coverage, 2 = between 5-20 % area coverage, 3 = between 21-40% area coverage and 4 = over 40% area 
coverage (100x magnification).  The mRNA IFN-γ data are expressed as actual copy number (qRT-PCR).  Data 
represents the mean triplicate results from three different lymph nodes (caudal mediastinal, cranial mediastinal 
and left bronchial) from every animal within each group.  Error bars represent standard deviation (±) of the mean.  
Statistical differences between levels of protein were displayed as * (p<0.05) and ** (p<0.005, Mann Whitney test). 
*****
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The immunohistochemistry studies on cells expressing IFN-γ protein within cattle from the five 
experimental groups (mean of all animals within each group) showed a similar pattern to the 
IFN-γ mRNA expression profiles observed using qRT-PCR (Figure 44).  This trend was also 
shown when analysing the three individual lymph nodes (left bronchial, caudal mediastinal and 
cranial mediastinal) data separately (Figure 45).  Statistically, using the data from the individual 
lymph nodes (Figure 45), there was a significant correlation between IFN-γ protein and IFN-γ 
mRNA expression levels (p<0.001, Spearmans correlation coefficient).  
 
There was also a significant difference in the number of cells expressing IFN-γ protein between 
each group (p<0.005, Kruskal Wallis test, Figure 44).  The non-vaccinated M. bovis infected 
group had a significantly higher level of IFN-γ protein expressing cells (mean score of 2.75, 
Figure 44) as compared to the BCG Pasteur challenged group (mean score of 1.5, p<0.05, 
Mann Whitney test and Bonferroni corrected).  The non-vaccinated infected group also had 
significantly higher levels of IFN-γ protein expressing cells as compared to the non-vaccinated 
non-infected group (mean score of 1.27) and the BCG vaccinated non-infected group (mean 
score of 1.42, p≤0.005, Mann Whitney test and Bonferroni corrected, Figure 44).  Cattle that 
received BCG (sigK) Pasteur vaccination prior to challenge had slightly lower levels of IFN-γ 
protein expressing cells (mean score of 1.8, Figure 44) as compared to the non-vaccinated 
infected group and higher levels compared to the BCG Pasteur vaccinated group, however this 
was not a significant difference.   
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Figure 45: Protein and mRNA expression of IFN-γ within the (a) left bronchial, (b) caudal mediastinal and (c) 
cranial mediastinal lymph nodes of cattle either BCG (sigK) Pasteur vaccinated M. bovis challenged (group 1), 
BCG Pasteur vaccinated challenged (group 2), non-vaccinated infected (group 3), non-vaccinated non-infected 
(group 4) and BCG vaccinated non-infected (group 5).  Protein data are expressed as a score of percentage area 
coverage of cells expressing IFN-γ (IHC) based on the scale of 0 = no positive cells, 1 = <5% area coverage, 2 = 
5-20 % area coverage, 3 = 21-40% area coverage and 4 = over 40% area coverage (100x magnification).  The 
mRNA IFN-γ data are expressed as actual copy number (qRT-PCR).  Data represents the averaged triplicate 
results from each lymph node.  
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Figure 46: Protein and mRNA expression of TNF-α within cattle either BCG (sigK) vaccinated M. bovis challenged 
(n=4), BCG vaccinated challenged (n=3), non-vaccinated infected (n=4), non-vaccinated non-infected (n=5) and 
BCG vaccinated non-infected (n=4).  Protein data are expressed as a score of percentage area coverage of cells 
expressing TNF-α (immunohistochemistry) based on the scale of 0 = no positive cells, 1 = <1% area coverage, 2 = 
between 2-10% area coverage, 3 = between 11-20% area coverage and 4 = over 20% area coverage (400x 
magnification).  The mRNA TNF-α data are expressed as actual copy number (qRT-PCR).  Data represents the 
mean results from three different lymph nodes (caudal mediastinal, cranial mediastinal and left bronchial) from 
every animal within each group.  Statistical differences between levels of protein were displayed as * (p<0.05, 
Mann Whitney test). 
 
 
 
The immunohistochemistry studies on cells expressing TNF-α protein within cattle from the five 
experimental groups (averaged data from all animals within each group) showed a slightly 
different pattern to the TNF-α mRNA expression profiles observed during qRT-PCR (Figure 
46).  This was also shown when analysing the three different lymph nodes (left bronchial, 
caudal mediastinal and cranial mediastinal) data separately (Figure 47).  Statistically, using the 
data from the individual lymph nodes (Figure 47), there was no significant correlation between 
TNF-α protein and TNF-α mRNA expression levels (p>0.05, Spearmans correlation coefficient).   
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Figure 47: Protein and mRNA expression of TNF-α within (a) the left bronchial, (b) caudal mediastinal and (c) 
cranial mediastinal lymph nodes of cattle either BCG (sigK) vaccinated M. bovis challenged (group 1), BCG 
vaccinated challenged (group 2), non-vaccinated infected (group 3), non-vaccinated non-infected (group 4) and 
BCG vaccinated non-infected (group 5).  Protein data are expressed as a score of percentage area coverage of 
cells expressing TNF-α (IHC) based on the scale of 0 = no positive cells, 1 = <1% area coverage, 2 = 2-10 % area 
coverage, 3 = 11-20% area coverage and 4 = over 20% area coverage (400x magnification).  The mRNA TNF-α 
data are expressed as actual copy number (qRT-PCR).  Data represents the mean triplicate results from each 
lymph node. 
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There was a significant difference in the number of cells expressing TNF-α protein between 
each group (p<0.005, Kruskal Wallis test, Figure 46).  The non-vaccinated M. bovis infected 
group had the highest level of cells expressing TNF-α protein (mean score of 2.17, Figure 46) 
and this was statistically higher than the BCG vaccinated non-infected group (mean score of 1, 
p<0.05, Mann Whitney test and Bonferroni corrected). The BCG (sigK) Pasteur vaccinated 
challenged group had a significantly higher number of cells expressing TNF-α protein (mean 
score of 1.82, p<0.05, Mann Whitney test and Bonferroni corrected) as compared to the BCG 
vaccinated non-infected group (Figure 46).  The BCG vaccinated challenged group and the 
non-vaccinated non-infected group had the same level of cells expressing TNF-α protein (mean 
score of 1.13, Figure 46). 
 
The TNF-α mRNA expression data of the five experimental groups showed a slightly different 
pattern when expressed as copy number (Figure 46) compared to when expressed as log2 
copy number (Figure 37).  Both forms of the data represented the average of the total data set 
for each experimental group.  However, the average of the data in copy number format was the 
arithmetic mean whereas the average of the data in log2 copy number format was the 
geometric mean.  This produced slightly different expression profiles although this difference 
was not significant (p>0.05, Mann Whitney test).   
 
There was also a significant correlation between the levels of IFN-γ protein and TNF-α protein 
in the five experimental groups (p<0.001, Spearmans correlation coefficient). 
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6%
35%
59%
Lymph node pathology of M. bovis challenged cattle   
   
Percentage granuloma coverage 
Granulomatous lesions within lymph nodes are a characteristic feature of M. bovis infection.  
The percentage area coverage of granulomas within individual lymph nodes can be used to 
indicate the extent of pathology caused by infection.  Microscope slides of lymph node tissue 
were prepared for each animal from three of the five experimental groups; BCG (sigK) Pasteur 
vaccinated M. bovis challenged, BCG Pasteur vaccinated challenged and non-vaccinated 
infected.  There was no gross pathology data for the non-vaccinated non-infected and BCG 
Pasteur vaccinated non-infected groups due to the absence of granulomas in non-infected 
animals.  The lymph node section was first measured by counting the total fields of view that 
the section covered (100 x magnifications).  Each individual granuloma within the section was 
then measured by counting the number of fields of view that the granulomas covered and the 
percentage area coverage calculated in respect to the entire lymph node section. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 48: Percentage area coverage of granulomas within the lymph nodes of cattle either vaccinated with BCG 
(sigK) Pasteur prior to M. bovis challenge (n=4), vaccinated with BCG Pasteur prior to challenge (n=3) or non-
vaccinated and infected (n=4).  The combined total area of granuloma coverage for each lymph node (left 
bronchial, caudal mediastinal and cranial mediastinal) of each animal was calculated.  This data was then 
transformed into a percentage of the total area of granuloma coverage in all three experimental groups. 
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Figure 49: Protein expression (IFN-γ and TNF-α) and extent of pathological disease within (a) the left bronchial, 
(b) caudal mediastinal and (c) cranial mediastinal lymph nodes of cattle either vaccinated with BCG (sigK) Pasteur 
prior to M. bovis challenge (group 1), vaccinated with BCG Pasteur prior to M. bovis challenge (group 2) or non-
vaccinated infected (group 3).  Protein data are expressed as a score of percentage area coverage of cells 
expressing TNF-α and IFN-γ (IHC) based on the scale 1 (lowest percentage coverage) to 4 (highest percentage 
coverage).  Pathological data are expressed as percentage area coverage of granulomas within the infected 
lymph nodes.  Data represents the mean duplicate results for each lymph node from each animal.  
2 
1 
1 
1 
2 
2 
   3 
  3 
3 
 
IFN gamma protein 
 
TNF alpha protein 
 
% Pathology 
  BCG Vaccination Study 
 
157  
Overall, there appeared to be a difference in the percentage of granuloma coverage between 
the three M. bovis experimentally infected animals, however this was not significant (p>0.05, 
Kruskal-Wallis test, Figure 48).  The non-vaccinated M. bovis infected cattle group (combined 
lymph node data) showed the highest level of pathological disease (total of 59% area coverage 
of granulomatous lesions over the lymph node section, Figure 48).  Vaccination prior to M. 
bovis challenge lessened the degree of pathology noted within the selected lymph nodes.  
However, the BCG (sigK) Pasteur vaccinated animals had a higher level of pathology (total of 
35% area coverage of granulomatous lesions over the lymph node section, Figure 48) as 
compared to the BCG Pasteur vaccinated animals (total of 6% area coverage, Figure 48). 
 
The individual lymph node data (Figure 49) showed the same trend as seen in the combined 
lymph node data (Figure 48).  The non-vaccinated M. bovis infected cattle lymph nodes 
generally had a higher level of pathology as compared to the vaccinated cattle.  The non-
vaccinated infected animals had between 0 and 90% granuloma coverage in the left bronchial 
(Figure 49a), between 0 and 60% granuloma coverage in the caudal mediastinal (Figure 49b) 
and between 0 and 50% granuloma coverage in the cranial mediastinal lymph node (Figure 
49c).  The BCG (sigK) Pasteur vaccinated challenged animals had between 0 and 40% 
granuloma coverage in the left bronchial (Figure 49a) and between 0 and 10% granuloma 
coverage in the caudal mediastinal lymph node (Figure 49b).  The exception to the rule was the 
BCG (sigK) vaccinated animal 3506 (cranial mediastinal lymph node) which had a higher level 
of pathology as compared to the same lymph nodes in the non-vaccinated animals (75% 
granuloma coverage, Figure 49c).  The BCG Pasteur vaccinated challenged animals had 0% 
granuloma coverage in the left bronchial (Figure 49a), between 0 and 25% granuloma 
coverage in the caudal mediastinal (Figure 49b) and between 0 and 11% granuloma coverage 
in the cranial mediastinal lymph node (Figure 49c).  
The BCG (sigK) vaccinated animals had higher levels of pathology as compared to the BCG 
vaccinated animals, with the exception of animal 3532 (caudal mediastinal lymph node) which 
had a higher level of granuloma coverage at 25% (Figure 49b). 
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Figure 50: Correlations between the percentage area coverage of granuloma and both (a) IFN-γ and (b) TNF-α.  
The graphs display both mRNA (log2 copy number) and protein (IHC score) data for the thoracic lymph nodes of 
cattle either vaccinated with BCG (sigK) Pasteur prior to M. bovis challenge (n=4), vaccinated with BCG Pasteur 
prior to challenge (n=3) or non-vaccinated infected (n=4).  The lymph node IFN-γ protein data are expressed as a 
score of percentage area coverage of cells expressing IFN-γ (IHC) based on the scale 1 (lowest percentage 
coverage) to 4 (highest percentage coverage).  The IFN-γ mRNA data are expressed in log2 copies obtained from 
the qRT-PCR experiments.  Each data point represents one animal.  The graph also displays both equations of 
the line including the R2 value.    
 
TNF alpha protein vs. % granuloma coverage 
 
TNF alpha mRNA vs. % granuloma coverage 
IFN gamma protein vs. % granuloma coverage 
 
IFN gamma mRNA vs. % granuloma coverage 
  BCG Vaccination Study 
 
159  
The individual lymph node data (Figure 49) suggested a relationship between the levels of IFN-
γ and TNF-α protein expression with the percentage of granuloma coverage within each lymph 
node section.  Statistically, there was a significant positive correlation between the percentage 
coverage of granuloma and both IFN-γ protein expression (p<0.05, Spearmans correlation co-
efficient, Figure 50a) and TNF-α protein expression (p<0.001, Spearmans correlation co-
efficient, Figure 50b).  There was also a significant positive correlation between levels of 
pathology and the level of IFN-γ mRNA expression within each lymph node (p<0.001, Pearsons 
correlation coefficient, Figure 50a) but not with TNF-α or IL10 (graph not shown) mRNA 
expression levels (p>0.05, Pearsons correlation coefficient, Figure 50b). 
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Granuloma score 
An additional method used to indicate the extent of pathology caused by M. bovis infection 
based on the score of each individual granuloma within the lymph node samples was also 
performed.  A scoring scale developed by Wangoo et al (2005) was used to organise each 
granuloma into one of four stages based on their morphological and physiological state.  The 
slides used previously for granuloma percentage coverage were used to determine the number 
of granuloma that corresponded with each stage (Table 27).  As granuloma advancement 
through the stages is coupled with an increase in size the counts were weighted using a log2 
scale, this allowed compensation for the larger sizes of the later stage granulomas.            
 
Table 27: Categorisation of granulomas within the lymph node sections of cattle infected with M. bovis and either 
non-vaccinated, BCG Pasteur vaccinated or BCG (sigK) Pasteur vaccinated.  Granuloma specific for each of the 
four stages of development (I-IV) were counted within slide mounted lymph node sections.   
 
 
Granuloma score (weighted score) 
Animal  Treatment Stage I Stage II Stage III Stage IV Total Mean (SEM) 
3523 
3518 
3513 
3508 
3527 
3532 
3522 
3521 
3516 
3511 
3506 
Non-vaccinated 
Non-vaccinated 
Non-vaccinated 
Non-vaccinated  
BCG vaccinated  
BCG vaccinated  
BCG vaccinated  
BCG (sigK) vaccinated 
BCG (sigK) vaccinated 
BCG (sigK) vaccinated 
BCG (sigK) vaccinated 
11 (11) 
5 (5) 
7 (7) 
9 (9) 
0 (0) 
12 (12) 
1 (1) 
5 (5) 
6 (6) 
16 (16) 
5 (5) 
10 (20) 
6 (12) 
3 (6) 
10 (20) 
0 (0) 
7 (14) 
7 (14) 
0 (0) 
0 (0) 
36 (72) 
46 (92) 
2 (8) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
1 (4) 
0 (0) 
0 (0) 
0 (0) 
6 (24) 
14 (56) 
4 (32) 
3 (24) 
4 (32) 
1 (8) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
71 
41 
45 
37 
0 
30 
15 
5 
6 
112 
153 
 
 
 
48.5 (7.67) 
 
 
15 (8.66) 
 
 
 
69 (37.6) 
 
The granuloma counts were weighted (in brackets) on a log2 scale to account for the increased size of the 
advanced stage granuloma.  Therefore, the count for stage I was multiplied by 1, stage II multiplied by 2, stage III 
multiplied by 4 and stage IV multiplied by 8.   The sum of the weighted scores for each animal was then calculated 
and the mean of the total sum (including the standard error of the mean) for each experimental group displayed in 
the final column. 
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The data for the percentage area coverage of granulomatous lesions (Figure 49) for each 
individual animal displayed a positive relationship with the categorised granuloma stage results 
(p<0.001, Spearmans correlation co-efficient, Table 27).  Therefore as the percentage area 
coverage of granulomas within the lymph nodes increased, there was also an increase in the 
weighted total of granuloma development. 
 
There was also a marked difference between the three experimental groups in granuloma 
development (Table 27) however, due to the large variations in the data sets these differences 
were not significant within the animals studied (p>0.05, Kruskal Wallis test).  The BCG Pasteur 
vaccinated challenged group showed the lowest score for granuloma development (mean 15, 
Table 27).  This score increased within the lymph nodes of cattle non-vaccinated infected 
(mean 48.5).  Finally, the BCG (sigK) Pasteur vaccinated challenged group displayed the 
highest level of granuloma development (mean 69, Table 27).   
 
Focusing on the individual granuloma stage results, stage IV granuloma were found within the 
non-vaccinated infected group only (scores of 32, 32 and 24 for the three animals within the 
non-vaccinated infected group, Table 27).  Both the non-vaccinated and BCG (sigK) Pasteur 
vaccinated challenged groups displayed the same total score for stage I granuloma (sum of 
32).  For the stage II and III granuloma, the BCG (sigK) Pasteur vaccinated group showed the 
highest scores (sum of 164 and 80, respectively, Table 27), followed by the non-vaccinated 
infected group (sum of 58 and 8, respectively, Table 27).  The BCG Pasteur vaccinated 
challenged group displayed the lowest scores for granuloma across the three stages of 
development I, II and III (13, 28 and 4, respectively, Table 27). 
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Figure 51: Correlations between granuloma stage (sum of weighted scores) and both (a) IFN-γ and (b) TNF-α.  
The graphs display both mRNA (log2 copy number) and protein (IHC score) data for the thoracic lymph nodes of 
cattle either vaccinated with BCG (sigK) Pasteur prior to M. bovis challenge (n=4), vaccinated with BCG Pasteur 
prior to challenge (n=3) or non-vaccinated infected (n=4).  The lymph node IFN-γ protein data are expressed as a 
score of percentage area coverage of cells expressing IFN-γ (IHC) based on the scale 1 (lowest percentage 
coverage) to 4 (highest percentage coverage).  The IFN-γ mRNA data are expressed in log2 copies obtained from 
the qRT-PCR experiments.  Each data point represents one animal.  The graph also displays both equations of 
the line including the R2 value.    
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There was no significant relationship between IFN-γ mRNA or protein data and the granuloma 
developmental score for each animal (p>0.05, Spearmans correlation coefficient, Figure 51a).  
There was also no significant relationship between TNF-α (Figure 51b) or IL10 mRNA (graph 
not shown) and the granuloma developmental score (p>0.05, Spearmans correlation 
coefficient).  There was however, a significant positive correlation for TNF-α protein levels 
(p<0.05, Spearmans correlation coefficient, Figure 51b).  
  BCG Vaccination Study 
 
164  
0
0.5
1
1.5
2
2.5
3
3.5
BCG (sigK)
vaccinated
challenged
BCG vaccinated
challenged
Non-vaccinated
infected
Experimental group
IF
N
 g
am
m
a 
IH
C
 s
co
re
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
M
ea
n 
O
D
 
Whole blood IFN-γ cultures  
 
Whole blood samples were taken from each animal within the M. bovis infected groups (BCG 
(sigK) Pasteur vaccinated, BCG Pasteur vaccinated and non-vaccinated) at five weeks post 
infection (prior to euthanisation).  The samples were incubated with tuberculin purified protein 
derivative (PPD) B to stimulate lymphocytes present within the blood to subsequently produce 
IFN-γ protein.  Using an enzyme-linked immunosorbent assay (ELISA), IFN-γ protein was 
detected via spectrophotometry (450 nm) and the results expressed as mean optical density 
(OD) for each animal.  The blood IFN-γ protein levels were compared to lymph node IFN-γ 
protein levels obtained by IHC.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52: IFN-γ protein levels in the blood and lymph nodes of cattle either vaccinated with BCG (sigK) Pasteur 
prior to M. bovis challenge (n=4), vaccinated with BCG Pasteur prior to challenge (n=3) or non-vaccinated infected 
(n=4).  The lymph node IFN-γ protein data are expressed as a score of percentage area coverage of cells 
expressing IFN-γ (IHC) based on the scale 1 (lowest percentage coverage) to 4 (highest percentage coverage).  
The data represents the mean of triplicate values from three lymph nodes (left bronchial, caudal mediastinal and 
cranial mediastinal) from every animal in each group.  The whole blood IFN-γ protein data are expressed as mean 
optical density (OD) readings obtained from ELISA’s of samples from each animal within each experimental group 
(performed in duplicate).  Error bars indicate the standard deviation (±) from the mean.    
 
 
IFN gamma protein: lymph node 
 
IFN gamma protein: whole blood 
  BCG Vaccination Study 
 
165  
y = 0.8502x + 6.7048
R2 = 0.1028
y = 0.8545x - 1.3029
R2 = 0.386
0
2
4
6
8
10
12
14
3 4 4 5 5
Mean OD
IH
C
 s
co
re
 / 
Lo
g 
(2
) c
op
y 
no
. 
Comparing the level of IFN-γ protein within whole blood cultures of cattle from the three 
experimental groups, the non-vaccinated M. bovis infected animals had the highest level of 
IFN-γ protein (mean OD reading of 4.57, Figure 52).  Vaccination prior to challenge produced a 
decrease in the levels of blood IFN-γ protein, as both the BCG (sigK) Pasteur vaccinated and 
BCG Pasteur vaccinated cattle had lower levels of IFN-γ protein as compared to the non-
vaccinated group (mean OD reading of 3.63, Figure 52). 
 
The trend in IFN-γ protein levels within whole blood cultures was very similar to the trend in 
IFN-γ protein and mRNA levels within the thoracic lymph nodes (Figure 52).  Statistically, there 
was a positive correlation (R value of 0.62) between lymph node IFN-γ protein and whole blood 
IFN-γ (p<0.05, Spearmans correlation coefficient, Figure 53).     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53: Correlation between IFN-γ protein in whole blood cultures and both IFN-γ mRNA (log2 copy number) 
and protein (IHC score) in thoracic lymph nodes of cattle either vaccinated with BCG (sigK) Pasteur prior to M. 
bovis challenge (n=4), vaccinated with BCG Pasteur prior to challenge (n=3) or non-vaccinated infected (n=4).  
The lymph node IFN-γ protein data are expressed as a score of percentage area coverage of cells expressing 
IFN-γ (IHC) based on the scale 1 (lowest percentage coverage) to 4 (highest percentage coverage).  The whole 
blood IFN-γ protein data are expressed as mean optical density (OD) readings obtained from ELISA’s from each 
animal (performed in duplicate).  The IFN-γ mRNA data are expressed in log2 copies obtained from the qRT-PCR 
experiments.  Each point represents one animal.  The graph also displays both equations of the line including the 
R2 value.    
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The non-vaccinated infected group had the highest level of both IFN-γ protein in the blood and 
IFN-γ protein in the thoracic lymph nodes (IHC score of 2.75, Figure 52).  Prior vaccination 
reduced both IFN-γ protein in the blood and IFN-γ protein in the thoracic lymph nodes (IHC 
scores of 1.84 and 1.55, respectively, Figure 52).  There was no difference in IFN-γ protein 
blood levels between the two vaccinated groups however there was a slight difference in IFN-γ 
protein lymph node levels between the two vaccinated groups (BCG (sigK) vaccinated group 
had an IHC score of 1.84 and the BCG vaccinated group had an IHC score of 1.55, Figure 52).       
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Discussion  
 
The Bacillus Calmette Guérin (BCG) vaccination is the ‘Gold standard’ in protection against TB 
infection (Buddle et al, 2005) to which all new vaccines are measured against.  Attenuated from 
a strain of M. bovis, BCG vaccination displays the ability to induce an immune response 
(Watanabe et al, 2006, Whelan et al, 2008, Huang et al, 2007) with reduced virulence 
(Junqueira-Kipnis et al, 2006).  The vaccination has been shown to protect against 
mycobacterial infection in a variety of species, including bovine (Vordermeier et al, 2002) and 
murine (Giri et al, 2006) models, however rarely been shown to completely eradicate the 
bacteria (Buddle et al, 2005, Orme et al, 2001).  In response to the growing need for a reliable 
bovine vaccination, the Krebs report (Krebs et al, 1997) highlighted the importance of creating 
a greater understanding of protective immunity.  It is widely accepted that an essential 
component of the immune response to TB infection is cell mediated and this therefore may 
represent a potential correlate of protective immunity (Endsley et al, 2007).  IFN-γ production 
and lymphocyte proliferation have been shown to be biomarkers of the cell mediated response 
although there are conflicting reports on their ability to indicate protection post vaccination 
(Wedlock et al, 2007, Buddle et al, 2003, Mittrucker et al, 2007).   In addition to this, those 
correlates that have been shown to successfully predict vaccine induced protection in smaller 
animal models have been less successful in human infection (Buddle et al, 2003, Hoft et al, 
2002).  The added complications associated with cattle challenge experiments (high costs and 
limited availability of appropriate holding facilities) increases the need for a reliable correlate of 
protection that can be measured post vaccination but prior to challenge (Vordermeier et al, 
2006).  This further emphasises the importance of an improved understanding on the host’s 
immune system in response to BCG Pasteur vaccination and M. bovis challenge (Endsley et al, 
2007).  
             
Modern molecular techniques have enabled genome sequencing of M. bovis (Garnier et al, 
2003), M. tuberculosis (Cole et al, 1998) and BCG Pasteur (Brosch et al, 2007), thus allowing 
extensive genomic comparisons between the different mycobacterial species.  A critical step in 
the attenuation of all BCG sub-types from M. bovis was the loss of the region of difference (RD) 
1 (Pym et al, 2002, Lewis et al, 2003).  However, genomic studies have also revealed apparent 
deletions, insertions and single nucleotide polymorphisms that differ between the BCG sub-
types, effectively dividing them into early (including BCG Russia, Japan and Sweden) and late 
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(including BCG Pasteur, Danish and Glaxo) strains (Brosch et al, 2005).  One such dividing 
factor is the production of antigenic proteins MPB70 and MPB83, which are produced in high 
levels by the earlier BCG strains and in low levels by late BCG strains (Harboe and Nagai, 
1984) due to a polymorphism in the gene encoding for the regulatory factor sigK (Charlet et al, 
2005).  Comparative vaccination studies of human infants using both BCG Japan and BCG 
Pasteur (Davids et al, 2006) have indicated a stronger protective ability of BCG Japan.  The 
difference in protective efficacy may be linked to the comparatively higher level of production of 
antigenic proteins MPB70 and MPB83, though there are no reports in the literature to support 
this hypothesis.   
Complementation of BCG Pasteur with a wild-type sigK (BCG (sigK) Pasteur) has been shown 
to produce increased levels of MPB70 and MPB83 (Charlet et al, 2005) and so it was possible 
within this study to apply the genetically modified vaccine in bovine M. bovis challenge 
experiments.  The immune response of cattle challenged with M. bovis post BCG Pasteur or 
BCG (sigK) Pasteur vaccination were analysed to provide an understanding of their protective 
efficacy.  Recombinant vaccines with enhanced antigenic capabilities have been shown to 
induce an increased cell mediated immune response post vaccination (Shi et al, 2007, Qie et 
al, 2008, Ryan et al, 2007).  Therefore by increasing the levels of MPB70 and MPB83, the BCG 
(sigK) Pasteur vaccine may induce a stronger immune response within the experimental cattle.  
The study also involved cattle from three control groups, non-vaccinated M. bovis infected, 
non-vaccinated non-infected and BCG Pasteur vaccinated non-infected to allow a more 
comprehensive overview of the immune system in response to different stimuli.      
 
Total RNA extraction 
To enable the quantification of target cytokine expression levels, total RNA was extracted from 
the freshly dissected bovine lymph node tissue samples using a Trizol/chloroform method 
(modified from Chomczynski and Sacchi, 1987).  The total RNA was then analysed by agarose 
gel electrophoresis and spectrophotometry to determine the overall integrity of the extracted 
samples. 
Reagents that have been developed to sequester RNA before the onset of degradation have 
proved extremely valuable for subsequent genetic analysis (Blow et al, 2008, Ahmed et al, 
2004, Müller et al, 2002).  Within this study, total RNA was extracted from freshly dissected 
lymph node samples and following agarose gel electrophoresis, both the 28S and 18S 
ribosomal bands were observed (Figure 34).  The spectrophotometry results confirmed the 
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purity of the total RNA samples (Table 25), as the 260/280 nm ratio of 1.9 was in the expected 
range (Fleige and Pfaffl, 2006), thus indicating a lack of protein contamination (Bustin, 2004).  
Finally, the lymph node samples produced variable quantities of total RNA (with an 
approximate range of 170 to 1,952 μg/ml, Table 25) and this may be due to the individual 
extraction processes and the quality of each sample.  The trizol/chloroform method resulted in 
a large quantity of total RNA from each sample (mean of 781.92 ug/ml, Table 25) and therefore 
it was decided to apply a one-step reverse transcriptase PCR method in which total RNA is 
added directly to the PCR reaction.  This has the advantage of reducing potential 
contamination that may be introduced between the reverse transcriptase and PCR steps 
(Wacker and Godard, 2005).   
 
Cytokine mRNA expression in the combined lymph nodes 
 
The total RNA extracted from the five experimental cattle group lymph nodes (BCG Pasteur 
vaccinated M. bovis challenged, BCG (sigK) Pasteur vaccinated M. bovis challenged, non-
vaccinated infected, non-vaccinated non-infected and BCG Pasteur vaccinated non-infected) 
were applied to qRT-PCR targeting the cytokines IFN-γ, TNF-α, IL10 and IL4, in addition to the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  As GAPDH is a 
constitutively expressed gene, it was therefore possible to use the amplified GAPDH PCR 
product to determine the overall integrity of the total RNA template.  The crossing point values 
for each GAPDH reaction displayed a consistency in mRNA expression across the five 
experimental groups (mean CP of 22.8 for the BCG Pasteur vaccinated challenged group, 23.3 
for the BCG (sigK) vaccinated challenged group, 22.8 for the non-vaccinated infected group, 
22.4 for the non-vaccinated non-infected group and 23 for the BCG vaccinated non-infected 
group, Figure 35).  This suggested that any potential differences in cytokine expression 
between the five experimental groups were unlikely to be due to the physical condition of the 
template.  The mRNA expression levels of IFN-γ, TNF-α, IL10 and IL4 were then measured 
quantitatively in three different lymph nodes (left bronchial, cranial mediastinal and caudal 
mediastinal) from each animal within the five experimental groups.  The qRT-PCR data from 
the individual lymph nodes was combined to produce a complete view of cytokine expression in 
response to BCG Pasteur/BCG (sigK) Pasteur vaccination and M. bovis infection (Figures 36 - 
39).  Cytokine expression was detected within all of the lymph node samples from every animal 
within each of the five experimental groups, including the non-vaccinated non-infected animals.  
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These results show that it is possible to detect cytokine expression within healthy cattle tissues 
and this has also been reported previously (Widdison et al, 2005). 
 
Immune response to BCG Pasteur vaccination 
The BCG Pasteur vaccinated non-challenged cattle displayed no significant change in cytokine 
expression as compared to the non-vaccinated non-infected cattle (p>0.05, Mann Whitney test, 
Figures 36 - 39) between fourteen and sixteen weeks post vaccination.  All four cytokines 
displayed slightly lower expression levels in response to BCG vaccination (mean log2 copies of 
7.84 for IFN-γ, 11.06 for TNF-α, 14.6 for IL10 and 12.2 for IL4, Figures 36 - 39) as compared to 
non-vaccinated non-infected cattle (mean log2 copies of 8.58 for IFN-γ, 11.8 for TNF-α, 15.5 for 
IL10 and 12.6 for IL4, Figures 36 - 39).  Therefore, in the non-stimulated thoracic lymph node 
tissues, BCG Pasteur vaccination did not appear to produce an immune response that was 
apparent fourteen to sixteen weeks after vaccination.   
A similar study performed by Widdison et al (2006) investigated cytokine expression levels in 
bovine parotid, submandibular and retropharyngeal lymph nodes.  Comparisons of BCG 
vaccinated non-infected and non-vaccinated non-infected cattle also revealed no significant 
differences in IFN-γ, TNF-α or IL4 mRNA expression.  However the study did show a significant 
increase in IL10 in response to vaccination (Widdison et al, 2006) which has also been 
reported in vaccination studies using human monocyte-derived dendritic cells (Gagliardi et al, 
2005, Larsen et al, 2007).  Analysis of the effects of BCG vaccination revealed the ability of 
dendritic cells to induce differentiation of naïve T cells into IL10 producing T regulatory (Tr1) 
cells (Larsen et al, 2007).  The authors suggest that the Tr1 cells contribute to the immune 
response by regulating excessive TH1 and TH2 responses.  This hypothesis is further supported 
by studies in IL10-deficient mice, which showed significantly enhanced levels of IL12 and TNF-
α accompanied by numerous advanced granulomas following BCG vaccination (Jacobs et al, 
2002).  The IL10-deficient mice quickly eradicated the bacilli however the granulomatous 
lesions remained in a destructive state even after bacterial cell clearance, leading to 
irreversible tissue damage (Jacobs et al, 2002).  This highlights the importance of IL10 as a 
regulatory cytokine and therefore the increase in expression post vaccination may represent 
the host’s efforts to limit pathological disease. 
Within this study, IL10 expression levels did not differ significantly in response to BCG Pasteur 
vaccination (Figure 38) and this may be due to the lymph nodes studied.  The parotid lymph 
node is present within the neck/head region of the cow (Whipple et al, 1996) and thus would 
directly drain lymph from the site of BCG vaccination.  A study observing the dissemination of 
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BCG Pasteur forty-two days post vaccination via subcutaneous injection to the neck of mice 
showed that very small numbers of bacilli reached the mediastinal lymph nodes (<5 cfu) in 
comparison to the spleen (between 90 to 110 cfu, Irwin et al, 2008).  Assuming that this data 
would be applicable to larger animals as well, the lymph nodes of the bovine thorax may have 
been less likely to be directly affected by BCG vaccination.     
 
The results from Widdison et al (2006) would suggest that BCG vaccination has a minimal 
affect on the bovine immune response as no significant difference was seen in pro-
inflammatory cytokine expression.  However, prior antigenic stimulation of whole blood bovine 
cultures isolated six weeks post BCG vaccination have been shown to produce significantly 
higher levels of IFN-γ as compared to non-stimulated vaccinated cultures (Endsley et al, 2007).  
Following BCG vaccination, naïve T cells are activated by antigen-presenting dendritic cells 
within the lymph nodes (Cella et al, 1997, Mellman and Steinman, 2001).  The naïve cells 
differentiate into primary effector T cells and migrate to the initial site of infection to eliminate 
the bacterial threat.  The majority of these effector T cells undergo apoptosis to maintain 
homeostasis and prevent the development of autoimmunity (Lin et al, 2000).  However a small 
population of primary effector T cells maintain their antigen specificity for the rest of the hosts 
lifetime and are termed long lasting ‘memory’ T cells (Zinkernagel, 2000, Sprent and Surh, 
2001).  Two types of memory cell have been described, T effector-memory (TEM) and T central-
memory (TCM) cells (Sallusto et al, 1999) which are recognised based on the expression of cell 
markers CD62L and CCR7 (TEM express both whereas TCM express neither, Campbell et al, 
2001).  Upon re-stimulation with the appropriate antigen, TEM cells provide immediate 
protection against the bacterial threat at the site of infection by producing IFN-γ (Masopust et 
al, 2001).  In contrast, TCM cells are located primarily within the lymph nodes and following 
antigenic stimulation produce IL2 and IL10 (Sallusto et al, 1999).  The TCM cells are also able to 
stimulate dendritic cells via CD40 to produce IL12 (Sallusto et al, 1999), thus aiding 
differentiation of naïve T cells into primary TH1 effector T cells.  Therefore the lack of IFN-γ 
expression post BCG vaccination observed within Widdison et al (2006) and this study may be 
linked to the absence of in vitro antigenic stimulation needed to activate both subsets of 
memory T cells.     
Isolated bovine PBMC CD4+ T cell populations also revealed a significant increase of both IFN-
γ and perforin expression in antigenic stimulated compared to non-stimulated cultures (Endsley 
et al, 2007).  In contrast, IFN-γ and perforin levels were not increased upon antigenic 
stimulation of non-vaccinated cattle (Endsley et al, 2007) implying that BCG vaccination 
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successfully primed the immune response.  In addition to this, the IFN-γ+ and perforin+ CD4+ 
cells were shown to express memory cell markers (CD45RA-,CD45RO+ and CD62L+), 
enabling future detection of M. bovis infection (Endsley et al, 2007).  It is important however, to 
be aware that in vitro stimulation can change cell phenotypes and therefore these results may 
not represent which memory cells were present in vivo.  
Vaccination protocols inducing a strong cell mediated immunity, characterised by IFN-γ and IL2 
expression (with a peak around two to four weeks post vaccination) have been shown to be 
suggestive of a protective ability if the host were to be challenged (Wedlock et al, 2007, Buddle 
et al, 1995, Skinner et al, 2003a, Vordermeier et al, 2002).  However there are several studies 
that provide conflicting results, such as reports of high levels of IFN-γ expression induced in 
vaccination protocols that did not show the capacity to protect the host post experimental 
challenge (Waters et al, 2007).  This was further illustrated in a recent study performed by 
Wedlock et al (2008) in which a prime-boost vaccination protocol involving BCG and CFP was 
employed in cattle alongside different combinations of adjuvants and immunostimulators.  The 
results showed a significant increase in protection when BCG was applied in combination with 
a CFP adjuvant system, as opposed to BCG vaccination alone (Wedlock et al, 2008).  
Interestingly, application of BCG followed by an adjuvant combination without CFP acted to 
decrease protection as compared to sole BCG vaccination.  Extensive analysis of the immune 
response post vaccination (including IFN-γ, IL10, IL4 and IL12) revealed no significant 
differences between the cattle vaccinated with BCG alone and those vaccinated with BCG 
followed by adjuvant (Wedlock et al, 2008). 
Nevertheless, where the cell mediated response was absent or slow to evolve, the vaccine 
inevitably failed to induce significant protection (Wedlock et al, 2003, Buddle 2001).  Therefore 
IFN-γ expression and the cell mediated immune response may be a valuable tool to prioritise 
protocols post vaccination but is limited in its usefulness as a correlate of protection 
(Vordermeier et al, 2006).     
 
Immune response to M. bovis infection 
In response to five weeks of M. bovis infection without prior vaccination, IFN-γ expression 
increased (from mean log2 copies of 8.58 in non-vaccinated non-infected cattle to 10.5 in non-
vaccinated infected cattle, Figure 36) however this was not significant due to the large spread 
of data.  This increase was accompanied by little change in TNF-α expression between the 
non-vaccinated infected and non-vaccinated non-infected groups (mean log2 copies of 11.8 
and 11.55, respectively, Figure 37) but a significant decrease in IL10 expression (mean log2 
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copies of 15.5 and 14.44, respectively, Figure 38).  Interestingly IL4 was not detected post M. 
bovis infection (Figure 39) whereas it was detected within non-infected cattle, suggesting that 
infection dramatically reduced the expression of IL4 at this time point.     
It is widely accepted that a cell mediated immune response (TH1 T cell type), supported by high 
levels of IFN-γ expression is the dominant profile induced early in infection (Welsh et al, 2005, 
Thacker et al, 2007).  The time course study described previously provided evidence that this 
occurs around five weeks post infection, the same time point used within this study. 
The competitive nature of the T cell profiles TH1 (pro-inflammatory) and TH2 (anti-inflammatory) 
denote that when one is highly expressed, the other is generally suppressed (Welsh et al, 
2005).  Therefore in environments of high IFN-γ expression, expression of TH2 cytokines such 
as IL4 is low (Sanders et al, 1995), as seen within this data.   
 
The study performed by Widdison et al (2006) also described a not significant change in IFN-γ 
expression in response to M. bovis infection.  However the mean IFN-γ expression level was 
lower for the non-vaccinated infected animals as compared to the non-vaccinated non-infected 
animals; in contrast to the observed increase in IFN-γ expression within this study.  This 
variation may be due to the time point post infection explored, as this study examined immune 
responses at five weeks as compared to at sixteen weeks post infection in the study by 
Widdison et al (2006).  Research on progression of the bovine (Thacker et al, 2007, Welsh et 
al, 2005) and murine (Zhu et al, 2003) immune response post M. bovis infection has shown the 
system to be extremely dynamic.  The time course study described previously produced data 
that suggested a mixed IFN-γ and IL10 profile at twelve weeks of infection.  This is believed to 
represent the ‘self-limiting’ ability of TH1 cells and the subsequent reduction in IFN-γ expression 
as observed at nineteen weeks post infection.  Therefore at sixteen weeks (the time point used 
in Widdison et al, 2006) IFN-γ expression may be at a lower level as compared to earlier time 
points due to the suppressive role of TH1-produced IL10.  Interestingly, Widdison et al (2006) 
also revealed significant reductions in TNF-α and IL4 expression in response to infection, 
mirroring the changes observed within this study.   
 
Immune response to vaccination and M. bovis challenge 
Vaccinated challenged cattle displayed an increase in IFN-γ expression as compared to the 
vaccinated non-infected group (mean log2 copies of 9.6 in BCG Pasteur vaccinated and 10.3 in 
BCG (sigK) Pasteur vaccinated challenged cattle, Figure 36).  This reflects the increase in cell 
mediated immunity observed post experimental challenge.  However, the level of IFN-γ 
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expression remained lower in the vaccinated challenged groups to that observed within the 
non-vaccinated infected animals, suggesting that prior vaccination modified the cell mediated 
response.  There was no significant difference in IFN-γ expression between the two BCG 
Pasteur vaccines (Figure 36).  However, the BCG Pasteur vaccinated animals displayed a 
lower level of IFN-γ than that shown by the BCG (sigK) Pasteur vaccinated animals, when 
compared to the non-vaccinated infected cattle.  Interestingly, the BCG (sigK) Pasteur 
vaccinated challenged animals displayed significantly higher levels of IFN-γ expression as 
compared to the BCG Pasteur vaccinated non-infected group, whereas the BCG Pasteur 
vaccinated challenged group did not.  This would suggest that at five weeks post challenge, 
cattle vaccinated with BCG Pasteur vaccination displayed levels of IFN-γ expression levels 
similar to those observed prior to challenge. 
 
Decreases in IFN-γ expression post challenge as compared to non-vaccinated animals have 
been reported previously in BCG vaccinated cattle (Vordermeier et al, 2002, Widdison et al, 
2006, Waters et al, 2007, Buddle et al, 1995) and have been associated with limited disease 
dissemination and severity (Waters et al, 2007).  Vordermeier et al (2002) observed the 
immune responses of BCG Pasteur vaccinated cattle infected with M. bovis over an eighteen 
week time period.  In vitro, rapid T cell proliferation within both ESAT-6 and PPD-B stimulated 
PBMCs isolated from the non-vaccinated infected controls was detectable three weeks post 
challenge and remained strong throughout the eighteen week period (Vordermeier et al, 2002).  
In comparison, PBMCs isolated from BCG Pasteur vaccinated cattle displayed levels of T cell 
proliferation towards PPD-B that were similar to those observed pre-challenge (Vordermeier et 
al, 2002).  These results were mirrored in the data obtained by IFN-γ assays (measured using 
both the BOVIGAM enzyme immunoassay and Direct enzyme-linked immunspots) as the levels 
were significantly lower in response to ESAT-6 within the BCG vaccinated cattle as compared 
to the non-vaccinated control animals (Vordermeier et al, 2002).  Similar results were obtained 
by Hope et al (2005) in a study aimed at measuring the immune response within in vitro 
stimulated PBMC from vaccinated and challenged neonatal calves over a sixteen week period.  
The BCG vaccinated cattle produced high levels of IFN-γ for the first two weeks immediately 
following challenge which remained consistent for the remainder of the sixteen weeks (Hope et 
al, 2005).  In contrast, the non-vaccinated bovine PBMC induced IFN-γ was produced at 
comparatively lower levels until four weeks after challenge, at which point the levels increased 
dramatically to almost double that seen in the vaccinated animals (Hope et al, 2005).  The 
authors suggest that this delay in cell mediated immunity allowed the bacterial cells to replicate 
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freely leading to a hyper-potent IFN-γ response and extensive lesion development (Hope et al, 
2005).  In comparison, the vaccinated animals were able to effectively remove the bacterial 
threat from the early stages of infection resulting in a decreased effector T cell population, 
lower levels of IFN-γ and less tissue damage (Vordermeier et al, 2002, Hope et al, 2005).        
Waters et al (2007) reported no significant difference in TNF-α expression post challenge in 
vaccinated cattle as compared to non-vaccinated infected cattle and this was paralleled within 
this study (mean log2 copies of 11.47 in BCG Pasteur and 11.53 in BCG (sigK) Pasteur 
vaccinated challenged, as compared to 11.55 for the non-vaccinated infected group, Figure 
37).  TNF-α is an essential cytokine of the innate immune response and is up-regulated in the 
presence of IFN-γ (Ding et al, 1988).  The lack of any significant differences between the five 
experimental groups in TNF-α expression would imply that there may be posttranscriptional 
controls regulating protein translation (Baseggio et al, 2002, Kruys et al, 1993).  This point will 
be discussed in further detail in relation to the immunohistochemistry data.       
Similarly, there was no significant difference in IL10 expression in vaccinated compared to non-
vaccinated cattle five weeks post M. bovis challenge (mean log2 copies of 14.4 for the BCG 
Pasteur vaccinated challenged, 14.44 for the BCG (sigK) vaccinated challenged and 14.44 for 
the non-vaccinated infected groups, Figure 38).  In contrast to this data, Widdison et al (2006) 
reported a significant increase in IL10 mRNA expression in BCG Pasteur vaccinated compared 
to non-vaccinated cattle following sixteen weeks of M. bovis infection.  The authors suggested 
that the increase in IL10 expression was in part due to the dampened IFN-γ response within 
the vaccinated animals, caused by a decreased bacterial load (Widdison et al, 2006).  Human 
T cells have been reported to be able to produce both IFN-γ and IL10 (Gerosa et al, 1999) and 
as previously mentioned in the time course study, it is believed that the ratio of IFN-γ/IL10 may 
have a huge impact on whether the T cell displays anti-inflammatory characteristics (Katsikis et 
al, 1995).  The increase in IL10 observed by Widdison et al (2006) may therefore be due to the 
‘self-limiting’ nature of the TH1 response, in which reduced antigenic loads result in down-
modulation of IFN-γ expression.  A probable explanation for the inconsistency in IL10 
expression between Widdison et al (2006) and this study may again be due to the differing time 
points of sample collection (sixteen and five weeks, respectively).  Interestingly, a study 
performed on BCG Pasteur vaccination of neonatal calves sixteen weeks post M. bovis 
challenge reported no significant difference in PBMC stimulated IL10 protein levels between 
vaccinated and non-vaccinated animals (Hope et al, 2005).  As previously mentioned within the 
time course study, translation of IL10 protein is also controlled by numerous posttranscriptional 
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regulatory elements (Powell et al, 2000, Nemeth et al, 2007), thus mRNA expression levels 
may not be representational of protein levels.   
As observed within the non-vaccinated infected group, IL4 expression was undetectable in both 
the BCG Pasteur and BCG (sigK) Pasteur vaccinated challenged groups (Figure 39).  The 
neonatal calf study by Hope et al (2005) also reported that IL4 protein was undetectable at 
sixteen weeks after challenge in both vaccinated and non-vaccinated animals.  IL4 mRNA is 
known to be extremely unstable (Dokter et al, 1993, Umland et al, 1998) and has been shown 
to be down-regulated in response to M. bovis infection (Rhodes et al, 2007, Welsh et al, 2005), 
thus making it even more difficult to detect.  In reference to the Widdison et al (2006) study, IL4 
mRNA was detected sixteen weeks post challenge in both vaccinated and non-vaccinated 
animals.  In addition to this, the vaccinated animals displayed significantly higher levels of IL4 
as compared to the non-vaccinated animals, due to the dampened IFN-γ response (Widdison 
et al, 2006).  These three studies (this study, Widdison et al, 2006 and Hope et al, 2005) 
illustrate the extreme heterogeneity in the immune response to vaccination and challenge, 
aggravated by differing sampling time points, vaccination protocols (intratracheal or intranasal) 
and target sample tissues (lymph nodes or PBMCs/ mRNA or protein).            
   
Correlations between cytokine mRNA expression levels  
 
The qRT-PCR data displayed significant positive relationships between IL10 and TNF-α (Table 
26 and Figure 40) as well as between IL4 and each of the other three cytokines (p<0.01 
Pearsons correlation co-efficient, Table 26 and Figures 41, 42 and 43). 
As IL4 expression was found within the two control groups only (non-vaccinated non-infected 
and BCG vaccinated non-infected) it is not surprising that a significant correlation was found 
between IL4 and each of the other three cytokines.  All four cytokines displayed a slight 
decrease in expression in the BCG Pasteur vaccinated non-infected group compared to the 
non-infected non-vaccinated group (Figure 39).  The data from these two groups would 
therefore produce a strong correlation between all of the four cytokines studied but would not 
represent a true relationship due to the small number of data points. 
A relationship between TNF-α and IL10 mRNA expression has been previously reported in 
published studies (Widdison et al, 2006).  Focusing on the mRNA expression data from this 
study (Figures 37 and 38); it is evident that the non-vaccinated non-infected group displayed 
the highest level of both TNF-α and IL10 mRNA.  However the differences in TNF-α expression 
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between the five experimental groups were insignificant and as both TNF-α and IL10 have 
been reported to experience posttranscriptional control (Powell et al, 2000, Nemeth et al, 
2007), the relationship in mRNA expression may not reflect a true relationship in protein 
production. 
 
Immunohistochemistry 
 
An important factor in the study of mRNA expression is the degree to which it represents 
protein production levels.  Therefore, analysis of the levels of IFN-γ and TNF-α protein were 
analysed in the selected lymph nodes of each animal within the five experimental groups using 
immunohistochemistry.  This allowed a direct comparison between the mRNA and protein 
levels within the same bovine samples and also a deeper understanding of the immune 
response occurring within each experimental group. 
There was a significant positive relationship between the level of IFN-γ mRNA expression and 
the level of IFN-γ protein (p<0.001, Spearmans correlation coefficient, Figures 44 and 45).  This 
would suggest that the expression of IFN-γ mRNA is in direct relation to the production of IFN-γ 
protein (Thacker et al, 2007).  Analysing the IHC data in experimental groups, the non-
vaccinated infected group had the highest level of IFN-γ protein (mean score of 2.75, Figure 
44).  This was statistically higher than both of the control groups, non-vaccinated non-infected 
(mean score of 1.27) and the BCG Pasteur vaccinated non-infected group (mean score of 1.42, 
p≤0.005, Figure 44).  Vaccination with either BCG Pasteur or BCG (sigK) Pasteur prior to 
challenge displayed an increase in IFN-γ protein post challenge as compared to the non-
infected groups (mean score of 1.5 and 1.8, Figure 44), however the level was not as high as in 
the non-vaccinated infected group.  This strongly resembles the mRNA expression data and 
reflects the variability of the IFN-γ response depending on the infection scenario.   
 
In contrast, there was no significant relationship between the level of TNF-α mRNA expression 
and the level of TNF-α protein (p>0.05, Spearmans correlation coefficient, Figures 46 and 47).  
This would suggest that the expression of TNF-α mRNA is not in direct relation to the 
production of TNF-α protein and that one or more forms of posttranscriptional regulation are in 
place.  Comparing the mRNA and protein data (Figure 46), posttranscriptional control is most 
evident in the non-vaccinated non-infected and BCG vaccinated non-infected groups, as the 
protein levels are lower than that displayed by the mRNA data (mean score 1.13 and 1, 
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respectively, Figure 46).  As previously mentioned, it is not unusual to detect TNF-α mRNA 
expression in non-infected tissues (Widdison et al, 2006) however, studies have found the 
TNF-α mRNA to be unstable and translation of TNF-α protein repressed in healthy tissues 
(Kruys et al, 1993, Beutler and Cerami, 1989, Geppert et al, 1994).  Therefore, as observed, 
the mRNA expression measured within the two control groups did not reliably represent protein 
levels due to repression of the translational process.  Following stimulation by 
lipopolysaccharide, the stability of TNF-α mRNA has been shown to be enhanced (Baseggio et 
al, 2002) and translation un-repressed (Skinner et al, 2008).  M. tuberculosis (Yang et al, 2005) 
and M. bovis BCG (Mendez-Samperio et al, 2004) have also displayed the ability to trigger 
intracellular signalling processes essential in TNF-α translation, such as the 
phosphatidylinositol 3-kinase (PI 3-K) cascade and the extracellular regulated kinase (ERK) 
pathway 1/2 in human monocyte-derived macrophages.  The role of M. bovis in up-regulating 
TNF-α translation would therefore support the data observed within this study, as the non-
vaccinated infected group had the highest level of TNF-α protein (mean score 2.17, Figure 46).  
Vaccination with BCG (sigK) Pasteur prior to challenge had a negligible effect on TNF-α protein 
levels (mean score 1.82) whereas prior vaccination with BCG Pasteur reduced TNF-α protein 
to pre-challenge levels (mean score 1.13, Figure 46).  A study performed on the 
bronchoalveolar lavage cells of guinea pigs revealed that, prior to M. tuberculosis challenge 
both non-vaccinated and BCG Tokyo vaccinated animals displayed a lower level of non-
antigenically stimulated TNF-α protein with little difference between the two groups (Yamamoto 
et al, 2007).  Three weeks after M. tuberculosis challenge; the non-vaccinated animals 
displayed relatively lower levels of TNF-α production.  However, by five weeks, non-vaccinated 
animals displayed significantly higher levels of PPD-B stimulated TNF-α protein as compared 
to pre-challenge levels and four fold greater levels than the BCG Tokyo vaccinated animals.  In 
contrast, the BCG Tokyo vaccinated animals displayed similar PPD-B stimulated TNF-α protein 
levels pre and post M. tuberculosis challenge (Yamamoto et al, 2007).  The authors suggest 
that BCG vaccination acts to modulate TNF-α production subsequently reducing 
immunopathological harm associated with increased TNF-α concentrations (Bekker et al, 
2000).  In contrast, the non-vaccinated animals did not control the infection in the early stages 
(low TNF-α level at three weeks post challenge).  Therefore, the increasing bacillary loads 
exasperated the immune response, leading to an uncontrolled TNF-α production at five weeks 
of challenge. 
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Lymph node pathology 
 
Percentage granuloma coverage 
Within this study two comparable factors were used to represent the levels of pathology within 
the M. bovis infected lymph nodes; percentage area coverage of granulomas (Figures 48 and 
49) and granuloma stage (Table 27).  As previously mentioned, the granuloma is initially a 
structure formed to protect the host, however as it grows in size as a response of cellular 
activity it becomes associated with immunopathological harm (Mustafa et al, 2008).  Therefore, 
the percentage area coverage of the granulomas within the lymph node sections can give an 
indication to the progression of the immune response. 
The percentage area of granuloma coverage for the three M. bovis challenged groups revealed 
differences between the vaccinated and non-vaccinated cattle, however due to the large 
variations in data these differences were not significant (p>0.05, Kruskal Wallis test, Figure 48).  
The non-vaccinated infected group showed the largest percentage area of granuloma coverage 
(mean of 59%) as compared to the BCG (sigK) Pasteur vaccinated challenged (mean of 35%) 
and BCG Pasteur vaccinated challenged (mean of 6%) groups (Figure 48). 
There are numerous studies reporting the beneficial effects of BCG vaccination on host 
disease pathology as compared to non-vaccinated infected controls (Widdison et al, 2006, 
Wedlock et al, 2007, Hope et al, 2005, Vordermeier et al, 2002, Ng et al, 1995).  A study by 
Johnson et al (2006) showed a significant reduction in percentage area of granulomatous 
inflammation within BCG vaccinated cattle lymph nodes (14.9%) as compared to non-
vaccinated infected controls (65.6%).  This suggests that BCG vaccination does provide a 
considerable degree of protection against pathological damage due to the limited immune 
response.  However, vaccination was not able to rid the host of disease entirely.   
 
The degree of granuloma growth and pathological disease displayed a positive correlation with 
both IFN-γ protein and mRNA expression (p<0.05, Spearmans correlation coefficient, Figure 
50a).  The non-vaccinated infected group had the highest level of IFN-γ expression, coinciding 
with the highest level of granuloma percentage coverage (Figure 48).  However at the time 
point studied, prior vaccination resulted in a lower level of IFN-γ and also a lower level of 
granulomatous coverage (Figure 48).  The association between high levels of IFN-γ post 
challenge and high levels of pathological damage have been described in similar studies 
(Wedlock et al, 2007, Vordermeier et al, 2006, Vordermeier et al, 2002).  IFN-γ is a potent pro-
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inflammatory cytokine that induces production of macrophage cytocidal compounds (such as 
reactive oxygen and nitric oxide synthesis) and bacterial phagocytosis (Ding et al, 1988).  
Activation of macrophages and enhancement of their antigen presenting ability leads to 
increased T cell maturation and subsequently increased IFN-γ production (Barnes et al, 1994).  
Bacterial cell load has been shown to be a significant factor in the number of T effector cells 
recruited to the infection site (Lalvani, 2004) and as a result, also the level of IFN-γ production 
(Lyashchenko et al, 2004, Vordermeier et al, 2002, Skinner et al, 2003a).  Non-vaccinated 
cattle have been reported to harbour significantly higher numbers of bacilli within lymph node 
granulomas as compared to BCG Pasteur vaccinated cattle at eighteen weeks post infection 
(Johnson et al, 2006).  It therefore seems probable that vaccination prior to challenge allows 
the host to eradicate the bacterial threat more efficiently and quickly, leading to a lower 
expression of IFN-γ at the time point these parameters were measured for this study and 
ultimately a lower level of granulomatous spread.  As previously mentioned, the same theory 
has also been applied to TNF-α and BCG vaccination (Yamamoto et al, 2007) and this is not 
surprising due to the role of IFN-γ in enhancing TNF-α production (Ding et al, 1988).  In 
addition, both TNF-α and IFN-γ have been shown to enhance expression of cell surface 
adhesion molecules thus aiding monocyte migration (Munro et al, 1989) and granuloma growth.  
A positive correlation was also revealed between granuloma growth and TNF-α protein 
(p<0.001) but not with TNF-α mRNA (p>0.05, Spearmans correlation coefficient, Figure 50b) 
due to the posttranscriptional regulation of the TNF-α transcript. 
 
Granuloma score 
A second method of measuring pathological development within this study was based on the 
stage of granuloma development (Table 27).  Granulomas can be categorised into four stages 
of development depending on their physiological and immunological status (Wangoo et al, 
2005).  The numbers of granuloma within each stage of development were counted for each 
lymph node sample and the data weighted to account for the larger size of the later staged 
granuloma (Table 27).  Comparison of the granuloma developmental stage results (Table 27) 
with the data for granuloma percentage area coverage (Figure 49) for each individual animal 
revealed a statistically positive relationship (p<0.001, Spearmans correlation co-efficient) 
between the two variables.  Granulomas have been reported to double in size (mean lesion 
size measured in millimetres) between each developmental stage (Wangoo et al, 2005) due to 
the accumulation of T cells and macrophages that both directly and indirectly (through 
cytokines and necrosis) mark the advancement through each stage.    
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The BCG (sigK) Pasteur vaccinated challenged cattle displayed the highest score for 
granuloma development (mean 69, Table 27), followed by the non-vaccinated infected group 
(mean 48.5, Table 27).  The lowest score for granuloma development was shown by the BCG 
Pasteur vaccinated challenged group (mean 15, Table 27) although these differences were not 
significant due to the small number of data points and large data variation.  Interestingly, the 
mean score for the BCG (sigK) Pasteur vaccinated challenged group was increased 
dramatically by two particular animals, identification numbers of 3511 and 3506 (scores of 112 
and 153, respectively, Table 27).  This suggests a large variability in both the ability of the 
vaccine to protect each individual host and the immune profile of each animal in response to 
challenge. 
 
As described for the time course study, there was a spread of granuloma developmental stages 
within each animal (Table 27), illustrating the vast heterogeneity between individual 
granulomas.  The main difference in granuloma development between the vaccinated and non-
vaccinated animals was the presence of stage IV lesions, as neither vaccinated group showed 
such advancement in lesions.  However, each of the four animals within the non-vaccinated 
infected group displayed advanced granuloma development (total IV granuloma score of 96, 
Table 27).  Johnson et al (2006) described granulomas within BCG vaccinated cattle to be 
much smaller and less advanced as compared to non-vaccinated controls after eighteen weeks 
of challenge.  The BCG vaccinated cattle also displayed higher levels of T and B cells with 
fewer macrophages and Langhans giant cells (Johnson et al, 2006).  The authors suggested 
that this immune profile enhanced the interaction between the cells, allowing the activity of 
infected macrophages to be maintained thereby reducing the development of caseous necrotic 
lesions (Johnson et al, 2006, Ulrichs et al, 2004).  The lower levels of IFN-γ and TNF-α 
observed within the BCG vaccinated animals of this study would support this theory, as both 
have been connected to the development of advanced necrosis (Hernandez-Pando and Rook, 
1994), characterising stage IV granuloma (Wangoo et al, 2005).   
 
Over the first three stages of granuloma development (stage I, II and III), the BCG Pasteur 
vaccinated group displayed the lowest scores (total of 13, 28 and 4, respectively, Table 27).  
Conversely, The BCG (sigK) Pasteur vaccinated group displayed the same score for stage I 
granuloma as compared to the non-vaccinated infected group (total of 32, Table 27).  The BCG 
(sigK) Pasteur vaccinated group also displayed a higher score for the stage II granuloma (total 
of 164 as compared to 58 for the non-vaccinated group) and a tenfold higher number of stage 
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III granuloma (total of 80 as compared to 8 for the non-vaccinated group, Table 27).  This 
would suggest that although the levels of IFN-γ and TNF-α were low enough to suppress the 
development of necrotic lesions (stage IV); the immune response had not removed the 
bacterial threat as efficiently as the BCG vaccinated animals, leading to increased numbers of 
early staged granuloma.  It seems probable that the reason behind the BCG (sigK) Pasteur 
vaccinated group showing a higher total granuloma development score than the non-
vaccinated infected animals is connected to the nature of the granulomas within each stage.  
As previously mentioned the stage IV granuloma can be considerably larger in size as 
compared to the smaller stage II and III (Wangoo et al, 2005) and therefore leaves limited 
lymph node surface area for new granuloma development.  In addition to this, the extensive 
necrosis associated with stage IV granuloma may obscure smaller granulomas situated 
adjacent to stage IV lesions, therefore lowering their total count.  This is supported by the 
results of the percentage area coverage of granuloma within each experimental group, as the 
non-vaccinated infected animals displayed a considerably higher percentage as compared to 
the BCG (sigK) Pasteur vaccinated group.  
 
Interestingly, TNF-α protein and not IFN-γ displayed a positive relationship with the granuloma 
developmental score (p<0.05, Spearmans correlation coefficient, Figure 51A and B).  Three of 
the main grouping factors used to characterise the granuloma into the four stages were the 
presence of necrosis, epithelioid macrophages and multi-nucleated giant cells (Wangoo et al, 
2005).  TNF-α has been shown to correlate positively with necrosis in human TB lesions 
(Fenhalls et al, 2000 and 2002) due to its destructive properties when present in either 
excessive levels (Bekker et al, 2000) or dominant TH2 environments (Hernandez-Pando and 
Rook, 1994).  In addition, M. bovis infected macrophage differentiation into epithelioid or giant 
multi-nucleated cells is believed to be connected to bacterial cell endocytosis (Lay et al, 2007), 
a process which also induces macrophage-produced TNF-α (Goldsby et al, 2003).  
 
Whole blood IFN-γ cultures  
 
The aforementioned cytokine expression studies were performed at the site of infection within 
the lung draining lymph nodes.  However, peripheral or whole blood mononuclear cells are 
frequently used to measure IFN-γ expression post vaccination due to the logistical problems of 
isolating lymph nodes.  Therefore, IFN-γ protein levels from PBMCs were also measured for 
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each animal within the BCG Pasteur vaccinated challenged, BCG (sigK) Pasteur vaccinated 
challenged and non-vaccinated infected groups of this study using stimulatory antigen purified 
protein derivative bovis (PPD-B, Figure 52).  Antigenic stimulation of PBMCs express high 
levels of IFN-γ and produce a delayed –type hypersensitivity (DTH) reaction during which 
activated T cells, macrophages and neutrophils converge (Pollock et al, 1997).  It was therefore 
possible to compare the levels of IFN-γ expression between the peripheral blood and at the 
actual site of infection within the lymph nodes.     
 
The non-vaccinated infected group displayed the highest level of whole blood stimulated IFN-γ 
(mean OD reading of 4.57, Figure 52) as compared to the level displayed by both vaccinated 
groups (mean OD reading of 3.63, Figure 52).  Although there was no statistical significance 
between the vaccinated and non-vaccinated groups, the results revealed a significantly positive 
correlation with the lymph node IFN-γ protein levels (p<0.05, Spearmans correlation coefficient, 
Figure 53).  This would suggest that, post challenge, the analysis of whole blood stimulated 
IFN-γ from this study was an accurate representation of the immune response at the site of 
infection.  Although there are studies that dispute this idea (Barnes et al, 2003), there are also 
some that provide evidence to support the relationship between whole blood and lymph node 
IFN-γ levels (Hope et al, 2005, Rhodes et al, 2000).   
These results show that IFN-γ levels both within the lymph nodes and whole blood were 
expressed at a lower level in BCG Pasteur vaccinated challenged cattle, similarly described in 
Wedlock et al (2007).  Interestingly, the whole blood stimulated IFN-γ levels did not differentiate 
between the two vaccination types as was found for the lymph node IFN-γ levels.  This 
suggests that the more subtle differences in cytokine expression observed within the lymph 
nodes that led to enhanced levels of pathological damage may not be mirrored within the whole 
blood immune profile. 
 
Conclusion 
 
The results of this study have reinforced those previously published by other groups 
(Vordermeier et al, 2002, Widdison et al, 2006, Waters et al, 2007, Buddle et al, 1995) on the 
benefits of BCG vaccination in reducing immunopathological development.  The M. bovis 
challenged non-vaccinated cattle displayed increased levels of IFN-γ (mRNA and protein) and 
TNF-α (protein) expression coinciding with significantly reduced IL10 and undetectable IL4 
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levels as compared to the non-infected animals.  This immune profile is characteristic of a 
strong cell mediated response and led to high levels of pathological damage.  BCG vaccination 
(both BCG Pasteur and BCG (sigK) Pasteur) resulted in lower levels of both IFN-γ and TNF-α 
expression but had little impact on either IL10 or IL4 levels post challenge as compared to the 
non-vaccinated cattle.  Vaccination acts to induce a cell mediated immune response via TB 
specific antigenic stimulation, leading to a population of both effector and memory CD4+ and 
CD8+ T cells (Irwin et al, 2008).  Future infection with M. bovis triggers the memory T cell 
population and therefore initiates a faster cell mediated and IFN-γ response, enabling more 
efficient eradication of the bacterial threat (Waters et al, 2007).  This protective memory 
response takes place early post challenge (approximately two to three weeks, Vordermeier et 
al, 2006 and 2002) and then declines, possibly in parallel with a decreased bacterial load.  This 
would explain the decreased IFN-γ expression found in this study measured at five weeks post 
challenge, in the vaccinated compared to non-vaccinated controls.         
 
However, experimental BCG vaccination of cattle has shown varying levels of protective 
efficacy (Buddle et al, 2005, Orme et al, 2001) and is currently impracticable for wide-scale use 
due to its interference with the tuberculin diagnostic skin test (Doherty et al, 1995).  With the 
number of bovine TB cases increasing annually (Reynolds, 2006) the need for an improved 
and more reliable vaccination protocol has become a priority of the veterinary scientific 
community.  BCG vaccination is still considered the ‘gold standard’ (Buddle et al, 2005) against 
TB infection and therefore the majority of newly developed protocols have included its use.  A 
potential pathway in increasing the efficacy of BCG vaccination has been to introduce antigenic 
genes that have been either deleted or repressed during its attenuation (Vordermeier et al, 
2006).  This study included analysis of the bovine immune response to vaccination with a 
recombinant BCG Pasteur expressing a wild-type sigK gene from BCG Russia (Charlet et al, 
2005).  The recombinant BCG Pasteur has been shown to produce increased levels of 
antigenic proteins MPB70 and MPB83 (Charlet et al, 2005) and therefore presented itself as an 
ideal candidate for vaccination studies.  It was hypothesised that by increasing the strength of 
the antigenic stimulation, the vaccine would be able to induce a stronger cell mediated 
response and thus a higher level of protection against challenge.  However, the results from 
this study did not support this hypothesis.  BCG (sigK) Pasteur was shown to induce protection 
against M. bovis by reducing IFN-γ and TNF-α expression as well as immunopathological 
disease in respect to the non-vaccinated infected animals.  However, the BCG (sigK) Pasteur 
vaccinated cattle displayed higher levels of pathology as well as increased expression of IFN-γ 
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and TNF-α as compared to the BCG Pasteur vaccinated cattle post challenge.  This suggests 
that increasing the MPB70 and MPB83-specific antigenic properties of the vaccine actually 
proved detrimental to the hosts’ protection against M. bovis challenge.  A possible reason for 
the reduced ability of the recombinant BCG vaccine could be linked to development of the 
central memory response.  The level of protection induced post challenge is dependent upon 
the strength and duration of antigenic stimulation as well as the level of co-stimulation induced 
by vaccination (Seder and Ahmed, 2003).  These factors combine to affect both T cell 
distribution and function following vaccination and subsequently the effectiveness of memory T 
cells to detect future infection (Seder and Ahmed, 2003).  It has been suggested that by 
increasing the immunogenicity of the vaccine, the host is able to mount a stronger immune 
response and eradicate the bacterial threat more quickly, thus reducing the duration of 
antigenic stimulation (Orme et al, 2006).  The cattle vaccinated with BCG (sigk) Pasteur were 
therefore not able to mount a sufficient memory response upon re-stimulation by M. bovis 
challenge, leading to a larger persistent bacterial load and a heightened IFN-γ response.  The 
increased pathological damage observed within the BCG (sigK) Pasteur vaccinated cattle may 
also imply involvement of the MPB83 and MPB70 proteins in pathogenesis of the disease.  
Structural studies of both MPB70 and MPB83 have revealed a potential ability of the antigens 
for binding to cell surface host proteins via specific interaction sites (Carr et al, 2003).  The 
authors suggest that this may represent a role for these antigens in modulating host cell 
behaviour by intercepting signalling pathways to the advantage of the pathogen (Carr et al, 
2003).  This may skew the hosts’ immune response and lead to increased immuno-pathological 
harm.        
Other studies have also shown vaccines expressing enhanced antigenic properties to be less 
effective in providing protection against infection as compared to BCG (Rao et al, 2005).  
Murine vaccination models of different BCG sub-strains have shown that increased antigenic 
properties did not increase protective efficacy against M. tuberculosis infection (Irwin et al, 
2008).  BCG Pasteur, BCG Sweden and BCG Connaught (lower antigenic level) induced 
differing levels of IFN-γ post vaccination in mice, with BCG Connaught inducing the highest 
response (Irwin et al, 2008).  Post challenge, there was no difference in protection between the 
different sub-strains, further illustrating the inadequacy of IFN-γ as a correlate of protection 
(Mittrucker et al, 2007).     
 
A potential solution to the problem of duration and strength of antigenic stimulation would be to 
vaccinate the same host twice in a prime-boost protocol using either BCG alone (homologous, 
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Griffin et al, 2006a) or in conjunction with a subunit vaccine (heterologous, Skinner et al, 
2003a, Wedlock et al, 2005).  This would enable the use of highly immunogenic vaccines and 
still lengthen the duration of antigenic stimulation.  Various vaccine candidates are currently 
being applied in this manner with some very encouraging results (Vordermeier et al, 2006).  An 
example of this is the ESAT-6:CFP10+GM-CSF+CD80/CD86 DNA vaccine in combination with 
BCG (Maue et al, 2007).  The DNA vaccine alone was able to induce a cell mediated immune 
response due to its ability to induce DC maturation and increase T cell stimulation; however the 
addition of a BCG boost significantly reduced bacterial loads and pathological damage (Maue 
et al, 2007).  Increased pathology has been directly related to the potential for the host to 
transmit the disease (McCorry et al, 2005) and thus vaccination also has the benefit of not only 
protecting the host but also suppressing transmission of the infection.    
 
In 2005 the government announced a ten year strategy to produce a sustainable reduction in 
bovine TB across the United Kingdom (DEFRA, 2005b).  A major part of this plan is the 
development of an improved bTB vaccine, to which over £4 million have been invested 
(Reynolds, 2006).  Of the approximate sixty candidate vaccines developed, ten have been 
trialled in experimental bovine models and those that have shown the most promising results 
are based on prime-boost protocols involving BCG (Haile et al, 2005, Hope et al, 2005, 
Vordermeier et al, 2004).  The results of this study further support the beneficial uses of BCG in 
bovine protection against M. bovis and the disadvantages of applying vaccines of high 
immunogenic capacities without a prime-boost protocol.  It has also highlighted the importance 
of the cell mediated response and in particular IFN-γ at the site of infection within the lymph 
nodes, illustrating the fine balance between protection and immunopathological harm.     
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The steady increase in cases of bovine tuberculosis over the past twenty years within the 
United Kingdom reflects the extensive threat M. bovis is currently posing on a global scale.  
Whilst the traditional test and slaughter method, developed in the beginning of the twentieth 
century, has performed exceptionally well at decreasing levels of bTB across the world, the 
increasing importance of wild animals as natural disease reservoirs has continually undermined 
control efforts.  Vaccination would provide a cost effective and reliable method of protection 
against bTB.  However, as the only vaccination currently available against M. bovis, BCG has 
provided extremely variable results on its efficacy and cannot be used successfully alongside 
the current intradermal tests.  Development of improved bTB vaccination protocols have been 
continually hindered by the absence of protection-specific immunological correlates (Elias et al, 
2005, Leal et al, 2001).   
 
The central aims of this study, in collaboration with the VLA (Surrey) and under the guidance of 
DEFRA (UK), were to:  
• Provide a greater understanding of the bovine immune response (in particular IFN-γ, 
TNF-α, IL10 and IL4 expression) to M. bovis infection in a time dependent manner.  
This would greatly aid vaccination developmental studies as the key to an effective 
vaccination is in the immune profile that it elicits.  However, before we use 
immunological status as a marker of vaccination success, it is essential that we 
understand which immune profiles afford the most protection against disease in the 
bovine model.   
• Apply this new knowledge on the immune response to assess the potential protective 
ability of a novel BCG Pasteur vaccination.  BCG Pasteur is believed to possess 
reduced antigenic properties due to the loss of genetic information during its 
production.   A BCG Pasteur complement containing a sigK transcript from BCG 
Russia has been shown to display enhanced antigenic properties and therefore may 
provide a relatively higher level of protection against M. bovis as compared to the 
original BCG Pasteur strain.     
 
The key findings that have emerged from this present study are: 
• The influential role of IL10 as a constituent of the bovine immune response to M. bovis 
infection.  The significant decrease in IL10 expression observed five weeks post 
infection (within the BCG vaccination study) has been reported previously (Thacker et 
al, 2007).  However, by analysing the expression over five, twelve and nineteen weeks 
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of infection, this study has provided a novel view of IL10 at the site of M. bovis 
infection.  The significant increase in IL10 expression after twelve weeks of infection in 
parallel to a sustained level of IFN-γ expression reflects the hosts endeavour to reduce 
the pathological damage associated with intense pro-inflammatory immune profiles.   
Thus the two lymph node types (caudal mediastinal and cranial tracheobronchial) that 
displayed significantly lower levels of IFN-γ and as a result, IL10 represented a larger 
component of the immune profile, also had the lowest levels of pathology.   
The ability of CD4+ T cells to produce both IFN-γ and IL10 has been described in 
human tuberculosis (Gerosa et al, 1999) and more recently for Leishmania infection in 
mice (Anderson et al, 2007).  However, this study is the first to reveal the ‘self-limiting’ 
mechanism in cattle, particularly in association with M. bovis infection.  IFN-γ levels are 
routinely measured as a correlate of infection and to predict the protective efficacy of 
vaccination, although the reliability of this has been questioned.  These results indicate 
the importance of IL10 in the progression of the disease and therefore suggest that, if 
measured alongside IFN-γ, IL10 would provide much more detail on M. bovis infection. 
 
• This study is the first to assess the protective efficacy of a sigK complemented BCG 
Pasteur in a bovine vaccination and M. bovis infection model.  As previously 
mentioned, the ability of a vaccine to protect a host against infection is based entirely 
on the immune response and resultant memory T cell population that it elicits.  
Therefore, it was hypothesised that by enhancing the antigenic properties of the 
vaccine, the heightened immune response induced would result in a higher level of 
protection against subsequent infection.  The data from this study did not support the 
hypothesis, as the cattle vaccinated with the modified sigK vaccination displayed 
increased IFN-γ expression levels and higher levels of lymph node pathology as 
compared to the animals vaccinated with the standard BCG.  It was suggested that a 
heightened immune profile in response to vaccination may prove detrimental to the 
host, as the host acts to remove the foreign bodies at a much faster rate, affecting the 
size of the memory T cell population.  Following infection, the smaller memory T cell 
population is not able to react as quickly and therefore the disease is able to progress 
further.  This study supports the development of prime-boost vaccination protocols, in 
which the immune responses are stimulated twice to enhance the memory T cell 
population.          
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The comprehensive nature of this thesis was enhanced by the number of similarities between 
both the time course and BCG vaccination studies.  Analysis was focused on the same lymph 
node types within cattle infected with similar concentrations of M. bovis for five weeks (in 
addition to twelve and nineteen weeks for the time course study).  The same primer sets and 
standard curves were also applied to each of the studies targeting IFN-γ, TNF-α, IL10 and IL4 
expression levels.  The major difference between the two studies was the use of formalin fixed 
tissues (time course study) and freshly dissected tissues (BCG vaccination study) however due 
to tissue availability this was an unavoidable aspect of this thesis.  Nevertheless, both studies 
produced some very interesting and comparable themes. 
Cytokine analysis of cattle lymph nodes within both the time course and the BCG vaccination 
studies displayed a prominent cell mediated immune response five weeks following infection.  
There was a significantly lower level of IL10 expression at five weeks post infection compared 
to twelve weeks within the time course study, suggestive of the suppressive influence of IFN-γ.  
This data set was complimented by the significant reduction in IL10 expression and significant 
increase in IFN-γ in the infected compared to the non-infected group of the BCG vaccination 
study, also taken after five weeks of infection.  In addition, IL4 expression was undetectable in 
both studies within the infected cattle, as compared to the detectable levels obtained from the 
non-infected cattle within the BCG vaccination study.  Collectively, this data presents a strong 
case for the dominance of a cell mediated immune profile in response to infection, displaying 
characteristically high levels of pro-inflammatory TH1 type cytokines such as IFN-γ and 
subsequent suppression of anti-inflammatory TH2 associated cytokines such as IL4.  This 
immune profile has been described previously (Welsh et al, 2005, Widdison et al, 2006).   
Another common theme in the cytokine analysis was the positive relationships revealed 
between IL10 and TNF-α expression as well as between TNF-α and IFN-γ levels (Figures 23 
and 40).  The relationship between IL10 and TNF-α was difficult to explain as IL10 is believed 
to have a negative effect on TNF-α production (Fratazzi et al, 1999) and therefore this data 
may be reflective of the posttranscriptional regulation of both of these cytokines.  This was 
further supported by the lack of difference in TNF-α mRNA expression between the two 
pathologically distinct lymph node types of the time course study (high vs. low pathology) and 
also between the five treatment groups of the BCG vaccination investigation.  Consequently, 
comparison of the TNF-α mRNA and protein data of the BCG vaccination study yielded a non-
significant correlation (Figures 46 and 47).  These results highlight the importance of 
posttranscriptional regulation of cytokines and should be taken into consideration when solely 
analysing mRNA expression.           
  Conclusions and Future Work 
 
190  
The comparison between the whole blood IFN-γ and the lymph node IFN-γ data also revealed 
some interesting similarities between the two studies.  The whole blood IFN-γ results did not 
reflect the differences in expression between the experimental groups to the same extent as 
was seen within the lymph nodes.  The time course whole blood stimulated with PPD-B results 
showed no difference in IFN-γ expression over the nineteen week period whereas the lymph 
node results suggested a change over time (Figure 26).  Similarly, the BCG vaccination whole 
blood stimulated with PPD-B results did not show any difference between the two vaccination 
types, although did show an increase in the non-vaccinated infected cattle (Figure 52).  This 
would suggest that the precise changes observed within the lymph nodes were not reflected in 
the whole blood of the host, as has been suggested by others (Barnes et al, 1993 and 
Coussens et al, 2004).  In addition to this, the time course study displayed a lack of correlation 
between the whole blood IFN-γ protein and lymph node IFN-γ mRNA expression levels and this 
was also seen for the BCG vaccination study.  However, the BCG vaccination study did display 
a positive correlation between the whole blood and lymph node IFN-γ protein levels, reiterating 
the potential consequences of analysing mRNA levels separate to protein.    
 
When interpreting the data from the time course and BCG vaccination studies, it is extremely 
important to consider the knowledge gained from the two supplementary studies (chapters 4 
and 5).  The time course study used lymph node tissues fixed in formalin from the experimental 
archives at the VLA (Surrey).  Unfortunately it took an extremely large quantity of tissue 
samples to obtain sufficient concentrations of total RNA for the subsequent qPCR experiments, 
thus severely depleting the archival sources.  A novel fixative, HOPE, was compared for its 
ability to preserve total RNA to a higher quality and the results indicated that its performance 
was superior to that of formalin fixative (chapter 4).  By conserving the integrity of the nucleic 
acid, smaller quantities of the starting tissue could be used to produce sufficient concentrations 
of RNA for qPCR.  The VLA has now started to routinely fix tissue samples in HOPE due to 
these results.  The impact that this supplementary study has on the time course is evident, as it 
confirmed that formalin does lead to RNA degradation and therefore the cytokine expression 
levels observed may differ from that which may have been observed if fresh lymph node tissue 
was used.  However, this does not mean that the key concepts revealed by the time course 
study should be dismissed, as many of the themes observed were also reflected in the BCG 
vaccination study using fresh tissue.  It would suggest that the quantified cytokine expression 
levels measured may be lower than the natural system due to the influence of the formalin 
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fixative and therefore further studies would need to be performed on either HOPE-fixed or fresh 
lymph node tissues. 
The second supplementary study (chapter 5) was performed to investigate the affect of M. 
bovis infecting dose on the cytokine expression levels within the bovine lymph nodes.  In the 
past, bovine infection models have regularly used considerably larger doses of M. bovis so as 
to ensure that the animal successfully displayed pathological disease.  However, studies have 
shown that a host need only inhale one to two bacterial cells to become infected (Schafer et al, 
1999) and that maybe experimental models are not true representatives of natural disease.  By 
measuring cytokine expression in cattle infected with increasing doses of M. bovis, it was 
revealed that the immune response increased as infecting dose increased (chapter 5, Table 
22).  This would suggest that the cytokines levels observed within experimental infection 
models do not truly reflect the natural disease, as they are likely to be higher in expression 
level.  However, the patterns in cytokine expression were very similar between the different 
dosages.  The conclusion from this study is that, although the cytokine levels may be higher, 
the immune profiles remain unchanged and thus experimental bovine models are still able to 
provide extremely useful data that would not be available from naturally infected cattle.  
Considering the immense costs associated with the infection and accommodation of larger 
animals such as cattle and also the ethical issues, it is probably more viable to use higher 
doses of M. bovis as this ensures that cattle display pathological disease.  The risk of using 
smaller doses is that the cattle will effectively eradicate the infection and therefore not provide 
useful experimental data.  This would then require a larger number of cattle to be infected to 
ensure that the investigation could be completed and thus larger doses of M. bovis would be 
justified.        
    
Finally, the dominant theme repeated throughout both the time course study and the BCG 
vaccination study was the powerful influence and importance of IFN-γ in the immune response 
against M. bovis.  Levels of IFN-γ expression displayed a significant division between the 
lymph node types displaying high levels of pathology (high IFN-γ) and those displaying low 
pathology (low IFN-γ) within the time course study.  Similarly, the BCG Pasteur vaccinated 
animals produced a dampened IFN-γ response post challenge and simultaneously displayed 
lower levels of pathological disease as compared to the non-vaccinated infected animals.  The 
varying levels of IFN-γ observed are believed to be a consequence of differing bacterial 
burdens, as portrayed within the supplementary study 2 (Boddu-Jasmine et al, 2008).  Previous 
studies (Ly et al, 2007, Griffin et al, 2006b, Mischenka et al, 2002) have suggested that higher 
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levels of bacterial burden in the hosts lungs and lymph nodes were due to the specific route of 
bacilli dissemination.  It may therefore be hypothesised that the contrasting levels of IFN-γ 
observed within the different lymph node types may be due to some lymph nodes becoming 
infected before others and thereby displaying increased bacterial loads.  Similarly, BCG 
vaccinated challenged cattle have been shown to display reduced levels of bacterial load as 
compared to non-vaccinated infected animals (Lyashchenko, et al, 2004, Johnson et al, 2006) 
alongside decreased levels of IFN-γ expression (Widdison et al, 2006, Waters et al, 2007, 
Buddle et al, 1995).  This has been directly linked to a reduction in both disease severity and 
bacterial dissemination (Waters et al, 2007).  Both of these studies therefore highlight the fine 
line between immune-induced protection and immune-induced pathology.  Vaccination prior to 
challenge allows the cell mediated immune response to react quickly to the invading bacilli, 
subsequently controlling both the infection and level of IFN-γ (Hope et al, 2005).  Unfortunately, 
despite the integral role of IFN-γ in the infection process and its potential use as a correlate of 
protection, numerous studies have shown that it is an unreliable indicator of the effectiveness 
of vaccination pre-challenge (Elias et al, 2005, Leal et al, 2001).  The discovery of new 
potential correlates of protection, such as CD4+ T cells specific to the M. tuberculosis antigen 
TB10.4 (Hervas-Stubbs et al, 2006) will better aid future vaccination studies.  Until a more 
effective correlate is found, IFN-γ expression remains a crucial immunological marker of the 
activated cell mediated response post vaccination and a useful method to prioritise further 
challenge experiments (Vordermeier et al, 2006).             
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Future work 
 
As previously mentioned the immune response to M. bovis infection is extremely dynamic and 
involves numerous different molecular components.  The four cytokines studied (IFN-γ, TNF-α, 
IL10 and IL4) are particularly useful in representing various immunological profiles (pro- and 
anti-inflammatory, regulatory T cells).  However, the work could be extended to include 
additional immunological markers to better enhance the knowledge gained on M. bovis 
infection and BCG vaccination.  Analysis of the cytokine IL12 would further support the 
hypothesis of a strong cell mediated response early in infection (Trinchieri, 2003, Szabo et al, 
1997) accompanied by the study of tumour growth factor (TGF-) β which has been shown to be 
dominantly expressed in advanced stages of infection (Bai et al, 2004).  Analysis of cell types 
such as macrophages, T cells and dendritic cells coupled with cytokine protein levels in a 
multiplex immune-staining method would allow an understanding of which cells dominate in 
expressing IFN-γ post challenge and vaccination.  An inclusive and comprehensive picture of 
the host immune response post BCG vaccination and M. bovis challenge would be invaluable 
for future vaccination experiments. 
An important aspect of cytokine analysis highlighted by both studies is the need to take into 
consideration posttranscriptional controls.  The expression levels of mRNA may not be directly 
representational of the levels of cytokine protein.  Therefore studying mRNA expression 
exclusively may not reflect significant changes in protein levels and would not correlate with 
immunological features such as associated pathology.  In future studies, it would be 
advantageous to include both mRNA and protein analysis accompanied by the study of M. 
bovis bacterial loads within the isolated lymph nodes. 
 
To improve upon the time course study, it may be beneficial to include time points prior to five 
weeks of infection.  Published studies have shown the immune response to be detectable as 
early as two-three weeks post infection (Thacker et al, 2007, Hanna et al, 1989, Palmer et al, 
2007) and an early cell mediated immune response (prior to four weeks following challenge) to 
be particular effective in vaccinated animals (Hope et al, 2005).  Thacker et al (2007) found 
cytokine levels to significantly correlate with pathological levels at thirty days post infection 
however this relationship was not detected at later time points.  The authors suggested that 
infected cattle should be studied during the first four to six weeks following infection to provide 
the most useful information.    
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The BCG Pasteur vaccination study confirmed previous reports on its protective efficacy 
against M. bovis infection (Widdison et al, 2006, Wedlock et al, 2007, Hope et al, 2005, 
Vordermeier et al, 2002, Ng et al, 1995).  However, the genetically recombinant BCG (sigK) 
Pasteur vaccine displaying a broader antigen repertoire did not perform to the same standard 
as the wild-type BCG Pasteur.  It was hypothesised that this drop in protection may be linked to 
a lower number of differentiated memory T cells.  Future studies could extend this work by 
analysing memory T cell populations post vaccination with the recombinant BCG (sigK) Pasteur 
to confirm this hypothesis.    
Ultimately it is becoming more apparent that the main method of future vaccinations against 
tuberculosis will be based on heterologous prime-boost protocols involving BCG (Wedlock et 
al, 2005, Vordermeier et al, 2006).  Increasing the antigen repertoire of the vaccination protocol 
to increase immune stimulation may play a crucial role in this.   
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Appendix 1 
 
Oligonucleotide sequences and molecular properties 
 
Genetic sequences of the designed GAPDH, IFN-γ, TNF-α, IL10 and IL4 primer and probe 
oligonucleotides specific to the bovine mRNA sequence (BLAST):  
 
 Blue: Forward and Reverse primers 
 Red:  Dual labelled probe 
   
GAPDH – PCR product 87 base pairs long 
BLAST accession number: AJ000039 (Bos Taurus mRNA)  
CGCATCGGGCGCCTGGTCACCAGGGCTGCTTTTAATTCTGGCAAAGTGGACATCGTCGCCATCAATGACCCCTTCATTGA
CCTTCACTACATGGTCTACATGTTCCAGTATGATTCCACCCACGGCAAGTTCAACGGCACAGTCAAGGCAGAGAACGGGA
AGCTCGTCATCAATGGAAAGGCCATCACCATCTTCCAGGAGCGAGATCCTGCCAACATCAAGTGGGGTGATGCTGGTGCT
GAGTATGTGGTGGAGTCCACTGGGGTCTTCACTACCATGGAGAAGGCTGGGGCTCACTTGAAGGGTGGCGCCAAGAGGG
TCATCATCTCTGCACCTTCTGCCGATGCCCCCATGTTTGTGATGGGCGTGAACCACGAGAAGTATAACAACACCCTCAAGA
TTGTCAGCAATGCCTCCTGCACCACCAACTGCTTGGCCCCCCTGGCCAAGGTCATCCATGACCACTTTGGCATCGTGGAG
GGACTTATGACCACTGTCCACGCCATCACTGCCACCCAGAAGACTGTGGATGGCCCCTCCGGGAAGCTGTGGCGTGACG
GCCGAGGGGCTGCCCAGAATATCATCCCTGCTTCTACTGGCGCTGCCAAGGCCGTGGGCAAGGTCATCCCTGAGCTCAA
CGGGAAGCTCACTGGCATGGCCTTCCGCGTCCCCACTCCCAACGTGTCTGTTGTGGATCTGACCTGCCGCCTGGAGAAA
CCTGCCAAGTATGATGAGATCAAGAAGGTGGTGAAGCAGGCGTCAGAGGGCCCTCTCAAGGGCATTCTAGGCTACACTGA
GGACCAGTT 
 
IFN-γ – PCR product 70 base pairs long 
BLAST accession number: NM_174086 (Bos Taurus mRNA) 
ATTAGAAAAGAAAGATCAGCTACCTCCTTGGGACCTGATCATAACACAGGAGCTACCGATTTCAACTACTCCGGCCTAACT
CTCTCCTAAACAATGAAATATACAAGCTATTTCTTAGCTTTACTGCTCTGTGGGCTTTTGGGTTTTTCTGGTTCTTATGGCCA
GGGCCAATTTTTTAGAGAAATAGAAAACTTAAAGGAGTATTTTAATGCAAGTAGCCCAGATGTAGCTAAGGGTGGGCCTCT
CTTCTCAGAAATTTTGAAGAATTGGAAAGATGAAAGTGACAAAAAAATTATTCAGAGCCAAATTGTCTCCTTCTACTTCAAAC
TCTTTGAAAACCTCAAAGATAACCAGGTCATTCAAAGGAGCATGGATATCATCAAGCAAGACATGTTTCAGAAGTTCTTGAA
TGGCAGCTCTGAGAAACTGGAGGACTTCAAAAAGCTGATTCAAATTCCGGTGGATGATCTGCAGATCCAGCGCAAAGCCA
TAAATGAACTCATCAAAGTGATGAATGACCTGTCACCAAAATCTAACCTCAGAAAGCGGAAGAGAAGTCAGAATCTCTTTCG
AGGCCGGAGAGCATCAACGTAATGGTCCTCCTGCCTGCAATATTTGAATTTTTAAATCTAAATCTATTTATTAATATTTAATA
TTTTACATTATTTATATGGGGGATATATATTTAGACATCAAAGTATTTATAATAGTAACTTTTATGTCATGAAAATGAGTATCT
ATTAATATATGTGTTATTTATAATTCCTGTATCCTGTGACTATTTCACTTGACCCTTTTTTTTCTGAGTAACTAGGCAAGTCTA
TGGGATTTCAAGGTTTTATCTCAGGGGCCAACTAGGCAGCTAACCTAAGCAAGAATCTGTGGGTTGTGCACTTATTTCACT
TGATGATGTAATGAATGCTGATAAATGAAATGATGCCATCTAGTCACTACTTATCTGAGACTAGATCTGGATTCTGAGCCAC
TACTTTGATGGCATGTCAGACAGCACTTGAATGTGTCAGGCTATATGAC 
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TNF-α RNA – PCR product 64 base pairs long 
BLAST accession number: AF348421 (Bos Taurus mRNA) 
ATGAGCACCAAAAGCATGATCCGGGATGTGGAGCTGGCGGAGGAGGTGCTCTCCGAGAAAGCAGGGGGCCCCCAGGGC
TCCAGAAGTTGCTTGTGCCTCAGCCTCTTCTCCTTCCTCCTGGTTGCAGGAGCCACCACGCTCTTCTGCCTGCTGCACTTC
GGGGTAATCGGCCCCCAGAGGGAAGAGCAGTCCCCAGGTGGCCCCTCCATCAACAGCCCTCTGGTTCAAACACTCAGGT
CCTCTTCTCAAGCCTCAAGTAACAAGCCGGTAGCCCACGTTGTAGCCGACATCAACTCTCCGGGGCAGCTCCGGTGGTGG
GACTCGTATGCCAATGCCCTCGTGGCCAACGGTGTGAAGCTGGAAGACAACCAGCTGGTGGTGCCTGCTGACGGGCTTT
ACCTCATCTACTCACAGGTCCTCTTCAGGGGCCAAGGCTGCCCTTCCACCCCCTTGTTCCTCACCCACACCATCAGCCGC
ATTGCAGTCTCCTACCAGACCAGGGTCAACATCCTGTCTGCCATCAAGAGCCCTTGCCACAGGGAGACCCCAGAGTGGGC
TGAGGCCAAGCCCTGGTACGAACCCATCTACCAGGGAGGAGTCTTCCAGCTGGAGAAGGGAGATCGCCTCAGTGCTGAG
ATCAACCTGCCGGACTACCTGGACTATGCCGAGTCTGGGCAGGTCTACTTTGGGATCATCGCCCTGTGA 
 
IL10 – PCR product 69 base pairs long 
BLAST accession number: NM_174088 (Bos Taurus mRNA) 
ATGCATAGCTCAGCACTACTCTGTTGCCTGGTCTTCCTGGCTGGGGTGGCAGCCAGCCGAGATGCGAGCACCCTGTCTGA
CAGCAGCTGTATCCACTTGCCAACCAGCCTGCCCCACATGCTGCGGGAGCTCCGAGCTGCCTTCGGCGAGGCGAAGACT
TTCTTTCAAATGAAGGACCAACTGCACAGCTTACTGTTGACCCAGTCTCTGCTGGATGACTTTAAGGGTTACCTGGGTTGC
CAAGCCTTGTCGGAAATGATCCAGTTTTACCTGGAAGAGGTGATGCCACAGGCTGAGAACCACGGGCCTGACATCAAGGA
GCACGTGAACTCACTGGGGGAGAAGCTGAAGACCCTGCGGCTGCGGCTGCGGCGCTGTCATCGCTTTCTGCCCTGCGAA
AACAAGAGCAAGGCGGTGGAGAAGGTGAAGAGAGTCTTCAGTGAGCTCCAAGAGAGGGGTGTCTACAAAGCCATGAGTG
AGTTTGACATCTTCATCAACTACATAGAAACCTACATGACAACGAAGATGCAAAAGTGAAGCATTCTAGGGAAGAAGACCT
CCAGGATGGTGACTCTACTAGACTCCATGACGTAAACGGAAGACCTCTGAAATCCAATCCAGGGTTCTGGGAGAGCAGAG
CCAGCTCCCTGGAGACCTGTACTGTGCCTCTCCCCTAGAGTATTTATTACCTCTGATACCTCAGCTCCCACATATATTTATT
TACTGAGCTTCTCTGTGAACTATT 
 
IL4 – PCR product 66 base pairs long 
BLAST accession number: NM_173921 (Bos Taurus mRNA) 
TGCATTGTTAGCGTCTCCTGGTAAACTAATTGTCTCACATTGTCAGTGCAAATAGAGATACTATTAATGGGTCTCACCTACC
AGCTGATCCCAGTGCTGGTCTGCTTACTGGTATGTACCAGTCACTTCGTCCATGGACACAAGTGTGATATTACCTTAGCAG
AGATCATCAAAACGCTGAACATCCTCACAACGAGAAAGAATTCATGCATGGAGCTGCCTGTAGCAGACGTCTTTGCTGCCC
CAAAGAACACAACTGAGAAGGAAACCTTCTGCAGGGTTGGAATTGAGCTTAGGCGTATCTACAGGAGCCACACGTGCTTG
AACAAATTCCTGGGCGGACTTGACAGGAATCTCAACAGCTTGGCAAGCAAGACCTGTTCTGTGAATGAAGCCAAGACGAG
CACAAGTACGCTGAAAGACCTCTTGGAAAGGCTAAAGACGATTATGAAGGAGAAATACTCCAAGTGTTGAAGCTGAATATT
TTAATTTATGAGTTTTTTATAGCCTTATTTTAAACATATTTATATATCTATAACTCATCATAAAATAAAATATATGTAGAGTCTG
AAAAAA 
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Table A1: Oligonucleotide (forward primer, reverse primer and dual labelled probes) properties for each gene; 
GAPDH, IFN-γ, TNF-α, IL10 and IL4 including the potential for the nucleotide to self-anneal (complimentary base 
sequences). 
 
Oligonucleotide Base length Melting temperature (Tm) 
Salt adjusted method (oC) 
GC content (%) Potential for self 
annealing 
 
GAPDH 
Forward  
Reverse 
Probe 
 
IFN-γ 
Forward 
Reverse 
Probe 
 
TNF-α 
Forward 
Reverse 
Probe 
 
IL10 
Forward 
Reverse 
Probe 
 
IL4 
Forward 
Reverse 
Probe 
 
 
19 
20 
26 
 
 
23 
20 
25 
 
 
19 
21 
21 
 
 
19 
21 
23 
 
 
20 
20 
19 
 
 
60 
60 
70 
 
 
63 
63 
69 
 
 
62 
61 
67 
 
 
62 
63 
68 
 
 
58 
58 
62 
 
 
58 
55 
54 
 
 
48 
60 
56 
 
 
63 
52 
67 
 
 
63 
57 
61 
 
 
50 
50 
63 
 
 
None 
None 
Potential hairpin 
 
 
None 
None 
2 hairpins 
 
 
None 
None 
None 
 
 
None 
None 
None 
 
 
None 
None 
None 
 
Calculations performed on OligoCalc: an online oligonucleotide properties calculator, 
www.basic.northwestern.edu+oligocalc.html 
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Appendix 2 
 
Quantitative RT-PCR: method development 
 
Aim: To optimise cytokine mRNA detection by qRT-PCR using firstly SYBR green methodology 
to ascertain product specificity followed by dual labelled probe methodology to explore reagent 
concentrations.   
 
Objectives:  
1. Total RNA was extracted from fresh M. bovis infected bovine lymph node tissue as per 
the trizol/chloroform method described in chapter 2.  The total RNA was then applied to 
real time PCR using primer sequences for GAPDH, IFN-γ, TNF-α, IL10, IL4 and a 
SYBR green method.  Following amplification of the target sequence, the PCR product 
was subjected to increasing temperatures and a dissociation curve plotted to reveal 
product specificity.   Different annealing temperatures were applied to the PCR 
reactions to ascertain the correct temperature. 
2. The total RNA was then applied to dual labelled RT-PCR using specifically designed 
fluorescent probes to explore the appropriate concentrations of template, primers and 
probes.  
 
SYBR Green qPCR 
Annealing temperature optimisation: 
Each of the gene primer sets were designed with an annealing temperature close to 60oC 
(using the salt adjusted method, Appendix 1; Table A1).  To confirm this, the primer sets were 
applied to real time PCR using SYBR green technology.  SYBR green is an intercalating dye 
that binds to double stranded targets and fluoresces.  Therefore, as the number of copies of the 
amplified target gene increased during PCR, the fluorescence of SYBR green also increased.  
Following amplification, the PCR product was subjected to a graduated rise in temperature and 
the level of SYBR green fluorescence recorded at each point.  Each target sequence had a 
particular melting temperature (Tm), and so as this temperature was reached, the PCR product 
dissociated and produced a specific drop in SYBR green fluorescence.  The product should 
produce only one peak to represent the efficiency of the primer set and also the optimised PCR 
conditions.  To confirm the annealing temperature of each primer set, the PCR machine was 
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set to apply a graduating annealing temperature across the PCR plate (+/- 10oC of 60oC).  In 
analysis, the PCR reaction that produced a single, clear dissociation curve revealed the 
optimised annealing temperature for that primer set.            
 
Method 
Real time qRT-PCR using SYBR® Green I dye was carried out according to the manufacturers 
guidelines for the ABsolute™ QRT-PCR Mix (ABgene, UK).  A standard reaction mixture (Table 
A3) was produced and aliquoted (25 μl) into a 96 well clear plate (ABgene, UK) followed by the 
total RNA template (extracted from fresh M. bovis infected lymph node tissue).   All reactions 
were set up on ice. 
 
Table A2: Reagents and suppliers for Dual labelled and SYBR Green qRT-PCR  
 
Reagent Supplier 
ABsolute QRT-PCR SYBR Green mix
QuantitectTM Probe RT-PCR kit  
Clear Seal Diamond 
THERMO-FAST ® 96 PCR Plate 
Primer and Probe oligonucleotides 
ABgene (Epsom, Surrey, UK) 
Qiagen (Crawley, Sussex, UK) 
ABgene (Epsom, Surrey, UK) 
Abgene (Epsom, Surrey, UK) 
Biomers.net (Ulm, Germany) 
 
 
Table A3: Standard reaction mixture components used for SYBR® Green qRT-PCR. 
 
Reaction mixture components Final Concentration 
ABsolute™ QRT-PCR SYBR® Green Mix 1x 
RNA template 100 ng 
Forward Primer 300 nmoles 
Reverse Primer 300 nmoles 
ABsolute™ QRTase Blend 2 U/μl 
RNase-free water Up to 25 μl 
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Control reactions were performed with the standard reaction mixture excluding the ABsolute™ 
QRTase Blend for the no RT negative and substituting the RNA sample for RNase-free water in 
the no template negative control.  Each reaction was completed in duplicate or triplicate. The 
reaction was carried out within a Quantica Real Time Nucleic Acid Detection System (Techne, 
UK) to a specific program (Table A4).  
 
Table A4: Amplification program for SYBR® Green qRT-PCR. 
 
First Strand Synthesis  
1 cycle 
 
47oC: 30 minutes 
QRTase inactivation and polymerase activation 
1 cycle 
 
95oC: 15 minutes 
Denaturation, Anneal/ Extension 
35 cycles 
 
95oC: 15 seconds 
60oC: 1 minute 
Denaturation 
1 cycle 
 
95oC: 30 seconds 
Annealing 
1 cycle 
 
+/- 10oC of 60oC: 30 seconds 
Dissociation Curve 
80 cycles 
 
55oC: 10 second hold 
Increase set point temp. by 
0.5oC per cycle 
 
The fluorescent SYBR® Green reading was taken at the annealing/extension stage and 
dissociation curve (80 cycles at 0.5oC increments) stage (Table A4).  The fluorescent readings 
at the annealing/extension stage were used in quantitative analysis of the specific target gene 
by calculating a crossing point value.  The software (Techne, UK) automatically calculated the 
crossing point value using the point at which the fluorescence of a reaction reaches a set 
threshold level relative to the corresponding PCR cycle number.  The fluorescent readings 
taken at the dissociation curve stage were used to produce a dissociation curve (plotting 
fluorescence versus temperature).  It was then possible to determine the specificity of the 
amplified product and calculate its melting temperature (Tm) and annealing temperature.  
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Results 
Following PCR amplification and the dissociation of the PCR product, each primer set 
produced a single, clear peak on the dissociation curve at an annealing temperature of 60oC.  
The dissociation peak of GAPDH PCR product (using 60oC annealing temperature) is displayed 
in Figure A1 and is representational of the dissociation peaks observed for IFN-γ, TNF-α, IL10 
and IL4.  It was therefore decided to continue to use 60oC as the annealing temperature of 
each primer set in subsequent PCR reactions. 
 
 
 
 
 
 
 
 
 
 
Figure A1: Dissociation peak of GAPDH PCR product (Tm approximately 84oC) following SYBR green RT-PCR.  
Total RNA extracted from freshly dissected M. bovis infected lymph node tissue was used as the template (100 
ng) accompanied by GAPDH primers (300 nmoles).  The PCR reaction involved an annealing step at 60oC and 
was performed in triplicate.  The graph shows the change in PCR product over varying temperatures (reflected by 
the negative derivative of the SYBR green fluorescence (dF) relative to the temperature (dT)).  As the gradually 
increasing temperature reaches the specific melting temperature of the PCR product (Tm), the product dissociates 
and causes a sharp reduction in SYBR green fluorescence.  By plotting the data as fluorescence relative to 
temperature (-dF/dT), the point of dissociation produces a peak on the graph.  The presence of one single peak 
reflects the purity of the PCR product and subsequently the specificity of both primers and PCR conditions 
(including annealing temperature). 
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Dual Labelled Probe qRT-PCR 
Template concentration: 
Due to the importance of conserving the total RNA template extracted from the bovine lymph 
node tissues, experiments were performed to optimise the concentration of total RNA applied 
to each reaction.  Total RNA concentrations of between 10 and 300 ng were applied to dual 
labelled probe qRT-PCR using the GAPDH primer set. 
 
Primer and dual labelled probe concentration optimisation: 
The efficiency of the reaction and therefore the accuracy of the cytokine analysis were 
dependent upon the optimisation of the primer and probe concentrations.  The primer 
concentration range as recommended by Qiagen (Crawley, Sussex, UK) was between 400 and 
1,000 nmoles.  A matrix was used to perform reactions using different primer concentrations 
(400, 700 and 1,000 nmoles) in nine different combinations of forward and reverse primer 
(Table A5).  The probe concentration range as recommended by Qiagen (Crawley, Sussex, 
UK) was between 100 and 200 nmoles.  QRT-PCR reactions were performed using the 
optimised primer concentrations and probe concentrations of 100, 150 and 200 nmoles. The 
primer combination and probe concentration with the lowest crossing point value whilst still 
maintaining the fluorescence were the optimised values for future experiments.   
 
Table A5: Combinations of reverse and forward primer concentrations (nmoles) used to optimise dual labelled 
probe qRT-PCR 
 
Forward / Reverse 400 nmoles 700 nmoles 1,000 nmoles 
400 nmoles 400/400 400/700 400/1,000 
700 nmoles 700/400 700/700 700/1,000 
1,000 nmoles 1,000/400 1,000/700 1,000/1,000 
 
Method 
Real time qRT-PCR using dual labelled probes was carried out according to the manufacturers’ 
guidelines for Quantitect™ Probe RT-PCR (Qiagen, Crawley, Sussex, UK).  A standard 
reaction mixture (Table A6) was produced and then aliquoted (25 μl) into a 96 well plate 
followed by the total RNA template extracted from M. bovis infected bovine lymph node tissue.  
All reactions were set up on ice. 
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Table A6: Standard Reaction mixture components for Dual labelled probe qRT-PCR  
 
Reaction mixture components Final Concentration 
2x QuantiTect Probe RT-PCR Master Mix 1x 
RNA template 10-300 ng 
Forward Primer 400-1,000 nmoles 
Reverse Primer 400-1,000 nmoles 
Probe 100-200 nmoles 
QuantiTect RT Mix 0.5 μl/reaction 
RNase-free water Up to 25 μl 
 
Control reactions were performed with the standard reaction mixture excluding the QuantiTect 
RT Mix for the no RT negative and the RNA sample for the no template negative control.  Each 
reaction was completed in duplicate. The reaction was carried out within a Quantica Real Time 
Nucleic Acid Detection System (Techne, UK) to a specific program (Table A7).  
 
Table A7: Amplification program for dual labelled probe qRT-PCR  
 
Reverse Transcription 
1 cycle 
 
50oC: 30 minutes 
Initial Activation step 
1 cycle 
 
95oC: 15 minutes 
Denaturation, annealing/extension 
40 cycles 
 
94oC: 15 seconds 
60oC: 1 minute 
 
The fluorescent dye reading was taken at the annealing/extension stage (Table A7). The 
crossing point value was calculated for each reaction and used to determine the relative 
amount of product formed. 
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Results 
Template concentration: 
 
Table A8: Dual labelled qRT-PCR crossing point (Cp) values of GAPDH mRNA expression (primer and probe 
concentration 400 and 200 nmoles respectively) in varying quantities of total RNA  
(10-300 ng) extracted from M. bovis infected fresh lymph node tissue 
 
Total RNA template 
concentration (ng) 
Replicate 1 
Cp value 
Replicate 2 
Cp value 
Mean 
Cp value 
Standard error 
of the mean 
300 24.67 21.61 23.14 1.53 
200 24.69 22.89 23.79 0.90 
100 22.25 22.64 22.44 0.19 
50 24.68 22.75 23.72 0.96 
10 26.94 25.99 26.46 0.47 
No RT negative Negative Negative 
No template negative Negative Negative 
 
Real time PCR was performed using different concentrations of total RNA extracted from M. 
bovis infected bovine lymph nodes (10-300 ng, Table A8).  The reactions using 100 ng of 
template produced the lowest crossing point values (mean 22.44) in addition to the replicates 
displaying consistent results (showing the smallest standard error of the mean 0.19, Table A8).  
The data displayed for GAPDH (Table A8) was representational of that obtained for the other 
four target genes and it was therefore decided to use 100 ng of total RNA in all future PCR 
experiments.  
 
Primer concentration: 
Real time PCR using different combinations of forward and reverse primer concentrations had 
an affect on the fluorescence and subsequently the resulting crossing point value of each 
reaction (Figure A2).  The GAPDH primer combination with the lowest crossing point value was 
700/700 nmoles (22.2) and this result was also reproduced for the four other gene target primer 
sets.    
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Figure A2: The effect of different GAPDH primer concentrations on the fluorescence and crossing point values for 
individual PCR reactions.  Total RNA extracted from freshly dissected M. bovis infected lymph nodes was used as 
a template (100ng) accompanied by GAPDH primers (nine combinations of forward and reverse concentrations 
between 400 and 1,000 nmoles) and probes (200 nmoles).  The data are displayed as the mean of triplicate 
reactions, each set involving a different combination of forward and reverse prime concentration. 
 
Probe optimisation: 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3: The effect of different GAPDH probe concentrations on the fluorescence and crossing point values for 
individual PCR reactions. Total RNA extracted from freshly dissected M. bovis infected lymph nodes was used as 
a template (100ng) accompanied by GAPDH primers (700n nmoles) and varying probe concentrations (100, 150 
and 200 nmoles).  The data are displayed as the mean of triplicate reactions, each set involving a different probe 
concentration. 
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Figure A3 displays the results from varying the probe concentration during GAPDH real time 
PCR.  The probe concentration 200 nmoles produced the lowest crossing point value (22.65) 
and the highest level of fluorescence (8700).  As the probe concentration decreased to 150 and 
100 nmoles, the crossing point value as decreased (22.83 and 23.12, respectively, Figure A3).  
 
Summary:  
The oligonucleotide primer sets designed for GAPDH, IFN-γ, TNF-α, IL10 and IL4 produced 
single dissociation peaks following real time PCR using SYBR green methodology (represented 
by Figure A1).  This signified the specificity of the primer sets.  The larger and clearer 
dissociation peaks were obtained after applying an annealing temperature of 60oC and so it 
was decided to use 60oC in future PCR experiments. 
As the main QPCR experiments were to be performed using dual labelled probe methodology, 
it was necessary to perform optimisation experiments using the probes.  Due to the importance 
of conserving the bovine total RNA sample, template optimisation was performed (Table A8).  It 
was revealed that 100 ng was sufficient to produce reliable and relatively low crossing point 
values.  Following template optimisation, different combinations of forward and reverse primer 
concentrations were applied to the PCR reactions.  The primer combination 700/700 nmoles 
produced the lowest crossing point values whilst maintaining the level of fluorescence 
(represented by Figure A2).  Lastly, the probe concentration was optimised by applying 100, 
150 or 200 nmoles of the dual labelled probe to each reaction.  The results revealed that 200 
nmoles of probe produced the lowest crossing point values and also the highest fluorescence 
(Figure A3).   
The results reveal the effects of differing template, primer and probe concentrations on the 
sensitivity of the PCR reaction and therefore highlight the importance of being consistent with 
PCR conditions throughout mRNA expression studies.  To aid reproducibility of the results, the 
concentrations of template, primer and probe (100ng, 700 nmoles and 200 nmoles, 
respectively) were maintained throughout the gene expression studies.   
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Abstract
The use of ribonucleic acid (RNA) extracted from Hepes glutamic acid buffer-mediated organic solvent protection
effect (HOPE)-ﬁxed tissues in quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) is fairly novel.
We compared qRT-PCR analysis of formalin- and HOPE-ﬁxed, parafﬁn-embedded lymph node tissues from
Mycobacterium bovis-infected cattle by extracting total RNA using a commercial kit (Ambion) and a Trizol method.
RNA extracted from HOPE-ﬁxed tissues showed comparable quantities between the commercial kit (82.7–107.9mg/ml
total RNA) and the Trizol method (87–161.1 mg/ml total RNA), displaying a high degree of integrity when analyzed by
electrophoresis. RNA extracted from formalin-ﬁxed tissues using the commercial kit produced similar concentrations
(80.6–145.7 mg/ml total RNA) in comparison to the HOPE tissue; however, the integrity was compromised. Extraction
of RNA from the formalin-ﬁxed tissues using Trizol was unsuccessful.
Following qRT-PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), total RNA from HOPE-ﬁxed
tissues showed higher levels of target messenger ribonucleic acid (mRNA) (4.05 102 pg/100 ng total RNA using the
commercial kit and 6.45 102 pg/100 ng total RNA using Trizol) in comparison to formalin-ﬁxed tissues
(5.69 104 pg/100 ng total RNA). This could be attributed to RNA degradation by exposure to formalin ﬁxation.
In conclusion, the HOPE ﬁxative proved to be a better source for RNA extraction from cattle lymph nodes and
subsequent qRT-PCR.
r 2007 Elsevier GmbH. All rights reserved.
Keywords: Quantitative polymerase chain reaction; RNA extraction; HOPE ﬁxative; Formalin ﬁxative; Mycobacterium bovis
Introduction
Molecular techniques such as quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) are
rapidly becoming the preferred methods of disease
prevention and diagnosis [8,14,17]. The study of nucleic
acids, in particular ribonucleic acid (RNA), has
provided vital information on the initial infection and
advancement [18] of disease within challenged hosts.
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The need for extracting RNA of a high quality is
integral in this process [3,4], and considerable effort has
been focused on developing methods that enable tissue
ﬁxation and archival storage without the associated
nucleic acid degradation [2,7]. Archival storage of tissue
samples has proved extremely useful in disease pathol-
ogy and molecular biology due to providing a vast array
of material morphologically conserved and with docu-
mented clinical backgrounds [6,7]. An example of this is
rabies-infected brain tissue samples that were ﬁxed in
formalin in the late 1980s, and, 16 years postﬁxation,
RT-PCR analysis of the disease was successfully
performed [16].
One of the most widely used ﬁxatives is neutral
buffered formalin [2,13], however, much debate has
surrounded its practical use for RNA extraction [4].
Variable results have been produced on the efﬁcacy of
formalin ﬁxation due to its ability to form methylene
bridges between amino acids within the RNA molecule,
thus proving extraction methods less reliable [7,13]. As
an alternative to formalin, the Hepes glutamic acid
buffer-mediated organic solvent protection effect
(HOPE) ﬁxative has been shown to conserve RNA
integrity [10,19] by avoiding amino acid cross linking.
HOPE-ﬁxed, parafﬁn-embedded human tissues have
been used as a source for RNA extraction, producing
transcript lengths of up to 2462 nucleotides and allowing
the ampliﬁcation of RT-PCR products of 183 bp in
length [19]. More recently, RNA has been extracted
from laser microdissected human lung tissue and applied
in real-time RT-PCR [5]. However, as far as the authors
are aware, HOPE ﬁxation of animal tissues such as
bovine material and its use in quantitative real-time
PCR (providing actual data on bovine messenger
ribonucleic acid (mRNA) concentration) is largely
unknown.
In addition to a high-quality starting material, the
extraction method itself is important in successfully
procuring RNA [7]. Studies on RNA extraction from
HOPE-ﬁxed human tissues using the RNeasy kit
(Qiagen, Germany), RNAzol B (Campro Scientiﬁc,
Netherlands) and the GenoPrep mRNA kit on the
GenoM- 48 Workstation (GenoVision, Norway) have
provided RNA transcripts of variable quality [5,19]. The
same methods were applied to formalin-ﬁxed tissues;
however, no quantiﬁable RNA was produced [19]. In
this study, we have compared two RNA extraction
methods, a commercial kit OptimumTM FFPE kit
(Ambion, UK) that is designed for extraction from
formalin-ﬁxed tissues [9] and a Trizol (Invitrogen, UK)
method that has had much success in non-ﬁxed material
[1]. Both of these methods are new in application to
HOPE-ﬁxed cattle lymph node tissues. These methods
were also performed on formalin-ﬁxed cattle lymph
node tissues. The extracted transcript was then analyzed
by agarose gel electrophoresis and qRT-PCR to
determine the quantity of housekeeping gene glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA. The results will provide information on the
reproducibility of the ﬁxative and extraction of RNA
using different commercial sources.
Materials and methods
Sample preparation
Tissue samples of cervical and thoracic lymph nodes
were taken at post mortem from Mycobacterium bovis-
infected cattle at the Veterinary Laboratory Agency
(VLA, Surrey). Cattle lymph node tissue samples were
either ﬁxed in 10% neutral-buffered formalin for 7 days
or were incubated in aqueous protection solution HOPE
for 14–36 h (0–4 1C) followed by incubation in a pre-
mixed ice-cold acetone solution (100ml acetone and
100 ml HOPE II solution at 0–4 1C) for 2 h and then
dehydration with freshly prepared acetone (0–4 1C) for
3 2 h (as per manufacturers instructions, DCS Inno-
vative, Germany). Both ﬁxation methods were followed
by embedding of the sections in parafﬁn wax. The
samples were cut into 10 mm sections and placed into
microcentrifuge tubes (Eppendorf, 3 10 mm2 sections
per tube) for subsequent RNA extraction. All tissue
ﬁxation and parafﬁn-embedding were performed at the
VLA (Surrey). This study details a representative
number of samples performed for total RNA extraction
using both methods (three samples of each ﬁxative for
each method), however, the isolation procedure was
repeated for each ﬁxative more than 10 times to ensure
reproducibility of the results.
RNA extraction
OptimumTM formalin-ﬁxed, parafﬁn-embedded (FFPE)
kit (Ambion) method
Total RNA was extracted from both formalin- and
HOPE-ﬁxed, parafﬁn-embedded sections following the
manufacturer’s instruction manual. Brieﬂy, samples
were deparafﬁnized using xylene at room temperature
and dissolved in Proteinase K (60 units/ml) solution
(Ambion) at 37 1C for 6 h. RNA extraction buffer
(Ambion, UK) was added to the supernatant and
vortexed vigorously for 10 s. The sample was passed
through a micro ﬁlter cartridge by centrifugation,
followed by two washes and transferred to a micro
elution tube into which 2 10 ml volumes of pre-heated
(70 1C) RNA elution solution (Ambion, UK) were
added. This was then left at room temperature for
1min before centrifuging (16,500g) for 1min to elute the
RNA.
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Trizol extraction method
Following deparafﬁnization using xylene at 57 1C,
both formalin- and HOPE-ﬁxed samples were pulver-
ized in liquid nitrogen and submerged in Trizol (800 ml).
The samples were left in a sonicating bath for intervals
of 1min (3 xs) before adding glycogen (1mg/ml) to
aid in pellet visualization. The sample was then
passed through a syringe and needle (24G) before the
addition of chloroform and the tube contents mixed
by vortexing for 30 s. After centrifuging for 10min at
4 1C, the supernatant was transferred into a new
microcentrifuge tube with ice-cold isopropanol (500 ml)
and incubated at 20 1C for 4 h. The microcentrifuge
tube was then centrifuged for 15min at 4 1C and
the supernatant discarded. The resultant pellet was
washed in 70% ethanol and resuspended in RNase-free
water.
Spectrophotometry was performed to analyze the
extracted total RNA for concentration and purity. Each
sample was also run on agarose gel (1%) electrophoresis
(using Tris Acetate EDTA (TAE) buffer) to determine
the integrity of the RNA by visual analysis of the 28S
and 18S rRNA bands.
Quantitative RT-PCR
Quantitative RT-PCR was performed using a dual
labeled probe and primer set (amplicon of 87 bp) for the
housekeeping gene GAPDH and the QuantitectTM
Probe RT-PCR (Qiagen, UK) kit according to the
manufacturers’ guidelines. Brieﬂy, QuantiTect RT-PCR
mastermix (1x), forward primer (0.4 mm), reverse
primer (0.4 mm), probe (0.2 mm), and QuantiTect RT
mix were added to 100 ng of total RNA to a ﬁnal
volume of 25 ml. The RT-PCR reaction was carried out
on a Quantica thermal cycler (Techne, UK) applying
the following conditions: 50 1C for 30min; 95 1C for
15min; 50 cycles at 94 1C for 15 s, 60 1C for 1min
followed by a 4 1C hold. The probe was dual labeled
with a FAM ﬂuorophore at the 50 end and a Black
Hole Quencher (BHQ-1) at the 30 end (Biomers,
Germany). Each reaction was carried out in duplicate
and included two negative controls (one excluding
reverse transcriptase and another excluding the tem-
plate). To produce a standard curve speciﬁc to GAPDH,
an oligonucleotide (107 bp) was designed and manufac-
tured (Biomers) identical to the amplicon produced
during PCR of the GAPDH transcript. Known quan-
tities of the designed oligonucleotide were then run
alongside the unknown samples to produce a standard
curve of crossing point (CP) number (the point at which
the ampliﬁcation curve crosses the threshold line)
against concentration (picograms). The results were
expressed as picograms of GAPDH mRNA in 100 ng of
total RNA (pg/100 ng).
Results
Total RNA extracted from formalin- and HOPE-
ﬁxed, parafﬁn-embedded tissues using the
OptimumTM FFPE kit (Ambion)
Total RNA extracted from both formalin- and HOPE-
ﬁxed tissues using the OptimumTM FFPE kit (Ambion)
produced spectrophotometer results of comparative
quantiﬁcation (the three representative formalin-ﬁxed
tissue samples produced 80.6, 145.7 and 97.9mg/ml total
RNA, and the HOPE-ﬁxed tissue samples produced
107.9, 82.7 and 97.3mg/ml total RNA, Table 1A). The
purity of each of these samples was also within range,
between 1.7 and 1.9 (260/280nm ratio, Table 1A).
Agarose gel electrophoresis of the RNA extracted from
formalin-ﬁxed tissues showed a visible 28S rRNA band
(Fig. 1A), and RNA extracted from HOPE-ﬁxed tissues
using the same method displayed both 28S and 18S
rRNA bands (Fig. 1B). Extracted transcripts for both
formalin- and HOPE-ﬁxed tissues displayed successful
mRNA expression of the housekeeping gene GAPDH
after qRT-PCR (Fig. 2) producing CP values of 34.71
and 28.19, respectively (Table 2). This was converted to
quantitative values using the standard curve (Fig. 3), and
it was found that the total RNA extracted from HOPE-
ﬁxed tissues had a higher level of GAPDH mRNA at
4.05 102 pg/100ng of total RNA in comparison to
total RNA extracted from formalin-ﬁxed tissues at
5.69 104 pg/100ng of total RNA (Table 2).
Total RNA extracted from formalin- and HOPE-
ﬁxed, parafﬁn-embedded tissues using the Trizol
method
Total RNA extracted from formalin-ﬁxed tissues
using the Trizol method proved unsuccessful as it could
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Table 1A. Quantiﬁcation and purity (as determined by 260/
280 nm ratio) of total RNA determined by spectrophotometery
isolated from three formalin-ﬁxed (FORM) and three HOPE-
ﬁxed, parafﬁn-embedded cattle lymph node tissue sections
using the OptimumTM FFPE kit (Ambion)
Fixation method and
sample number
Total RNA
quantiﬁcation
(mg/ml)
260/280 nm ratio
(purity)
HOPE 1 107.9 1.8
HOPE 2 82.7 1.9
HOPE 3 97.3 1.9
FORM 1 80.6 1.7
FORM 2 145.7 1.8
FORM 3 97.9 1.9
The three tissue sections from each ﬁxative are a representative group
of the isolation procedure that was repeated more then 10 times.
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not be quantiﬁed using spectrophotometry (Table 1B)
and the results were conﬁrmed as we did not get any
rRNA bands on the agarose gel (Fig. 1C). It subse-
quently did not produce an ampliﬁable product above
the set threshold in qRT-PCR (Table 2). The concen-
tration of RNA extracted from HOPE-ﬁxed tissues
using spectrophotometry for the three representative
samples was 87, 146.7, and 161.1 mg/ml total RNA
(Table 1B), and the purity was 1.8 and 1.9, respectively
(260/280 nm ratio, Table 1B). The total RNA from
HOPE-ﬁxed tissues also exhibited strong 28S and 18S
rRNA bands when analyzed by gel electrophoresis
(Fig. 1C). The extracted transcript displayed successful
mRNA expression of the housekeeping gene GAPDH
after qRT-PCR (Fig. 2), producing a CP value of 27.39
(Table 2). This was converted to quantitative values
using the standard curve (Fig. 3) and found to contain a
GAPDH mRNA concentration of 6.45 102 pg/100 ng
of total RNA (Table 2).
All controls used in qRT-PCR were negative, and the
standard curve produced an adequate line coefﬁcient of
0.98 and ampliﬁcation efﬁciency of 1.9 (Fig. 3).
Discussion
Studies on disease infection and progression are fast
becoming reliant on modern molecular techniques such
as PCR [17]. The need for intact RNA extraction
methods is an extremely important prelude to PCR [3,4]
and has seen vast improvements over the last decade
[13]. This includes the use of different tissue ﬁxation
methods to secure the integrity of RNA during archival
storage. In this study, we have compared two ﬁxatives
(HOPE and formalin) for their ability to maintain RNA
integrity. We have also compared two different RNA
extraction methods (a commercial kit (Ambion) and a
Trizol method) to determine which method produced
the highest quantity of total RNA from tissues ﬁxed in
both HOPE and formalin. Using the commercial
OptimumTM FFPE kit (Ambion), total RNA extracted
from HOPE-ﬁxed tissues showed comparatively similar
quantities and was of a similar purity to total RNA
extracted from formalin-ﬁxed tissues (statistically, there
was no signiﬁcant difference between the concentration
of total RNA extracted from the two ﬁxation methods,
ARTICLE IN PRESS
18S rRNA 
28S rRNA
  
        1             2             3            4 
6.0Kb 
3.0Kb 
28S rRNA 
1
6.0Kb 
3.0Kb 
28S rRNA
18S rRNA
       1          2          3          4        5         6 
6.0Kb 
3.0Kb 
2 3 4
Fig. 1. Agarose gel electrophoresis (ethidium bromide staining) of total RNA samples (1 mg) isolated using the OptimumTM FFPE
kit (Ambion, UK) from (A) formalin-ﬁxed (lanes 3 and 4, lane 2 not used) and (B) HOPE-ﬁxed (lanes 2-4) parafﬁn-embedded cattle
lymph node tissues. Agarose gel electrophoresis (ethidium bromide staining) of total RNA samples (1 mg) isolated using the Trizol
method (C) from formalin-ﬁxed (lanes 2 and 4) and HOPE-ﬁxed (lanes 3 and 5, lane 6 not used) parafﬁn-embedded cattle lymph
node tissues. Lane 1 was a 0.5-10 kb RNA ladder. Experiments were repeated three times.
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Mann–Whitney test p40.05). However, when using
qRT-PCR to analyze the content of GAPDH mRNA,
the mRNA concentration was higher in HOPE-ﬁxed
tissues (4.05 102 pg/100 ng total RNA) compared to
formalin-ﬁxed tissues (5.69 104 pg/100 ng total
RNA), suggesting that HOPE ﬁxation maintained the
integrity of the RNA to a much higher degree [19]. This
was supported by the agarose gel electrophoresis, as the
total RNA extracted from HOPE-ﬁxed tissues displayed
both rRNA bands (18S and 28S) in comparison to the
one band (28S) shown in total RNA from formalin-ﬁxed
tissues. This work agrees with previously published data
where it has been shown that total RNA extracted from
HOPE-ﬁxed tissues displayed a stronger integrity and
therefore a much higher level of detectable mRNA in
RT-PCR (5,15,19). This ability of HOPE ﬁxation could
be due to the increased rate of acetone tissue dehydra-
tion, enabled by the diffusion of a protective solution of
amino acids into the sample, thus conserving both its
morphological and nucleic acid composition [13].
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Fig. 2. Real-time RT-PCR of total RNA extracted from both the formalin-ﬁxed and HOPE-ﬁxed, parafﬁn-embedded tissues using
the OptimumTM FFPE kit (brown and red lines, respectively) and the Trizol method (blue and green lines, respectively). The target
sequence was an 87 bp fragment of the RNA of bovine glyceraldehyde-3-phosphate dehydrogenase, and each reaction was
performed in duplicate.
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Fig. 3. Real-time RT-PCR of the manufactured standard
template (Biomers.net), designed to be identical in sequence to
the amplicon produced during the PCR of the GAPDH
transcript. Known concentrations of the standard template
(50, 5, 5 103 and 5 107 pg) were run on qRT-PCR
alongside the unknown samples to produce a standard curve of
crossing point (CP) value against log concentration (pg). The
equation of the plotted line (above the graph) was then used to
quantify the GAPDH mRNA concentration within the
unknown samples (Table 2).
Table 1B. Quantiﬁcation and purity (as determined by 260/
280 nm ratio) of total RNA determined by spectrophotometery
isolated from three formalin-ﬁxed (FORM) and three HOPE-
ﬁxed, parafﬁn-embedded cattle lymph node tissues using the
Trizol method
Fixation method and
sample number
Total RNA
quantiﬁcation
(mg/ml)
260/280 nm ratio
(purity)
HOPE 1 146.7 1.8
HOPE 2 87.0 1.8
HOPE 3 161.1 1.9
FORM 1 Negative Negative
FORM 2 Negative Negative
FORM 3 Negative Negative
The three tissue sections from each ﬁxative are a representative group
of the isolation procedure that was repeated more then 10 times.
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Using the Trizol method, the HOPE-ﬁxed tissues
produced total RNA of a very similar quantity and
purity to the total RNA extracted from HOPE-ﬁxed
tissues using the commercial kit (statistically, there was
no signiﬁcant difference between the concentration of
total RNA using the two extraction methods, Mann–
Whitney test p40.05). The resultant GAPDH mRNA
quantity calculated by qRT-PCR was also extremely
similar, 4.05 102 pg/100 ng total RNA extracted
using the commercial kit and 6.45 102 pg/100 ng total
RNA extracted using the Trizol method. As previously
mentioned, the Ambion kit was successful in extracting
total RNA from formalin-ﬁxed tissues, however, we
were unable to isolate quantiﬁable RNA from formalin-
ﬁxed tissues using the Trizol method. In the Ambion
OptimumTM kit, this is most likely attributed to the
proteinase K step in the protocol, which is much more
efﬁcient at separating the RNA from its cross-linked
matrix [7]. However, the period of sample incubation in
proteinase K is extremely long (in our experience, it took
6 h to solubilize only a fraction of the tissue present) and
has been reported to take up to 48 h [11], leading to
further RNA degradation. The cross-linked matrix is
believed to form due to the reaction of RNA with
formaldehyde, producing methylene bridges between the
amino groups [13]. Due to the absence of formaldehyde
in the HOPE ﬁxative method, tissues ﬁxed in HOPE do
not possess cross linkage and therefore perform equally
well in RNA isolation methods with or without
proteinase K solution. Similar results have been
reported by Weidorn et al. [19].
In conclusion, this study supports a strong consensus
that HOPE ﬁxative is a more appropriate ﬁxative to use
for subsequent RNA extraction and molecular techni-
ques. This study is the ﬁrst to demonstrate the potential
of HOPE ﬁxation of M. bovis-infected cattle lymph
nodes with the subsequent quantifying of gene-speciﬁc
mRNA within a known amount of total RNA using
qRT-PCR. This complements the work already shown
on the beneﬁts of HOPE ﬁxative in human tissue types
such as lung [5], cancer cells [15], spleen, and heart [19].
Due to the vastly improved nucleic acid conservation,
HOPE ﬁxative is being applied to tissues samples used in
subsequent disease diagnosis, such as the possible
detection and even differentiation of the Mycobacterium
tuberculosis complex within archived infected mice
tissues [12]. In addition to this, this study has high-
lighted the need to apply, not just the more efﬁcient
ﬁxative technique but also the appropriate extraction
method speciﬁc to the ﬁxative used, adding new
methods to those previously reported [5,19]. By con-
sidering these factors and exploring the most effective
combination of ﬁxative and extraction methods, the
quality of molecular techniques such as PCR and their
practical use in exploring genetic expression of both host
and pathogen can provide a basis for future research
into intervention and treatment.
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Summary
Cytokine mRNA expression of pro-inflammatory cytokines, i.e., interferon-gamma (IFN-g),
tumor necrosis factor-alpha (TNF-a) and anti-inflammatory cytokines, i.e., interleukin-4
(IL-4), interleukin-10 (IL-10) was quantified using quantitative reverse transcriptase polymer-
ase chain reaction (qRT-PCR) in cattle infected with different doses (1e1000 colony-forming
units (cfu)) of Mycobacterium bovis. RNA was extracted from the Hepes glutamic acid buffer
mediated organic solvent protection effect (HOPE) fixed lymph node tissues using Trizol
method.
The expression levels of all the four cytokines gradually increased in cattle infected with
1 cfue1000 cfu. Statistical significance (P< 0.05) was observed for the cytokines IFN-g, IL-4
and IL-10 between the cattle infected with 1 cfu and 1000 cfu. Though there was an increase
in the expression levels of TNF-a from cattle infected with 1 cfue1000 cfu, this difference in
expression was not statistically significant (P> 0.05). The increase in the levels of IFN-g
indicates that the host may be responding to control the infection and the increased level
of IL-4 and IL-10 which are anti-inflammatory cytokines, suggests that these cytokines are
trying to protect the host by reducing the inflammation and also by controlling the levels of
TNF-a (the cytokine that may cause tissue damage).
ª 2008 Elsevier Ltd. All rights reserved.
Abbreviations:mRNA, messenger ribonucleic acid; cfu, colony-forming units; qRT-PCR, quantitative reverse transcriptase polymerase chain
reaction; HOPE, Hepes glutamic acid buffer mediated organic solvent protection effect; IFN-g, interferon-gamma; TNF-a, tumor necrosis
factor-alpha; IL-4, interleukin-4; IL-10, interleukin-10.
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Introduction
Bovine tuberculosis (TB), caused by Mycobacterium bovis
(M. bovis), is a zoonotic infection in awide range of domestic
and wild mammalian hosts. The infected cattle can transmit
infection to other cattle and humans.1 It is one of the major
economic problems for the agricultural trade and industry in
several countries. The prevalence of M. bovis infection in
cattle is increasing rapidly in some countries, including the
UK and Ireland.2 The organism infects a wide range of mam-
malian hosts and eradication of the disease is difficult if
there is an extensive reservoir in a wild life population.
Existing evidence suggests that the European badger is the
main wild life reservoir in the UK and Ireland.3
The innate immune response is extremely effective in
removing the tubercle bacilli, but following the failure of the
innate immune system, the cell-mediated immune system
(CMI) is initiated as the bacteria remains intra-cellular.1 This
leads to the induction of a large number of cytokines, some
of which are essential for the control of infection.4 The mag-
nitude of infection is not only related to the virulence of the
infected bacilli but also to the immunity of the host, infect-
ing dose of bacilli and environmental factors. From previous
studies, it has been concluded that the inhalation of a small
number of mycobacteria can initiate the lesions, which are
equivalent in number to the quantity of organisms delivered5
and when large infective doses of M. bovis are delivered
intranasally, it results in extensive infection and progression
of the disease in challenged animals. As the size of the chal-
lenge dose was reduced, severity of the disease decreased.
In the same way, when the immune response was observed
in cattle infected with different magnitudes of M. bovis, an-
imals challenged with a higher dose lead to CMI response,
and the production of anti-M.bovis antibodies. Low doses
of M. bovis lead to gradual development of CMI and little
or no antibody response.6 During natural infection, a small
number of bacilli (2 or more cells) have been shown to be
enough to initiate tuberculosis in a potential host.7 Recent
studies by Dean et al. reported that 1 cfu is sufficient to in-
duce a disease in cattle,8 and the degree of lesion advance-
ment and granuloma distribution was similar between the
lowest dose group (1 cfu) and the highest dose of the four
groups (1000 cfu).9 Therefore, in the present study we
have extended the previous work to determine the mRNA
cytokine expression in the HOPE fixed lymph node tissues
of cattle infected with 1, 10, 100 and 1000 cfu using qRT-
PCR. Cytokine expression was assessed at 26 weeks
post-infection.
HOPE fixative has been shown to conserve RNA integrity
by avoiding amino acid cross-linking.10,11 RNA extracted
from HOPE fixed human tissues has been successfully used
in RT-PCR for PCR products ranging from 220 to 663 base
pairs.12 Hence this study also demonstrates the potential
of HOPE fixation of M. bovis infected cattle lymph node
tissues with the subsequent quantification of gene specific
mRNA using qRT-PCR.
Materials and methods
Experimental infection of cattle with M. bovis, post-mor-
tem of the infected cattle and HOPE fixation of infected
samples were carried out at Veterinary Laboratories Agency
(VLA), Weybridge, Surrey, UK.
Experimental animals
Twenty Friesian Holstein heifers, that were six months old,
with no history of tuberculosis, were intratracheally
infected with 1, 10, 100, and 1000 cfu doses of M. bovis
(Field strain GB e AF 2122/97), as reported by Dean et al.
Briefly, an endotracheal tube (80 cm) holding a fine cannula
was used to inject 1.5 ml of prepared inoculum into an anes-
thetized animal. The animals were euthanized at 26 weeks
post-infection by intravenous injection of sodium pentobar-
bitone and lymph nodes were collected aseptically. From
each dosage group, four cattle were included in this study.
Three lymph nodes (caudal mediastinal, left-bronchial and
cranial mediastinal)8 from each calf and in total 12 lymph
node samples were obtained for each group.
Preparation of tissue samples
The infected lymph node tissues were incubated in the
aqueous HOPE solution for 14e36 h (0e4 C) and then incu-
bated in acetone (0e4 C) for 2 h, followed by dehydration
with freshly prepared acetone (0e4 C) for 3 2 h (as per
manufacturer’s instructions, DCS Innovative, Germany). This
was followed by embedding of the sections in paraffin wax.11
Subsequent RNA extraction and study of cytokine gene
expression were carried out for these HOPE fixed samples
at the University of Hertfordshire, Hatfield, UK.
Isolation of total RNA
The HOPE fixed tissue blocks were kept at 20 C for 10 min
before sectioning. These tissue blocks were cut into 10 mm
sections using a microtome.
The sections were deparafinized using xylene (1 ml) at
57 C for 10 min in an eppendorf. The samples were centri-
fuged and the pellet formed was washed with ethanol. The
pellet was pulverized in liquid nitrogen and Trizol (800 ml)
reagent was added. This was followed by sonication for
2e3 min. Glycogen (1 mg/ml) was added; the samples
were then passed through a syringe and needle (24 G)
before the addition of chloroform (160 ml) and the tube
contents mixed by vortexing for 30 s. After centrifuging
for 10 min at 4 C, the supernatant was transferred into
a new micro centrifuge tube with ice cold isopropanol
(500 ml) and incubated at 20 C for 4 h. This was followed
by centrifugation and the resultant pellet was washed in
70% ethanol and resuspended in 50 ml of RNase free water
and stored at 70 C. Concentration and purity of the
extracted RNA were analyzed using a spectrophotometer
and the quality was checked using Agarose gel electro-
phoresis. DNase treatment was performed for the total
RNA before qRT-PCR using Turbo DNA free kit (Ambion,
Warrington, UK) to reduce the genomic DNA contamination.
Quantitative RT-PCR
One step qRT-PCR was carried out within a Quantica
thermal cycler (Techne, Staffordshire, UK) using
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Quantitect probe RT-PCR master mix (Qiagen, West
Sussex, UK) that allows both reverse transcription and
PCR to take place in a single tube.
Primers and probes oligonucleotide sequence
Oligonucleotide primer and dual labelled probe sequenced
for qRT-PCR (sequences were designed at VLA, Weybridge,
Surrey, UK). Primers and probes sequences are as follows.
IFN-g:
Forward primere 50-C AGAAAGCGGAAGAGAAGTCAGA-30
Reverse primer e 50-CAGGCAGGAGGACCATTACG-30
Probe e FAM: 50-TCTCTTTCGAGGCCGGAGAGCATCA-30:
BHQ-1
TNF-a:
Forward primer e 50-CGGTGGTGGGACTCGTATG-30
Reverse primer e 50-GCTGGTTGTCTTCCAGCTTCA-30
Probe e FAM: 50-CAATGCCCTCGTGGCCAACGG-30: BHQ-1
IL-10:
Forward primer e 50-GGTGATGCCACAGGCTGAG-30
Reverse primer e 50-AGCTTCTCCCCCAGTGAGTTC-30
Probe e FAM: 50-CACGGGCCTGACATCAAGGAGCA-30:
BHQ-1
IL-4:
Forward primer e 50-GCCACACGTGCTTGAACAAA-30
Reverse primer e 50-TCTTGCTTGCCAAGCTGTTG-30
Probe e FAM: 50-TCCTGGGCGGACTTGACAGG-30: BHQ-1
Probes for Taqman analysis were labeled at the 50 end
with the reporter dye FAM (6-carboxyfluorescein) and at the
30 end with the quencher dye BHQ-1 (Black Hole Quencher).
qRT-PCR for quantification of cytokine mRNA
qRT-PCR was carried out according to the manufacturer’s
guidelines for Quantitect probe RT-PCR kit (Qiagen, UK),
with 200 ng of RNA template, Quantitect probe RT-PCR
master mix with the final concentration of 1, Quantitect
RT mix of 0.5 ml/reaction, forward and reverse primers with
final concentration of 700 nmoles and probe with
200 nmoles. Each reaction was performed in duplicate
with one positive and two negative controls (one excluding
the template and the other excluding the reverse transcrip-
tase enzyme).
The reactions were carried out within a Quantica
thermal cycler, applying the programme: reverse tran-
scription (1 cycle) at 50 C for 30 min, initial activation
step (1 cycle) at 95 C for 15 min followed by
denaturation, annealing/extension step (50 cycles) at
94 C for 15 s and 60 C for 1 min.
Statistical analysis
All the statistical analyses were carried out using Microsoft
Excel 2002 (Microsoft Co., Redmond, WA, USA) and non-
parametric statistical tests. The KruskaleWallis test and
ManneWhitney U test were used to analyze the signifi-
cance of IFN-g, TNF-a, IL-10 and IL-4 expression levels
between the cattle infected with 1, 10, 100 and 1000
cfu doses. Effects with a P value of <0.05 were
considered significant.
Results
Pro- and anti-inflammatory cytokine gene expression was
compared in cattle infected with 1, 10, 100 and 1000 cfu of
M .bovis. The expression for IFN-g, TNF-a, IL-10 and IL-4
expression was observed in all the tissue samples. The
cytokine gene expression was observed to increase with
the increase in dosage of M. bovis.
The average copy number of different cytokines in the
lymph node tissues of cattle infected with different doses is
shown in Table 1. There was a gradual increase in the
expression of IFN-g from 1 cfu to 1000 cfu (4.23-fold in-
crease) (Figure. 1a). A statistical significance (P< 0.05)
was observed between the cattle infected with 1 cfu and
1000 cfu and also between the cattle infected with 10 cfu
and 1000 cfu (3.88-fold change). A slight increase in the level
of IFN-g expression was observed in animals infected with
10 cfu and 100 cfu as compared to animals infected with
1 cfu (1.99 and 1.09-fold increase, respectively), however,
this difference was not statistically significant (P> 0.05).
TNF-a mRNA levels were determined as shown in the
Table 1. Though there was an increase in the expression
from cattle infected with 1 cfue1000 cfu (2.83-fold
changes), but this difference was not statistically signifi-
cant (P> 0.05). There was a slight increase in the level of
TNF-a expression in the animals infected with 10 cfu and
100 cfu as compared to animals infected with 1 cfu (2.23
and 1.03-fold increase, respectively) (Figure. 1b). This dif-
ference was also not statistically significant (P> 0.05).
Similarly when IL-4 expression was quantified (Table 1),
there was an increase in the level of expression from 1 cfu
to 1000 cfu (3.15-fold change) (Figure. 1c). ManneWhitney
U test showed the statistical significance (P< 0.05)
between the cattle infected with 1 cfu and 1000 cfu and
between the cattle infected with 10 cfu and 1000 cfu
Table 1 The average copy number of cytokines (IFN-g, TNF-a, IL-4 and IL-10) expression in the cattle infected with 1, 10, 100
and 1000 cfu of M. bovis.
Cytokines Experimental dose
1 cfu (molecules/ml) 10 cfu (molecules/ml) 100 cfu (molecules/ml) 1000 cfu (molecules/ml)
IFN-g 213,500 234,665 425,825 904,750
TNF-a 252,450 260,675 565,000 715,125
IL-4 200,875 221,125 449,250 633,000
IL-10 93,850 288,975 450,000 510,750
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(2.86-fold change). The increase in the level of expression
in cattle infected with 10 cfu and 100 cfu (1.10 and 2.23-
fold change, respectively) was not statistically significant
(P> 0.05).
The IL-10 expression levels gradually increased in the
cattle infected with 1 cfue1000 cfu (5.44-fold change) as
shown in Figure. 1d. ManneWhitney U test showed the sta-
tistical significance between the cattle infected with 1 cfu
and 100 cfu (3.07-fold change) and between the cattle in-
fected with 1 cfu and 1000 cfu of M. bovis (P< 0.05).
Discussion
In this study we analyzed the cytokine gene expression in
the lymph nodes from cattle infected with 1, 10, 100 and
1000 cfu of M. bovis. The key objective of this study was
to compare the expression levels of pro-inflammatory
and anti-inflammatory cytokines in the bovine lymph
nodes of cattle infected intratracheally with logarithmic
increasing doses of M. bovis using qRT-PCR. This would
help to understand the immune response in cattle natu-
rally infected with M. bovis (4e6 bacilli) versus those in-
fected experimentally (more than 1000 cfu). Previous
study carried out by our group on the cattle infected
with M. bovis showed that 1 cfu of M. bovis induced pa-
thology equivalent to that was seen in animals infected
with 1000 cfu of M. bovis.8 In this study we have carried
out further work on the same set of cattle (used only
four cattle out of five for 1 cfu and 10 cfu dose) and
analyzed the expression of four cytokine genes (IFN-g,
TNF-a, IL-10 and IL-4) that are known to be essential
for the host defence against tuberculosis and play a ma-
jor role in regulating the formation of granulomatous
lesions.13 The expression of the four cytokines was also
measured in the fresh lymph nodes obtained from non-
infected cattle using real time PCR (unpublished data).
These non-infected cattle showed expression of all the
cytokines and the expression of IFN-g, TNF-a and IL-4
was significantly lower (P< 0.05, ManneWhitney U Test)
than in the cattle infected with 1, 10, 100 and 1000 cfu
of M.bovis. The expression of IL-10 was also lower in
the non-infected cattle but the difference was not signif-
icant (P> 0.05, ManneWhitney U Test) when compared
with cattle infected with 1 cfu or 10 cfus. However, the
expression was significantly lower (P< 0.05) when com-
pared with cattle infected with 100 cfu and 1000 cfu of
M. bovis.
Our results show that IFN-g expression levels gradually
increased as the dose of infection was increased from 1 cfu
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Figure. 1 The level of expression of cytokines e (a) IFN-g, (b) TNF-a, (c) IL-4 and (d) IL-10 in the cattle experimentally infected
with 1, 10, 100, 1000 cfu of M. bovis. The level of cytokine expression was determined by qRT-PCR. The copy number of cytokines in
each group represents the average of the three lymph node (cranial mediastinal, left bronchial and caudal mediastinal) taken from
each dose.
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to 1000 cfu. The increase in the IFN-g level was statistically
significant when the results of 1 cfu infected lymph nodes
were compared with 1000 cfu and 10 cfu with 1000 cfu.
This cytokine is known to play a major role in protection
and pathology during infection.14 Previous studies on immu-
nohistochemistry assay for cytokine IFN-g, showed that the
expression was more apparent in the lymph nodes from
animals infected with higher doses of M. bovis.9 The
increased levels of IFN-g mRNA with the potential of a de-
veloping humoral response is a characteristic of a Th-0 type
response and associated with increased pathogenesis.15
Previous work carried out by Dean et al. on minimum infec-
tive dose of M. bovis did not find a correlation between
dose of M. bovis and pathology score or the time to detect
the IFN-g positivity. This may be because the systemic
responses measured by Dean et al. are not totally reflective
of responses at the site of disease and may also include
antigens that are not part of tuberculin.
The level of TNF-a mRNA was not significantly differ-
ent in different dosage groups though there was increase
in the cytokine expression from 1 cfu to 1000 cfu. The
possible reason is that this cytokine is primarily involved
in the initial stages of innate immunity.16 Generally TNF
is a multi-potent cytokine which plays a part in apopto-
sis, cell activation and differentiation.18 The role of
TNF during TB is both antibacterial and production of in-
flammatory response. A study performed by Widdison
et al.17 on non-infected and M. bovis experimentally
infected (1.3 104 cfu) cattle, showed significant de-
crease in the expression level of TNF-a in the infected
animals at 16 weeks post-infection. The two possible
reasons for the discrepancies in the expression of TNF-
a level between the two studies could be due to the
time point at which samples were taken (26 within this
study and 16 weeks post-infection in Widdison et al.)
and also the dose of M. bovis used for infection, which
was lower in our study. One of the other possible reasons
for this might be that the levels are controlled by other
anti-inflammatory cytokines (IL-4 and IL-10).
The expression of anti-inflammatory cytokines IL-4 and
IL-10 was also measured in this study as these cytokines
potentially have a major role in the pathogenesis of
mycobacterial infection.19 The IL-4 gene expression was
observed in animals infected with 1 cfu and 10 cfu and
there was an increase in the expression levels in the
lymph node of animals infected with 100 cfu and
1000 cfu. This increase was statistically significant,
when the results of animals infected with 1 cfu were com-
pared with 1000 cfu and 10 cfu with 1000 cfu. IL-4 mRNA
levels in Mycobacterium tuberculosis infected humans
have been reported to increase significantly with
established pulmonary TB.20 In bovine TB the expression
of IL-4 m-RNA was reported to be relatively low until
6e8 weeks of post-inoculation thereafter it peaked and
remained at high levels for 2 weeks, followed by a sharp
decrease.21
IL-10 cytokine expression levels gradually increased
when the animals were infected with 1 cfue1000 cfu and
there was a statistically significant difference between
the animals infected with 1 cfue100 cfu and between
the animals infected with 1 cfue1000 cfu. Previous stud-
ies of bovine infection (106 cfu) in cattle have shown
that IL-10 mRNA levels were low at 5 weeks of infection
with an increase at 26 weeks post-infection.15 The low
expression of Th-2 cytokines (IL-4 and IL-10) during early
stages of infection shown by previous studies15,21 may be
because during the early stages of infection Th-1 re-
sponse to TB infection is activated and IFN-g is the pre-
dominant cytokine. In the later stages of infection the
response shifts to a combined IFN-g and IL-4 mediated
response and subsequently an IL-4 dominant Th-2
response as the infection progresses.22,23 The increased
expression of these anti-inflammatory cytokines in the
later stages may be to control the expression of pro-
inflammatory cytokines and regulate the Th-1 and Th-2
balance during TB.
In conclusion, the trends in cytokine mRNA expression
seen in this study were encouragingly similar to those
previously reported,9,15,20 and centered primarily on
a Th-1 type response that evolved into a Th-2 type later
in the disease process.
By scrutinizing the expression of these cytokines and
pathology of the cattle infected with a logarithmically
increasing dose of M. bovis, whilst the pathology remains
the same in cattle infected with both low and high doses
of M. bovis9 the expression of cytokines varies. Irrespec-
tive of the pathology the expression of pro-inflammatory
and anti-inflammatory cytokines increased as the dose of
infection increased. All the cytokines were detected after
26 weeks post-infection, even in the cattle infected with
the lower doses. As the amount of cytokines produced
were elevated, in the cattle infected with high doses of
M. bovis it may be possible that less amount of cytokine
expression is required to prevent the disease at low
dose of infection and high amount of cytokine is required
when the cattle are infected with higher doses of M. bovis
as shown in our study.
Thus, as the general response to cytokine expression was
dependent on the dose of infection it is possible that the
infection with 1 cfu of M. bovis activates the immune
response to a lesser degree, compared to the cattle
infected with higher doses. This is because less antigenic
stimulation is seen when cattle are inoculated with lower
doses of M. bovis.
This study also supports a strong consensus that
HOPE fixative can be an appropriate fixative to use
for subsequent RNA extraction and molecular tech-
niques. This study demonstrates the potential of HOPE
fixation of M. bovis infected cattle lymph node with the
subsequent quantifying of gene specific mRNA using
qRT-PCR. This complements the work already shown
on the benefits of HOPE fixative in human tissue types
such as lungs,24 cancer cells,25 spleen and heart.12
Due to the vastly improved nucleic acid conservation,
HOPE fixative being applied to tissue samples used in
subsequent disease diagnosis and even differentiation
of the MTB complex within archived infected mice
tissues.26
Consideration of these factors and exploration of
the most effective combination of fixative and PCR
methods and their use in exploring the cytokine
expression can provide an aid for the outgoing research
to develop an effective vaccine against the organism
responsible for TB.
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